‫תשע"א‬/'‫ד‬
12/2010
‫רשומות‬
ISRAEL STATE RECORDS
‫כג' בטבת התשע"א‬
December 30 ,0202
‫יומן הפטנטים והמדגמים‬
PATENTS AND DESIGNS JOURNAL
Page/‫עמוד‬
Patents
Applications filed
Applications accepted
Patents renewed
Patents renewed for 20 years
Corrections
Country codes
Indices of applications accepted
Designs
Designs registered
Designs void
1
4
060
330
330
333
360
333
335
343
‫פטנטים‬
‫בקשות שהוגשו‬
‫בקשות שקובלו‬
‫פטנטים שחודשו‬
‫פטנטים שחודשו לעשרים שנה‬
‫תיקונים‬
‫קודים למדינות‬
‫מפתחות לבקשות שהתקבלו‬
‫מדגמים‬
‫מדגמים שנרשמו‬
‫מדגמים שבוטלו‬
December 30, 2010-‫כג' בטבת התשע"א‬
‫ידיעות כלליות‬
:‫ וכו' בענייני פטנטים ומדגמים יש לשלוח אל‬,‫ מסמכים‬,‫מכתבים‬
.‫ ירושלים‬,‫ מלחה‬5 ‫ בנין‬,‫ גנים טכנולוגיים ירושלים‬,‫רשם הפטנטים והמדגמים‬
'‫אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הרשות בבנק הדואר מס‬
‫ יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה‬.0-54145-5
.‫שולמה‬
GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to:
The Patent Authority, Jerusalem Technology Park, Building5, Malcha., Jerusalem.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the
Authority, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office
together with the application for the action for which the fee has been paid.
Copyright by the State of Israel. No
Extracts may be published except with the
permission of the Patent Office.
2
‫זכות היוצרים בתקצירים אלה שמורה למדינת‬
‫ אין להעתיק מתקצירים אלה אלא‬,‫ישראל‬
.‫ברשות לשכת הפטנטים‬
December 30, 2010-‫כג' בטבת התשע"א‬
PATENTS
NOTICE UNDER SECTION 16 OF THE
PATENTS LAW, 5727-1967
In the following there are listed new
applications complying with the provisions
of rule 32(a) of the Patent Regulations, 57281968:
Particulars of the applications are given in
the following order:
Number and date of application and the first
four symbols of the International
Classification.
Title of invention (as proposed by applicant)
Applicant
Priority right:
Convention countryNumber and date of
Foreign application
International Application Number
International Publication Number
3
‫פטנטים‬
-‫ תשכ"ז‬,‫ לחוק הפטנטים‬11 ‫הודעה לפי סעיף‬
1611
‫להלן רשימת בקשות חדשות הממלאות אחר‬
‫(א) לתקנות‬25 ‫הדרישות שנקבעו בתקנה‬
:1611-‫ תשכ"ח‬,‫הפטנטים‬
:‫פרטי הבקשות מובאים לפי סדר זה‬
‫מספר הבקשה – ותאריך הגשתה וארבעה‬
‫הסמנים הראשונים של הסיווג הבינלאומי‬
)‫שם האמצאה (כפי שהוצע ע"י המבקש‬
‫המבקש‬
– ‫מדינת האיגוד‬
:‫דין קדימה‬
‫תאריך ומספר‬
‫בקשת החוץ‬
‫מספר בקשה בינלאומית‬
‫מספר פרסום בינלאומי‬
December 30, 2010-‫כג' בטבת התשע"א‬
40////1440
501654
F41H )5010.01(
‫מגן נגד רסיסים‬
‫דוד פאינגולד‬
FRAGMENT DEFENSE DEVICE
DAVID FAINGOLD
///40/14/4
504612
METHOD AND SYSTEM FOR
PERFORMING COMPLEX SAMPLING
OF SIGNALS BY USING TWO OR
MORE SAMPLING CHANNELS AND
FOR CALCULATING TIME DELAYS
BETWEEN THESE CHANNELS
ELTA SYSTEMS LTD.
11/40/14/4
SYSTEM AND METHOD FOR
DETERMINING COMMONLY USED
COMMUNICATION TERMINALS
VERINT SYSTEMS LTD.
11/40/14/4
SYSTEM AND METHOD FOR
IDENTIFYING NOISY ENTITIES IN
LARGE SCALE LINK ANALYSIS
4
H04K )5010.01(
‫שיטה ומערכת לביצוע דגימה מרוכבת של‬
‫אותות על ידי שימוש באחד או יותר ערוצי‬
‫דגימה ולחישוב של השהיות בזמן בין‬
‫הערוצים האלה‬
‫אלתא מערכות בע"מ‬
505265
H04L )5010.01(
‫מערכת ושיטה לקביעת מסופי תקשורת‬
‫בשימוש משותף‬
‫ורינט מערכות בע"מ‬
505261
G06F )5010.01(
‫מערכת ושיטה לזיהוי ישויות רועשות‬
‫בניתוח קשרים בהיקף רחב‬
December 30, 2010-‫כג' בטבת התשע"א‬
‫ורינט מערכות בע"מ‬
VERINT SYSTEMS LTD.
10/40/14/4
505450
SYSTEMS AND METHODS FOR
IDENTIFICATION OF MOBILE
PHONES IN A RESTRICTED
ENVIRONMENT
VERINT SYSTEMS LTD.
/1/4//14/4
‫מערכות ושיטות לזיהוי טלפונים ניידים‬
‫בסביבה מבוקרת‬
‫ורינט מערכות בע"מ‬
505152
DPP - DOUBLE PRESSURE
PROTECTION ESCAPE HOOD
ILAN YOGEV
/1/4//14/4
5
A62B )5010.01(
‫ברדס מילוט עם הגנה של לחץ חיובי כפול‬
‫אילן יוגב‬
505155
TECHONLOGY FOR FLUSHING AND
RELEARNING MAC ADDRESSES IN
TELECOMMUNICATION NETWORKS
ECI TELECOM LTD.
10/4//14/4
H04W )5010.01(
501565
H04L )5010.01(
‫טכנולוגיה למחיקה וללימוד מחדש של‬
‫ ברשתות תקשורת‬MAC ‫כתובות‬
‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
H04L )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
MECHANICAL BIOMETRIC LOCKING
DEVICE
OFER PORAT
10/4//14/4
‫מנגנון מנעול ביומטרי מכני‬
‫עופר פורת‬
501120
‫שיטה ומגנון רתיעה‬
‫סולתם מערכות בע"מ‬
METHOD AND RECOIL MECHANISM
SOLTAM SYSTEMS LTD
11/4//14/4
501115
CIRCUMFERENTIAL BODY ARMOUR
SYSTEM
CPE PRODUCTION OY
4//4//14/4
4//4//14/4
6
F41H )5010.01(
‫מערכת שריון גוף היקפית‬
.‫ ווי‬.‫ פרודקשין או‬.‫אי‬.‫פי‬.‫סי‬
501110
METHOD AND REAGENTS FOR THE
EARLY DETECTION OF MELANOMA
VERIDEX, LLC
US
61/223894
08/07/2009
F41H )5010.01(
G01N )5010.01(
‫שיטות ומגיבים לזיהוי מוקדם של מלנומה‬
501151
G09B )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
NETHOD, SYSTEM AND MEDIUMS
FOR PROVISION OF
COMMUNICATION AND
ENTERTAINMENT SRERVICES
ONBOARD THE MOVINF
PLATFORMS
ZELIKMAN SEMION
41/4//14/4
‫ מערכת ותווך לאספקת שרותי‬,‫שיטה‬
‫תקשורת ובידוד במערכת נעות‬
‫זליקמן סמיון‬
501114
NEW PIPERIDINE COMPOUNDS, A
PROCESS FOR THEIR PREPARATION
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THEM
UNIVERSITE DE NANTES OF
FR
09/03573
21/07/2009
41/4//14/4
‫ תהליך להכנתן‬,‫תרכובות פיפרידין חדשות‬
‫ותכשירי רוקחות המכילים אותן‬
501115
NEW CHROMENE COMPOUNDS, A
PROCESS FOR THEIR PREPARATION
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THEM
LES LABORATOIRES SERVIER
FR
09/03572
21/07/2009
1//4//1440
501021
STEM CELL AGGREGATES AND
METHODS FOR MAKING AND USING
7
A61K )5010.01(
C04B )5010.01(
‫ תהליך להכנתן‬,‫תרכובות כרומן חדשות‬
‫ותכשירי רוקחות המכילים אותן‬
C12N )5010.01(
‫צברים של תאי גזע ושיטות להכנה‬
‫ולשימוש‬
December 30, 2010-‫כג' בטבת התשע"א‬
REGENTS OF THE UNIVERSITY OF
MINNESOTA,
US
61/022121
18/01/2008
PCT/US/2009/031528
WO/2009/092092
41/41/1440
501125
COMPOSITION AND METHOD FOR
SEED TREATMENT USE
BASF SE
EP
08101247.8 04/02/2008
PCT/EP/2009/051167
WO/2009/098188
1//4//14/4
1//4//14/4
C09B )5010.01(
‫ תהליך להכנתן‬,‫תרכובות דיהידרואינדולון‬
‫ותכשירי רוקחות המכילים אותן‬
501526
METHOD OF DESIGNING A DRIVER'S
COMPARTMENT
PLASAN SASA LTD.
8
‫תכשיר ושיטה לשימוש בטיפול בזרעים‬
501112
NEW DIHYDROINDOLONE
COMPOUNDS, A PROCESS FOR
THEIR PREPARATION AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM
LES LABORATOIRES SERVIER
FR
09/03839
04/08/2009
A01H )5010.01(
B60F )5010.01(
‫שיטת עיצוב תא נהג‬
‫פלסן סאסא בע"מ‬
December 30, 2010-‫כג' בטבת התשע"א‬
1//4//14/4
501545
‫חלון סובב על ציר‬
‫פלסן סאסא בע"מ‬
PIVOTING WINDOW
PLASAN SASA LTD.
10/4//14/4
501515
501541
PROCESS FOR FABRICATING A
THREE DIMENSIONAL MOLDED
FEED STRUCTURE
RAYTHEON COMPANY
US
12/620562
17/11/2009
/1/41/14/4
501100
FOREING OBJECT DEBRIS BARRIER
FOR RUNWAYS
IVRY SHAPIRA
4//41/1440
9
F41H )5010.01(
‫שריון בליסטי‬
‫פלסן סאסא בע"מ‬
BALLISTIC ARMOR
PLASAN SASA LTD.
///41/14/4
E06B )5010.01(
501165
C12N )5010.01(
–‫תהליך לייצור מבנה הזנה מעוצב תלת‬
‫מימדי‬
B64F )5010.01(
‫מחסום לעצמים זרים למסלולי המראה‬
‫עברי שפירא‬
E04B )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
METHOD FOR MAKING BUILDINGS
FROM PREFABRICATED MODULES
FRANCOISE DAURON
FR
0801460
18/03/2008
PCT/FR/2009/000239
WO/2009/118480
/0/40/1440
‫שיטה להכנת מבנים ממודולים טרומיים‬
501162
METHOD AND APPARATUS FOR
DUCTAL TUBE TRACKING IMAGING
FOR BREAST CANCER DETECTION
AND DIAGNOSIS, AND PRODUCT
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
US
61/044697
14/04/2008
PCT/US/2009/040423
WO/2009/129200
4//40/1440
/0/41/1440
‫ידע חברה למחקר ופיתוח בע"מ‬
A01N )5010.01(
‫צירופים של גורמי בקרה ביולוגים וקוטלי‬
‫חרקים או פטריות‬
501165
ULTRA LOW-POWER TRANSMISSION
SYSTEM
TEXTRON SYSTEMS CORPORATION
US
12/077601
19/03/2008
PCT/US/2009/037681
WO/2009/117587
10
‫שיטה ומערכת להדמיית מעקב לגילוי‬
‫ואבחון סרטן השד ומוצר‬
501164
COMBINATIONS OF BIOLOGICAL
CONTROL AGENTS AND
INSECTICIDES OR FUNGICIDES
BAYER CROPSCIENCE AG
US
61/123254
07/04/2008
41//1//081
/1/41/1441
EP
PCT/EP/2009/002538
WO/2009/124707
G01R )5010.01(
H03K )5010.01(
‫מערכת שידור אולטרה בהספק נמוך‬
December 30, 2010-‫כג' בטבת התשע"א‬
/1//1/1441
501161
‫מערכת שידור השראתי‬
‫פאוורמאט בע"מ‬
INDUCTIVE TRANSMISSION SYSTEM
POWERMAT LTD
US
61/064618
17/03/2008
///4/////
///40/1441
US
////10/1/
41/4//1441
US
////101/0
1//4//1441
US
////100/4
40/41/1441
US
PCT/IL/2008/001641
WO/2009/116025
///41/1440
501161
METHOD FOR PRODUCING
FLUORINE-CONTAINING
ACYLACETIC ACID DERIVATIVE,
METHOD FOR PRODUCING
FLUORINE-CONTAINING
PYRAZOLECARBOXYLIC ACID
ESTER DERIVATIVE, AND METHOD
FOR PRODUCING FLUORINECONTAINING
PYRAZOLECARBOXYLIC ACID
DERIVATIVE
MITSUI CHEMICALS AGRO, INC.
2008JP
18/03/2008
069937
PCT/JP/2009/054602
WO/2009/116435
11////144/
11
C07C )5010.01(
‫שיטה להכנת נגזרת של חומצה‬
‫ שיטה נגזרת של‬,‫אצילאטית הכוללת פלור‬
‫אסטר של חומצה פיראזולקרבוקסילית‬
‫ ושיטה להכנת נגזרת של‬,‫הכוללת פלור‬
‫חומצה פיראזולקרבוקסילית הכוללת פלור‬
501166
METHODS AND COMPOSITIONS FOR
DETERRING ABUSE OF ORLLY
ADMINISTERED PHARMACEUTICAL
PRODUCTS
ACURA PHARMACEUTICALS, INC.
US
60/630991
24/11/2004
/4//1011/
11//1/1440
US
H01F )5010.01(
A61K )5010.01(
‫שיטות ותכשירים להרתיע שימוש לרע של‬
‫מוצרים פרמצבטיים הניתנים דרך הפה‬
December 30, 2010-‫כג' בטבת התשע"א‬
/4//01/1/
US
/4///10/1
US
////1//1/
US
/4//01101
US
PCT/US/2005/042808
WO/2006/058249
/1/41/1440
/1/4//144/
11/41/144/
10/4//144/
10/4//144/
501501
HYDROGEN GENERATOR,
AMMONIA COMBUSTION INTERNAL
COMBUSTION ENGINE, AND FUEL
CELL
TOYOTA JIDOSHA KABUSHIKI
KAISHA
2008JP
18/03/2008
070360
PCT/JP/2009/056013
WO/2009/116679
/1/41/1440
1//41/1440
C25D )5010.01(
‫ציפוי אלקטרוכימי של שכבות לא מוליכות‬
‫במצעים מוליכים למחצה‬
501502
HETEROCYCLIC DERIVATIVES
C & C RESEARCH LABORATORIES
10-2008KR
31/03/2008
0030067
PCT/KR/2009/001659
WO/2009/145456
12
‫ מנוע שריפה‬,‫ שריפת אמוניה‬,‫מחולל מימן‬
‫ ותא דלק‬,‫פנימית‬
501505
ELECTRODEPOSITION OF
DIELECTRIC COATINGS ON
SEMICONDUCTIVE SUBSTRATES
PPG INDUSTRIES OHIO, INC.
US
61/037814
19/03/2008
/1/04/100
///41/1440
US
PCT/US/2009/037489
WO/2009/117475
C01B )5010.01(
C07D )5010.01(
‫תולדות התרוציקליות‬
December 30, 2010-‫כג' בטבת התשע"א‬
1//41/1440
501504
HER2/NEU-SPECIFIC ANTIBODIES
AND METHODS OF USING SAME
MACROGENICS, INC.
US
61/041649
02/04/2008
PCT/US/2009/038201
WO/2009/123894
1//41/1440
501505
BCR-COMPLEX-SPECIFIC
ANTIBODIES AND METHODS OF
USING SAME
MACROGENICS, INC.
US
61/041659
02/04/2008
PCT/US/2009/038171
WO/2009/151717
1//41/1440
501501
PHARMACEUTICAL COMPOSITION
271
ASTRAZENECA AB
US
61/040372
28/03/2008
PCT/GB/2009/050293
WO/2009/118562
14/40/1441
501501
LASER DOPPLER VELOCIMETER
A61K )5010.01(
NEU/2HER ‫נוגדנים ספציפיים כנגד‬
‫ושיטות להשתמש בהם‬
C07K )5010.01(
BCR ‫נוגדנים ספציפיים כנגד קומפלקס‬
‫ושיטות להשתמש בהם‬
A61K )5010.01(
511 ‫תכשיר רפואי‬
G01P )5010.01(
‫מד לייזר לחישוב מהירות המתחשב‬
‫באפקט דופלר‬
OPTICAL AIR DATA SYSTEMS, LLC
PCT/US/2008/005515
WO/2009/134221
13
December 30, 2010-‫כג' בטבת התשע"א‬
///41/1440
501501
tPA MUTANT IN THE TREATMENT
OF ACUTE BRAIN INJURY AND
NEURODEGENERATIVE DISORDERS
HADASIT MEDICAL RESEARCH
SERVICES AND DEVELOPMENT LTD
IL
190184
16/03/2008
PCT/IL/2009/000300
WO/2009/116035
1//40/1440
‫ לטיפול בפגיעות מח חמורות‬PA t ‫מוטנט‬
‫ומחלות עצבים ניווניות‬
‫הדסית שירותי מחקר רפואי ופיתוח בע"מ‬
501506
DIFFUSER FOR SHAVING FOAM
SPRAY CAN
LINDAL FRANCE SAS
FR
0802409
29/04/2008
PCT/EP/2009/055062
WO/2009/133069
MONOCLONAL ANTIBODIES CAPABLE
OF REACTING WITH A PLURALITY OF
INFLUENZA VIRUS A SUBTYPES
POMONA RICERCA S.R.L.
IT
TO2008A000204
PCT/IB/2009/051068
WO/2009/115972
4//40/1440
C07K )5010.01(
‫נוגדנים מונוקלונאליים המסוגלים‬
‫להגיב עם מגוון תת–סוגים של וירוס‬
A ‫השפעת‬
17/03/2008
501511
DISUBSTITUTED PHTHALAZINE
HEDGEHOG PATHWAY
ANTAGONISTS
ELI LILLY AND COMPANY
US
61/048729
29/04/2008
14
A45D )5010.01(
‫מפזר למיכל ריסוס קצף גילוח‬
501510
///41/1440
C12N )5010.01(
C07D )5010.01(
‫פתאלאזין דו–מותמר כאנטגוניסטים‬
‫למסלול קיפוד‬
December 30, 2010-‫כג' בטבת התשע"א‬
PCT/US/2009/039065
WO/2009/134574
10/41/1440
501515
‫ מבוססי‬B ‫מעכבים של דהאצטילאז‬
‫הידרוקסאמאט‬
HYDROXAMATE-BASED INHIBITORS
OF DEACETYLASES B
NOVARTIS AG
US
61/039674
26/03/2008
PCT/EP/2009/053421
WO/2009/118305
1//4//144/
501514
METHODS FOR MAKING 4TETRAZOLYL-4-PHENYLPIPERIDINE
COMPOUNDS
EURO-CELTIQUE S.A.
US
60/540839
30/01/2004
/4///1011
///41/1440
US
PCT/US/2005/003170
WO/2005/075455
1//41/1441
C07C )5010.01(
–4–‫–טטראזוליל‬4 ‫שיטות להכנת תרכובות‬
‫פנילפיפרדין‬
501511
SOLID FORMS COMPRISING (+)-2-[1[3-ETHOXY-4-METHOXYPHENYL)-2METHYLSULFONYLETHYL]-4ACETYLAMINOISOINDOLINE-1,3DIONE, COMPOSITIONS THEREOF,
AND USES THEREOF
CELGENE CORPORATION
C07D )5010.01(
A61K )5010.01(
–2(–1[–5–)+( ‫צורות מוצקות המכילות‬
–5–)‫–מתוקסיפניל‬4–‫אתוקסי‬
–4–]‫מתילסולפונילאתיל‬
‫ תכשירים‬,‫–דיון‬1,2–‫אצטילאמינואיזואינדולין‬
‫המכילים אותן ושימושיהן‬
PCT/US/2008/004021
WO/2009/120167
15
December 30, 2010-‫כג' בטבת התשע"א‬
/0/41/1440
501511
A23L )5010.01(
VITAMIN COMPOSITIONS FOR
PREVENTING NAUSEA
PREGNANT PRINCESS & CO. LTD
US
61/064750
25/03/2008
PCT/IL/2009/000310
WO/2009/118726
‫הרכבי וויטמינים למניעת בחילה‬
‫פרגננט פרינסס בע"מ‬
501550
11/41/1440
SUBSTITUTED IMIDAZOQUINOLINES,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
4SC AG
IN
614/MUM/2008 24/03/2008
PCT/EP/2009/053399
WO/2009/118296
1//41/1441
501555
A61K )5010.01(
‫ תכשירים‬,‫אימידאזוקוינולינים מותמרים‬
‫המכילים אותם ושימושים בהם‬
C07D )5010.01(
‫תהליך להכנת הטרואריל סולפמאטים‬
‫בנזו–דחוסים וצורה‬
–2,5–‫–כלורו‬N–(((s2)–6 ‫גבישית של‬
–4,1–‫דיהידרו‬
‫–יל)מתיל)סולפאמיד‬5–‫בנזודיאוקסין‬
PROCESS FOR THE PREPARATION
OF BENZO-FUSED HETERORYL
SULFAMATES AND CRYSTALLINE
FORM OF N-(((2S)-6-CHLORO-2,3DIHYDRO-1,4-BENZODIOXIN-2YL)METHYL)SULFAMIDE
JANSSEN PHARMACEUTICA, N.V.
PCT/US/2008/058233
WO/2009/120191
1//41/1441
501552
PROCESSES FOR THE PREPARATION
OF BENZO-FUSED DIOXIN
DERIVATIVES
JANSSEN PHARMACEUTICA, N.V.
C07D )5010.01(
–‫תהליכים להכנת תולדות דיאוקסין בנזו‬
‫דחוסות‬
PCT/US/2008/058247
16
December 30, 2010-‫כג' בטבת התשע"א‬
WO/2009/120192
/1/40/1440
501554
‫מפעל אנרגיה תרמית סולרית‬
SOLAR THERMAL POWER PLANT
ALSTOM TECHNOLOGY LTD.
US
61/045361
16/04/2008
///4//1/4
14/4//1441
US
/1/01/410
40/40/1440
US
/1/01/40/
40/40/1440
US
PCT/US/2009/040326
WO/2009/129166
/1/40/1440
501555
501551
SOLAR STEAM GENERATOR
HAVING A STANDBY HEAT SUPPLY
SYSTEM
ALSTOM TECHNOLOGY LTD.
US
61/045361
16/04/2008
///4//0/4
14/4//1441
US
/1/01/40/
40/40/1440
US
/1/01//10
40/40/1440
US
PCT/US/2009/040334
WO/2009/129169
/1/40/1440
17
F03G )5010.01(
‫מחולל אנרגיה סולרית‬
A SOLAR STEAM GENERATOR
ALSTOM TECHNOLOGY LTD.
US
61/045361
16/04/2008
/1/01/40/
40/40/1440
US
PCT/US/2009/040328
WO/2009/129167
/1/40/1440
F03G )5010.01(
F03G )5010.01(
‫מחולל אנרגיה סולרית בעל מערכת כוננית‬
‫לאספקת חם‬
501551
F03G )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
CONTINUOUS MOVING BED SOLAR
STEAM GENERATION SYSTEM
ALSTOM TECHNOLOGY LTD.
US
61/045361
16/04/2008
///4/0414
4//4//1441
US
/1/01/40/
40/40/1440
US
/1/01/4/4
40/40/1440
US
PCT/US/2009/040338
WO/2009/129170
14/41/1440
501551
CARNALLITE-LIKE FOOD SALTS
AND PRODUCTS THEREOF
SMART SALT, INC.
US
61/038706
21/03/2008
41144//84
1///4/1441
GB
PCT/US/2009/037877
WO/2009/117702
4//4//1440
‫מערכת לייצור אנרגיה סולרית בעלת מצע‬
‫רציף נע‬
‫מלחי מאכל דמויי קארנאליט ותוצרים מכך‬
501556
OXYGEN ABSORBING PLASTIC
STRUCTURE
MULTISORB TECHNOLOGIES, INC.
US
12/055632
26/03/2008
PCT/US/2009/030070
WO/2009/120393
14/41/1440
18
B32B )5010.01(
‫מבנה פלסטי הסופג חמצן‬
501520
OXYMETHYLENE ARYL
COMPOUNDS AND USES THEREOF
METABOLEX, INC.
US
61/041196
31/03/2008
PCT/US/2009/038847
WO/2009/123992
A23L )5010.01(
A61K )5010.01(
‫תרכובות אריל אוקסימתילן ושימושים בהן‬
December 30, 2010-‫כג' בטבת התשע"א‬
1//41/1440
501521
AGENT FOR PREVENTING AND/OR
TREATING VASCULAR DISEASES
ASTELLAS PHARMA INC.
2008JP
01/04/2008
095370
PCT/JP/2009/056708
WO/2009/123210
14/41/1440
A61K )5010.01(
‫או טיפול במחלות כלי–דם‬/‫גורם למניעה ו‬
501525
NOVEL PIPERIDINE DERIVATIVES AS
INHIBITORS OF STEAROYL-COA
DESATURASE
FOREST LABORATORIES HOLDINGS
LIMITED
IN
575/KOL/2008 20/03/2008
///400014
4//4//1441
US
PCT/US/2009/037835
WO/2009/117676
14/41/1440
10////1441
SCREW CLOSURE FOR BOTTLES
19
‫תולדות פיפרידין חדשות כמעכבות‬
‫ דאסאטוראז‬COA –‫סטיארואיל‬
501522
NOVEL PIPERAZINE DERIVATIVES AS
INHIBITORS OF STEAROYL-COA
DESATURASE
FOREST LABORATORIES HOLDINGS
LIMITED
IN
574/KOL/2008 20/03/2008
///4000/0
4//4//1441
US
PCT/US/2009/037807
WO/2009/117659
A01N )5010.01(
A61K )5010.01(
‫תולדות פיפראזין חדשות כמעכבות של‬
‫ דיסאטוראז‬COA–‫סטיארויל‬
501524
B65D )5010.01(
‫סגר הברגה לבקבוקים‬
December 30, 2010-‫כג' בטבת התשע"א‬
DABBUR, ISMAIL, OMAR
DE
202008003820.0
PCT/DE/2008/001998
WO/2009/115066
1//41/1440
USE OF CATHEPSIN C
SANOFI AVENTIS
EP
08290285.9
PCT/EP/2009/002091
WO/2009/118137
///41/1440
‫ עומר‬,‫ אסמעיל‬,‫דבור‬
18/03/2008
501521
C ‫שימוש של קתפסין‬
26/03/2008
501521
EXPRESSION-LINKED GENE
DISCOVERY
EXPRESSIVE RESEARCH B.V.
EP
08152859.8 17/03/2008
PCT/NL/2009/050128
WO/2009/116863
COMBINED PUMPING SYSTEM
COMPRISING A GETTER PUMP AND AN
ION PUMP
SAES GETTERS S.P.A.
IT
MI2008U00011228 28/03/2008
4//41/1441
IT
MI2008U000250
PCT/EP/2009/053634
WO/2009/118398
20
H01J )5010.01(
‫מערכת שאיבה משולבת הכוללת‬
‫משאבת גטר ומשאבת יונים‬
501526
HIGHLY BRIDGED PEPTIDES FROM
ACTINOMADURA NAMIBIENSIS
C12Q )5010.01(
‫גילוי ביטוי קשור גן‬
501521
1//41/1440
/1/41/1440
G01N )5010.01(
C07K )5010.01(
‫פפטידים בעלי רמת גשרים גבוהה‬
NAMIBIENSIS ACTINOMADURA–‫מ‬
December 30, 2010-‫כג' בטבת התשע"א‬
SANOFI AVENTIS
EP
08290324.6
PCT/EP/2009/001982
WO/2009/121483
/1/41/1440
02/04/2008
501540
IMPROVED OPTICAL BRIGHTENING
COMPOSITIONS
CLARIANT FINANCE (BVI) LIMITED
EP
08102906.8 26/03/2008
41///11180
/4//1/1441
EP
41///01484
/1//1/1441
EP
PCT/EP/2009/052919
WO/2009/118247
/0/41/1440
1//41/1440
‫תכשירים בעלי הארה אופטית משופרת‬
501541
HEAT SHOCK PROTEIN GP96
VACCINATION AND METHODS OF
USING SAME
UNIVERSITY OF MIAMI
US
61/038313
20/03/2008
PCT/US/2009/001727
WO/2009/117116
21
A61K )5010.01(
‫ ושיטות‬GP96 ‫חיסון על ידי חלבון שוק חום‬
‫לשימוש בו‬
501545
DRILL-AIMING METHOD AND
APPARATUS
K.M.B.Y. LTD
IL
190438
25/03/2008
PCT/IL/2009/000333
WO/2009/118733
4//40/1440
D21H )5010.01(
501544
A61B )5010.01(
‫שיטה והתקן לכיוון מקדח‬
‫ בע"מ‬.‫י‬.‫ב‬.‫מ‬.‫ק‬
G01N )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
METHODS OF USING A G PROTEINCOUPLED RECEPTOR TO IDENTIFY
PEPTIDE YY (PYY) SECRETAGOGUES
AND COMPOUNDS USEFUL IN THE
TREATMENT OF CONDITIONS
MODULATED BY PYY
ARENA PHARMACEUTICALS, INC.
US
61/123273
07/04/2008
/1/10/40/
11/41/1440
US
PCT/US/2009/002154
WO/2009/126245
14/41/1440
G ‫שיטות לשימוש בקולטן מצומד לחלבון‬
)YY (PYY ‫לזהות גורמי הפרשת פפטיד‬
‫ותרכובות יעילות בטיפול במצבים‬
PYY ‫מאופננים על ידי‬
501545
POLYSUBSTITUTED DERIVATIVES
OF 2-HETEROARYL-6-PHENYLIMIDAZO[1,2-A]PYRIDINES, AND
PREPARATION AND THERAPEUTIC
USE THEREOF
SANOFI-AVENTIS
FR
0801584
21/03/2008
PCT/FR/2009/000303
WO/2009/144395
14/41/1440
501541
POLYSUBSTITUTED 2-ARYL-6PHENYL-IMIDAZO[1,2-A]PYRIDINE
DERIVATIVES, AND PREPARATION
AND THERAPEUTIC USE THEREOF
SANOFI-AVENTIS
FR
0801581
21/03/2008
4///4/14/4
PCT/FR/2009/000302
WO/2009/144394
14/41/1440
22
501541
C07D )5010.01(
‫–פניל–אימידאזו‬1–‫–הטרואריל‬5 ‫נגזרות‬
‫ הכנתן‬,‫]פירידין רב– מותמרות‬A–5,1[
‫ושימושן התראפיוטי‬
C07D )5010.01(
–5,1[‫–פניל–אימידאזו‬1–‫–אריל‬5 ‫נגזרות‬
‫ הכנתן ושימושן‬,‫]פירידין רב–מותמרות‬A
‫התראפיוטי‬
C07D )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
POLYSUBSTITUTED DERIVATIVES
OF 6-HETEROARYL-IMIDAZO[1,2A]PYRIDINES, AND PREPARATION
AND THERAPEUTIC USE THEREOF
SANOFI-AVENTIS
FR
0801585
21/03/2008
PCT/FR/2009/000298
WO/2009/144392
14/41/1440
–5,1[‫–הטרואריל–אימידאזו‬1 ‫נגזרות‬
‫ הכנתן ושימושן‬,‫]פירידין רב–מותמרות‬A
‫התאפיוטי‬
501541
POLYSUBSTITUTED DERIVATIVES
OF 2-ARYL-6-PHENYL-IMIDIZO[1,2A]PYRIDINES, AND PREPARATION
AND THERAPEUTIC USE THEREOF
SANOFI-AVENTIS
FR
0801580
21/03/2008
PCT/FR/2009/000297
WO/2009/144391
1//41/1440
A61K )5010.01(
–5,1{‫–פניל–אימידאזו‬1–‫–אריל‬5 ‫נגזרות‬
‫ הכנתן ושימושן‬,‫]פירידין רב–מותמרות‬A
‫התראפיוטי‬
501550
‫מתקן מהדק לכיסא‬
FASTENING DEVICE FOR A CHAIR
PETER OPSVIK AS
NO
20081658
03/04/2008
PCT/NO/2009/000121
WO/2009/123470
///40/1441
501551
PHOTO BIOREACTOR WITH LIGHT
DISTRIBUTOR AND METHOD FOR THE
PRODUCTION OF A PHOTOSYNTHETIC
CULTURE
FEYECON B.V.
NL
PCT/NL2008/050154 19/03/2008
PCT/NL/2008/050604
WO/2009/116853
23
A47D )5010.01(
C12M )5010.01(
‫פוטו–ביוריאקטור עם מפלג אור‬
‫ושיטה להפקת תרבית‬
‫פוטוסינטטית‬
December 30, 2010-‫כג' בטבת התשע"א‬
501555
///40/1441
PHOTO BIOREACTOR WITH LIGHT
DISTRIBUTOR AND METHOD FOR THE
PRODUCTION OF A PHOTOSYNTHETIC
CULTURE
FEYECON B.V.
NL
PCT/NL2008/050154 19/03/2008
PCT/NL/2008/050602
WO/2009/116852
‫פוטו–ביוריאקטור עם מפלג אור‬
‫ושיטה להפקת תרבית‬
‫פוטוסינטטית‬
501554
C07D )5010.01(
14/41/1440
SUBSTITUTED PYRROLIDINE AND
PIPERDINE COMPOUNDS
DERIVATIVES THEREOF, AND
METHODS FOR TREATING PAIN
CHLORION PHARMA, INC.
US
61/038662
21/03/2008
PCT/CA/2009/000366
WO/2009/114950
/0/41/1440
,‫ נגזריהם‬,‫הרכבי פירולדין ופיפרדין חליפים‬
‫ושיטות לטיפול בכאב‬
501551
SOLID DOSAGE FORM FOR
TREATING HEADACHES
PAINDURE LTD.
US
61/038431
21/03/2008
PCT/IL/2009/000314
WO/2009/116047
1//41/1440
NANOPARTICLES FOR TARGETED
DELIVERY OF ACTIVE AGENTS TO
THE LUNG
24
C12M )5010.01(
501510
A61K )5010.01(
‫צורת מתן מוצקה לטיפול בכאבי ראש‬
‫פיינדיור בע"מ‬
A61K )5010.01(
‫נאנו חלקיקים לשיגור מכוון של גורמים‬
‫אקטיביים לריאות‬
December 30, 2010-‫כג' בטבת התשע"א‬
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
EP
08075267.8 31/03/2008
PCT/EP/2009/002513
WO/2009/121631
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
501511
1//41/1440
SELF-DESTRUCTING TRANSDERMAL
THERAPEUTIC SYSTEM HAVING
IMPROVED FUNCTIONALITY AND
EFFICACY
A61K )5010.01(
‫מערכת תוך עורית עם השמדה עצמית‬
‫לטיפול רפואי בעלת תפקודיות ויעילות‬
‫משופרת‬
LTS LOHMANN THERAPIE-SYSTEME
AG
DE
102008016804.1 02/04/2008
PCT/EP/2009/002205
WO/2009/121514
10/41/1440
501515
HYDROXYQUINOXALINECAR
BOXAMIDE DERIVATIVES,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
DAIICHI SANKYO COMPANY,
LIMITED
2008JP
26/03/2008
079919
1441-111/4/ 1///1/1441
JP
PCT/JP/2009/055741
WO/2009/119537
1//41/1440
LONG-TERM INTERFERENCE
MITIGATION IN AN
ASYNCHRONOUS WIRELESS
NETWORK
25
C07D )5010.01(
,‫הידרוקסיקוינוזאלינקרבוקסאמיד‬
‫תכשירים המכילים אותם ושימושים בהם‬
501512
H04W )5010.01(
‫שיכוך הפרעה לטווח ארוך ברשת‬
‫אלחוטית לא סינכרונית‬
December 30, 2010-‫כג' בטבת התשע"א‬
QUALCOMM INCORPORATED
US
61/040347
28/03/2008
///40401/
11/41/1441
US
///4//1//
1//4//1441
US
/1/0401/1
11/41/1440
US
PCT/US/2009/038519
WO/2009/120934
1//41/1440
501514
LOW REUSE PREAMBLE FOR A
WIRELESS COMMUNICATION
NETWORK
QUALCOMM INCORPORATED
US
61/040308
28/03/2008
///4/04/0
///4//1441
US
/1/0/41/1
10/41/1440
US
PCT/US/2009/038461
WO/2009/120904
1//41/1440
501515
POWER EFFICIENT SMALL BASE
STATION SCANNING AND
ACQUISITION
QUALCOMM INCORPORATED
US
61/040095
27/03/2008
///40//01
1//41/1441
US
///41///0
///4//1441
US
/1/0401/1
11/41/1440
US
PCT/US/2009/038458
WO/2009/120902
1//41/1440
501511
FEMTO CELL SYSTEM SELECTION
QUALCOMM INCORPORATED
US
61/040297
28/03/2008
/1/0/4///
1//41/1440
US
26
H04L )5010.01(
‫מבוא בעל שימוש חוזר נמוך עבור‬
‫תקשורת אלחוטית‬
H04W )5010.01(
‫סריקה ורכישה עם נצולות כח גבוהה‬
‫בתחנת בסיס קטנה‬
H04W )5010.01(
‫בחירת מערכת תא פמטו‬
December 30, 2010-‫כג' בטבת התשע"א‬
PCT/US/2009/038524
WO/2009/120939
1//41/1440
501511
DEVICE MANAGED ACCESS POINT
LISTS IN WIRELESS
COMMUNICATIONS
QUALCOMM INCORPORATED
US
61/039728
26/03/2008
////4111/
41//4/1441
US
/1/04///0
/0/41/1440
US
PCT/US/2009/038454
WO/2009/120898
1//41/1440
501511
SCREEN BOWL CENTRIFUGE
ANDRITZ SEPARATION, INC.
US
61/040254
28/03/2008
PCT/US/2009/038354
WO/2009/120834
/0//4/1441
501516
METHOD AND SYSTEM FOR
CONTROLLING PRODUCTION OF
ITEMS
SICPA HOLDING SA
PI0800754BR
25/03/2008
3
PCT/IB/2008/002713
WO/2009/118583
1//41/1440
27
501510
H04W )5010.01(
‫רשימות נקודת גישה מנוהלות על ידי‬
‫התקן בתקשורת אלחוטית‬
B04B )5010.01(
‫צנטריפוגת קערת רשת‬
G07D )5010.01(
‫שיטה ומערכת לבקרת ייצור פרטים‬
G01N )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
CHEMICAL SENSORS BASED ON
CUBIC NANOPARTICLES CAPPED
WITH AN ORGANIC COATING FOR
DETECTING EXPLOSIVES
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.
IL
190475
27/03/2008
PCT/IL/2009/000342
WO/2009/118739
11////1440
‫גלאים כימיים המבוססים על ננו–חלקיקים‬
‫קוביים בציפוי אורגני לגילוי של חומר נפץ‬
‫מוסד הטכניון למחקר ופתוח בע"מ‬
501511
‫מערכת בקרה‬
‫מידורי טכנולוגיות בע"מ‬
CONTROLLER SYSTEM
MIDORI TECHNOLOGIES LTD
US
61/117242
24/11/2008
PCT/IB/2009/055266
WO/2010/058376
1//4//1440
501515
ONE-PIECE INCLINED DENTAL
IMPLANT
ADIN DENTAL IMPLANTS SYSTEMS,
LTD.
US
61/054818
21/05/2008
PCT/IB/2009/052141
WO/2009/141801
1//41/1440
28
A61C )5010.01(
‫יחידת שתל דנטלי נוטה‬
ADIN DENTAL IMPLANTS SYSTEMS,
.LTD
501512
CRYSTAL FOR OPTICAL
CONCERSION
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
US
61/064759
25/03/2008
PCT/IL/2009/000339
WO/2009/118738
G05B )5010.01(
G02F )5010.01(
‫גביש להמרה אופטית‬
‫ידע חברה למחקר ופיתוח בע"מ‬
December 30, 2010-‫כג' בטבת התשע"א‬
11//1/1441
501514
METHOD APPARATUS AND SYSTEM
FOR ANALYZING THERMAL IMAGES
REAL IMAGING LTD
US
61/064823
28/03/2008
PCT/IL/2008/001684
WO/2009/118721
1//41/1440
501515
CORL-DERIVED COLLAGEN AND
METHODS OF FARMING SAME
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.
US
61/064792
27/03/2008
PCT/IL/2009/000334
WO/2009/118734
1//41/1440
501511
A DRY POWDER INHALATION
SYSTEM
MANNKIND CORPORATION
US
61/040112
27/03/2008
////011/4
41/4//1440
US
PCT/US/2009/038668
WO/2009/121020
1//40/14/4
VEHICLE ESCAPE WINDOW
PLASAN SASA LTD.
29
501511
A61B )5010.01(
‫ מכשיר ומערכת לניתוח תמונות‬,‫שיטה‬
‫תרמיות‬
‫ריל אימג'ינג בע"מ‬
C07K )5010.01(
‫קולאגן מאלמוג ושיטות לגידולו‬
‫אביב בע"מ‬-‫רמות ליד אוניברסיטת תל‬
A61M )5010.01(
‫מערכת לשאיפת אבקה יבשה‬
B60J )5010.01(
‫חלון מילוט לרכב‬
‫פלסן סאסא בע"מ‬
December 30, 2010-‫כג' בטבת התשע"א‬
1//41/1440
501511
SUBSTITUTED SPIROCYCLIC
CYCLOHEXANE DERIVATIVES
GRUNENTHAL GMBH
EP
08005808.4 27/03/2008
PCT/EP/2009/002186
WO/2009/118173
1//41/1440
SPIRO (5,5,) UNDECANE
DERIVATIVES
GRUNENTHAL GMBH
EP
08005804.3
PCT/EP/2009/002180
WO/2009/118169
1//41/1440
–‫תולדות מותמרות של ציקלוהקסאן ספירו‬
‫ציקליים‬
501516
27/03/2008
501510
501511
SUBSTITUTED
CYCLOHEXYLDIAMINES
GRUNENTHAL GMBH
EP
08005759.9 27/03/2008
PCT/EP/2009/002188
WO/2009/118174
30
C07D )5010.01(
‫) אונדקאן‬5,5(‫תולדות ספירו‬
HYDROXYMETHYLCYLOHEXYL
AMINES
GRUNENTHAL GMBH
EP
08005809.2 27/03/2008
PCT/EP/2009/002184
WO/2009/118171
1//41/1440
C07D )5010.01(
C07C )5010.01(
‫הידרוקסי מתיל ציקלוהקסיל אמינים‬
C07D )5010.01(
‫ציקלוהקסילדיאמינים מותמרים‬
December 30, 2010-‫כג' בטבת התשע"א‬
1//41/1440
SUBSTITUTED 4AMINOCYCLOHEXANE
DERIVATIVES
GRUNENTHAL GMBH
EP
08005748.2
PCT/EP/2009/002179
WO/2009/118168
10/41/1440
501515
‫–אמינוציקלוהקסאן מותמרות‬4 ‫תולדות‬
27/03/2008
501512
PERFORATED-WEB COMPOSITE
PANEL, DEVICE AND METHOD OF
MAKING SUCH A PANEL
SOCIETE INTERNATIONALE POUR
LE COMMERCE ET L'INDUSTRIE
FR
0852111
31/03/2008
PCT/FR/2009/050504
WO/2009/125124
‫ התקן‬,‫לוח מרוכב בעל רשת מחוררת‬
‫ושיטה לייצור לוח כזה‬
COMPOSITIONS AND METHODS FOR
PREPARING AND USING SAME
ARDEA BIOSCIENCES, INC.
US
61/044886
14/04/2008
US
PCT/US08/071392 11/4//1441
/////0//1
/1/41/1440
US
PCT/US/2009/040538
WO/2009/129246
501515
NOVEL COMPOSITIONS AND
METHODS FOR THE TREATMENT OF
IMMUNE RELATED DISEASES
31
B32B )5010.01(
501514
/0/40/1440
41/40/1440
C07D )5010.01(
C07C )5010.01(
‫תכשירים ושיטות להכנתם ולשימוש‬
‫בהם‬
C07C )5010.01(
‫תכשירים חדשים ושיטות לטיפול במחלות‬
‫הקשורות לחיסון‬
December 30, 2010-‫כג' בטבת התשע"א‬
GENENTECH, INC.
US
61/123530
////001//
US
PCT/US/2009/039868
WO/2009/126688
11/40/1440
09/04/2008
1//40/1441
501511
(5R)-1,5-DIARYL-4,5-DIHYDRO-1HPYRAZOLE-3-CARBOXAMIDINE
DERIVATIVES HAVING CB1ANTAGONISTIC ACTIVITY
ABBOTT HEALTHCARE PRODUCTS
B.V.
EP
08155009.7 23/04/2008
///40/01//
11/40/1441
US
PCT/EP/2009/054788
WO/2009/130234
4//4//1440
501511
TITANIUM DIOXIDE
TIOXIDE EUROPE LIMITED
GB
0808239.8
07/05/2008
41/0///81
41/41/1441
GB
PCT/GB/2009/001096
WO/2009/136141
1//41/1440
501511
PROCESS FOR THE PREPARATION
OF TRIAMIDES FROM AMMONIA
AND AMIDO-DICHLORIDES
BASF SE
EP
08153960.3 02/04/2008
PCT/EP/2009/053577
WO/2009/121786
32
C07D )5010.01(
–‫–דיהידרו‬5,4–‫–דיאריל‬R5)–5,1( ‫תולדות‬
‫–קרבוקסאמידין בעלות‬2–‫–פיראזול‬H1
CB1–‫פעילות אנטגוניסטית‬
C09C )5010.01(
‫דו–תחמוצת טיטניום‬
C07F )5010.01(
‫תהליך להכנת טריאמידים מאמוניה‬
‫ואמידו–דיכלוריד‬
December 30, 2010-‫כג' בטבת התשע"א‬
11/40/1440
501516
MODULATORS OF DOPAMINE
NEUROTRANSMISSION
NSAB, FILIAL AF NEUROSEARCH
SWEDEN AB, SVERIGE
DK
PA200800598 29/04/2008
///4004/0
14/40/1441
US
PCT/EP/2009/055137
WO/2009/133107
11/41/1440
‫מאפננים של העברת אותות דופאמינית‬
501561
ASSEMBLIES FOR USE WITH AN
ENDOSCOPE
SMART MEDICAL SYSTEMS LTD
US
61/064881
31/03/2008
PCT/IL/2009/000322
WO/2009/122395
41/40/1440
POOL CLEANER WITH HIGH
PRESSURE CLEANING JETS
33
A61B )5010.01(
‫הרכבה לשימוש עם אנדוסקופ‬
‫סמארט מערכות רפואיות בע"מ‬
501565
SELECTIVE BEARER
ESTABLISHMENT IN EVOLVED
UNIVERSAL TERRESTRIAL RADIO
ACCESS (E-UTRA) AND EVOLVED
PACKET SYSTEM (EPS)
QUALCOMM INCORPORATED
US
61/042676
04/04/2008
/1/0//1/1
1//41/1440
US
PCT/US/2009/039422
WO/2009/124234
1//41/1440
C07D )5010.01(
H04W )5010.01(
‫הקמת נושא בררני בגישת רדיו כללית‬
‫) ומערכת חבילות מפותחות‬UTRA–E(
)EPS(
501562
E04H )5010.01(
‫מנקה בריכות עם סילוני ניקוי בלחץ גבוה‬
December 30, 2010-‫כג' בטבת התשע"א‬
AQUA PRODUCTS, INC.
US
12/079667
PCT/US/2009/001968
WO/2009/154662
26/03/2008
41/40/1440
501564
PROCESS FOR PURIFYING AN ?KETO ESTER
LONZA LTD.
EP
08007277.0 14/04/2008
///40///0
/4/40/1441
US
PCT/EP/2009/002602
WO/2009/127352
1//41/1440
41/40/1440
‫שיטה לטיהור אלפא–קטו אסטר‬
501565
POOL CLEANER WITH HIGH
PRESSURE CLEANING JETS
AQUA PRODUCTS INC.
US
12/079666
26/03/2008
PCT/US/2009/001969
WO/2009/120388
E04H )5010.01(
‫מנקה בריכות עם סילוני ניקוי בלחץ גבוה‬
501561
ALZHEIMER'S DISEASE-SPECIFIC
ALTERATIONS OF THE ERK1/ERK2
PHOSPHORYLATION RATIOALZHEIMER'S DISEASE-SPECIFIC
MOLECULAR BIOMARKERS
(ADSMB)
C07C )5010.01(
G01N )5010.01(
ERK/1ERK 5 ‫שינויים ביחס זרחון‬
‫ספציפיים למחלת אלזהיימר–ביוסמנים‬
‫מולקולאריים ספצייפים למחלת אלזהיימר‬
)ADSMB(
BLANCHETTE ROCKEFELLER
NEUROSCIENCES INSTITUTE
US
12/078857
07/04/2008
PCT/US/2009/002120
WO/2009/126232
34
December 30, 2010-‫כג' בטבת התשע"א‬
41/40/1440
501561
NECK RING AND METHOD OF
MAKING FOR A GLASS CONTAINER
FORMING MACHINE
OWENS-BROCKWAY GLASS
CONTAINER INC.
US
12/080974
08/04/2008
PCT/US/2009/039845
WO/2010/051060
1//41/1440
41/40/1440
G01N )5010.01(
‫ מוצר תוכנת מחשב ושיטות‬,‫מערכת‬
‫הקשורות להם לרישום דגמים תלת‬
‫ממדיים המצביעים לנתונים המייצגים את‬
‫הפוזה של חלק‬
501202
METHOD FOR PRODUCING
OPTICALLY ACTIVE CYANOHYDRIN
COMPOUND
SUMITOMO CHEMICAL COMPANY,
LIMITED
2008JP
18/04/2008
108772
PCT/JP/2009/057302
WO/2009/128390
35
‫טבעת צוואר ושיטה לייצורה למכונה‬
‫לייצור מיכל זכוכית‬
501201
SYSTEM, PROGRAM PRODUCT AND
RELATED METHODS FOR
REGISTERING THREE-DIMENSIONAL
MODELS TO POINT DATA
REPRESENTING THE POSE OF A
PART
LOCKHEED MARTIN CORPORATION
US
61/040415
28/03/2008
/1/1414//
10/41/1441
US
PCT/US/2009/038309
WO/2009/120813
C03B )5010.01(
C07C )5010.01(
‫שיטה עבור ייצור תרכובת ציאנוהידרנית‬
‫אופטית פעילה‬
December 30, 2010-‫כג' בטבת התשע"א‬
1/////1441
501204
‫קונוס מתקפל‬
FOLDABLE CONE
VANGUARD ADA SYSTEMS OF
AMERICA, INC,
US
61/070696
24/03/2008
/1/1/1/14
////4/1441
US
PCT/US/2008/084977
WO/2009/120241
4//40/1440
501205
METHOD AND SYSTEM FOR FINE
ADJUSTMENT OF OPTICAL
ELEMENTS POSITION
RAICOL CRYSTALS LTD
US
61/048612
29/04/2008
PCT/IL/2009/000368
WO/2009/133546
10/41/1440
‫רייקול גבישים בע"מ‬
501201
36
A61B )5010.01(
‫שיטות ומערכות לשימוש בקביעת מצב‬
‫הלב של חולה‬
‫דיפבריז בע"מ‬
501201
METHOD OF DETECTION AND/OR
TITRATION IN VITRO OF AN
UNCONVENTIONAL
TRANSMISSIBLE AGENT
LFB-BIOTECHNOLOGIIES
FR
0851998
27/03/2008
PCT/FR/2009/050520
WO/2009/125139
H01S )5010.01(
‫שיטה ומערכת להתאמה טובה של מיקום‬
‫רכיבים אופטיים‬
METHODS AND SYSTEMS FOR USE
IN DETERMINATION OF A PATIENT'S
CONDITION
DEEPBREEZE LTD
US
61/064739
24/03/2008
PCT/IL/2009/000326
WO/2009/118729
1//41/1440
E01F )5010.01(
G01N )5010.01(
‫או טיטרציה חוץ–גופית של‬/‫שיטה לזיהוי ו‬
‫גורם שניתן להעברה באופן לא‬
‫קונבנציונאלי‬
December 30, 2010-‫כג' בטבת התשע"א‬
501201
4///4/1440
1,3 IMIDAZOLIDINE DERIVATIVES AND
THEIR USE IN THE PRODUCTION OF
CARBAPENEM
ACS DOBFAR S.P.A.
IT
MI2008A001901 28/10/2008
PCT/EP/2009/062754
WO/2010/049233
41/40/1440
‫ אימידאזולידין והשימוש בהן‬2,1 ‫תולדות‬
‫בייצור של קרבפנם‬
501206
501210
METHODS AND APPARATUS FOR
AUTHENTICATION AND IDENTITY
MANAGEMENT USING A PUBLIC
KEY INFRASTRUCTURE (PKI) IN AN
IP-BASED TELEPHONY
ENVIRONMENT
ALCATEL-LUCENT USA INC.
US
12/100781
10/04/2008
PCT/US/2009/001920
WO/2009/126209
/0/41/1440
37
H02J )5010.01(
DC ‫מערכת הפצה‬
DC DISTRIBUTION SYSTEM
MASCO CORPORATION
US
61/042449
04/04/2008
PCT/US/2009/039384
WO/2009/124227
1//41/1440
C07D )5010.01(
H04L )5010.01(
‫שיטות ומערכות לניהול אימות וזהות‬
‫באמצעות שימוש בתשתית מפתח ציבורי‬
IP ‫) בסביבת טלפוניה מבוססת‬PKI(
501211
H04W )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
METHOD AND APPARATUS TO
ENABLE FALLBACK TO CIRCUIT
SWITCHED DOMAIN FROM PACKET
SWITCHED DOMAIN
INTERDIGITAL PATENT HOLDINGS,
INC.
US
61/038701
21/03/2008
PCT/US/2009/037685
WO/2009/117588
1//41/1440
‫שיטה ומערכת המאפשרים נסיגה למעגל‬
‫עם תחום משתנה מחבילה עם תחום‬
‫משתנה‬
501215
LENTIVIRUS-BASED IMMUNOGENIC
VECTORS
VIRXSYS CORPORATION
US
61/040581
28/03/2008
PCT/US/2009/038535
WO/2009/120947
1//41/1440
501212
NEUTRALIZING MOLECULES TO
VIRAL ANTIGENS
SEA LANE BIOTECHNOLOGIES, LLC.
US
61/040459
28/03/2008
PCT/US/2009/038636
WO/2009/121004
1//41/1440
501251
RECOMBINANT RHINOVIRUS
VECTORS
SANOFI PASTEUR BIOLOGICS CO.
US
61/072036
27/03/2008
PCT/US/2009/001941
WO/2009/120380
38
C12N )5010.01(
‫מערכים אימונוגנים מבוססי לנטיוירוס‬
C07K )5010.01(
‫מולקולות מנטרלות לאנטיגנים וירליים‬
A61K )5010.01(
‫וקטורי רינו–וירוס ריקומביננטים‬
December 30, 2010-‫כג' בטבת התשע"א‬
14/41/1440
501255
BENZOFURANE, BENZOTHIOPHENE,
BENZOTHIAZOL DERIVATIVES AS
FXR MODULATORS
MERCK PATENT GMBH
EP
08300183.4 18/04/2008
PCT/EP/2009/002297
WO/2009/127321
1//41/1440
11/41/1441
,‫ בנזותיופין‬,‫נגזרות של בנזופוראן‬
FXR ‫בנזותיאזול כמאפנני‬
501252
METHODS AND SYSTEMS FOR
ASSESSING CLINICAL OUTCOMES
THERANOS, INC.
US
61/039721
26/03/2008
PCT/US/2009/038467
WO/2009/120909
G06F )5010.01(
‫שיטות ומערכות להערכת הוצאות קליניות‬
501254
COMPOSITIONS COMPRISING
ARNOX-INHIBITORS FOR THE
INHIBITION OF REACTIVE OXYGEN
SPECIES
NU SKIN INTERNATIONAL, INC.
C07D )5010.01(
A61K )5010.01(
‫ לעיכוב‬NOX ar ‫תכשירים המכילים מעכבי‬
‫נגזרות חמצן פעילות‬
PCT/US/2008/058683
WO/2009/120214
1//41/1440
501255
STABILIZING LIPIS COMPOSITIONS
FOR ORAL PHARMACEUTICAL
AGENTS
TARO PHARMACEUTICALS U.S.A.
INC.
US
61/064782
26/03/2008
///4/0/11
1//41/1441
US
PCT/US/2009/038435
39
A61K )5010.01(
‫ייצוב תכשירים שומניים לשימוש במתן‬
‫דרך הפה‬
December 30, 2010-‫כג' בטבת התשע"א‬
WO/2009/120885
41/40/1440
501251
SYSTEM AND METHOD OF WATER
TREATMENT
NEOS INTERNATIONAL LLC.
US
61/123180
04/04/2008
PCT/US/2009/002093
WO/2009/123749
10/41/1440
501251
METHODS TO PRODUCE
STRECHABLE PRODUCTS
TAMICARE LTD.
US
12/056040
26/03/2008
PCT/IB/2009/005465
WO/2009/118654
1//41/1440
501256
SAFETY OCCLUDER AND METHOD
OF USE
ZEVEX, INC
US
61/041555
01/04/2008
PCT/US/2009/039029
WO/2009/146045
4//41/1444
40
501220
B01D )5010.01(
‫מערכת ושיטה לטיפול במים‬
B29C )5010.01(
‫שיטה ליצור מוצרים מתיחים‬
A61M )5010.01(
‫חסם בטיחותי ושיטה לשימוש‬
A61K )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
3-HYDROXY-3-METHYLGLUTARYL
COENZYME A REDUCTASE
INHIBITORS ('STATIN DRUGS') AND
LISINOPRIL, FORMULATIONS
COMPRISING THEM AND THEIR USE
IN THE MANUFACTURE OF
MEDICAMENTS AND AS
MEDICAMENTS FOR IMPROVING
NERVE CONDUCTION VELOCITY OR
NERVE BLOOD FLOW IN A NONHUMAN ANIMAL HAVING DIABETIC
NEUROPATHY AND FOR TREATING
DIABETIC NEUROPATHY IN A NONHUMAN ANIMAL
THE UNIVERSITY COURT OF THE
UNIVERSITY OF ABERDEEN
GB
9902591.8
06/02/1999
0041/0081
4//41//000
GB
PCT/GB/2000/000280
WO/2000/045818
///41/14/4
–‫ –הידרוקסי‬A 3 ‫מעכבי רדוקטאז קואנזים‬
)‫–מתילגלוטאריל (חומרי סטאטין‬2
‫ פורמולציות המכילות אותם‬,‫וליזינופריל‬
‫והשימוש בהם ליצור תרופות וכתרופות‬
‫לשיפור מהירות הולכה עצבית או זרימת‬
‫דם עצבית בבעל–חיים בלתי אנושי הלוקה‬
‫בנוירופתיה סוכרתית ולטיפול בנוירופתיה‬
‫סוכרתית בבעל–חיים בלתי אנושי‬
501225
A SYSTEM, A METHOD AND A
COMPUTER PROGRAM PRODUCT
FOR AUTOMATED REMOTE
CONTROL
COMMUNITAKE TECHNOLOGIES
LTD.
US
61/152760
16/02/2009
PCT/IL/2010/000135
WO/2010/092585
1//41/1440
501222
DOUBLY REDUCED PERYLENEDIIMIDES AND SUPRAMOLECULAR
POLYMERS DERIVED FROM
PERYLENE-DIIMIDES
YEDA RESEARCH AND
DEVELOPMENT CO., LTD.
US
61/064778
26/03/2008
PCT/IL/2009/000348
41
G06F )5010.01(
‫ שיטה ומוצר תוכנת מחשב‬,‫מערכת‬
‫לשליטה אוטומטית מרחוק‬
‫קומיוניטייק טכנולוגיות בע"מ‬
C07D )5010.01(
‫דיאימיד פרילנים מחוזרים פעמיים‬
‫ופולימרים סופרא–מולקולרים שנגזרים‬
‫מדיאימיד–פרילנים‬
‫ידע חברה למחקר ופיתוח בע"מ‬
December 30, 2010-‫כג' בטבת התשע"א‬
WO/2009/118742
1//41/1440
501224
A01N )5010.01(
HUMAN CARDIOVASCULAR
PROGENITOR CELLS
MOUNT SINAI SCHOOL OF
MEDICINE
US
61/040049
27/03/2008
PCT/US/2009/038220
WO/2009/120762
1//41/1440
‫תאי אב קרדיוואסקולרים הומניים‬
501225
B65D )5010.01(
CHID-RESISTANT MEDICATION
CONTAINER
MERCK SERONO SA,
EP
08007030.3 09/04/2008
PCT/IB/2009/005131
WO/2009/125267
10/41/1440
‫מארז לתרופות בעל מנגנון נעילה‬
501221
PYRISAZINONE DERIVATIVES
MERCK PATENT GMBH
DE
102008019907.9 21/04/2008
PCT/EP/2009/002137
WO/2009/129905
/4/40/1440
HARMFUL ORGANISM CONTROL
COMPOSITION, AND METHOD FOR
CONTROL OF HARMFUL
ORGANISMS
ISHIHARA SANGYO KAISHA LTD.
42
501226
C07D )5010.01(
‫נגזרות פירידאזינון‬
A01N )5010.01(
‫תכשיר ושיטה לשליטה על אורגניזמים‬
‫מזיק‬
December 30, 2010-‫כג' בטבת התשע"א‬
2008107804
PCT/JP/2009/057394
WO/2009/128409
JP
1//41/1440
17/04/2008
501246
ANTENNA ARRANGEMENT FOR A
HEARING INSTRUMENT
AUDIODENT ISRAEL LTD
US
61/041578
01/04/2008
PCT/IL/2009/000349
WO/2009/122403
///40/1440
14/40/1440
‫סידור אנטנה למכשיר שמיעה‬
‫אודיודנט ישראל בע"מ‬
501250
AMINODIHYDROTHIAZINE
DERIVATIVES AS BACE INHIBITORS
FOR THE TREATMENT OF
ALZHEIMER'S DISEASE
ELI LILLY AND COMPANY
US
61/049881
02/05/2008
PCT/US/2009/040589
WO/2009/134617
43
C07D )5010.01(
BACE ‫תולדות אמינודיהידרותיאזין כמעכבי‬
‫לטיפול במחלת אלצהיימר‬
501251
ANTIVIRAL THERAPY
UNIVERSITY HOSPITAL BASEL
EP
08154878.6 21/04/2008
PCT/EP/2009/054641
WO/2009/130176
///41/1440
H04R )5010.01(
501255
C12Q )5010.01(
‫תרפיה אנטיויראלית‬
A61B )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
IMAGE-BASED DYNAMIC
ULTRASOUND SPECTROGRAPHY TO
LOCATE BREAST MICROCALCIFICATION
BIOQUANTETICS, INC.
US
12/079272
26/03/2008
PCT/US/2009/001652
WO/2009/120274
11//1/1441
‫ספקטרוגרפיית אולטראסאונד דינאמית‬
‫מבוססת–דמות לאיתור מיקרו–הסתיידות‬
‫בחזה‬
501252
H03M )5010.01(
‫ממיר קוד מודולרי בשיטת פייפליין‬
MODULAR TRANSCODING PIPELINE
VANTRIX CORPORATION
US
12/118690
10/05/2008
/1/1100/1
/1//1/1441
US
PCT/CA/2008/002286
WO/2009/137910
1//41/1440
501254
A61K )5010.01(
‫שיטות לטיפול‬
METHODS OF TREATMENT
GLAXOSMITHKLINE LLC
US
61/040363
28/03/2008
PCT/US/2009/038509
WO/2009/120927
11/41/1440
501255
HETEROCYCLIC COPMPOUNDS AS
ADENOSINE RECEPTOR ANTAGONIST
ADVINUS THERAPEUTICS PRIVATE
LIMITED
IN
746/CHE/2008 26/03/2008
PCT/IN/2009/000192
WO/2009/118759
44
C07D )5010.01(
‫תרכובות הטרוציקליות כאנטגוניסט של‬
‫רצפטור אדנוזין‬
December 30, 2010-‫כג' בטבת התשע"א‬
501251
4//41/1440
WHITE LIGHT EMISSION DIODE AND
WHITE LIGHT EMISSION DIODE LAMP
ZHEJIANG MANELUX LIGHTING CO,
LTD
CN
200810094414.X 30/04/2008
PCT/CN/2009/000238
WO/2009/132508
4//40/1440
‫דיודת אור לבן ומנורת דיודת אור לבן‬
501251
SPIRO-INDOLE DERIVATIVES FOR
THE TREATMENT OF PARASITIC
DISEASES
NOVARTIS AG
EP
08155342.2 29/04/2008
40//////84
11/4//1440
EP
PCT/EP/2009/053902
WO/2009/132921
41//4/14/4
501251
E04B )5010.01(
‫מבנה נושא עומסים ושיטה לייצורו‬
‫בלוקל רביד מוצרי בניה‬
501256
BENZOPYRAN AND BENZOXEPIN
PI3K INHIBITOR COMPOUNDS AND
METHODS OF USE
GENENTECH, INC.
US
61/040827
31/03/2008
////41114
41//4/1441
US
45
C07D )5010.01(
‫תולדות ספירו–אינדול לטיפול במחלות‬
‫פרזיטיות‬
LOAD BEARING BUILDING
STRUCTURE AND CONSTRUCTION
METHOD THEREFOR
BLOKAL-RAVID BUILDING
PRODUCTS
14/41/1440
H01L )5010.01(
C07D )5010.01(
‫תרכובות בנזופיראן ובנזאוקספין מעכבות‬
‫ ושיטות לשימוש‬K3PI
December 30, 2010-‫כג' בטבת התשע"א‬
PCT/US/2009/038795
WO/2009/123971
501210
///41/144/
METHOD OF FORMING DIELECTRIC
FILMS, NEW PRECURSORS AND THEIR
USE IN THE SEMI-CONDUCTOR
MANUFACTURING
L'AIR LIQUIDE, SOCIETE ANONYME
POUR L'ETUDE ET L'EXPLOITATION DES
PROCEDES GEORGES CLAUDE
EP
PCT/EP06/062893 02/06/2006
PCT/EP/2007/052507
WO/2007/141059
1//41/1440
501211
ONLINE CHARGING FOR ROAMING
USERS IN A PROXY ONLINE
CHARGING SYSTEM OF A VISITED
NETWORK
ALCATEL-LUCENT USA INC.
US
12/104145
16/04/2008
PCT/US/2009/001919
WO/2009/128874
10/41/1440
46
,‫שיטה ליצרת קרומים דיאלקטריים‬
‫חומרי מוצא חדשים והשימוש בהם‬
‫ביצור מוליך למחצה‬
H04M )5010.01(
‫גביה מקוונת למשתמשים שונים במערכת‬
‫גביה מקוונת סמכותית של רשת מבקרת‬
501215
CELL SELECTION AN RESELECTION
FOR CLOSED SUBSCRIBER GROUP
CELLS
INTERDIGITAL PATENT HOLDINGS,
INC.
US
61/038833
24/03/2008
///4114/1
/1/4//1441
US
PCT/US/2009/038083
WO/2010/044903
C23C )5010.01(
H04W )5010.01(
‫בחירת תא ובחירה מחדש עבור קבוצת‬
‫תאים מנויים סגורה‬
December 30, 2010-‫כג' בטבת התשע"א‬
1//41/1440
501212
DEVICE FOR DISPENSING A LIQUID
IN THE FORM OF DROPS
REXAM HEALTHCARE LA
VERPILLIERE
FR
0851994
27/03/2008
414////
////4/1441
FR
PCT/FR/2009/000356
WO/2009/130411
1//41/1440
‫התקן לחלוקת נוזל בצורה של טיפות‬
501211
COMPOSITIONS AND METHODS FOR
TREATING AND DIAGNOSING
ASTHMA
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
61/072572
31/03/2008
///40/014
4//40/1441
US
////11111
14/4//1441
US
///14/101
///4//1440
US
PCT/US/2009/039033
WO/2009/124090
4//40/1440
/4/40/1441
ROBOTICS SYSTEMS
47
C12Q )5010.01(
‫תכשירים ושיטות לטיפול ואבחון של‬
‫אסטמה‬
501211
MOTOR NEURONS DEVELOPED
FROM STEM CELLS
HADASIT MEDICAL RESEARCH
SERVICES & DEVELOPMENT LTD.
US
61/064854
31/03/2008
PCT/IL/2009/000367
WO/2009/122413
B65D )5010.01(
C12N )5010.01(
‫נוירונים מוטוריים המתקבלים מתאי אב‬
‫הדסית שרותי מחקר רפואי ופיתוח בע"מ‬
501216
G06N )5010.01(
‫מערכות רובוטיות‬
December 30, 2010-‫כג' בטבת התשע"א‬
IROBOT CORPORATION
US
61/041707
PCT/US/2008/059856
WO/2009/123650
1//40/1440
02/04/2008
501210
IMPROVED FORMULATIONS FOR
POORLY PERMEABLE ACTIVE
PHARMACEUTICAL INGREDIENTS
ABBOTT PRODUCTS GMBH
EP
08103657.6 22/04/2008
PCT/EP/2009/054720
WO/2009/130204
/1/4//1440
4//40/1440
C07D )5010.01(
‫שיטה לייצור חומר ביניים של דביגאטראן‬
‫אטקסילאט‬
501215
FATTY ACID AMIDES AND USES
THEREOF
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD.
US
61/043483
09/04/2008
PCT/IL/2009/000403
WO/2009/125409
48
‫הרכבים משופרים עבור מרכיבים רוקחיים‬
‫פעילים בעלי חדירות נמוכה‬
501211
METHOD FOR PRODUCING AN
INTERMEDIATE PRODUCT OF
DABIGATRAN ETEXILATE
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
08158364.3 16/06/2008
PCT/EP/2009/057266
WO/2009/153215
A61K )5010.01(
C07C )5010.01(
‫חומצות שומן אמידיות ושימושיהן‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים בע"מ‬
December 30, 2010-‫כג' בטבת התשע"א‬
/4/40/1440
501212
‫ מותאמים‬VII ‫פוליפפטידים פקטור‬
‫ושימושים בהם‬
FACTOR VII POLYPEPTIDES THAT
ARE MODIFIED AND USES THEREOF
CATALYST BIOSCIENCES, INC.
US
61/124021
11/04/2008
PCT/US/2009/002248
WO/2009/126307
1//41/1440
501214
DOUBLE-STRANDED LIPIDMODIFIED RNA HAVING HIGH RNA
INTERFERENCE EFFECT
OTSUKA PHARMACEUTICAL CO.,
LTD.
2008JP
31/03/2008
094154
PCT/JP/2009/056638
WO/2009/123185
11/41/1440
METHOD OF ISOLATING
BIOMACROMOLECULES USING
POLYALKYLENE GLYCOL AND
TRANSITION METALS
BIOGEN IDEC MA INC.
49
C12N )5010.01(
‫ בסלילים כפולים שעברו שינוי‬RNA
‫ גבוה‬RNA ‫בליפיד בעלי אפקט התערבות‬
501215
SYSTEMS AND METHODS FOR
SECURE SHORT MESSAGING
SERVICE AND MULTIMEDIA
MESSAGING SERVICE
CELLTRUST CORPORATION
US
61/040526
28/03/2008
PCT/US/2009/038706
WO/2009/121046
///40/1440
C12N )5010.01(
501211
H04L )5010.01(
‫מערכות ושיטות לשירות מאובטח‬
‫להודעות קצרות ושירות הודעות‬
‫מולטימדיה‬
A61K )5010.01(
‫שיטה לבידוד מקרומוליקולות ביולוגיות‬
‫באמצעות שימוש בפוליאלקילן גליקול‬
‫ומתכות מעבר‬
December 30, 2010-‫כג' בטבת התשע"א‬
US
61/071182
PCT/US/2009/002390
WO/2009/128935
40/4//1440
16/04/2008
501211
‫תרופה חדשה לעיכוב הצטברות של‬
‫חלבונים המעורבים במחלות הקשורות‬
‫או מחלות ניווניות‬/‫להצטברות חלבונים ו‬
‫של מערכת העצבים‬
NEW DRUG FOR INHIBITING
AGGREGATION OF PROTEINS
INVOLVED IN DISEASES LINKED TO
PROTEIN AGGREGATION AND/OR
NEURODEGENERATIVE DISEASES
MAX-PLANCK-GESELLSCHAFT ZUR
FOERDERUNG DER
WISSENSCHAFTEN E.V.
EP
08010458.1 09/06/2008
PCT/EP/2009/004144
WO/2010/000372
4//4//1440
501216
AFFINITY MATURED CRIg
VARIANTS
GENENTECH, INC.
US
61/050888
06/05/2008
////10//1
14/41/1441
US
PCT/US/2009/043020
WO/2009/137605
1//4//1440
50
C07K )5010.01(
‫ בעלי אפיניות טובה‬g CRI ‫וריאנטים של‬
501210
ABROGATING PROINFLAMATORY
CYTOKINE PRODUCTION DURING
ONCOLYTIC REOVIRUS THERAPY
ONCOLYTICS BIOTECH INC.
US
61/056292
27/05/2008
/////1/0/
/1////1441
US
PCT/CA/2009/000721
WO/2009/143611
C07D )5010.01(
A61K )5010.01(
‫ביטול יצור ציטוקינין פרו–דלקתיים במהלך‬
‫ריפוי ריאוירוס אונקוליטי‬
December 30, 2010-‫כג' בטבת התשע"א‬
1//4//1440
501211
MODULATING INTERSTITIAL
PRESSURE AND ONCOLYTIC VIRAL
DELIVERY AND DISTRIBUTION
ONCOLYTICS BIOTECH INC.
US
61/056276
27/05/2008
/////110/
/1////1441
US
PCT/CA/2009/000720
WO/2009/143610
4//4//1440
41/40/1440
‫אפנון לחץ בין רקמתי ומתן וחלוקה של‬
‫וירוס אונקוליטי‬
501215
SYNTHESIS OF
DIHYDROTHIENO[3,2-D]PYRIMIDINE
DIOLS AND SIMILAR PYRIMIDINE
DIOLS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
US
61/052816
13/05/2008
PCT/US/2009/043068
WO/2009/140127
51
C07D )5010.01(
‫ פירימידין‬d[–5,2[ ‫סינטזה של דיהידרו תיאנו‬
‫דיאולים ופירימידין דיאולים דומים‬
501212
ACTION TIMES FOR HANDOVER OF
MOBILE STATIONS
NOKIA SIEMENS NETWORKS OY
US
12/098156
04/04/2008
/1/40/0///
40/40/1441
US
/////00/4
/1////1441
US
/////1//0
11////1441
US
PCT/IB/2009/005681
WO/2009/122304
4//40/1440
A61K )5010.01(
501214
H04W )5010.01(
‫זמני פעולה עבור העברה של תחנות‬
‫ניידות‬
B28B )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
PRESSURE CAST CONCRETE OR
MORTAR LINED STEEL PIPES AND
METHODS OF MAKING THE SAME
AMERON INTERNATIONAL
CORPORATION
US
12/061263
02/04/2008
PCT/US/2009/039091
WO/2009/139974
41/40/1440
501215
USE OF A COMBINATION OF
UDENAFIL AND ALFUZOSIN OR
OXYBUTYNIN FOR THE TREATMENT
OF OVERACTIVE BLADDER
PELVIPHARM
EP
08300170.1 02/04/2008
///40////
41/40/1441
US
PCT/EP/2009/053951
WO/2009/121929
40/40/1441
‫צינורות פלדה מרופדים בבטון או בטיח‬
‫תחת לחץ ושיטות להכנתם‬
‫שימוש בצירוף של אודנאפיל ואלפוזוסין או‬
‫אוקסיבוטינין לטיפול בשלפוחית פעילה‬
‫יתר על המידה‬
501211
LIPID-OIL-WATER NANOEMULSION
DELIVERY SYSTEM FOR
MICROTUBULE-INTERACTING
AGENTS
ROBERT SHORR
A61K )5010.01(
A01N )5010.01(
–‫מערכת לנתינת ננואמולסיה ליפיד–שמן‬
‫מים עבור גורמים הפועלים‬
‫במיקרוצינוריות‬
PCT/US/2008/004393
WO/2009/123595
40/40/1441
PHARMACEUTICAL COMPOSITION
ROBERT SHORR
501211
A61K )5010.01(
‫תכשיר רוקחות‬
PCT/US/2008/004410
WO/2009/123597
52
December 30, 2010-‫כג' בטבת התשע"א‬
1//41/1440
501211
A FIELD EMISSION SYSTEM AND
METHOD
CEDAR RIDGE RESEARCH, LLC
US
61/123019
04/04/2008
/1//11//1
14/4//1441
US
PCT/US/2009/038925
WO/2009/124030
4//40/1440
501216
SEPARATION-APPARATUS
INASHCO R&D B.V.
NL
2001431
02/04/2008
PCT/NL/2009/050165
WO/2009/123452
1//41/1440
501260
PERMEANT DELIVERY SYSTEM AND
METHODS FOR USE THEREOF
ALTEA THERAPEUTICS
CORPORATION
US
61/040744
31/03/2008
////11/4/
1//4//1441
US
PCT/US/2009/039045
WO/2009/124096
///40/1440
501265
NOVEL ESTROGEN RECEPTOR
LIGANDS
KARO BIO AB
GB
0806944.5
16/04/2008
41111//81
11//1/1441
GB
53
H01J )5010.01(
‫שיטה ומערכת לפליטת שדה‬
B07B )5010.01(
‫מכשיר הפרדה‬
A61F )5010.01(
‫מערכת הובלה קבועה ושיטות לשימוש‬
‫שלה‬
C07D )5010.01(
‫ליגנדים חדשים לרצפטור אסטרוגן‬
December 30, 2010-‫כג' בטבת התשע"א‬
PCT/EP/2009/054521
WO/2009/127686
40/40/1440
501262
3-PHENYLPYRAZOLO[5,1b]THIAZOLE COMPOUND
EISAI R&D MANAGEMENT CO., LTD.
2008JP
15/04/2008
106080
///40/410
///40/1441
US
PCT/JP/2009/057270
WO/2009/128383
1//41/1440
41//4/14/4
‫]תיאזול‬b–1,5[‫–פנילפירזולו‬2 ‫תרכובת‬
501265
METHODS OF EXPRESSING A
PLOYPEPTIDE IN THE BRAIN AND
NUCLEIC ACID CONSTRUCTS
CAPABLE OF SAME
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
US
61/064939
03/04/2008
PCT/IL/2009/000341
WO/2009/122401
54
C12N )5010.01(
‫שיטות לביטוי פוליפפטידים במוח‬
‫וקונסטקרטים של חומצות גרעין למטרה‬
‫זו‬
501261
GUIDED SURGERY
NAVOTEK MEDICAL LTD
US
60/865888
15/11/2006
///111//0
///4//14/4
US
///40/1441
C07D )5010.01(
501261
‫ידע חברה למחקר ופיתוח בע"מ‬
A61B )5010.01(
‫ניתוח מודרך‬
‫נבוטק מדיקל בע"מ‬
A61B )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
INTRAMEDULLARY DEVICE
ASSEMBLY AND ASSOCIATED
METHOD
OLECRANAIL LLC
US
12/059701
31/03/2008
PCT/US/2008/060294
WO/2009/139758
11/4//1441
501266
4-[(-METHYL-4-OXIDO-1PIPERAZINYL)-METHYL]-N-{4METHYL-3[[4-(3-PYRIDINYL)-2PYRIMIDINYL]-AMINO]-PHENYL}BENZAMIDE,PHARMACEUTICAL
COMPOSITIONS COMPRISING IT
AND USE THEREOF FOR THE
PREPARATION OF MEDICAMENTS
FOR THE TREATMENT OF A
PROLIFERATIVE DISORDER
NOVARTIS AG
GB
0201508.9
23/01/2002
PCT/EP/2003/000613
WO/2003/062220
41//4/14/4
‫התקן ושיטה להרכבה תוך–עצמית‬
–)‫–פיפראזיניל‬1–‫–אוקסידו‬4–‫–מתיל‬4([–
–5–)‫–פירידיניל‬N–{4–(3–]‫מתיל‬
‫ תכשירי‬,‫פירימידיניל]–אמינו]–פניל}–בנזמיד‬
‫רוקחות המכילים אותו ושימושו בייצור‬
‫תכשירים רוקחיים לטיפול בליקוי‬
‫פרולפרטיבי‬
501400
APPARATUS FOR FOLDING TEXTILE
ARTICLES
FOLD FOR ME LTD
41/40/1440
501401
SHARED VIRTUAL AREA
COMMUNICATION ENVIRONMENT
BASED APPARATUS AND METHODS
55
C07D )5010.01(
B65B )5010.01(
‫התקן לקיפול מוצרי טקסטיל‬
‫קפל לי בע"מ‬
G06F )5010.01(
‫שיטות והתקנן המבוססים על סביבת‬
‫תקשורת שיתופית‬
December 30, 2010-‫כג' בטבת התשע"א‬
SOCIAL COMMUNICATIONS
COMPANY
US
61/042714
05/04/2008
PCT/US/2009/039470
WO/2009/146130
41/40/1440
501405
NOVEL ANTIBODIES AGANIST
CANCER TARGET BLOCK TUMOR
GROWTH, ANGIOGENESIS AND
METASTASIS
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
61/042604
04/04/2008
/////14/0
/4////1441
US
PCT/US/2009/039526
WO/2009/124281
41/40/1440
501402
COMPOSITIONS AND USE OF EPAS1
INHIBITORS
CALANDO PHARMACEUTICALS,
INC.
US
61/123069
04/04/2008
PCT/US/2009/002125
WO/2009/123764
///41/1440
501404
WEB FOR RETENTION OF INTERNAL
BODILY SECRETIONS
BTAMPON IP
US
61/064565
12/03/2008
///4/0011
4//40/1441
US
PCT/EP/2009/052867
WO/2009/112527
56
C07K )5010.01(
‫נוגדנים חדשים כנגד סרטן המיועדים‬
‫לחסום צמיחת גידולים היווצרות כלי דם‬
‫חדשים והיווצרות גרורות‬
C12N )5010.01(
EPAS1 ‫הרכבים ושימושים של מעכבי‬
A61F )5010.01(
‫רשת לאצירת הפרשות גוף פנימיות‬
December 30, 2010-‫כג' בטבת התשע"א‬
14/40/1440
501405
SUBSTITUTED PYRIMIDIN-5CARBOXAMIDES 281
ASTRAZENECA AB
US
61/046836
22/04/2008
////0414/
11//1/1441
US
PCT/GB/2009/050392
WO/2009/130496
1//41/1440
1//41/1440
511 ‫–קרבוקסאמידים מותמרים‬5–‫פירימידינ‬
501401
TREATMENT OF BRAIN DAMAGE
DAMAGE USING UMBILICAL CORD
CELLS
STEMCYTE, INC.
US
61/072173
28/03/2008
PCT/US/2009/001915
WO/2009/120368
STRUCTURALLY ENHANCED
PLASTICS WITH FILLER
REINFORCEMENTS
57
A61K )5010.01(
‫טיפול בנזק מוחי באמצעות תאי דם מחבל‬
‫הטבור‬
501401
EXPANSIBLE BIOCOMPATIBLE
COATS COMPRISING A
BIOLOGICALLY ACTIVE
SUBSTANCE
AVIDAL VASCULAR GMBH
EP
08006483.5 31/03/2008
///4040//
1//41/1441
US
PCT/EP/2009/002348
WO/2009/121565
1//4//1440
C07D )5010.01(
501401
A61M )5010.01(
‫ציפויים נמתחים מתאימים ביולוגית‬
‫המכילים חומר פעיל ביולוגית‬
C08J )5010.01(
‫מילוי פלסטי לחיזוק מבני‬
December 30, 2010-‫כג' בטבת התשע"א‬
ECOPURO
US
61/070876
PCT/US/2009/045180
WO/2009/132361
4//41/144/
26/03/2008
501406
COUPLING REACTIONS USEFUL IN
THE PREPARATION OF (1HTETRAZOL-5-YL)-BIPHENYL
DERIVATIVES
NOVARTIS AG
GB
0402262.0
02/02/2004
PCT/EP/2005/000978
WO/2005/075462
41/40/1440
C07D )5010.01(
‫תגובות צימוד השימושיות להכנת נגזרות‬
‫–יל)–ביפניל‬5–‫–טטרזול‬H1( ‫של‬
501410
C07D )5010.01(
B ‫אנלוגים של הליקונדרין‬
HALICHONDRIN B ANALOGS
EISAI R&D MANAGEMENT CO., LTD.
US
61/042643
04/04/2008
///4/////
///40/1441
US
PCT/US/2009/039432
WO/2009/124237
4//40/1440
501411
BLOW MOLDED POLYESTER
CONTAINER WITH AN OVERMOLDED THERMOPLASTIC LAYER
COLGATE-PALMOLIVE COMPANY
US
12/062999
04/04/2008
PCT/US/2009/039628
WO/2009/154845
1//41/1440
58
B65D )5010.01(
‫מיכל פוליאסטר המתמצק בנשיפה עם‬
‫שכבה תרמופלסטית המוצקת מעליו‬
501415
F16K )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
DEVICE FOR DISPENSING
EFFERVESCENT BEVERAGES AND A
THREE-WAY VALVE
SERGEI ALEKSANDROVICH BUCHIK
RU
RU2008112626 01/04/2008
PCT/RU/2009/000141
WO/2009/123504
1//41/1440
‫התקן לאספקת משקאות תוססים‬
‫ושסתום תלת–כיווני‬
501412
‫מנגנון למשאבות הזנה המונע זרימה‬
‫חופשית‬
ANTI-FREE FLOW MECHSNISM FOR
ENTERAL FEEDING PUMPS
ZEVEX, INC
US
61/041561
01/04/2008
PCT/US/2009/039034
WO/2009/124091
41/40/1440
501414
HANDS-FREE BREAST PUMP
SYSTEM
BRITTNER LYNDON
US
61/042095
03/04/2008
PCT/US/2009/039335
WO/2009/124199
4//40/1440
59
A61M )5010.01(
‫משאבת הנקה המאפשרת ידיים חופשיות‬
501415
GUIDED DENTAL IMPLANTATION
SYSTEM AND ASSOCIATED DEVICE
AND METHOD
NEOCIS, LLC
US
61/041722
02/04/2008
PCT/US/2009/039081
WO/2009/124110
A61M )5010.01(
A61C )5010.01(
‫מערכת מונחית להשתלה דנטלית והתקן‬
‫ושיטה הקשורים בה‬
December 30, 2010-‫כג' בטבת התשע"א‬
41/40/1440
501411
LOW THRESHOLD VOLTAGE ANTIFUSE DEVICE
SIDENSE CORP.
US
61/042511
04/04/2008
/1/1//111
4/////1441
US
PCT/CA/2009/000429
WO/2009/121182
10/41/1440
‫רכיב נגד היתך בעל מתח סף נמוך‬
501411
TEST CIRCUIT FOR AN
UNPROGRAMMED OTP MEMORY
ARRAY
SIDENSE CORP.
US
61/042052
03/04/2008
/1/1011//
11//1/1441
US
PCT/CA/2009/000368
WO/2009/121165
14/41/1441
APPARATUS AND METHOD FOR
TRACKING REQUESTS IN A MULTI
THREADED MULTI TIER
COMPUTERIZED ENVIRONMENT
CORRELSENSE LTD
G11C )5010.01(
G11C )5010.01(
‫מעגל מבדק עבור מערך זכרון הניתן‬
‫ שאינו מתוכנת‬,‫לתכנות חד–פעמי‬
501411
G06F )5010.01(
‫מערכת ושיטה למעקב אחר בקשות‬
‫בסביבה ממוחשבת מרובת נתיבים ומרובת‬
‫רבדים‬
PCT/IL/2008/000439
WO/2009/122390
41//4/14/4
HEATING ASSEMBLY FOR A HOT
WATER TANK
ELIAHU BABI
60
501416
A47J )5010.01(
‫מכלול חימום לדוד מים‬
‫יונה‬-‫אמנון חכם‬
December 30, 2010-‫כג' בטבת התשע"א‬
4//40/1440
501450
METHOD AND APPARATUS FOR
COOLING BIOLOGICAL TISSUE
THE GENERAL HOSPITAL
CORPORATION
US
61/041593
01/04/2008
PCT/US/2009/039067
WO/2009/146053
4//40/1440
501451
PROCOLLAGEN C-PROTEINASE
ENHANCER (PCPE) BIOMARKER FOR
BONE FORMATION
TEL HASHOMER MEDICAL
RESEARCH INFRASTRUCTURE AND
SERVICES LTD
US
61/064901
02/04/2008
PCT/IB/2009/051376
WO/2009/122367
10/41/1440
501455
BIOLAMINATE COMPOSITE
ASSEMBLY AND RELATED
METHODS
BIOVATION, LLC,
US
61/038971
24/03/2008
PCT/US/2009/001827
WO/2009/120311
1//41/1440
501452
DEVICE FOR IN SITU PRODUCTION
AND TOPICAL ADMINISTRATION OF
ALLICIN
61
A61F )5010.01(
‫שיטה ומערכת לקירור רקמה ביולוגית‬
‫ דיאטר‬,‫מנשטיין‬
G01N )5010.01(
C ‫מגביר פרוקולאגן פרוטאינזה‬
‫()ביוסאמן ליצירת עצם‬PCPE
‫תל השומר למחקר רפואי תשתיות‬
‫ושירותים בע"מ‬
G01N )5010.01(
‫מכלול ביו–מרובד (ביולמינט) מרוכב‬
‫ושיטות להכנתו‬
A61K )5010.01(
‫מתקן להכנה במקום ומתן מקומי של‬
‫אליצין‬
December 30, 2010-‫כג' בטבת התשע"א‬
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
US
61/041452
01/04/2008
PCT/IL/2009/000350
WO/2009/122404
4//40/1441
501454
MODIFIED HYDROXYPOLYMER
CONJUGATES WITH BONE SEEKING
AND TUMOR KILLING MOIETIES
DEXTECH MEDICAL AB
‫ידע חברה למחקר ופיתוח בע"מ‬
A61K )5010.01(
‫מצמדי הידרוקסיפרופיל ששונה עם‬
‫קבוצות מבוייתות עצם וקוטלות גידול‬
PCT/EP/2008/054139
WO/2009/124580
41/40/1440
501455
METHOD FOR ASSEMBLING TWO
SURFACES, OR ONE SURFACE WITH
A MOLECULE OF INTEREST
COMMISSARIAT A L'ENERGIE
ATOMIQUE ET AUX ENERGIES
ALTERNATIVES
FR
0852209
03/04/2008
41//1/0
1///4/1441
FR
PCT/EP/2009/053977
WO/2009/121944
14/41/1440
501451
METHODS AND APPARATUS FOR
DYNAMIC LOAD BALANCING WITH
E-AICH
QUALCOMM INCORPORATED
US
61/041059
31/03/2008
/1/040///
///41/1440
US
PCT/US/2009/038765
WO/2009/123963
62
C09J )5010.01(
‫שיטה להרכבת שני משטחים או משטח‬
‫אחד עם מולקולה מעניינת‬
H04W )5010.01(
‫שיטות והתקנים לאיזון עומס דינמי עם‬
AICH–E
December 30, 2010-‫כג' בטבת התשע"א‬
14/41/1440
501451
DYNAMIC FREQUENCY SCALING OF
A SWITCHED MODE POWER SUPPLY
QUALCOMM INCORPORATED
US
61/041085
31/03/2008
/1/10/04/
1//41/1440
US
PCT/US/2009/038753
WO/2009/123955
10/40/1440
‫שינוי גודל תדר דינמי של ספק כוח במצב‬
‫מוחלף‬
501451
ASSIGNMENT OF ACK RESOURCE IN
A WIRELESS COMMUNICATION
SYSTEM
QUALCOMM INCORPORATED
US
61/048911
29/04/2008
///4010//
10/40/1441
US
///40011/
41/4//1441
US
/1/01/010
11/40/1440
US
PCT/US/2009/042166
WO/2009/134926
41/40/1440
63
H04W )5010.01(
‫ במערת תקשורת‬ACK ‫הקצאה משאב‬
‫אלחוטית‬
501456
EX-VIVO MULTI-DIMENSIONAL
SYSTEM FOR THE SEPARATION AND
ISOLATION OF CELLS, VESICLES,
NANOPARTICLES AND
BIOMARKERS
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
61/042228
03/04/2008
PCT/US/2009/039565
WO/2009/146143
H04B )5010.01(
G01N )5010.01(
‫מערכת רב–מימדית חוץ–גופנית ובידוד של‬
‫ ננוחלקיקים וסמנים‬,‫ שלפוחיות‬,‫תאים‬
‫ביולוגיים‬
December 30, 2010-‫כג' בטבת התשע"א‬
4//40/1441
501420
TRANSMISSION OF OVERHEAD
CHANNELS WITH TIMING OFFSET
AND BLANKING
QUALCOMM INCORPORATED
US
61/043102
07/04/2008
///4///14
1//4//1441
US
/1/0/41//
10/41/1440
US
PCT/US/2009/039818
WO/2009/126658
40/40/1440
11/40/1440
SIGNALING MESSAGE
TRANSMISSION IN A WIRELESS
COMMUNICATION NETWORK
64
A01N )5010.01(
‫שיטות דיכוי משופרת להשבחת פתוגן תא‬
‫דם אדום‬
501425
NULL PILOTS FOR INTERFERENCE
ESTIMATION IN A WIRELESS
COMMUNICATION NETWORK
QUALCOMM INCORPORATED
US
61/047063
22/04/2008
////41010
10//4/1441
US
/1/01/101
///40/1440
US
PCT/US/2009/041456
WO/2009/132143
1//41/1440
‫שידור של ערוצי תקורה עם פיצוי תזמון‬
‫ומחיקה‬
501421
IMPROVED QUENCHING METHODS
FOR RED BLOOD CELL PATHOGEN
INACTIVATION
CERUS CORPORATION
US
61/043666
09/04/2008
///41/410
4//41/1441
US
PCT/US/2009/040032
WO/2009/126786
H04W )5010.01(
H04W )5010.01(
‫פיילוטים בטלים להערכת הפרעה ברשת‬
‫תקשורת אלחוטית‬
501422
H04L )5010.01(
‫שידור מסר איתות ברשת תקשורת‬
‫אלחוטית‬
December 30, 2010-‫כג' בטבת התשע"א‬
QUALCOMM INCORPORATED
US
61/040489
28/03/2008
/1/0//1/1
1//41/1440
US
PCT/US/2009/038526
WO/2009/120941
1//41/1440
501424
MESSAGE SIGNALLING VIA
SELECTION OF ONE MULTIPLE
SUBCARRIERS IN A SYMBOL
PERIOD OR SELECTION OF ONE OF
MULTIPLE SYMBOL PERIODS ON
ONE SUBCARRIER
QUALCOMM INCORPORATED
US
61/040489
28/03/2008
/1/0//1/1
1//41/1440
US
PCT/US/2009/038530
WO/2009/120943
1//40/1440
‫איתות מסר דרך בחירת אחד מתוך הרבה‬
‫תת–נשאים בתקופת סמל או בחירת אחת‬
‫מתוך הרבה תקופות סמל בתת–נשא אחד‬
501425
METHOD AND APPARATUS FOR
MANAGEMENT OF AUTOMATIC
NEIGHBOR RELATION FUNCTION IN
WIRELESS NETWORKS
QUALCOMM INCORPORATED
US
61/046713
21/04/2008
///4//01/
41/4//1441
US
/1/01///0
14/40/1440
US
PCT/US/2009/041297
WO/2009/132034
///40/1440
65
H04W )5010.01(
‫שיטה והתקן לניהול פונקצית יחס שכן‬
‫אוטומטית ברשתות אלחוטיות‬
501421
METHOD AND APPARATUS FOR
MAINTAINING SPEECH AUDIBILITY
IN MULTI-CHANNEL AUDIO WITH
MINIMAL IMPACT ON SURROUND
EXPERIENCE
H04L )5010.01(
G10L )5010.01(
‫שיטה והתקן לשמורה על שמיעות דיבור‬
‫באודיו רב–ערוצי עם השפעה מזערית על‬
‫חווית סראונד‬
December 30, 2010-‫כג' בטבת התשע"א‬
DOLBY LABORATORIES LICENSING
CORPORATION
US
61/046271
18/04/2008
PCT/US/2009/040900
WO/2010/011377
11/40/1440
501421
SILICIA FOR THE INHINITION OF A
APROTEASE
INEOS HEALTHCARE LIMITED
GB
0807621.8
25/04/2008
PCT/GB/2009/001055
WO/2009/130478
4//4//1440
41/40/1440
‫סיליכה לעיכוב פרוטאז‬
501421
COMPOSITIONS FOR ENHANCING
THE ANTIBACTERIAL ACTIVITY OF
MYELOPEROXIDASE AND METHODS
OF USE THEREOF
EXOXEMIS, INC.
US
12/118586
09/05/2008
PCT/US/2009/043172
WO/2009/137697
A61K )5010.01(
‫תכשירים להגברת הפעילות‬
‫האנטיבקטריאלית של מיילופראוקסידאז‬
‫ושיטות לשימוש בהם‬
501426
IDENTIFICATION AND AUTHENTICATION
USING LIQUID CRYSTAL MATERIAL
MARKINGS
SICPA HOLDING SA
WO
PCT/IB2008/000785 02/04/2008
PCT/EP/2009/002435
WO/2009/121605
66
A61K )5010.01(
B42D )5010.01(
‫זיהוי ואימות המשתמשים בסימוני‬
‫חומר גביש נוזלי‬
December 30, 2010-‫כג' בטבת התשע"א‬
41/41/1440
501440
ORAL AND INJECTABLE
FORMULATIONS OF TETRACYCLINE
COMPOUNDS
PARATEK PHARMACEUTICALS, INC.
US
61/040398
28/03/2008
PCT/US/2009/001973
WO/2009/120389
41/40/1440
‫תכשירי תרכובות טטראציקלין למתן פומי‬
‫ולהזרקה‬
501441
NOVEL SUSTAINABLE BUILDING
MODEL
EDIFICIOS SOSTENIBLES GETECH,
S.L.
ES
P200800952 04/04/2008
PCT/ES/2009/000180
WO/2009/121990
4//40/1440
501445
METHOD AND APPARATUS FOR
TISSUE GRAFTING
THE GENERAL HOSPITAL
CORPORATION
US
61/041587
01/04/2008
PCT/US/2009/039114
WO/2009/146068
1//41/1440
501442
APPARATUS AND METHOD FOR
SURFACE COOLING
THE GENERAL HOSPITAL
CORPORATION
US
61/040053
27/03/2008
PCT/US/2009/038422
WO/2009/120876
67
A61K )5010.01(
F24F )5010.01(
‫מודל בנייה בר קיימא‬
A61B )5010.01(
‫שיטה ומערכת להשתלת רקמות‬
A61F )5010.01(
‫מערכת ושיטה לקירור משטח‬
December 30, 2010-‫כג' בטבת התשע"א‬
4//40/1440
501444
STATIONARY SOLAR SPECTRUMSPLITTING SYSTEM AND METHOD
FOR STIMULATING A BROAD BAND
PHOTOVOLTIAIC CELL ARRAY
MOSAIC CRYSTALS LTD.
US
61/041366
01/04/2008
PCT/IL/2009/000371
WO/2009/122414
41/40/1440
H01L )5010.01(
–‫מערכת סולארית נייחת מפצלת‬
‫ספקטרום ושיטה לעירור מערך תאים‬
‫פוטו–וולטאים רחבי פס‬
‫מוזאיק קריסטלס בע"מ‬
501445
A61K )5010.01(
COMPOSITIONS AND METHODS FOR
IMMUNOTHERAPY
COGNATE 3, LLC
US
61/042210
03/04/2008
PCT/US/2009/002134
WO/2009/145841
501441
41//4/14/4
G08B )5010.01(
EARTHQUAKE DETECTION AND
ALARMING APPARATUS
HABIB JERIES NASSER
US
US61/042768
04/07/2008
WO
PCT/IL2009/000370 4//40/1440
‫מכשיר לאיתור ואתראה על רעידת‬
‫אדמה‬
‫מאיר גיטליס‬
501441
G06F )5010.01(
4//40/1440
DROP CONTROLLING AND
COUNTING-VALVE ON KEY
PRO-IV LTD
US
61/064902
02/04/2008
PCT/IB/2009/051379
68
‫תרכובות ושיטות לאימונותרפיה‬
‫בקרה ומניית טיפה שסתום על מפתח‬
‫איי וי בע"מ‬-‫פרו‬
December 30, 2010-‫כג' בטבת התשע"א‬
WO/2009/122369
/0/41/1440
501441
ACTIVATION TIME FOR TARGET
BASED HIGH SPEED SERVING CELL
CHANGE
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL)
US
61/041283
01/04/2008
PCT/SE/2009/050285
WO/2009/123545
/0//1/1441
‫זמן הפעלה עבור שינוי תא שרת מהירות‬
‫גבוהה מבוסס יעד‬
501446
METHOD AND DEVICE FOR
OPERATING AN ACCESS NETWORK
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL)
US
61/046190
18/04/2008
PCT/EP/2008/068099
WO/2009/127276
/1/41/1440
/0/41/1440
69
H04W )5010.01(
‫שיטה והתקן להפעלת רשת גישה‬
501450
UNMANNED AIRCRAFT SYSTEM
AND METHOD OF OPERATING SAME
MITSUBISHI HEAVY INDUSTRIES,
LTD.
2008JP
21/08/2008
212958
PCT/JP/2009/064315
WO/2010/021295
H04W )5010.01(
B64C )5010.01(
‫מערכת מטוס ללא טייס ושיטה להפעלתה‬
501451
A61K )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
PHARMACEUTICAL COMPOSITIONS
COMPRISING A
CHEMOTHERAPEUTIC AGENT AND
AN ANTI-GLYPICAN 3 ANTIBODY
FOR USE IN TREATING HEPATIC
CANCER
CHUGAI SEIYAKU KABUSHIKI
KAISHA
2008JP
04/04/2008
098309
1441/441/04 1//40/1441
JP
PCT/JP/2009/001249
WO/2009/122667
14/4//1440
‫תכשירי רוקחות המכילים חומר כימותרפי‬
‫ לשימוש בטיפול‬2 ‫ונוגדן נגד גליפיקן‬
‫בסרטן הכבד‬
501452
‫התקן צינור מכני מתאם‬
‫פלסים אביזרים בע"מ‬
MECHANICAL PIPE FITTING DEVICE
PLASSIM FITTINGS LTD.
US
61/041490
03/04/2008
PCT/IL/2009/000079
WO/2009/122391
1//41/1440
501454
METHODS OF CHEMOTYPE
EVOLUTION
SUNESIS PHARMACEUTICALS, INC.
US
61/039422
25/03/2008
///40/1//
///40/1441
US
///401/0/
11/40/1441
US
PCT/US/2009/038276
WO/2009/120795
1//41/1440
70
C12Q )5010.01(
‫שיטות של התפתחות כימוטייפ‬
501455
CAPSULE FOR THE PREVENTION OF
CARDIOVASCULAR DISEASES
FUNDACION CENTRO
EP
08153615.3 28/03/2008
PCT/EP/2009/053545
F16L )5010.01(
A61K )5010.01(
‫כמוסה למניעת מחלות קרדיו–וסקורליות‬
December 30, 2010-‫כג' בטבת התשע"א‬
WO/2009/118359
1//41/1440
501451
IMPAIRED ALLELES OF GENES
INVOLVED IN METABOLIC
PATHWAYS AND METHODS FOR
DETECTING AND USING THE SAME
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
61/040020
27/03/2008
PCT/US/2009/038703
WO/2009/121044
14/41/1440
501451
COMPOSITIONS AND METHODS FOR
THE PREPARATION OF
NANOEMULSIONS
THE UNIVERSITY OF
MASSACHUSETTS
US
61/040,482
28/03/2008
////00011/
/1/4//1440
US
////00010/
/1/4//1440
US
PCT/US/2009/038835
WO/2009/121069
10/41/1440
501451
COMPOSITIONS AND METHODS FOR
SKIN CARE
ANTIPODEAN PHARMACEUTICALS,
INC.
US
61/041551
01/04/2008
PCT/US/2009/038123
WO/2009/145982
71
C12Q )5010.01(
‫אללים פגומים של גנים מעורבים‬
‫במסלולים מטבולים ושיטות גילויהם‬
‫ושימושיהם‬
A61K )5010.01(
‫הרכבים ושיטות להכנת מיקרואמולסיות‬
A61K )5010.01(
‫הרכבים ושיטות לטיפול בעור‬
December 30, 2010-‫כג' בטבת התשע"א‬
/1/41/1440
501456
GYPSUM MORTAR WITH ADDED
EXPANDED VERMICULITE AND
METHOD FOR OBTAINING SAME
TORRES ZACARIAS, PILAR
ES
P200800891 31/03/2008
PCT/ES/2009/000148
WO/2009/121984
14//1/144/
‫גבס לטיוח בתוספת של ורמיקוליט מורחב‬
‫ושיטה להשגתו‬
501410
HIGH ENERGY SOLID-STATE LASER
WITH OFFSET PUMP AND
EXTRACTION GEOMETRY
RAYTHEON COMPANY
US
11/033585
12/01/2005
PCT/US/2005/047620
WO/2007/084111
14/41/1440
501411
3-SUBSTITUTED-2 (ARYLALKYL)-1AZABICYCLOALKANES AND
PHARMACEUTICAL COMPOSITIONS
COMPRISING THEM
TARGACEPT, INC.
US
10/372642
21/02/2003
PCT/US/2004/005044
WO/2004/076449
14/41/1440
501415
3-SUBSTITUTED-2 (ARYLALKYL)-1AZABICYCLOALKANES AND
PHARMACEUTICAL COMPOSITIONS
COMPRISING THEM
TARGACEPT, INC.
US
10/372642
21/02/2003
PCT/US/2004/005044
72
C04B )5010.01(
H01S )5010.01(
‫לייזר מצב מוצק בעל אנרגיה גבוהה עם‬
‫משאבה מאזנת ויחוס גאומטרי‬
C07D )5010.01(
‫–אזאביציקלואלקנים‬1–‫ארילאלקיל‬
‫ ותכשירים‬2 ‫ בעמדה‬5–‫המותמרים‬
‫רוקחיים המכילים אותם‬
C07D )5010.01(
‫–אזאביציקלואלקנים‬1–‫ארילאלקיל‬
‫ ותכשירים‬2 ‫ בעמדה‬5–‫המותמרים‬
‫רוקחיים המכילים אותם‬
December 30, 2010-‫כג' בטבת התשע"א‬
WO/2004/076449
40/40/1440
501412
FUSED RING COMPOUNDS AND USE
THEREOF
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
2008JP
10/04/2008
102691
PCT/JP/2009/057625
WO/2009/125873
/0/40/1440
501414
ALLOCATION OF CONTROL
RESOURCES OF A FEMTO CELL TO
AVOID INTERFERENCE WITH A
MACRO CELL
QUALCOMM INCORPORATED
US
61/044835
14/04/2008
/1/0/011/
4//40/1440
US
PCT/US/2009/040558
WO/2009/129261
1//40/1440
501415
PHENYL -SUBSTITUTED 2-IMINO-3METHYL PYRROLO PYRIMIDINONE
COMPOUNDS AS BACE1INHIBITORS, COMPOSITIONS, AND
THEIR USE
SCHERING CORPORATION
US
61/047006
22/04/2008
PCT/US/2009/041202
WO/2009/131975
73
C07D )5010.01(
‫תרכובות טבעת מאוחה ושימוש שלהן‬
H04W )5010.01(
‫הקצאת משאבי בקרה של תא פמטו‬
‫למניעת הפרעה עם תא מקרו‬
C07D )5010.01(
‫–מתיל פירולו‬2–‫–אימינו‬5 ‫תכתובות‬
–1 ‫פירימידון המותמרות בפניל כמעכבי‬
‫ הרכבים ושימושיהן‬,BACE
December 30, 2010-‫כג' בטבת התשע"א‬
501411
11/40/1440
‫נגזרות איזוקינולינון כאנטגוניסטים של‬
NK2
ISOQUINOLINONE DERIVATIVES AS
NK3 ANTAGONISTS
H. LUNDBECK A/S
DK
DK/2008/050092 24/04/2008
PCT/EP/2009/054806
WO/2009/130240
40/4//1440
501411
3,4-SUBSTITUTED PIPERIDINE
DERIVATIVES AS RENIN INHIBITORS
MERCK SHARP & DOHME LIMITED
US
61/126529
05/05/2008
////11141
4//41/1441
US
PCT/CA/2009/000611
WO/2009/135299
10/40/1440
501411
501416
BODY PASSAGE CELEANSING
DEVICE
JETPREP LTD
US
61/043136
08/04/2008
///4/11/1
41/4//1441
US
PCT/IL/2009/000346
WO/2009/125387
74
C07D )5010.01(
4–‫ ו‬2 ‫נגזרות פיפרידין המותמרות בעמצות‬
‫המעקבי רנין‬
NOVEL PYRIPROXYFEN
COMPOSITIONS
VALENT U.S.A. CORPORATION
US
61/048974
30/04/2008
PCT/US/2009/002615
WO/2009/134375
1//41/1440
C07D )5010.01(
A01N )5010.01(
‫הרכבי פיריפרוקסיפן חדשים‬
A61B )5010.01(
‫מתקן שטיפה למעבר גופני‬
‫ג'טפרט בע"מ‬
December 30, 2010-‫כג' בטבת התשע"א‬
41/40/1440
501410
METHOD OF MANUFACTURING A
DISPOSABLE EJECTION DEVICE
PRIMEQUAL S.A.
FR
08/01972
10/04/2008
PCT/IB/2009/051475
WO/2009/125353
41/40/1440
501415
PROCESS FOR BROMINNATING
BUTADIENE/VINYL AROMATIC
COPOLYMERS
DOW GLOBAL TECHNOLOGIES INC.
US
61/042915
07/04/2008
////401/4
10//4/1441
US
PCT/US/2009/039461
WO/2009/126531
10/41/1440
501412
SYSTEMS AND METHODS FOR
INCIDENT RECORDING
TASER INTERNATIONAL, INC.
US
61/042751
06/04/2008
/1/1//0//
4/////1441
US
PCT/US/2009/038093
WO/2009/126432
4///4/14/4
501414
INFRA-RED IMAGER
SEMI-CONDUCTOR DEVICES - AN
ELBIT SYSTEMS - RAFAEL
PARTNERSHIP
US
61/249320
07/10/2009
75
A61M )5010.01(
‫שיטה לייצור התקן פליטה חד–פעמי‬
C08C )5010.01(
‫תהליך לברומינציה של פולימרים‬
‫ויניל‬/‫ארומטיים של בוטאדיאן‬
H04N )5010.01(
‫מערכת ושיטה לרישום אירועים‬
G01J )5010.01(
‫מדמה אינפרא–אדום‬
‫ שותפות אלביט‬- ‫התקני מצב מוצק‬
‫ רפא"ל‬- ‫מערכות‬
December 30, 2010-‫כג' בטבת התשע"א‬
4//40/1440
501415
MOBILE INTELLIGENT METERING
AND CHARGING SYSTEM FOR
CHARGING UNIQUELY
IDENTIFIABLE CHARGEABLE
VEHICLE DESTINATIONS AND
METHOD FOR EMPLOYING SAME
JUICE TECHNOLOGIES, LLC
US
61/123701
10/04/2008
///41/1//
4//41/1441
US
/1/1/////
1/////1441
US
PCT/US/2009/039768
WO/2009/126622
1//41/1440
501411
CHARGING IN LTE/EPC
COMMUNICATION NETWORKS
ALCATEL-LUCENT USA INC.
US
12/107507
22/04/2008
PCT/US/2009/001917
WO/2009/131614
14/41/1440
501416
METHOD AND APPARATUS FOR
LOCAL MODIFICATION OF
ATMOSPHERE
SERGEY BOLOGUROV
RU
2008113605 10/04/2008
PCT/IB/2009/005049
WO/2009/125264
76
G01R )5010.01(
‫מערכת מדידה חכמה למדידה וגבייה‬
‫לגביית יעדי רכב הניתנים לזיהוי ולגבייה‬
‫ושיטה לשימוש בה‬
H04W )5010.01(
EPC/LTE ‫חיוב במערכת תקשורת‬
A01G )5010.01(
‫שיטה ומערכת לשינוי מקומי של‬
‫האטמוספירה‬
December 30, 2010-‫כג' בטבת התשע"א‬
40/40/1440
501410
THIAZOLOPYRIDIN-2-YLOXYPHENYL AND THIAZOLOPYRAZIN-2YLOXY-PHENYL AMINES AS
MODULATORS OF LEUKOTRIENE A4
HYDROLASE
JANSSEN PHARMACEUTICA, N.V.
US
61/044349
11/04/2008
////00/10
41/41/1440
US
PCT/US/2009/040070
WO/2009/126806
/4/40/1440
‫–אילאוקסי–פניל‬5–‫תיאזולופירידין‬
‫–אילאוקסי–פניל אמינים‬5–‫ותיאזולופיראזין‬
‫ הידרולאז‬A4 ‫כמאפנני לוקוטריאן‬
501411
501415
STABILIZED OLEOSOME
PREPARATIONS AND METHODS OF
MAKING THEM
SEMBIOSYS GENETICS INC.
US
61/044141
11/04/2008
PCT/US/2009/002243
WO/2009/126302
14/40/1440
77
A61K )5010.01(
‫הרכבים מיוצבים המכילים אוליאוסום‬
‫ושיטות להכנתם‬
501412
LIMK2 INHIBITORS, COMPOSITIONS
COMPRISING THEM, AND METHODS
OF THEIR USE
LEXICON PHARMACEUTICALS, INC.
US
61/046602
21/04/2008
A61K )5010.01(
‫שחרור מבוקר של רכיבים פעילים‬
‫מאוליאוסום‬
CONTROLLED RELEASE OF ACTIVE
AGENTS FROM OLEOSOMES
SEMBIOSYS GENETICS INC.
US
61/071109
11/04/2008
PCT/US/2009/002242
WO/2009/126301
/4/40/1440
C07D )5010.01(
C07D )5010.01(
‫ תכשירים המכילים אותם‬,LIMK 5 ‫מעכבי‬
‫ושיטות לשימוש בהם‬
December 30, 2010-‫כג' בטבת התשע"א‬
PCT/US/2009/041126
WO/2009/131940
/1/41/1440
501414
METHOD OF TREATING CITRUS
PLANTS TO REDUCE BACTERIAL
INFECTIONS
BAYER CROPSIENCE LP
US
61/125039
22/04/2008
PCT/US/2009/033854
WO/2009/131735
11/40/1440
‫שיטה לטיפול בצמחי פרי הדר על מנת‬
‫להקטין זיהומים בקטריאליים‬
501415
AN ELECTRICALLY HEATED
SMOKING SYSTEM HAVING A
LIQUID STORAGE PROTION
PHILIP MORRIS PRODUCTS S.A.
EP
08251579.2 30/04/2008
PCT/EP/2009/002923
WO/2009/132793
11/40/1440
PROJECTION OF IMAGES ONTO
TANGIBLE USER INTERFACES
78
A24F )5010.01(
‫מערכת עישון מחוממת באופן אלקטורני‬
‫ובעלת חלק אחסון לנוזל‬
501411
SOLID PHARMACEUTICAL
FORMULATION WITH DELAYED
RELEASE
BAYER ANIMAL HEALTH GMBH
DE
102008022520.7 07/05/2008
PCT/EP/2009/002951
WO/2009/135593
1//41/1440
C07D )5010.01(
501411
A61K )5010.01(
‫הרכבי רוקחות מוצקים בעלי שחרור‬
‫מושהה‬
G03B )5010.01(
‫הקרנת דמויות על ממשקים משתמש‬
‫ממשיים‬
December 30, 2010-‫כג' בטבת התשע"א‬
MICROSOFT CORPORATION
US
12/114421
02/05/2008
PCT/US/2009/038532
WO/2009/134563
/1/40/1440
501411
PAGING HEIRARCHICAL DATA
MICROSOFT CORPORATION
US
12/127006
26/05/2008
PCT/US/2009/040296
WO/2009/151763
14/40/1440
501416
SCHEDULING OPPORTUNITY
PREVIEWER
MICROSOFT CORPORATION
US
12/129682
30/05/2008
PCT/US/2009/041064
WO/2009/146212
40/40/1440
501460
AMINOSUGAR COMPOUND AND
PROCESS FOR PRODUCTION
THEREOF
ASTELLAS PHARMA INC.
2008JP
11/04/2008
102983
PCT/JP/2009/057292
WO/2009/125819
4///4/14/4
79
501461
G06F )5010.01(
‫דפדוף במידע בעל חשיבות משתנה‬
G06Q )5010.01(
‫תזמון אפשרות של סקירה מקדימה‬
C12P )5010.01(
‫תרכובת אמינוסוכר ותהליך להכנתה‬
A47B )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
ADJUSTABLE ANATOMICALLY
SUPPORT OF ARM FOR THE MOUSE
AND KEYBOARD
GOLDBERG LEONID
4///4/14/4
‫גולדברג לאוניד‬
501465
METHOD FOR INCREASING THE
SPECIFICITY OF ENZYMES DURING
THE ENZYMATIC REACTIONS BY
USING AN ELECTRIC FIELD
KAIYAL MUHAMMAD
4///4/14/4
‫זרוע הניתנים להתאמה אנטומית תמיכה‬
‫עבור לוח המקשים והעכבר‬
‫שיטה להגברת הספציפיות של אנזימים‬
‫במהלך תגובות אנזימטיות באמצעות שדה‬
‫חשמלי‬
501462
CLAMPING DEVICE FOR A CUTTING
INSERT IN A TOOL HOLDER
ISCAR LTD.
4///4/14/4
ROTARY CUTTING TOOL AND
CUTTING INSERT THEREFOR
ISCAR LTD.
80
G01N )5010.01(
501464
‫כיאל מוחמד‬
B23C )5010.01(
‫מנגנון דפינה עבור שימת חיתוך במחזיק‬
‫כלי‬
‫ישקר בע"מ‬
B23C )5010.01(
‫כלי חיתוך סיבובי ושימת חיתוך עבורו‬
‫ישקר בע"מ‬
December 30, 2010-‫כג' בטבת התשע"א‬
4///4/14/4
501465
G06F )5010.01(
A QUEUE SCHEDULING SYSTEM
AND METHOD
ROHAN OBIED
///40/1440
‫מערכת ושיטה לתזמון תורים‬
‫רוהאן עביד‬
501461
‫מערכת ושיטה להסרת מזהמים ומשקעים‬
‫ממי פסולת וממי סערה‬
BIORETENTION SYSTEM AND
METHOD
INTEGRATED LAND MANAGEMENT,
INC.
US
61/045506
16/04/2008
////00///
41/41/1440
US
PCT/US/2009/040844
WO/2009/129406
11/4//144/
501461
PHARMACEUTICAL COMPOSITIONS
CONTAINING ERYTHROPOIETIN AND
DERIVATIVES THEREOF
EPOPLUS GMBH & CO., KG
DE
102004004509.7 23/01/2004
PCT/EP/2005/000618
WO/2005/070450
41/40/1440
A61K )5010.01(
‫תכשירי רוקחות המכילים אריתרופויטין‬
‫ושימושים בהם‬
501461
LIMIB STUMP RECEIVING SLEEVE
COMPRISING AN INTEGRATED
LOCKING DEVICE FOR A SEALING
ELEMENT
MEDI GMBH & CO. KG
DE
202008004714.5 05/04/2008
/4144141/4/080
1//40/1441
DE
81
B01D )5010.01(
A61F )5010.01(
‫שרוול חיבור לגדם הכולל התקן נעילה‬
‫מוכלל לאמצעי אטימה‬
December 30, 2010-‫כג' בטבת התשע"א‬
PCT/DE/2009/000425
WO/2009/121340
4//40/1440
501500
COMPUTING SOLUTIONS TO
PROBLEMS USING DYNAMIC
ASSOCIATION BETWEEN ABSTRACT
GRAPHS
ELBIT SYSTEMS LTD.
US
61/045665
17/04/2008
///40///0
///40/1441
US
/1////110
11/4//1441
US
PCT/IL/2009/000389
WO/2009/144705
‫פתרונות ממוחשבים לבעיות בעזרת‬
‫הקשר דינמי בין גרפים אבסטרקטים‬
‫אלביט מערכות בע"מ‬
501501
/1/41/1440
STABILIZING DEVICE
RHEINMETALL WAFFE MUNITION
GMBH
DE
102008017926.4 08/04/2008
PCT/EP/2009/001976
WO/2009/124641
///41/1440
501505
FIELD MANAGEMENT FOR
SUBSTANTIALLY CONSTANT
COMPOSITION GAS GENERATION
EXXONMOBIL UPSTREAM
RESEARCH COMPANY
US
61/128664
23/05/2008
PCT/US/2009/037419
WO/2009/142803
82
G06F )5010.01(
F41A )5010.01(
‫מתקן ייצוב‬
E21B )5010.01(
‫ניהול שדה לייצור גז תברכובת קבועה‬
December 30, 2010-‫כג' בטבת התשע"א‬
11/40/1440
501502
‫ מקומית‬IP ‫תכנית גישה‬
LOCAL IP ACCESS SCHEME
QUALCOMM INCORPORATED
US
61/047700
24/04/2008
/1/01///1
1//40/1440
US
PCT/US/2009/041451
WO/2009/132139
11/40/1440
501504
INTERFERENCE MANAGEMENT
WITH REDUCE INTERFERENCE
REQUESTS AND INTERFERENCE
INDICATORS
QUALCOMM INCORPORATED
US
61/047063
22/04/2008
////41010
10//4/1441
US
/1/01/141
///40/1440
US
PCT/US/2009/041444
WO/2009/132133
///40/1440
1//40/1440
83
H04W )5010.01(
‫בחירת בסיס משרתת המשתמשת בנתוני‬
‫איכות מרוכזים‬
501501
AN ASSAY TO DETECT A
GYNECOLOGICAL CONDITION
HEALTHLINX LIMITED
AU
2008902029 23/04/2008
H04W )5010.01(
‫ניהול הפרעה עם בקשות להפחתת‬
‫הפרעה וסימני הפרעה‬
501505
SERVING BASE STATION SELECTION
USING BACKHAUL QUALITY
INFORMATION
QUALCOMM INCORPORATED
US
61/046996
22/04/2008
/1/011//1
/0/40/1440
US
PCT/US/2009/040854
WO/2009/131898
H04W )5010.01(
G01N )5010.01(
‫בדיקה לגילוי מצב גניקולוגי‬
December 30, 2010-‫כג' בטבת התשע"א‬
144104//14
AU
PCT/AU/2009/000500
WO/2009/129569
4///4/1441
4///4/14/4
501501
AN ARTIFICIAL FINGERNAIL AND
METHOD FOR ATTACHING THEREOF
DANA ATIAS
4///4/14/4
‫ציפורן מלאכותית ושיטה להצמדתה‬
‫דנה אטיאס‬
501501
SYSTEM AND METHOD FOR
CORRELATION OF MOBILE
COMMUNICATION TERMINALS AND
INDIVIDUALS AT CONTROL
CHECKPOINTS
VERINT SYSTEMS LTD.
4///4/14/4
APPARATUS AND METHOD FOR
DISPENSING OBJECTS ON A
SUBSTRATE
SHLOMO OZMO
4///1/144/
84
A45D )5010.01(
H04B )5010.01(
‫מערכת ושיטה לשיוך מסופי תקשורת‬
‫ניידים ובני אדם בנקודות ביקורת‬
‫ורינט מערכות בע"מ‬
501506
B42B )5010.01(
‫מנגנון ושיטה לפריסת אובייקטים על מצע‬
‫שלמה אוזמו‬
501510
C12N )5006.01(
December 30, 2010-‫כג' בטבת התשע"א‬
METHOD OF COLLECTING
PLACENTAL STEM CELLS
ROBERT J. HARIRI
US
60/251900
06/12/2000
PCT/US/2001/046506
WO/2002/046373
14/41/1440
ARRANGEMENT FOR
NEUTRALISATION OF
MICROORGANISMS
ARC AROMA PURE AB
SE
0800771-8
PCT/SE/2009/000164
WO/2009/126084
11/40/1440
501515
07/04/2008
501512
501514
PROCESS FOR PREPARING
SUBSTITUTED BIPHENYLANILIDES
BAYER CROPSCIENCE AG
EP
08155977.5 09/05/2008
85
C02F )5010.01(
‫התקן לניטרול מיקרואורגניזמים‬
CARBOXAMIDE COMPOUNDS FOR
THE TREATMENT OF METABOLIC
DISORDERS
RIGEL PHARMACEUTICALS, INC.
US
61/047399
23/04/2008
///40100/
14/40/1441
US
///4/041/
///4//1441
US
///4/0010
1//4//1441
US
///4/11/0
40/4//1441
US
///4/1///
41/4//1441
US
///4/1140
41/4//1441
US
///4/1/14
41/4//1441
US
PCT/US/2009/041448
WO/2009/132136
10/40/1440
‫שיטה לאיסוף תאי גזע פלסתיים‬
C07D )5010.01(
–‫תרכובות קרבוקסאמידיות לטיפול באי‬
‫סדרים מטבוליים‬
C07C )5010.01(
‫תהליך להכנת ביפנילאנילידים מותמרים‬
December 30, 2010-‫כג' בטבת התשע"א‬
////14///
US
PCT/EP/2009/003005
WO/2009/135598
11/40/1440
41/4//1441
501515
1'-SUBSTITUTED CARBANUCLEOSIDE ANALOGS FOR
ANTIVIRAL TREATMENT
GILEAD SCIENCES, INC.
US
61/047263
23/04/2008
////10000
/0//1/1441
US
PCT/US/2009/041447
WO/2009/132135
/4/40/1440
501511
ANTIGEN-BINDING MOLECULE
CAPABLE OF BINDING TO TWO OR
MORE ANTIGEN MOLECULES
REPEATEDLY
CHUGAI SEIYAKU KABUSHIKI
KAISHA
2008JP
11/04/2008
104147
1441-10///1 1//40/1441
JP
1440-4/1/00 /0/41/1440
JP
PCT/JP/2009/057309
WO/2009/125825
/4/40/1440
501511
DETECTION AND TREATMENT OF
PANCREATIC, OVARIAN AND
OTHER CANCERS
SEATTLE GENETICS, INC.
US
61/044457
11/04/2008
PCT/US/2009/040275
WO/2009/126934
86
C07D )5010.01(
‫'–מותמר‬1 ‫אנלוגים של קרבא–נוקליאוזיד‬
‫לטיפול אנטי ויראלי‬
C07K )5010.01(
‫מולקולה קושרת אנטיגן המסוגלת‬
‫להיקשר לשתיים או יותר מוליקולות‬
‫אנטיגן שוב ושוב‬
A61K )5010.01(
‫ השחלות‬,‫גילוי וטיפול בסרטן הלבלב‬
‫וסרטנים אחרים‬
December 30, 2010-‫כג' בטבת התשע"א‬
/0/40/1440
501511
MODIFIED HYALURONIDASES AND
USES IN TREATING HYALURONANASSOCIATED DISEASES AND
CONDITIONS
HALOZYME, INC.
US
61/124278
14/04/2008
////141//
10/4//1441
US
////0//10
41//4/1441
US
PCT/US/2009/002352
WO/2009/128917
41/40/1440
‫היאלורונידאזים מותאמים ושימושים‬
‫בטיפול במחלות ובתנאים הקשורים‬
‫להיאלורונאן‬
501516
SUBSTITUTED SULFONAMIDE
DERIVATIVES
GRUNENTHAL GMBH
EP
08006957.8 08/04/2008
PCT/EP/2009/002578
WO/2009/124733
/0////1440
SYSTEM AND METHOD FOR ONLINE ANALYSIS AND SORTING OF
MILK COAGULATION PROPERTIES
87
C07D )5010.01(
‫תולדות סולפונאמיד מותמרות‬
501550
C07D )5010.01(
AKT ‫מעכבי קינאז לחלבון‬
AKT PROTEIN KINASE INHIBITORS
ARRAY BIOPHARMA INC.
US
60/524003
21/11/2003
PCT/US/2004/039094
WO/2005/051304
11/41/1440
A61K )5010.01(
501555
G01N )5010.01(
‫מערכת ושיטה לניתוח תכונות קרישה של‬
‫חלב על קוו החליבה ולמימון החלב על‬
‫בסיס הניתוח‬
December 30, 2010-‫כג' בטבת התשע"א‬
S.A.E. AFIKIM MILKING SYSTEMS AGRICULTURAL COOPERATIVE LTD
US
12/078,999
09/04/2008
PCT/IL/2009/000324
WO/2009/125386
/1/41/1440
501552
HAIR CLIPPER WITH CUTTING
GUIDE
BABYLISS FACO S.A.
EP
08447023.6 08/04/2008
PCT/EP/2009/052978
WO/2009/124822
40/40/1440
501554
METHOD AND KIT FOR THE EX VIVO
EVALUATION OF THE RESPONSE OF
A TUMOR TO CONDITIONS TO BE
TESTED
UNIVERSITAT LEIPZIG
US
61/044082
11/04/2008
PCT/EP/2009/054297
WO/2009/124997
/0/4//1440
501555
LONG ACTING INSULIN FOR
REDUCING CARDIOVASCULAR
MORBIDITY AND MORTALITY IN
PREDIABETIC PATIENTS AND
PATIENTS WITH TYPE 2 DIABETES
AVENTIS PHARMACEUTICALS INC.
US
60/439941
14/01/2003
PCT/US/2004/000879
WO/2004/064862
88
‫ אגודה‬- ‫ אפיקים מערכות חליבה‬.‫מ‬.‫ח‬.‫צ‬
‫שיתופית חקלאית בע"מ‬
B26B )5010.01(
‫חותך שיער עם מוביל חיתוך‬
G01N )5010.01(
‫שיטה וערכה להערכה חוץ–גופית של‬
‫תגובת גידול לתנאים נבדקים‬
A61K )5010.01(
‫אינסולין ארוך טווח להורדת התחלואה‬
‫הקרדיווסקולרית והתמותה בחולים קדם‬
5 ‫סכרתיים ובחולים עם סכרת מסוג‬
December 30, 2010-‫כג' בטבת התשע"א‬
///4//1440
501551
PROVIDING BASE STATION
ALMANAC TO MOBILES STATION
QUALCOMM INCORPORATED
US
61/052571
12/05/2008
/1/01/010
4//4//1440
US
PCT/US/2009/043482
WO/2009/142943
///41/1441
‫אספקת אלמנך תחנת בסיס לתחנה ניידת‬
501551
TIME ACQUISITION IN A WIRELESS
POSITION DETERMINATION SYSTEM
QUALCOMM INCORPORATED
US
60/276722
15/03/2001
PCT/US/2002/007695
WO/2002/075349
/0//4/1440
501551
CARBAMOYL ESTERS THAT INHIBIT
CHOLINESTERASE AND RELEASE
PHARMACOLOGICALLY ACTIVE
AGENTS
SENTION, INC.
US
60/512971
21/10/2003
PCT/US/2004/034548
WO/2005/042475
/0/40/1440
501556
NOVEL MACROCYCLIC INHIBITORS
OF HEPATITIS C VIRUS
REPLICATION
INTERMUNE, INC.
US
61/045220
15/04/2008
89
G01S )5010.01(
G01S )5010.01(
‫רכישת זמן במערכת קביעת מיקום‬
‫אלחוטית‬
C07C )5010.01(
‫אסטרים קרסמואיליים המעכבים‬
‫כולינאסטראז והמשחררים גורמים בעלי‬
‫פעילות פרמקולוגית‬
C07D )5010.01(
‫מעכבים רב–צקליים של שכפול וירוס‬
‫ חדשים‬C ‫דלקת הכבד‬
December 30, 2010-‫כג' בטבת התשע"א‬
////4////
US
////4//1/
US
////01/11
US
/////4/01
US
PCT/US/2009/040565
WO/2009/142842
4//40/1440
////4/1441
////4/1441
40/4//1440
4//41/1440
501521
METHOD AND SYSTEM FOR
QUANTITATION OF RESPIRATORY
TRACT SOUNDS
DEEPBREEZE LTD
US
61/064993
08/04/2008
PCT/IL/2009/000400
WO/2009/125407
/4/4//1440
501525
ANTIBODIES TO IL-6 AND THEIR
USES
PFIZER INC
US
61/073430
18/06/2008
/1/01400/
40/4//1440
US
PCT/US/2009/046837
WO/2009/155180
///40/1440
501522
GESTURE-RELATED FEEDBACK IN
ELCTRONIC ENTERTAINMENT
SYSTEM
MICROSOFT CORPORATION
US
12/121240
15/05/2008
PCT/US/2009/040865
WO/2009/140024
90
A61B )5010.01(
‫שיטה ומערכת למדידת קולות של דרכי‬
‫הנשימה‬
‫דיפבריז בע"מ‬
C07K )5010.01(
‫ ושימושיהם‬IL–1–‫נוגדנים ל‬
G11B )5010.01(
‫היזון חוזר באמצעות הבעה במערכת‬
‫שעשועים אלקטרונית‬
December 30, 2010-‫כג' בטבת התשע"א‬
11/40/1440
501524
‫ נמוך‬K ‫חומרים דיאלקטריים בעלי ערך‬
‫אשר ניתן לקבלם מפולימריזציה זוגית‬
LOK-K DIELECTRICS OBTAINABLE
BY TWIN POLYMERIZATION
BASF SE
EP
08155304.2 28/04/2008
PCT/EP/2009/055092
WO/2009/133082
41/40/1440
501525
501521
INHIBITORS OF FATTY ACID AMIDE
HYDROLASE
INFINITY DISCOVERY, INC.
US
61/043686
09/04/2008
PCT/US/2009/039872
WO/2009/126691
///40/1440
91
A61K )5010.01(
‫מעכבי אמיד הידרולאז של חומצת שומן‬
501521
RECOMBINANT FSH INCLUDING
ALPHA 2,3-AND ALPHA 2,6SIALYLATION
FERRING INTERNATIONAL CENTER
SA
US
61/045424
16/04/2008
411///1180
1//40/1441
EP
PCT/GB/2009/000978
WO/2009/127826
C07H )5010.01(
‫ שיטות להכנה‬,‫טריטרפן ספונינים‬
‫ושימושים בהם‬
TRITERPENE SAPONINS, METHODS
OF SYNTHESIS, AND USES THEREOF
SLOAN-KETTERING INSTITUTE FOR
CANCER RESEARCH
US
61/043197
08/04/2008
PCT/US/2009/039954
WO/2009/126737
41/40/1440
H01B )5010.01(
C07K )5010.01(
‫–ואלפא‬2,5 ‫ רקומביננטי המכיל אלפא‬FSH
‫–סיאלילציה‬1,5
December 30, 2010-‫כג' בטבת התשע"א‬
501526
11/40/1441
METHODS, SYSTEMS AND
APPARATI FOR CELLULAR
THERAPEUTIC AGENT
PREPARATION AND DELIVERY
OSIRIS THERAPEUTICS, INC.
A61M )5010.01(
‫ מערכות והתקנים להכנת ומתן‬,‫שיטות‬
‫גורם רפואי תאי‬
PCT/US/2008/061220
WO/2009/131575
14/40/1440
501540
PROCESS FOR PREPARING 2(AMINOMETHYLIDENE)-4,4DIFLUORO-3-OXOBUTYRIC ESTERS
BASF SE
EP
08155612.8
PCT/EP/2009/055283
WO/2009/133178
40/4//1440
92
–5 ‫תהליך להכנת אסטרים‬
–2–‫–דיפלואורו‬4,4–)‫(אמינומתילאידן‬
‫אוקסובוטירים‬
02/05/2008
501541
METHOD FOR PREPARING 1,3,4SUBSTITUTED PYRAZOL
COMPOUNDS
BASF SE
EP
08155657.3 05/05/2008
PCT/EP/2009/055328
WO/2009/135808
4//40/1440
C07C )5010.01(
501542
C07D )5010.01(
‫–פיראזול‬4,2,1 ‫שיטה להכנת תרכובות‬
‫מותמרות‬
C07K )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
OPIORPHIN PEPTIDE DERIVATIVES
AS POTENT INHIBITORS OF
ENKEPHALIN-DEGRADING
ECTOPETIDASES
INSTITUT PASTEUR
US
61/042922
07/04/2008
PCT/EP/2009/054171
WO/2009/124948
4//40/1440
501544
A KIT FOR DIAGNOSIS, PROGNOSIS,
AND MONITORING THE IMMUNE
STATUS OF PATIENTS WITH
CHRONIC INFLAMMATORY
DISEASES
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD.
US
61/042873
07/04/2008
PCT/IL/2009/000402
WO/2009/125408
1//41/1440
93
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים בע"מ‬
G02B )5010.01(
‫ ושיטות להקטנת השפעת סטיות‬,‫מערכות‬
‫במערכת דימות‬
501541
COIL FOR MAGNETIC STIMULATION
G01N )5010.01(
‫ פרוגנוזה וניטור המצב‬,‫ערכה לדיאגנוזה‬
‫החיסוני בחולים במחלות דלקתיות כרוניות‬
501545
SYSTEMS AND METHODS FOR
MINIMIZING ABERRATING EFFECTS
IN IMAGING SYSTEMS
CDM OPTICS, INC.
US
60/459417
31/03/2003
PCT/US/2004/009743
WO/2004/090581
/0//4/144/
‫תולדות פפטיד אופיורפין כמעכבים רבי‬
‫עוצמה של אנקפאלין–מפרק‬
‫אקטופפטידאזות‬
A61N )5010.01(
‫סליל לעירור מגנטי‬
December 30, 2010-‫כג' בטבת התשע"א‬
THE GOVERNMENT OF THE UNITED
STATES OF AMERICA AS
REPRESENTED BY THE SECRETARY
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
US
60/242297
20/10/2000
PCT/US/2001/050737
WO/2002/032504
501541
40/40/1440
SUBSTITUTED 2-PHENYL-PYRIDINE
DERIVATIVES
ACTELION PHARMACEUTICALS LTD.
IB
PCT/IB08/051384 11/04/2008
PCT/IB/2009/051499
WO/2009/125366
2-PHENYL-4-CYCLOPROPYLPYRIMIDINE DERIVATIVES
ACTELION PHARMACEUTICALS LTD.
IB
PCT/IB08/051389 11/04/2008
PCT/IB/2009/051498
WO/2009/125365
1//40/1440
501546
AURIS FORMULATIONS FOR
TREATING OTIC DISEASES AND
CONDITIONS
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
61/046543
21/04/2008
///4011/1
10/40/1441
US
////1///1
/0/4//1441
US
///4///1/
11/4//1441
US
///4/401/
/4/4//1441
US
///4/1///
/1/4//1441
US
94
‫–פניל–פירידין מותמרות‬5 ‫תולדות‬
501541
40/40/1440
C07F )5010.01(
C07D )5010.01(
–‫–ציקלופרופיל‬4–‫–פניל‬5 ‫תולדות‬
‫פירימידין‬
A61K )5010.01(
‫הרכבי אוריס לטיפול במחלות אוזניים‬
‫ובתנאים‬
December 30, 2010-‫כג' בטבת התשע"א‬
///4/0/11
US
///4/////
US
///4/////
US
///4110/4
US
///4111//
US
///411114
US
///41//4/
US
///41/400
US
///41/04/
US
///41/0//
US
///4111//
US
///400110
US
////4///1
US
////04411
US
/////4111
US
PCT/US/2009/041320
WO/2009/132050
4//40/1440
14/4//1441
1//4//1441
1//4//1441
1//4//1441
1//4//1441
1//4//1441
40/41/1441
40/41/1441
///41/1441
///41/1441
/1/41/1441
40/40/1441
10/40/1441
11//1/1441
/1/41/1440
501550
SYSTEM AND METHOD FOR
GENERATING AN INTERACTIVE OR
NON-INTERACTIVE BRANCHING
MOVIE SEGMENT BY SEGMENT AND
METHODS USEFUL IN
CONJUNCTION THEREWITH
RAMOT AT TEL AVIV UNIVERSITY
LTD.
US
61/042773
07/04/2008
PCT/IL/2009/000397
WO/2009/125404
4//40/1440
95
‫מערכת ליצירת קטע סרט מסועף‬
‫אינטראקטיבי או שאינו אינטראקטיבי‬
‫באמצעות קטע ושיטות שימושיות בשילוב‬
‫עימו‬
‫רמות ליד אוניברסיטת תל אביב בע"מ‬
501551
AN ARTIFICIAL PANEL, A METHOD
FOR MANUFACTURING SAME AND
FURNITURE ARTICLES THEREFROM
KETER PLASTIC LTD.
US
61/071122
14/04/2008
PCT/IL/2009/000369
WO/2009/144703
H04N )5010.01(
B29C )5010.01(
‫ שיטה לייצורו ופריטי ריהוט‬,‫לוח מלאכותי‬
‫העשויים ממנו‬
‫כתר פלסטיק בע"מ‬
December 30, 2010-‫כג' בטבת התשע"א‬
40/40/1440
501555
A MEDICAL SYSTEM COMPRISING A
PERCUTANEOUS PROBE
A61N )5010.01(
‫מערכת רפואית המכילה בוחן מלעורי‬
L'UNIVERSITE PIERRE ET MARIE
CURIE ( PARIS 6 )
US
61/043501
09/04/2008
PCT/EP/2009/054319
WO/2009/125002
4//40/1440
501552
‫תכשירים קוטלי מזיקים‬
PESTICIDAL COMPOSITIONS
BASF CORPORATION
US
61/044297
11/04/2008
//////11/
//////1441
US
/1/0/1001
41/40/1440
US
/1/0/10//
41/40/1440
US
/1/0/10//
41/40/1440
US
PCT/US/2009/039664
WO/2009/126577
11/40/1440
501554
SUPER FAST-ACTING INSULIN
COMPOSITIONS
HALOZYME, INC.
US
61/125835
28/04/2008
////1/400
40/4//1441
US
PCT/US/2009/002625
WO/2009/134380
1//40/1440
HUMANIZED ANTI-FACTOR D
ANTIBODIES AND USES THEREOF
96
A01N )5010.01(
A61K )5010.01(
‫תכשירי אינסולוין הפועלים במהירות רבה‬
501555
C07K )5010.01(
‫ ממקור אנושי‬D ‫נוגדנים אנטי–פקטור‬
‫ושימושיהם‬
December 30, 2010-‫כג' בטבת התשע"א‬
GENENTECH, INC.
US
61/048431
///401/10
US
PCT/US/2009/041785
WO/2009/134711
11/40/1440
28/04/2008
10/40/1441
501551
ALCOGHOL ALKOXYLATES,
AGENTS COMPRISING THE SAME
AND USE OF THE ALCOHOL
ALKOXYLATES AS ADJUVANTS IN
THE AGROCHEMICAL FIELD
BASF SE
EP
08155135.0 24/04/2008
PCT/EP/2009/054897
WO/2009/130281
/4/40/1440
‫ גורמים‬,‫אלכוהול אלקוקסילאטים‬
‫המכילים אותם ושימוש באלכוהול‬
‫אלקוקסילאטים כחומרים מסייעים בתחום‬
‫האגרוכימי‬
501551
PYRIDYL INHIBITORS OF
HEDGEHOG SIGNALLING
GENENTECH, INC.
US
61/044451
11/04/2008
PCT/US/2009/040165
WO/2009/126863
41/41/144/
97
C07D )5010.01(
‫מעכבי פירידיל למסלולי הדג'הוג‬
501551
NUCLEIC ACIDS ENCODING
ANTHELMINTIC AGENTS AND
PLANTS MADE THEREFORM
DIVERGENCE, INC.
US
10/912534
04/08/2004
PCT/US/2005/027566
WO/2006/017577
C08G )5010.01(
A01H )5010.01(
‫חומצות גרעין המקודדות גורמים וצמחים‬
‫העשויים מהם‬
December 30, 2010-‫כג' בטבת התשע"א‬
41/41/144/
501556
NUCLEIC ACIDS ENCODING
ANTHELMINTIC AGENTS AND
PLANTS MADE THEREFORM
DIVERGENCE, INC.
US
10/912534
04/08/2004
PCT/US/2005/027566
WO/2006/017577
41/41/144/
41/41/144/
98
A01H )5010.01(
‫חומצות גרעין המקודדות גורמים וצמחים‬
‫העשויים מהם‬
501515
NUCLEIC ACIDS ENCODING
ANTHELMINTIC AGENTS AND
PLANTS MADE THEREFORM
DIVERGENCE, INC.
US
10/912534
04/08/2004
PCT/US/2005/027566
WO/2006/017577
A01H )5010.01(
‫חומצות גרעין המקודדות גורמים וצמחים‬
‫העשויים מהם‬
501511
NUCLEIC ACIDS ENCODING
ANTHELMINTIC AGENTS AND
PLANTS MADE THEREFORM
DIVERGENCE, INC.
US
10/912534
04/08/2004
PCT/US/2005/027566
WO/2006/017577
41/41/144/
‫חומצות גרעין המקודדות גורמים וצמחים‬
‫העשויים מהם‬
501510
NUCLEIC ACIDS ENCODING
ANTHELMINTIC AGENTS AND
PLANTS MADE THEREFORM
DIVERGENCE, INC.
US
10/912534
04/08/2004
PCT/US/2005/027566
WO/2006/017577
A01H )5010.01(
A01H )5010.01(
‫חומצות גרעין המקודדות גורמים וצמחים‬
‫העשויים מהם‬
December 30, 2010-‫כג' בטבת התשע"א‬
4///4/14/4
501514
FRAME TO ANY KIND OF GLASSES
THAT ENABBLES LENS ADJUSTING
THAT ENABLES A PERDECT VISION
MISHA FRIEDMAN
40/40/1440
‫מסגרת למשקפיים מכל סוג שהם‬
‫המאפשרת הכוונת העדשות לזוית נכונה‬
‫המאפשרת ראייה מושלמת‬
‫מישה פרידמן‬
501515
COMPOSITIONS FOR USE IN
REGULATING ACTIN
CYTOSKELETAL REARRANGEMENT
AND INTERCELLULAR GAP
FORMATION
THE UNIVERSITY OF NORTH
CAROLINA AT CHAPEL HILL
US
61/043586
09/04/2008
PCT/US/2009/040098
WO/2009/126822
///40/1440
501511
CD-37 SPECIFIC BINDING
MOLECULE, COMPOSITIONS
COMPRISING THE SAME AND USES
THEREOF
TRUBION PHARMACEUTICALS, INC.
US
61/190067
11/04/2008
PCT/US/2009/040288
WO/2009/126944
/1/40/1440
99
G02C )5010.01(
501511
A61K )5010.01(
‫תכשירים לשימוש בווסת וסידור מחדש‬
‫של אקטין בשלד התא וייצור צומתות‬
‫ממברניות בין תאיים‬
C07K )5010.01(
,CD–21–‫מולקולה ספציפי שנקשר ל‬
‫תכשירים המכילים אותן ושימושים בו‬
A61K )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
OLIGOMER-ARYLOXYSUBSTITUTED PROPANAMINE
CONJUGATES, COMPOSITIONS
COMPRISING THE SAME AND USES
THEREOF
NEKTAR THERAPEUTICS
US
61/123929
11/04/2008
PCT/US/2009/002285
WO/2009/126333
/4/40/1440
‫מוצמדי אוליגומר–ארילאוקסי–צותמרי‬
‫ תכשירים המכילים אותם‬,‫פרופאנאמין‬
‫ושימושים בהם‬
501516
DOPED CONJUGATED POLYMERS,
DEVICES, AND METHODS OF
MAKING DEVICES
PLEXTRONICS, INC.
US
61/044380
11/04/2008
/////0110
41//1/1441
US
PCT/US/2009/040257
WO/2009/126918
14/40/1440
,‫פולימרים מצומדים המכילים מאלח‬
‫ומכשירים עשויים מפולימרים אלה‬
501510
APPARATUS AND METHOD OF
MEASURING A PROPERTY OF A
SUBSTRATE
ASML NETHERLANDS B.V.
US
61/071281
21/04/2008
PCT/EP/2009/002857
WO/2009/129974
/4/40/1440
100
G01N )5010.01(
‫התקן ושיטה למדידת תכונה של‬
‫סובסטרט‬
501511
ELECTROSPUN DEXTRAN FIBERS
AND DEVICES FORMED THEREFROM
VIRGINIA COMMONWEALTH
UNVERSITY
US
61/044165
11/04/2008
PCT/US/2009/040182
C08G )5010.01(
D01F )5010.01(
‫סיבי דקסטרן מסובבים חשמלית והתקנים‬
‫הנוצרים מהם‬
December 30, 2010-‫כג' בטבת התשע"א‬
WO/2009/126870
///40/1440
501515
SOLID ORAL FORM WITH DUAL
RELEASE PROFILE, CONTAINING
MULTIPARTICULATES
FLAMEL TECHNOLOGIES
FR
0852627
18/04/2008
///4//1/4
/1/40/1441
US
PCT/FR/2009/050719
WO/2009/138642
‫צורה פומית מוצקה בעלת פרופיל שחרור‬
‫כפול המכילה רב–חלקיקים‬
501512
40/40/1440
PHARMACEUTICAL DEPOT
COMPRISING N-{5[(CYCLOPROPYLAMINO)CARBONYL]-2METHYLPHENYL}-3-FLUORO-4(PYRIDIN-2-YLMETHOXY)BENZAMIDE
ASTRAZENECA AB
US
61/043491
09/04/2008
PCT/GB/2009/050353
WO/2009/125226
///40/1440
501514
INDOLES AS MODULATORS OF
NICOTINIC ACETYLCHOLIN
RECEPTOR SUBTYPE ALPHA-71
A61K )5010.01(
A61K )5010.01(
–N–{5 ‫מאחסן רוקחי המכיל‬
–5–]‫[(ציקלופרופילאמינו)קרבוניל‬
–5–‫–(פירידין‬4–‫–פלואורו‬2–}‫מתילפניל‬
‫ילמתוקסי)בנזאמיד‬
C07D )5010.01(
‫אינדולים כמאפננים של הקולטן‬
‫לאצטילכולין ניקוטיני מתת–הקבוצה‬
11–‫אלפא‬
GLAXO GROUP LIMITED
GB
0807050.0
17/04/2008
41/41108/
40/4//1441
GB
PCT/EP/2009/054493
WO/2009/127678
101
December 30, 2010-‫כג' בטבת התשע"א‬
///40/1440
501515
C07D )5010.01(
‫אינדולים כמאפננים של הקולטן‬
‫לאצטילכולין ניקוטיני מתת–הקבוצה‬
1–‫אלפא‬
INDOLES AS MODULATORS OF
NICOTINIC ACETYLCHOLIN
RECEPTOR SUBTYPE ALPHA-7
GLAXO GROUP LIMITED
GB
0807050.0
17/04/2008
41/41108/
40/4//1441
GB
PCT/EP/2009/054495
WO/2009/127679
14/4//1440
501511
SUBSTRATE MATRIX TO DECOUPLE
TOOL AND PROCESS EFFECTS
KLA-TENCOR CORPORATION
US
61/054897
21/05/2008
PCT/US/2009/044594
WO/2009/143200
/1/40/1440
501511
ELECTRO-ACTIVE DIFFRACTIVE
LENS AND METHOD FOR MAKING
THE SAME
PIXELOPTICS INC.
US
61/044205
11/04/2008
/////10/1
///41/1440
US
PCT/US/2009/040300
WO/2009/126946
40/40/1440
501511
PRODUCTION OF NUCLEIC ACID
FERMENTAS UAB
GB
0806562.5
10/04/2008
PCT/EP/2009/054329
WO/2009/125006
102
H01L )5010.01(
‫מטריצת מצע להפריד השפעות כלי‬
‫ותהליך‬
G02C )5010.01(
‫עדשה מרכזת מופעלת–חשמל ושיטה‬
‫לייצורה‬
C12N )5010.01(
‫הפקה של חומצת גרעין‬
December 30, 2010-‫כג' בטבת התשע"א‬
40/40/1440
501516
METHODS AND USE OF INDUCING A
POPTOSIS IN CANCER CELLS
CYTOTECH LABS, LLC
US
61/044085
11/04/2008
PCT/US/2009/039992
WO/2009/126764
40/40/1440
41/40/1440
C07C )5010.01(
‫ תהליך‬,‫תרכובות חדשות הנגזרות מטאורין‬
‫להכנתן והרכבים רוקחיים המכילים אותן‬
501511
SODIUM ION BASED AQUEOUS
ELECTROLYTE ELECTROCHEMICAL
SECONDARY ENERGY STORAGE
DEVICE
CARNEGIE MELLON UNIVERSITY
US
61/123230
07/04/2008
////101//
/1/4//1441
US
/////0///
14/41/1440
US
PCT/US/2009/039436
WO/2009/126525
103
‫שיטות ושימוש לגרימת אפופטוסיס בתאי‬
‫הסרטן‬
501510
NOVEL COMPOUNDS DERIVED
FROM TAURINE, PROCESS OF THEIR
PREPARATION AND
PHAMACEUTOICAL COMPOSITIONS
CONTAINING THESE
UNIVERSIDADE ESTADUAL
PAULISTA JULIO DE MESQUITA
FILHO-UNESP
PI0800951BR
09/04/2008
1
PCT/BR/2009/000097
WO/2009/124371
A61K )5010.01(
H01M )5010.01(
‫מצבר אלקטרוכימי המבוסס על תמיסה‬
‫מימית אלקטרוליטית של יוני נתרן‬
December 30, 2010-‫כג' בטבת התשע"א‬
/4//4/14/4
501515
‫מכלול גוף תאורה‬
‫ארקוסין רם‬
A LIGHT FIXTURE ASSEMBLY
ARCUSIN RAM
41/40/1440
501514
OVERMOLDED CONTAINERS WITH
IMPROVED GRIP AND METHOD OF
MANUFACTURE
COLGATE-PALMOLIVE COMPANY
US
12/099404
08/04/2008
PCT/US/2009/039910
WO/2009/116712
/4//4/14/4
501515
501511
VALIDATION OF STORED OR
INCOMING MESSAGES
QUALCOMM INCORPORATED
US
12/115297
05/05/2008
PCT/US/2009/042825
WO/2009/137467
104
B65D )5010.01(
‫מיכלים עם שכבות המוצקות מעליהם ועם‬
‫אחיזה משופרת ושיטה לייצורם‬
DEVICE AND METHOD FOR
ADJUSTING AN IMPEDANCE OF AN
OUTPUT DRIVER OF AN
INTEGRATED CIRCUIT
CAMTEK LTD.
US
61/251936
15/10/2009
4//4//1440
F21V )5010.01(
B41J )5010.01(
‫מערכות ושיטות לבדיקה אופטית‬
‫באמצעות קרינה קרובה לאינפרה אדום‬
‫קמטק בע"מ‬
H04L )5010.01(
‫אימות הודעות שמורות או נכנסות‬
December 30, 2010-‫כג' בטבת התשע"א‬
10/40/1440
501516
ENCODED CONTROL CHANNEL
INFORMATION INTERLEAVING
QUALCOMM INCORPORATED
US
61/048923
29/04/2008
/1/01/0/4
11/40/1440
US
PCT/US/2009/042150
WO/2009/134913
11/40/1440
501560
PARTIAL RADIO LINK CONTROL
STATUS REPORT
QUALCOMM INCORPORATED
US
61/048490
28/04/2008
/1/014/0/
1//40/1440
US
PCT/US/2009/041982
WO/2009/134806
/4/40/1440
501561
NANOPARTICLE FORMULATIONS
AND USES THEREOF
ABRAXIS BIOSCIENCES. LLC
US
61/044006
10/04/2008
///40///0
/1/40/1441
US
PCT/US/2009/040281
WO/2009/126938
4//4//1440
501565
METHOD AND APPARATUS FOR
UPLINK ACK/NACK RESOURCE
ALLOCATION
QUALCOMM INCORPORATED
US
61/049827
02/05/2008
105
H04L )5010.01(
‫שילוב מידע ערוץ בקרה מקודד‬
H04L )5010.01(
‫דוח מצב בקרת קישור רדיו חלקי‬
A61K )5010.01(
‫תכשירי ננוחלקיקים ושימושים שלהם‬
H04L )5010.01(
‫שיטה והתקן להקצאת משאבי‬
‫ בקישור למעלה‬ACK/NACK
December 30, 2010-‫כג' בטבת התשע"א‬
/1/011//1
US
PCT/US/2009/042632
WO/2009/135194
14/40/1440
/4//4/14/4
501562
METHOD AND SYSTEM FOR
SELECTING AND STORING A
SPECIFIC CHINESES SCRIPT
CHARACTER
AMIRAM CARMON
41/40/1440
‫שיטה ומערכת לבחירה ואחסון של אות‬
‫סינית מסוימת‬
‫עמירם כרמון‬
501565
NOVEL ANTIBODIES USED TO
TREAT CANCER
PIERRE FABRE MEDICAMENT
FR
0801985
11/04/2008
PCT/FR/2009/050612
WO/2009/136070
/4//4/14/4
WALL OR CEILING BOX FOR
ELECTRICAL WIRING
PHOTEX MOLDS LTD
40/40/1440
ANHYDROUS CRYSTAL FORM OF
ORVEPITANT MALEATE
106
G06F )5010.01(
C07K )5010.01(
‫נוגדנים חדשים לשימוש בטיפול בסרטן‬
501561
H02G )5010.01(
‫קופסת קיר או תיקרה עבור חיווט חשמלי‬
‫פוטקס תבניות בע"מ‬
501561
C07D )5010.01(
‫צורה גבישית נטולת מים של‬
‫אורבפיטאנאט מאלאט‬
December 30, 2010-‫כג' בטבת התשע"א‬
GLAXO GROUP LIMITED
GB
0806652.4
11/04/2008
PCT/EP/2009/054295
WO/2009/124996
/4/40/1440
501561
HUMAN SERUM ALBUMIN LINKERS
AND CONJUGATES THEREOF
MERRIMACK PHARMACEUTICALS,
INC
US
61/123942
11/04/2008
///////0/
/1////1441
US
PCT/US/2009/040259
WO/2009/126920
40/40/1440
‫קושרים של סרום אלבומין אנושי ותלכידים‬
‫שלהם‬
501566
BLAST RESISTANT GLASS BLOCK
PANEL
PITTSBURGH CORNING
CORPORATION
US
61/043959
10/04/2008
PCT/US/2009/040117
WO/2009/126837
41/40/1440
DRIED FORMULATIONS
ZYMES, LLC
US
61/043345
PCT/US/2009/039955
WO/2009/126738
/4//4/14/4
MEZUZAH CASE
107
C12P )5010.01(
501101
E04C )5010.01(
‫פנל בלוק עמיד בפני הדף‬
A61K )5010.01(
‫פורמולציות מיובשות‬
08/04/2008
501105
B65D )5010.01(
‫בית מזוזה‬
December 30, 2010-‫כג' בטבת התשע"א‬
TOMER SHAPIRA
US
12/577192
‫תומר שפירא‬
11/10/2009
4//4//1440
501102
METHOD, SYSTEM AND COMUTER
PROGRAM FOR USER-DRIVEN
DYNAMIC GENERATION OF
SEMANTIC NETWORKS AND MEDIA
SYNTHESIS
ROBERT BARLOW-BUSCH
US
61/049581
01/05/2008
PCT/CA/2009/000567
WO/2009/132442
////4/14/4
,‫ מערכת ותוכנה לייצור דינמי‬,‫שיטה‬
‫ של רשתות סמנטיות‬,‫שביוזמת המשתמש‬
‫וסינתזת מדיה‬
501104
501105
VEHICLE COLLISION PREVENTION
SYSTEM
REVITAL ROZENBERG
/0/4//144/
108
H04R )5010.01(
‫פלטפורמה שמע זעיר‬
‫מישל כמון‬
MINIATURE AUDIO PLATFORM
MICHEL KAMOUN
////4/14/4
A61K )5010.01(
B60T )5010.01(
‫מערכת למניעת התנגשות רכב‬
‫רויטל רוזנברג‬
501101
C07K )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
IMPROVED NANOBODIESTM FOR
THE TREATMENT OF
AGGREGATION-MEDIATED
DISORDERS
ABLYNX N.V.
US
60/683474
20/05/2005
PCT/EP/2006/004773
WO/2006/122825
11/40/1440
501101
PERPROPIONIC ACID COMPOSITION
THAT IS STABLE IN A BASIC
MEDIUM
ARKEMA FRANCE
FR
0852895
29/04/2008
PCT/FR/2009/050778
WO/2009/141547
11/40/1440
109
A62D )5010.01(
‫תכשיר ותהליך להשמדת חומרים אורגנים‬
‫או גופרית‬/‫מזהמים המכילים זרחן ו‬
501110
NOVEL METHOD FOR DIAGNOSING
PREGNANCY-RELATED
COMPLICATIONS
DIAGNOSTIC TECHNOLOGIES LTD.
US
61/071209
17/04/2008
PCT/IL/2009/000366
WO/2009/144702
C07D )5010.01(
‫תכשיר חומצה פרפרופיונית שיציב במדיום‬
‫בסיסי‬
501106
COMPOSITION AND PROCESS FOR
THE DESTRUCTION OF
ORGANOPHOSPHORUS AND/OR
ORGANOSULPHUR POLLUTANTS
ARKEMA FRANCE
FR
0852911
30/04/2008
PCT/FR/2009/050779
WO/2009/141548
4//40/1440
‫ננובודיס משופרים לטיפול באי סדרים‬
‫הקשורים לאגרגציה‬
G01N )5010.01(
‫שיטה חדשה לאבחון סיבוכים הקשורים‬
‫להיריון‬
‫דיאגנוסטיקס טכנולוגיות בע"מ‬
December 30, 2010-‫כג' בטבת התשע"א‬
40/40/1440
501111
DEVICE AND PROCESS FOR THE
FORMATION OF
MICRODEPOSITIONS
DIOSCURE
FR
0852466
11/04/2008
PCT/FR/2009/050631
WO/2009/136085
1//40/1440
‫מכשיר ותהליך ליצירת מיקרו שכבות‬
501115
LIPID COMPOSITIONS COMPRISING
ANDROGENS
DIURNAL LIMITED
GB
0807605.1
28/04/2008
PCT/GB/2009/001068
WO/2009/133352
4//4//1440
4//4//1440
THE USE OF SOLID CARRIER
PARTICLES TO IMPROVE THE
PROCESSABILITY OF A
PHARMACEUTICAL AGENT
110
A61K )5010.01(
‫תכשירים שומניים המכילים אנדרוגנים‬
501112
AZETIDINES AND CYCLOBUTANES
AS HISTAMINE H3 RECEPTOR
ANTAGONISTS
EVOTEC AG,
EP
08155915.5 08/05/2008
////100//
/0//1/1441
US
PCT/EP/2009/055418
WO/2009/135842
B01J )5010.01(
C07D )5010.01(
‫אזטידינים וציקלובוטאנים כאנטאגוניסטים‬
H 2 ‫לקולטן היסטאמין‬
501114
A61K )5010.01(
‫שימוש בחלקיקי נשא מוצק לשיפור‬
‫היכולת לעיבוד חומר רוקחי‬
December 30, 2010-‫כג' בטבת התשע"א‬
GILEAD SCIENCES, INC.
US
61/049935
/////4//1
US
/////4///
US
PCT/US/2009/042607
WO/2009/135179
41/41/1440
02/05/2008
4//41/1440
4//41/1440
501115
USE OF A RADIOACTIVELY
LABELLED MOLECULE
SPECIFICALLY BINDING TO ED-B
FIBRONECTIN IN A METHOD OF
TREATMENT OF HODGKIN
LYMPHOMA
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT
US
61/051500
08/05/2008
414//01/8/
41/4//1441
EP
PCT/EP/2009/003168
WO/2009/135627
10/40/1441
‫שימוש במולקולה המסומנת באופן‬
B––‫רדיואקטיבי שנקשרת באופן ספציפי ל‬
‫ פיברונקטין בשיטה לטיפול בסרטן‬ED
‫בלוטות הלימפה‬
501111
METHOD AND APPARATUS FOR
FREQUENCY REUSE IN A MULTICARRIER COMMUNICATIONS
SYSTEM
QUALCOMM INCORPORATED
US
12/111073
28/04/2008
PCT/US/2008/061910
WO/2009/134248
4//4//1440
501111
BUNDLING OF ACK INFORMATION
IN A WIRELESS COMMUNICATION
SYSTEM
QUALCOMM INCORPORATED
US
61/051296
07/05/2008
111
C07K )5010.01(
H04W )5010.01(
‫שיטה והתקן לשימוש חוזר של תדרים‬
‫במערכת תקשורת רב–נשאית‬
H04L )5010.01(
‫ במערכת תקשורת‬ACK ‫איגוד מידע‬
‫שלחוטית‬
December 30, 2010-‫כג' בטבת התשע"א‬
/1/01////
US
PCT/US/2009/043087
WO/2009/137646
4//4//1440
4//4//1440
501111
SYSTEM, APPARATUS AND METHOD
TO ENABLE MOBILE STATIONS TO
IDENTIFY CALLS BASED ON
PREDETERMINED VALUES SET IN A
CALL HEADER
QUALCOMM INCORPORATED
US
61/051304
07/05/2008
///414/11
///4//1441
US
/1/011041
14/40/1440
US
PCT/US/2009/043035
WO/2009/137617
/0/40/1441
501116
SYSTEM AND METHOD FOR
EMBEDDING DATA IN VIDEO
NDS LIMITED
H04W )5010.01(
‫ התקן ושיטה לאפשר תחנות‬,‫מערכת‬
‫ניידות לזהות שיחות על בסיס ערכים‬
‫קבועים מראש בכותרות שיחה‬
H04N )5010.01(
‫מערכת ושיטה להטעמת מידע בוידאו‬
PCT/IB/2008/051411
WO/2009/127900
////4/14/4
501150
LARYNGOSCOPE HANDLE
TRUPHATEK INTERNATIONAL LTD.
////4/14/4
112
501151
A61B )5010.01(
‫ידית לרינגוסקוף‬
‫תרופאטק אינטרנשיונל בע"מ‬
A61F )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
INTRAOCULAR LENS (IOL)
INJECTOR APPARATUS INCLUDING
IOL CARTRIDGE WITH IOL SUPPORT
FOR SUPPORTING AN IOL
NULENS LTD.
14/40/1440
‫ניולנס בע"מ‬
501155
METHOD OF UTILIZATION OF
COMBINATION OF BENZOPHENONE
DERIVATIVE OR SALT THEREOF
AND IMMUNOSUPPRESSING AGENT,
AND PHARMACEUTICAL
COMPOSITION COMPRISING THESE
COMPONENTS
TOYAMA CHEMICAL CO., LTD.
2008JP
22/04/2008
111295
PCT/JP/2009/057860
WO/2009/131098
1//40/1440
)IOL( ‫התקן להזרקת עדשה תוך עינית‬
‫ לתמוך‬IOL ‫ עם תומך‬IOL ‫כולל מחסנית‬
IOL–‫ב‬
‫שיטת ניצול של שילוב נגזרת בנזופטנטן‬
‫ ותרכובת‬,‫או מלח שלה וגורם דיכוי חיסוני‬
‫רוקחות המכילה מרכיבים אלה‬
501152
CYCLOPENTYLACRYLAMIDE
DERIVATIVE
TEIJIN PHARMA LIMITED
2008JP
28/04/2008
116995
1441-//0/41 10/4//1441
JP
PCT/JP/2009/001907
WO/2009/133687
///40/1440
COMPOSITIONS FOR THE
TREATMENT OF LICE
113
A61K )5010.01(
501154
C07D )5010.01(
‫נגזרת ציקלופאנתילאקרילאמיד‬
A61K )5010.01(
‫תרכובות עבור הטיפול בכינים‬
December 30, 2010-‫כג' בטבת התשע"א‬
SINCLAIR PHARMACEUTICALS
LIMITED
GB
0806948.6
16/04/2008
PCT/GB/2009/000982
WO/2009/127830
14/40/1440
501155
STEAM GENERATION SYSTEM
HAVING A MAIN AND AUXILIARY
STEAM GENERATOR
NEM B.V.
US
61/046948
22/04/2008
PCT/NL/2009/000097
WO/2009/131438
1//40/1440
‫מערכת יצירת אדים בעלת גנרטור עזר עם‬
‫צינור אדים ראשי‬
501151
IMIDAZOLIDINONE DERIVATIVES
AS 11B-HSD1 INHIBITORS
F. HOFFMANN-LA ROCHE AG
EP
08155430.5 30/04/2008
PCT/EP/2009/054701
WO/2009/132986
////4/14/4
REGULATED JOULE THOMPSON
COOLING SYSTEM WHICH
COMPRISES AN ACTIVE CLOSED
CONTROL LOOP FOR INCREASING
RELIABILITY AND PREVENTING
INSTANTANEOUS OVERHEATING
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
114
F01K )5010.01(
501151
C07D )5010.01(
‫תולדות אימידזולידינון כמעכבים של‬
HSD–B111
F25B )5010.01(
‫מערכת קירור ג'אול תומסון מיוצבת‬
‫הכוללת מעגל ייצוב אקטיבי סגור‬
‫להעלאת האמינות ולמניעת חימום יתר‬
‫רגעי‬
‫רפאל מערכות לחימה מתקדמות בע"מ‬
December 30, 2010-‫כג' בטבת התשע"א‬
40/40/1440
501151
SYSTEM AND METHOD FOR
DEPLOYING AND RETRIEVING A
WAVE ENERGY CONVERTER
AUSTRALIAN SUSTAINABLE
ENERGY CORPORATION PTY LTD.
AU
2008901763 11/04/2008
PCT/AU/2009/000429
WO/2009/124344
////4/14/4
‫מערכת ושיטה עבור פריסת ואחזור ממיר‬
‫אנרגיה בגלים‬
501156
COMPUTERIZED SYSTEM FOR
ADDICTION CONTROL ESPECIALLY
CALORIE, DIET AND WEIGHT
CONTROL
KNAAN TZACHI
4//40/1440
/1/40/1440
CRYOSURGICAL INSTRUMENT
ICECURE MEDICAL LTD
115
G09B )5010.01(
‫מערכת ממוחשבת לשליטה ובקרה על‬
,‫התמכרות בין השאר בתחום הקלוריות‬
‫דיאטות והורדת משקל‬
‫צחי כנען‬
501120
AUTOMATIC ADJUSTABLE
VOLTAGE TO STABILIZE PRESSURE
FOR SHOCKWAVE MEDICAL
THERAPY DEVICE
SPECTOR AVENER
US
61/071113
14/04/2008
PCT/IL/2009/000375
WO/2009/128061
F03B )5010.01(
G10K )5010.01(
‫התקן לבקרה ושליטה אוטומטית במתח‬
‫חשמלי לייצוב לחץ עבור טיפול בגלי הלם‬
501121
‫ספקטור אבנר‬
A61B )5010.01(
‫התקן קייוגני‬
‫אייסקיור מדיקל בע"מ‬
December 30, 2010-‫כג' בטבת התשע"א‬
US
61/045372
PCT/IB/2009/051532
WO/2009/128014
16/04/2008
////4/14/4
501125
AEROSOL SPRAY CAN DISCHARGE
TUBES
TEFENTOOLS LTD.
////4/14/4
‫צינורות הפלטה לפחיות התזה‬
‫תפנטולס בע"מ‬
501122
501124
501125
CANDLE WITH WATER IN WAX
H.A. INDUSTRIES INTELLECTUAL
PROPERTY LTD.
US
61/045329
16/04/2008
PCT/IL/2009/000408
WO/2009/128069
116
A61B )5010.01(
‫מגן מחט למשאבה‬
‫לה מודל בע"מ‬
NEEDLE PROTECTOR FOR PUMP
LAMODEL LTD
///40/1440
E05B )5010.01(
‫מערכת נעילה החשה חתכי מפתח‬
‫מולטילוק טכנולוגיות בע"מ‬
KEY CUT SENSINGLOCK SYSTEM
MUL-T-LOCK TECHNOLOGIES LTD.
////4/14/4
B65D )5010.01(
C11C )5010.01(
‫נר עם מים בשעווה‬
‫ תעשיות איטלקטואל פרופרטי בע"מ‬.‫א‬.‫ח‬
December 30, 2010-‫כג' בטבת התשע"א‬
/0/40/1440
501121
SPIROCYCLIC DERIVATIVES AS
HISTONE DEACETYLASE
INHIBITORS
DAC S.R.L.
EP
08154528.7 15/04/2008
PCT/EP/2009/054376
WO/2009/127609
///40/1440
C07D )5010.01(
‫נגזרות ספירו–ציקליות כמעכבות היסטון‬
‫דה–אצטילאז‬
501121
C07D )5010.01(
–‫–יל‬5–‫ –דיאמינו–פירימידין‬1 ,5
‫ או‬SYK ‫קרבוקסיאמידים כמעכבים של‬
‫ קינזות‬JAK
2,6-DIAMINO-PYRIMIDIN-5-YLCARBOXAMIDES AS SYK OR JAK
KINASES INHIBITORS
PORTOLA PHARMACEUTICALS, INC.
US
61/045417
16/04/2008
///40/04/
///40/1441
US
///40/100
///40/1441
US
////14101
4///1/1441
US
////14100
4///1/1441
US
////1410/
4///1/1441
US
PCT/US/2009/002420
WO/2009/145856
///40/1440
501121
2,6-DIAMINO-PYRIMIDIN-5-YLCARBOXAMIDES AS SYK OR JAK
KINASES INHIBITORS
C07D )5010.01(
–‫–יל‬5–‫–דיאמינו–פירימידין‬1 , 5
‫ או‬SYK ‫קרבוקסיאמידים כמעכבים של‬
‫ קינזות‬JAK
PORTOLA PHARMACEUTICALS, INC.
US
61/045406
16/04/2008
///40/000
///40/1441
US
///40/100
///40/1441
US
////1410/
4///1/1441
US
////14101
4///1/1441
US
////1410/
4///1/1441
US
PCT/US/2009/002401
117
December 30, 2010-‫כג' בטבת התשע"א‬
WO/2009/136995
///41/1440
501126
EFFICIENT FILTRATION PROCESS OF
WATER IN A TANK FOR
RECEATIONAL AND ORNAMENTAL
USES, WHERE THE FILTRATION IS
PERFORMED OVER A SMALL
VOLUME OF WATER AND NOT
OVER THE TOTALITY OF THE
WATER FROM THE TANK
CRYSTAL LAGOONS CORPORATION
LLC.
CL
3900-2008
24/12/2008
PCT/US/2009/036809
WO/2010/074770
/1//4/14/4
‫תהליך סינון יעול של מים במיכל למטרות‬
‫ כשהסינון נעשה על נפח‬,‫בילוי וקישוט‬
‫מים מוגבל ולא על כל תכולת המים במיכל‬
501140
METHOD FOR ACCELERATING
START UP OF A COMPUTERIZED
SYSTEM
ECI TELECOM LTD.
118
B65D )5010.01(
‫בקבוק משקאות בעל נוחות מוגברת‬
‫בשימוש‬
‫שמעון גויכמן‬
BOTTLE FOR BEVERAGES WITH
INCREASED COMFORT OF USING
SHIMON GOIKHMAN
/1//4/14/4
B01D )5010.01(
501141
G06F )5010.01(
‫שיטה להאצת הפעלתה של מערכת‬
‫ממוחשבת‬
‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
December 30, 2010-‫כג' בטבת התשע"א‬
41/4//144/
501145
USE OF ANTI-PD-1 ANTIBODY FOR
PREPARING A PHARMACEUTICAL
COMPOSITION FOR TREATING A
HYPERPROLIFERATIVE DISEASE
ONO PHARMACEUTICAL CO., LTD.
US
60/679466
09/05/2005
/4//11010
1/////144/
US
/4//010/0
41//1/144/
US
PCT/JP/2006/309606
WO/2006/121168
/0/40/1440
‫ להכנת תכשיר‬PD–1 ‫שימוש בנוגדן אנטי‬
‫רוקחי לטיפול במחלת התרבות–יתר‬
501144
TAMPON HAVING AN AUXILIARY
PATCH
THE PROCTER & GAMBLE
COMPANY
US
12/102588
14/04/2008
PCT/US/2009/040412
WO/2009/129196
4//40/1440
11/40/1440
119
C23C )5010.01(
‫מתמרי פלסמון מקומיים ושיטות לייצורם‬
501141
SGC STIMULATORS, SGC
ACTIVATORS AND COMBINATIONS
THEREOF FOR THE TREATMENT OF
HEARING IMPAIRMENT
A61F )5010.01(
‫טמפון בעל נתיב מסייע‬
501145
LOCALIZED PLASMON
TRANSDUCERS AND METHODS OF
FABRICATION THEREOF
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
US
61/045069
15/04/2008
PCT/IL/2009/000404
WO/2009/128067
C12N )5010.01(
‫ידע חברה למחקר ופיתוח בע"מ‬
A61K )5010.01(
‫ וצירופים לטיפול‬SGC ‫ממריצי ומשפעלי‬
‫בלקות שמיעה‬
December 30, 2010-‫כג' בטבת התשע"א‬
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT
EP
08008797.6 10/05/2008
PCT/EP/2009/003073
WO/2009/138165
41/40/1440
501141
METHOD FOR DESIGNING
ORTHODONTIC APPARATUS
PASCAL BARON
FR
0852493
14/04/2008
PCT/EP/2009/054006
WO/2009/127536
///40/1440
‫שיטה לעיצוב מערכת אורתודנטית‬
501141
STENTS HAVING BIOABSORBABLE
LAYERS
MICELL TECHNOLOGIES, INC.
US
61/045928
17/04/2008
////40//0
/4//4/1441
US
PCT/US/2009/041045
WO/2009/146209
///40/1440
///40/1440
FETAL ECG MONITORING
120
A61F )5010.01(
‫תומכנים בעלי שכבות הנספגות בגוף‬
501146
INTERACTIVE VIRTUAL REALITY
IMAGE GENERATING SYSTEM
VIRTUAL PROTEINS B.V.
NL
1035303
16/04/2008
PCT/EP/2009/054553
WO/2009/127701
A61C )5010.01(
G06F )5010.01(
‫מערכת ליצירת תמונת מציאות ויטואלית‬
‫אינטראקטיבית‬
501150
A61B )5010.01(
‫ניטור אק"ג עוברי‬
December 30, 2010-‫כג' בטבת התשע"א‬
TUFTS MEDICAL CENTER
US
61/045055
15/04/2008
////4414/
10/40/1441
US
PCT/US/2009/040624
WO/2009/146181
///40/1440
501151
VACCINE
GLAXOSMITHKLINE BIOLOGICALS
S.A.
US
61/045291
16/04/2008
PCT/EP/2009/054491
WO/2009/127676
///40/1440
501155
VACCINE
GLAXOSMITHKLINE BIOLOGICALS
S.A.
US
61/045292
16/04/2008
PCT/EP/2009/054492
WO/2009/127677
1//40/1440
501152
MEDICAL DEVICES FOR
DELIVARING FLUIDS DURING
SURGERY AND METHODS FOR
THEIR USE
ZYMOGENETICS INC.
US
61/125504
25/04/2008
PCT/US/2009/041772
WO/2009/132331
11/40/1440
121
501154
A61K )5010.01(
‫חיסון‬
A61K )5010.01(
‫חיסון‬
A61B )5010.01(
‫התקנים רפואיים למתן נוזלים במהלך‬
‫ניתוח ושיטות לשימוש בהם‬
C07D )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
SUBSTITUTED
THIOPHENECARBOXAMIDES AS
IKK-BETA SERINE-, THREONINEPROTEIN KINASE INHIBITORS
CHROMA THERAPEUTICS LTD.
GB
0807642.4
26/04/2008
41////480
1//41/1441
GB
PCT/GB/2009/001051
WO/2009/130475
4//4//1440
‫תיאפון קרבוקסאמידים מותמרים כבטא‬
‫ סרין המעכבים תראונין–פרוטאין‬IKK
‫קינאז‬
501155
ENCAPSULATION OF
BIOLOGICALLY ACTIVE AGENTS
GLAXO GROUP LIMITED
US
61/050775
06/05/2008
///4/0///
14/4//1441
US
PCT/EP/2009/055438
WO/2009/135855
‫תרמול של גורמים פעילים ביולוגית‬
501151
14/40/1440
CYCLIC INHIBITORS OF 11 BETAHYDROXYSTEROID DEHDROGENASE 1
VITAE PHARMACEUTICALS, INC.
US
61/049650
01/05/2008
US
PCT/US08/009017 1//4//1441
////1//01
1//4//1441
US
///14//1/
40/41/1440
US
PCT/US/2009/002653
WO/2009/134400
4//4//1440
501151
METHOD FOR MANUFACTURING
ARYL CARBOXAMIDES
BASF SE
EP
08155888.4 08/05/2008
PCT/EP/2009/055446
122
A61K )5010.01(
C07D )5010.01(
–‫–בטא‬11 ‫מעכבים ציקליים של‬
1 ‫הידרוקסי סטרואידים דהידרוגנאז‬
C07D )5010.01(
‫שיטה ליצור אריל קרבוקסאמידים‬
December 30, 2010-‫כג' בטבת התשע"א‬
WO/2009/135860
1//40/1440
501156
BRAID-BALL EMBOLIC DIVICES
AND DELIVERY SYSTEMS
NFOCUS NEUROMEDICAL, INC.
US
61/046594
21/04/2008
///40///4
1//40/1441
US
///4110//
11/4//1441
US
///4110//
11/4//1441
US
////0/40/
///4//1440
US
PCT/US/2009/041313
WO/2009/132045
1//4//1440
‫התקנים הקשורים לתסחיף דם ומערכות‬
‫נתינה‬
501110
COCCIDIDOSIS VACCINES
INTERVET INTERNATIONAL B.V.
US
61/057003
29/05/2008
PCT/US/2009/045241
WO/2009/148895
4//40/1440
501111
DISINFECTANT WET WIPE
KIMBERLY-CLARK WORLDWIDE,
INC.
US
61/053360
15/05/2008
/1/110///
////1/1441
US
PCT/IB/2009/051381
WO/2009/138888
/0/4//1440
123
A61B )5010.01(
501115
A61K )5010.01(
‫חיסון לקוקסידיאוסיס‬
D21H )5010.01(
‫מגבון לח עם חומר חיטוי‬
C07B )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
NOVEL [F-18]-LABELLED LGLUTAMIC ACID-AND LGLUTAMINE DERIVATIVES (I), USE
THEREOF AND METHOD FOR THEIR
PRODUCTION
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT
EP
08075510.1 20/05/2008
PCT/EP/2009/003420
WO/2009/141091
/0/40/1440
‫) חדשות המסומנות באטום‬I( ‫תולדות‬
– L–‫–חומצה גלוטמית ו‬L ‫ של‬11–‫פלואור‬
‫ שימוש בהן ושיטה להכנתן‬,‫גלוטמין‬
501112
ELECTRICAL ANOMALY DETECTION
METHOD AND SYSTEM
CORPORATION NUVOLT INC.
US
61/044631
14/04/2008
PCT/CA/2009/000512
WO/2009/127068
/1/4//1440
‫מערכת ושיטה לגילוי סטייה חשמלית‬
501114
CONJUGATES FOR THE TREATMENT
OF MESOTHELIOMA
MOLMED SPA
EP
08008872.7 13/05/2008
PCT/EP/2009/055704
WO/2009/138396
1/////1440
124
A61K )5010.01(
‫תצמידים לטיפול במזותליומה‬
501115
METHOD AND APPARATUS FOR
GENERATING FRESH WATER, AND
METHOD AND APPARATUS FOR
DESALINATING SEA WATER
KOBELCO ECO-SOLUTIONS CO, LTD
2008JP
28/11/2008
304623
1440-41/1/0 /1/41/1440
JP
1440-41/1// /1/41/1440
JP
G01R )5010.01(
C02F )5010.01(
‫שיטה ומערכת לייצור מים מתוקים ושיטה‬
‫ומערכת להתפלת מי–ים‬
December 30, 2010-‫כג' בטבת התשע"א‬
1440-4114/1
JP
1440-4114//
JP
PCT/JP/2009/069932
WO/2010/061879
/0/41/1440
/0/41/1440
501111
4//4//1440
ENCAPSULATION OF
BIOLOGICALLY ACTIVE AGENTS
GLAXO GROUP LIMITED
US
61/050775
06/05/2008
///4/0///
14/4//1441
US
PCT/EP/2009/055437
WO/2009/135854
501111
/1/40/144/
CHEMICAL PROCESS
SYNGENTA LIMITED
GB
0508422.3
PCT/GB/2006/001361
WO/2006/114572
‫תרמול של גורמים פעילים ביולוגית‬
C07D )5010.01(
‫תהליך כימי‬
26/04/2005
/1//4/14/4
501111
DETACHABLE DEVICE FOR
MEASUREMENT OF ROOT CANAL
LENGTH
MEDIC NRG LTD.
///40/1440
STABLE CELL BINDING CHIMERIC
PEPTIDES
125
A61K )5010.01(
A61B )5010.01(
‫התקן פריק למדידת עומק התעלה‬
‫בטיפולי שורש‬
‫מדיק נרג בע"מ‬
501110
C07K )5010.01(
‫פפטידים כימרים קושרי תא‬
December 30, 2010-‫כג' בטבת התשע"א‬
HADASIT MEDICAL RESEARCH
SERVICES AND DEVELOPMENT LTD
US
61/044513
14/04/2008
PCT/IL/2009/000420
WO/2009/128077
41/41/144/
501111
A COVERING FOR AN
ENDOPROSTHETIC DEVICE AND
METHODS OF USING FOR
ANEURYSM TREATMENT
MEDINOL LTD.
US
60/673304
19/04/2005
PCT/IB/2006/000471
WO/2006/111801
41/41/144/
126
‫מדינול בע"מ‬
A61F )5010.01(
‫מכסה להתקן תותב פנימי ושיטות שימוש‬
‫עבור טיפול במפרצת‬
501112
QUINUCLIDINE COMPOUNDS AS
ALPHA-7 NICOTINIC
ACETYLCHOLINE RECEPTOR
LIGANDS
BRISTOL-MYERS SQUIBB COMPANY
US
61/047211
23/04/2008
/1/011100
/0/40/1440
US
PCT/US/2009/041076
WO/2009/131926
A61F )5010.01(
‫מכסה להתקן תותב פנימי ושיטות שימוש‬
‫עבור טיפול במפרצת‬
501115
A COVERING FOR AN
ENDOPROSTHETIC DEVICE AND
METHODS OF USING FOR
ANEURYSM TREATMENT
MEDINOL LTD.
US
60/673304
19/04/2005
PCT/IB/2006/000471
WO/2006/111801
14/40/1440
‫הדסית שירותי מחקר רפואי ופיתוח בע"מ‬
‫מדינול בע"מ‬
C07D )5010.01(
‫תרכובות קינוקלידין כליגנדים לקולטן‬
1–‫אצטילכולין הניקוטיני אלפא‬
December 30, 2010-‫כג' בטבת התשע"א‬
///4//1444
501114
PREPARATION OF QUINOLINESUBSTITUTED CARBONATE
ANDCARBAMATE DERIVATIVES
ABBOTT LABORATORIES
US
60/141042
24/06/1999
PCT/US/2000/016404
WO/2001/000582
/1//4/14/4
‫הכנת נגזרי קרבונט וקרבמט המותמרים‬
‫בקוינולין‬
501115
APPLICATOR TUBE FOR CREAM
USED ON RUBBER PRODUCTS
DROR ATUYA
/1//4/14/4
SPATULA
RAIEK AHMED ABO-JANB
127
B65D )5010.01(
‫שפופרת למריחת קרם למוצרי גומי‬
‫דרור עטיה‬
501111
UNIVERSAL BIKE RACK CARGO
SHELV
ALON REUVEN
/1//4/14/4
C07D )5010.01(
B60H )5010.01(
‫מדף מטען אוניברסלי לרכב‬
‫אלון ראובן‬
501111
E04F )5010.01(
‫מרית‬
‫גנב‬-‫ראיק אחמד אבו‬
December 30, 2010-‫כג' בטבת התשע"א‬
501116
40/40/1440
METHOD FOR THE SELECTIVE DOPING
OF SILICON AND SILICON SUBSTRATE
TREATED THEREWITH
GEBR. SCHMID GMBH & CO.
DE
102008019402.6 14/04/2008
PCT/EP/2009/002671
WO/2009/127369
11////1440
‫שיטה לזיהום בררני של סיליקון ומצע‬
‫סיליקון שטופל בשיטה זו‬
501110
METHODS AND SYSTEMS FOR
PERSONALIZED NETWORK
SEARCHING
GOOGLE INC.
US
10/726410
03/12/2003
PCT/US/2004/039176
WO/2005/062210
POWER CONTROL
INDICE PTY LTD
AU
2008902051
PCT/AU/2009/000515
WO/2009/129581
1//4//1441
H05B )5010.01(
‫מערכת בקרת כוח‬
24/04/2008
501115
MEDICAL DEVICE FOR THE
TREATMENT OF STENOSES OF
CORPORAL LUMINA AND FOR THE
PREVENTION OF IMPENDING
RESTENOSES
HEMOTEQ AG
128
G06F )5010.01(
‫שיטות ומערכות לביצוע חיפוש אישי‬
‫ברשת‬
501111
10/40/1440
H01L )5010.01(
A61L )5010.01(
‫התקן רפואי לטיפול בהצרויות של חללים‬
‫בגוף ולמניעת הצרויות חוזרות עתידות‬
December 30, 2010-‫כג' בטבת התשע"א‬
10 2007 003
914.1
44/ 144/ /4
DE
///8/
4/1 144/ /4
DE
/1/81
PCT/DE/2008/000096
WO/2008/086794
DE
///40/1440
21/01/2007
40/41/144/
1//41/144/
501112
‫מגן לרכב ולמבנה‬
VEHICLE AND STRUCTURE SHIELD
FOSTER-MILLER, INC.
US
61/124428
16/04/2008
PCT/US/2009/002363
WO/2010/048428
/1//4/14/4
501115
PISTOL CONVERSION ASSEMBLY
WITH SAFETY LATCH
TACTICAL ARMS LTD.
IL
201629
19/10/2009
14//11
/0//4/1440
IL
41/41/1440
F41A )5010.01(
‫ממיר לאקדח‬
‫טקטיקל ארמס בע"מ‬
501111
DEVICE AND NON-CUTTING SHAPING
METHOD FOR INTRODUCING AN
OUTSIDE PROFILE INTO A WORKPIECE
GOTTFRIED WILHELM LEIBNIZ
UNIVERSITAT HANNOVER
DE
102008019437.9 17/04/2008
PCT/DE/2009/000285
WO/2009/127178
129
F41H )5010.01(
B21H )5010.01(
‫מתקן ושיטה ללא חיתוך ליצירת‬
‫פרופיל חיצוני בחלק הנמצא בעיבוד‬
December 30, 2010-‫כג' בטבת התשע"א‬
/1/4//1440
501111
‫מערכת חום לח ניידת‬
PORTABLE MOIST HEAT SYSTEM
WYETH LLC
US
61/053480
15/05/2008
///401440
10/41/1441
US
PCT/US/2009/043779
WO/2009/140377
4//4//1440
501116
FAST CHANNEL ZAPPING AND HIGH
QUALITY STREAMING PROTECTION
OVER A BROADCAST CHANNEL
DIGITAL FOUNTAIN, INC.
US
61/051325
07/05/2008
PCT/US/2009/043184
WO/2009/137705
///4//1440
4//4//1440
130
H04W )5010.01(
‫התאמת כיסוי דינמית במערכת תקשורת‬
‫רב–נשאית‬
501161
METHOD OF PREVERNTING THE
DEVELOPMENT OF RHEUMATOID
ARTHRITIS IN SUBJECTS WITH
UNDIFFERENTIATED ARTHRITIS
BRISTOL-MYERS SQUIBB COMPANY
US
61/050336
05/05/2008
/1/11/1/0
4//4//1440
US
H04N )5010.01(
‫החלפת ערוצים מהירה והגנת זרימה‬
‫באיכות גבוהה בערוץ שידור‬
501160
DYNAMIC CONVERAGE
ADJUSTMENT IN A MULTI-CARRIER
COMMUNICATION SYSTEM
QUALCOMM INCORPORATED
US
61/054019
16/05/2008
/1/0//404
/0/4//1440
US
PCT/US/2009/044237
WO/2009/140653
A61F )5010.01(
C07K )5010.01(
‫שיטות למניעת התפתחות דלקת מפרקים‬
‫שגרונית במטופלים בעלי דלקת מפרקים‬
‫שלא עברה דיפרנציאציה‬
December 30, 2010-‫כג' בטבת התשע"א‬
PCT/US/2009/042761
WO/2009/137424
///41/1440
501165
STEROIDAL LIGANDS AND THEIR
USE IN GENE SWITCH MODULATION
INTREXON CORPORATION
US
61/036648
14/03/2008
///40/4//
11/40/1441
US
///4/4/4/
///4//1441
US
PCT/US/2009/001639
WO/2009/114201
11/40/1440
/0//4/14/4
‫ליגנדים סטרוידיים ושימושיהן במודולציה‬
‫של סוויטש גן‬
501162
DUAL VARIABLE DOMAIN
IMMUNOGLOBULINS AND USES
THEREOF
ABBOTT LABORATORIES
US
61/125834
29/04/2008
////10111
41/4//1441
US
////0//0/
11//4/1441
US
////00440
/1////1441
US
PCT/US/2009/041945
WO/2009/134776
131
A61K )5010.01(
‫אימונוגלובולינים שמכילים דומאיין עם שני‬
‫אזורים משתנים‬
501164
‫אאאאאאאאאאאאאאאאאאאאאאאאאאאאאאא‬
IZHAK ZOHAR
/0//4/14/4
A01N )5010.01(
501165
B05B )5010.01(
‫טפטפת תת קרקעית עם ראש פריק‬
‫יצחק זוהר‬
B65D )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
‫אריזת תקרובת‬
‫אבנר אברהם‬
REFRESHMENT PACKAGE
AVNER AVRAHAM
/0//4/14/4
501161
SALF-CLEANING AIR CONDITIONER
FILTER
AVRAHAM DISKIN
1///1/1441
501161
AQUEOUS BASED
PHARMACEUTICAL FORMULATIONS
OF WATER-SOLUBLE PRODRUGS OF
PROPOFOL
EISAI INC.
US
60/342755
28/12/2001
PCT/US/2002/041468
WO/2003/057153
10/40/1440
501166
SECURE WEB BASED
TRANSACTIONS
THE ICE ORGANISATION LTD
GB
0807678.8
28/04/2008
PCT/GB/2009/050421
WO/2009/133386
11/4//1440
132
501100
B01D )5010.01(
‫ניקוי עצמי לפילטר של מזגנים‬
‫אברהם דיסקין‬
A61K )5010.01(
–‫הרכבי רוקחות על בסיס מימי של פרה‬
‫תרופות מסיסות במים של פרופופול‬
G06Q )5010.01(
‫עיסקאות מבוססות רשת מוגנות‬
C12N )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
‫גורמים מווסתים חדשים‬
NOVEL REGULATORY ELEMENTS
BOEHRINGER INGLHEIM PHARMA
GMBH &CO. KG
EP
08161029.7 23/07/2008
PCT/EP/2009/059399
WO/2010/010107
11/40/1440
501101
C07D )5010.01(
‫אנלוגים של קרבא–נוקליאוזיד לטיפול‬
‫אנטי–ויראלי‬
CARBA-NUCLEOSIDE ANALOGS FOR
ANTIVIRAL TREATMENT
GILEAD SCIENCES, INC.
US
61/047263
23/04/2008
////10000
/0//1/1441
US
PCT/US/2009/041432
WO/2009/132123
11/40/1441
501105
C07D )5010.01(
‫ –בטא סרין–תראונין פרוטאין‬IKK ‫מעכבי‬
‫קינאז‬
INHIBITORS OF IKK-B SERINETHREONINE PROTEIN KINASE
CHROMA THERAPEUTICS LTD.
PCT/GB/2008/001434
WO/2009/130434
4//4//1440
501102
ENCAPSULATION OF
BIOLOGICALLY ACTIVE AGENTS
GLAXO GROUP LIMITED
US
61/050775
06/05/2008
///4/0///
14/4//1441
US
PCT/EP/2009/055435
WO/2009/135852
133
A61K )5010.01(
‫תרמול של גורמים פעילים ביולוגית‬
December 30, 2010-‫כג' בטבת התשע"א‬
/0/4//1440
501104
INSECTICIDAL FORMULATIONS
WITH IMPROVED LONG-TERM
EFFECT ON SURFACES
BAYER CROPSCIENCE AG
EP
08156623.4 21/05/2008
41//110/8/
///4//1441
EP
/////11//
10/40/1440
US
PCT/EP/2009/003546
WO/2009/141109
/4/40/1440
/0//4/14/4
‫הרכבים קוטלי חרקים בעלי השפעה‬
‫ארוכת טווח משופרת על משטחים‬
501105
SYSTEMS AND METHODS FOR
REMOTE TRACKING AND REPLAY
OF USER INTERACTION WITH A
WEBPAGE
FORESEE RESULTS
US
61/124392
15/04/2008
PCT/US/2009/040194
WO/2009/139994
501101
B65D )5010.01(
‫מאגר מקורי למים‬
‫גול סרחאן‬
501101
MATERIALS AND METHODS FOR
RESPIRATORY DISEASE CONTROL
IN CANINES
UNIVERSITY OF FLORIDA
RESEARCH FOUNDATION, INC.
US
60/673443
21/04/2005
PCT/US/2006/015090
134
G06F )5010.01(
‫מערכות ושיטות למעקב מרחוק ושידור‬
‫חוזר של האינטראקציה של משתמש עם‬
‫דף אינטרנט‬
ORIGINAL RESERVOIR WATER
JOUL SRHAN
1//40/144/
A01N )5010.01(
C07K )5010.01(
‫חומרים ושיטות לבקרת מחלות נשימתיות‬
‫בכלביים‬
December 30, 2010-‫כג' בטבת התשע"א‬
WO/2006/116082
///40/1440
501101
CARBIDOPA/LIPODOPA
GASTRORETENTIVE DRUG
DELIVERY
INTEC PHARMA LTD
US
61/046261
18/04/2008
////144//
40//1/1441
US
PCT/IB/2009/005691
WO/2009/144558
40/4//1440
4//4//1440
135
‫אינטק פארמה בע"מ‬
H05K )5010.01(
‫מערכת לניהול חום עבור ארון המכיל ציוד‬
‫אלקטרוני‬
501110
ANALYTE MEASUREMENT AND
MANAGEMENT DEVICE AND
ASSOCIATED METHODS
LIFESCAN, INC.
US
61/051258
07/05/2008
/1/0//1//
41/40/1440
US
PCT/US/2009/043125
WO/2009/137661
/0/40/1440
‫מתן תרופה המושהית בקיבה‬
‫ליפודופה‬/‫קרבידופה‬
501106
HEAT-MANAGEMENT SYSTEM FOR
A CABINET CONTAINING
ELECTRONIC EQUIPMENT
3M INNOVATIVE PROPERTIES
COMPANY
EP
08155830.6 07/05/2008
PCT/US/2009/042672
WO/2009/137387
A61K )5010.01(
A61B )5010.01(
‫ מכשיר טיפול ושיטות‬,‫מדידת חומר מומס‬
‫קשורות‬
501112
A61K )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
STIMULATION OF AN IMMUNE
RESPONSE BY ENANTIOMERS OF
CATIONIC LIPIDS
PDS BIOTECHNOLOGY
CORPORATION,
US
61/045837
17/04/2008
PCT/US/2009/040500
WO/2009/129227
14/40/1440
501114
ANTIOXIDANT INFLAMMATION
MODULATORS: OLEANOLIC ACID
DERIVATIVES WITH SATURATION
IN THE C-RING
REATA PHARMACEUTICALS, INC.
US
61/046332
18/04/2008
//////111
40////1441
US
PCT/US/2009/041170
WO/2009/129545
4//4//1440
‫המרצת תגובה חיסונית באמצעות‬
‫אננטיומרים של שומנים קטיוניים‬
‫ תולדות חומצה‬:‫מאפנני דלקת מונעי חמצון‬
C ‫אוליאנואית עם רוויה בטבעת‬
501115
A SYSTEM AND METHOD FOR
MAINTAINING OR RECOVERING
NOZZLE FUNCTION FOR AN INKJET
PRINTHEAD
VIDEOJET TECHNOLOGIES INC.
US
61/049490
01/05/2008
/1/0111/1
14/40/1440
US
PCT/US/2009/042466
WO/2009/135099
1//4//1440
501111
PHOSPHOROUS DERIVATIVES AS
KINASE INHIBITORS
ARIAD PHARMACEUTICALS, INC.
US
61/128317
21/05/2008
////1/004
1//4//1441
US
136
C07J )5010.01(
B41F )5010.01(
‫מערכת ושיטה לשמירה או תיקון של‬
‫תפקוד זרבובית עבור ראש להזרקת דיו‬
A61K )5010.01(
‫תולדות זרחן כמעכבי קינאז‬
December 30, 2010-‫כג' בטבת התשע"א‬
////11/0/
US
////01011
US
////010/0
US
PCT/US/2009/044918
WO/2009/143389
11/40/1440
/1/41/1441
11/40/1441
11/40/1441
501111
METHODS OF IDENTIFYING ANTIINFLAMMATORY COMPUNDS
THE ROCKEFELLER UNIVERSITY
US
61/046847
22/04/2008
///40/100
///40/1441
US
PCT/US/2009/041441
WO/2009/132130
///40/1440
‫שיטות לזיהוי תרכובות נגד דלקות‬
501111
501116
137
C07D )5010.01(
‫מעכבים של קינזות של חלבונים‬
INHIBITORS OF PROTEIN KINASES
PORTOLA PHARMACEUTICALS, INC.
US
61/047077
22/04/2008
PCT/US/2009/002512
WO/2009/131687
4//40/1440
C07K )5010.01(
‫ מותאמים‬IX ‫פוליפפטידים פקטור‬
‫ושימושים בהם‬
MODIFIED FACTOR IX
POLYPEPTIDES AND USES THEREOF
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT
US
61/124567
16/04/2008
///40/0//
///40/1441
US
PCT/US/2009/040813
WO/2009/137254
11/40/1440
G01N )5010.01(
501150
B65G )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
DISPLACEABLE LIFT TRUCK EQUIPPED
WITH RELEASABLE ENGAGING MEANS
FOR MAKING UP A MIXED PACK OF
SLAB MATERIAL AND METHOD
ASSOCIATED THEREWITH
TONCELLI, LUCA
IT
TV2008A000063 18/04/2008
PCT/IB/2009/051452
WO/2009/127994
///40/1440
501151
USE OF MYRTLE EXTRACT AS
DEPIGMENTING AGENT
PIERRE FABRE DERMOCOSMETIQUE
FR
0852570
16/04/2008
PCT/EP/2009/054487
WO/2009/127673
///40/1440
501155
DUAL APPLICATOR APPARATUS
CATCHPOINT LIMITED
GB
0806858.7
16/04/2008
PCT/GB/2009/000985
WO/2009/136138
/0/40/1441
501152
METHOD AND PHARMACEUTICAL
COMPOSITION FOR OBTAINING THE
PLASMATIC PROGESTERONE
LEVELS REQUIRED FOR DIFFERENT
THERAPEUTIC INDICATIONS
POSI VISIONARY SOLUTIONS LLP
‫משאית הרמה ניידת המצויידת באמצעי‬
‫שילוב ניתנים לפירוק לשם יצירת‬
‫חבילה מעורבת של לוחות עבים‬
‫ושיטה הקשורה בכך‬
A61K )5010.01(
–‫שימוש בתמצית הדס כגורם לדה‬
‫פיגמנטציה‬
B65C )5010.01(
‫מכשיר השמה דואלי‬
A61K )5010.01(
‫שיטה ותכשיר רוקחות לקבלת רמות‬
‫הפרוגסטרון הפלסמי הדרושות‬
‫לאינדיקציות רפואיות שונות‬
PCT/MX/2008/000051
WO/2009/128692
138
December 30, 2010-‫כג' בטבת התשע"א‬
14/40/1440
501154
TREATMENT OF INFLAMMATORY
BOWEL DISEASE WITH 6MERCAPTOPURINE
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
61/046152
18/04/2008
PCT/US/2009/002460
WO/2009/128955
11/40/1440
11/40/1440
‫טבע תעשיות פרמצבטיות בע"מ‬
G01N )5010.01(
‫שיטות לניטור האיפנון של פעילות הקינז‬
‫של קולטן לגורם גידול פיברובלסטי‬
‫ושימושים של שיטות אלה‬
501151
TREATMENT OF HEPATITIS C VIRUS
INFECTIONS IN PATIENTS NONRESPONSIVE TO TREATMENT WITH
PEGYLATED INTERFERON-ALPHA2A/2B AND RIBAVIRIN
VERTEX PHARMACEUTICALS
INCORPORATED
US
61/047336
23/04/2008
///4/4441
14/4//1441
US
///4000/1
11/40/1441
US
////4014/
14//4/1441
US
/////1/1/
/1/41/1440
US
///////1/
/0/41/1440
US
139
–1 ‫טיפול במחלות מעי דלקתיות ע"י‬
‫מרקפטופורין‬
501155
METHODS OF MONITORING THE
MODULATION OF THE KINASE
ACTIVITY OF FIBROBLAST GROWTH
FACTOR RECEPTOR AND USES OF
SAID METHODS
NOVARTIS AG
EP
08155401.6 29/04/2008
41///1//84
11/4//1441
EP
PCT/EP/2009/055127
WO/2009/133101
A61K )5010.01(
A61K )5010.01(
‫טיפול בזיהומים של נגיף הפטיטיס סי‬
‫בחולים שאינם מגיבים לטיפול‬
‫ בעל פגילציה‬A2/B2–‫באינטרפרון–אלפא‬
‫וריבאווירין‬
December 30, 2010-‫כג' בטבת התשע"א‬
PCT/US/2009/002526
WO/2009/131696
4//4//1440
501151
HIGH REFRACTIVE INDEX
OPHTHALMIC DEVICE MATERIALS
ALCON, INC.
US
61/050866
06/05/2008
PCT/US/2009/042903
WO/2009/137525
/0//4/14/4
‫חומרים בעלי מקדם שבירה גבוה למכשירי‬
‫ניתוח תוך עיני‬
501156
MODULAR CONSTRUCTION
ELEMENT
DANIEL TIBI
/0//4/14/4
A DEVICE FOR CARRYING BAGS
ELI SWISSA
140
E04B )5010.01(
‫אלמנט בניה מודולרי‬
‫דניאל טיבי‬
501120
SECURITY SYSTEM FOR A
COMPUTER AND METHOD THEREOF
VADIM SENDEROVYCH
/0//4/14/4
G02B )5010.01(
G06F )5010.01(
‫מערכת אבטחה למחשב ושיטה בעבורה‬
501121
‫סמי כהן‬
A45F )5010.01(
‫מתקן לנשיאת שקיות‬
‫או בע"מ‬.‫אר‬.‫אנ‬.‫סי‬
December 30, 2010-‫כג' בטבת התשע"א‬
///40/1440
501125
METHODS FOR ENHANCED
PRODUCTION OF BONE
MORPHOGENETIC PROTEINS
WYETH LLC
US
61/045643
17/04/2008
PCT/US/2009/040789
WO/2009/129379
40/4//1440
501124
ELECTRODEPOSITION
COMPOSITION AND METHOD FOR
COATING A SEMICONDUCTOR
SUBSTRATE USING SAID
COMPOSITION
ALCHIMER S.A.
FR
0852970
05/05/2008
////000//
41//4/1441
US
PCT/FR/2009/050812
WO/2009/141551
/0//4/14/4
501125
501121
SOLAR ENERGY REFLECTOR
AGC GLASS EUROPE
EP
08154780.4 18/04/2008
141
‫שיטות להגברת ייצור של חלבוני עצם‬
‫מורפוגנטיים‬
C25D )5010.01(
‫תרכובת לציפוי ושיטה לציפוי למצע של‬
‫מוליך למחצה בעזרת אותה תרכובת‬
H04L )5010.01(
‫מאבחן אותות רחב–פס‬
‫אלביט מערכות בע"מ‬
WIDEBAND SIGNAL ANALYZER
ELBIT SYSTEMS LTD.
///40/1440
C12P )5010.01(
F24J )5010.01(
‫רפלקטור לאנרגיה סולרית‬
December 30, 2010-‫כג' בטבת התשע"א‬
PCT/EP/2009/054601
WO/2009/144095
///40/1440
501121
HYDROPHILIC AND HYDROPHOBIC
SILANE SURFACE MODIFICATION
OF ABRASIVE GRAINS
Saint-Gobain ABRASIFS
US
61/124168
18/04/2008
PCT/US/2009/040797
WO/2009/129384
4//40/1440
‫התאמות של גרגרי שחיקה על ידי פני‬
‫שטח מסילן סופח מים ודוחה מים‬
501121
HYBRID MEDICAL DEVICE
LOCALIZATION SYSTEM
NAVOTEK MEDICAL LTD
US
61/045270
15/04/2008
PCT/IL/2009/000383
WO/2009/128062
10//4/144/
4//40/1440
142
A61B )5010.01(
‫מערכת מיקום הברידית למכשור רפואי‬
‫נבוטק מדיקל בע"מ‬
501126
ISOLATED POLYPEPTIDES,
POLYNUCLEOTIDES ENCODING
SAME, TRANSGENIC PLANTS
EXPRESSING SAME AND METHODS
OF USING SAME
EVOGENE LTD.
US
60/729181
24/10/2005
PCT/IL/2006/001223
WO/2007/049275
B24D )5010.01(
C12N )5010.01(
‫ פולינוקלאוטידים המקודדים‬,‫פוליפפטידים‬
‫ צמחים טרנסגנים המבטאים אותם‬,‫להם‬
‫ושיטות לשימוש בהם‬
501141
‫אבוג'ן בע"מ‬
G06K )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
MULTISPECTRAL ENHANCED
VISION SYSTEM AND METHOD FOR
AIRCRAFT LANDING IN INCLEMENT
WEATHER CONDITIONS
ELBIT SYSTEMS LTD.
US
61/045460
16/04/2008
PCT/IL/2009/000390
WO/2009/128065
11/41/1440
‫מערכת מולטי–ספקטראלית לראיה‬
‫משופרת ושיטה להנחתת כלי טיס בתנאי‬
‫מזג אוויר קשים‬
501145
PRESSURE DIFFERENTIAL
METERING DEVICE
WEINGARTEN, ZVI
US
12/112051
30/04/2008
PCT/IB/2009/051196
WO/2009/133482
1//40/1440
501142
SMOKELESS PIPE
URTSEV, VLADIMIR NIKOLAEVICH
RU
2008116282 28/04/2008
PCT/RU/2009/000190
WO/2009/134164
///40/1440
501144
NUCLEIC ACID-LIPID PARTICLES,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
PROTIVA BIOTHERAPEUTICS, INC.
US
61/045228
15/04/2008
PCT/CA/2009/000496
WO/2009/127060
143
‫אלביט מערכות בע"מ‬
G01F )5010.01(
‫מכשיר למדידת הפרשי לחץ‬
‫ צבי‬,‫ויינגרטן‬
A24F )5010.01(
‫מקטרת נטולת עשן‬
C12N )5010.01(
‫ תכשירים‬,‫חלקיקי חומצות גרעין–לפיד‬
‫המכילים אותם ושימושים בהם‬
December 30, 2010-‫כג' בטבת התשע"א‬
41/40/1440
501145
MEMBRANES FOR SUPPORTING
CELL GROWTH AND USE THEREOF
UCL BUSINESS PLC
GB
0806746.4
14/04/2008
PCT/GB/2009/000917
WO/2009/127809
///40/1440
144
‫ממברנות תומכות גידול תאים ושימוש בהן‬
501141
PROCESSES FOR THE PREPARTION
OF REVERSE OSMOSIS MEMBRANES
AND MEMBRANES PRODUCED
THEREBY
NANOH20, INC.
US
61/045262
15/04/2008
///40/110
///40/1441
US
///40/11/
///40/1441
US
///40/10/
///40/1441
US
///40/100
///40/1441
US
///40/1/1
///40/1441
US
///4/0/00
/4/4//1441
US
///411///
/1/41/1441
US
////4004/
/1//4/1441
US
////1110/
/1//1/1441
US
/////1101
/1//1/1441
US
////11101
/1//1/1441
US
////11100
/1//1/1441
US
////1110/
/1//1/1441
US
////1110/
/1//1/1441
US
////1110/
/1//1/1441
US
////11101
/1//1/1441
US
////111//
/1//1/1441
US
////111/1
/1//1/1441
US
////111/0
/1//1/1441
US
////111//
/1//1/1441
US
////111//
/1//1/1441
US
////111/1
/1//1/1441
US
//////111
1//41/1440
US
//////100
1//41/1440
US
/////041/
1//41/1440
US
////111/4
41//4/14/4
US
PCT/US/2009/040732
WO/2009/129354
C12N )5010.01(
B01D )5010.01(
‫שיטות יצור ממברנות לאוסמוזה הפוכה‬
‫וממהרנות המיוצרות על ידי כך‬
December 30, 2010-‫כג' בטבת התשע"א‬
///4//1440
501141
A ONE-PIECE MICROWAVEABLE
PACKAGE
NESTEC S.A.
EP
08104552.8 26/06/2008
PCT/EP/2009/057484
WO/2009/156310
14/41/144/
501141
METHOD OF MAKING EMBRYOID
BODIES FROM PRIMATE
EMBRYONIC STEM CELLS
WISCONSIN ALUMNI RESEARCH
FOUNDATION
US
09/510444
21/02/2000
PCT/US/2001/005252
WO/2001/062899
///40/1440
501146
COMBINATION OF DRONEDARONE
WITH AT LEAST ONE DIURETIC,
AND THERAPEUTIC USE THEREOF
SANOFI-AVENTIS
FR
08/02128
17/04/2008
///40/000
/1/40/1441
US
PCT/FR/2009/000450
WO/2009/133310
///4///00/
ISOLATED LEPTIN RECEPTOR
POLYPEPTIDE
THE ROCKEFELLER UNIVERSITY
145
501150
B65D )5010.01(
‫אריזת מיקשה אחת למיקרו‬
C12N )5006.01(
‫שיטה לייצרת גוף עוברי מתאי גזע‬
‫פרימאט עובריים‬
A61K )5010.01(
‫תערובת של דרונדרון עם לפחות מעורר‬
‫ ושימוש תראפיוטי שלה‬,‫השתנה אחד‬
C07K )5010.01(
‫פוליפפטיד מבודד של קולטן לפטין‬
December 30, 2010-‫כג' בטבת התשע"א‬
US
08/586594
41//000/0
US
PCT/US/1997/001010
WO/1997/026335
///40/1440
16/01/1996
/0/41//00/
501151
USE OF DRONEDARONE OR A
PHARMACEUTICALLY ACCEPTABLE
SALT THEREOF, FOR THE
PREPARATION OF A MEDICAMENT
FOR REGULATING THE POTASSIUM
LEVEL IN THE BLOOD
SANOFI-AVENTIS
US
61/045995
18/04/2008
4141/1/
10/4//1441
FR
PCT/IB/2009/005605
WO/2009/144551
///40/1440
146
‫שימוש בדרונדרון או מלח קביל מבחינה‬
‫פארמצבטית שלו להכנת תרופה לוויסות‬
‫רמת אשלגן בדם‬
501155
USE OF DRONEDARONE FOR THE
PREPARATION OF A MEDICAMENT
FOR USE IN THE PREVENTION OF
CARDIOVASCULAR
HOSPITALIZATION OR OF
MORTALITY
SANOFI-AVENTIS
FR
0802127
17/04/2008
///40/00/
/1/40/1441
US
4141141
/4/4//1441
FR
///4/41//
/4/4//1441
US
4010440/84
///41/1440
EP
/////////
///41/1440
US
4010440180
///41/1440
EP
///////11
///41/1440
US
/////00//
/1/41/1440
US
PCT/IB/2009/005587
WO/2009/144550
A61K )5010.01(
A61K )5010.01(
‫שימוש בדרונדרון להכנת תרופה לשימוש‬
‫במניעת אשפוז קרדיוו–וסקולארי או‬
‫תמותה‬
December 30, 2010-‫כג' בטבת התשע"א‬
4//4//1440
501152
7H-INDOLO[2,1-A][2]BENZAZEPINE10-CARBOXYLIC ACID
DERIVATIVES FOR THE TREATMENT
OF HEPATITIS C
BRISTOL-MYERS SQUIBB COMPANY
US
61/050743
06/05/2008
PCT/US/2009/042805
WO/2009/137454
///40/1440
////4/14/4
DISH SOLAR AIR ELECTROPLANT
WOLFTSUN LEONID
147
C07D )5010.01(
‫אקטיבטור לקולטן המופעל על פרוקסיזום‬
‫פרוליפרטור‬
501155
INSPECTION SYSTEM AND METHOD
FOR HIGH SPEED IMAGING
CAMTEK LTD.
US
61/253099
20/10/2009
////4/14/4
–‫] בנזאזפין‬A][2–1,5[ ‫–אינדולו‬H7 ‫נגזרות‬
‫–חמצה קרבוקסילית לטיפול בהפטיטיס‬10
C
501154
ACTIVATOR FOR PEROXISOME
PROLIFERATOR-ACTIVATED
PECEPTOR
NIPPON CHEMIPHAR CO., LTD.
2008JP
15/04/2008
105899
PCT/JP/2009/057946
WO/2009/128558
C07D )5010.01(
G02B )5010.01(
‫מערכת בדיקה ושיטה להדמיה במהירות‬
‫גבוהה‬
‫קמטק בע"מ‬
501151
F24J )5010.01(
‫תחנת צלחת כוח סולארית מופעלת עם‬
‫אוויר‬
‫וולפצון לאוניד‬
December 30, 2010-‫כג' בטבת התשע"א‬
////4/14/4
501151
A COMPUTERIZED AID FOR
PLANNING A NUTRITIONALLY
BALANACED MENU
LOGI-DIET LTD
US
12/626638
26/11/2009
14/40/1440
14/40/1440
148
‫לוגי דיאט בע"מ‬
A61K )5010.01(
‫ תולדות חומצה‬:‫מאפנני דלקת מונעי חמצון‬
–‫אוליאנולית עם אמינו ושינויים נוספים ב‬
C–11
501156
ANTIOXIDANT INFLAMMATION
MODULATORS: C-17
HOMOLOGATED OLEANOLIC ACID
DERIVATIVES
REATA PHARMACEUTICALS, INC.
US
61/046366
18/04/2008
//////100
40////1441
US
PCT/US/2009/041176
WO/2009/129548
14/40/1440
‫שיטה ממוחשבת לתכנון תפריט הזנה‬
‫מאוזן‬
501151
ANTIOXIDANT INFLAMMATION
MODULATORS: OLEANOLIC ACID
DERIVATIVES WITH AMINO AND
OTHER MODIFICATIONS AT C-17
REATA PHARMACEUTICALS, INC.
US
61/046342
18/04/2008
//////1/0
40////1441
US
PCT/US/2009/041172
WO/2009/129546
G06F )5010.01(
C07J )5010.01(
‫ תולדות חומצה‬:‫מאפנני דלקת מונעי חמצון‬
C–11 ‫אוליאנולית מותאמות‬
501110
C07J )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
COMPOUNDS INCLUDING AN ANTIINFLAMMATORY PHARMACORE
AND METHODS OF USE
REATA PHARMACEUTICALS, INC.
US
61/046363
18/04/2008
PCT/US/2009/041177
WO/2009/146218
///40/1440
‫תרכובות המכילות פארמקור נגד דלקת‬
‫ושיטות לשימוש‬
501115
HIGH-SPEED PERMANENT MAGNET
MOTOR AND GENERATOR WITH
LOW-LOSS METAL ROTOR
SYNCHRONY, INC
US
61/045660
17/04/2008
PCT/US/2009/040735
WO/2009/146189
///40/1440
‫מנוע מגנטי קבוע בעל מהירות גבוהה‬
‫וגנרטור עם מנוע מתכתי עם פחת נמוך‬
501112
501114
EVAPORATIVE COOLING TOWER
ENHANCEMENT THROUGH
COOLING RECOVERY
JARRELL WENGER
US
61/046036
18/04/2008
PCT/US/2009/041056
WO/2009/129517
149
H02K )5010.01(
‫מסב לחץ מגנטי עם אלקטרוניקה‬
‫משולבת‬
MAGNETIC THRUST BEARING WITH
INTEGRATED ELECTRONICS
SYNCHRONY, INC
US
61/046171
18/04/2008
PCT/US/2009/040790
WO/2009/140022
/1/40/1440
F02N )5010.01(
F28C )5010.01(
‫הגברת מגדל קירור אויר באמצעות קירור‬
‫חוזר‬
December 30, 2010-‫כג' בטבת התשע"א‬
501115
11/40/1440
METHODS AND COMPOUNDS FOR
MITIGATING PATHOGENIC OUTBREAKS
USING REPLIKIN COUNT CYCLES
SAMUEL WINSTON BOGOCH
US
12/108458
US
PCT/US08/061336
///4/04/4
US
///41/1/0
US
////01//1
US
PCT/US/2009/041565
WO/2009/132209
C07K )5010.01(
‫שיטות ותרכובות להקלת התפרצויות‬
‫פתוגניות ע"י שימוש בספירת מחזורי‬
‫רפליקין‬
23/04/2008
11/40/1441
///4//1441
41/41/1441
40/4//1440
/1/4//1441
501111
CATOPTRIC, ZERO-POWER, WIDEFIELD-OF-VIEW OPTICAL SYSTEM
WITH A POSTERIOR APERTURE
STOP AND A LONG BACK FOCAL
LENGTH
RAYTHEON COMPANY
G02B )5010.01(
‫מערכת אופטית קטופטרית בעלת כח‬
‫אפס ושדה ראייה רחב עם עצירת פתח‬
‫אחורי ורוחק מוקד אחורי ארוך‬
PCT/US/2008/063482
WO/2009/139767
14/40/1440
501111
GENETICALLY MODIFIED HUMAN
UMBILICAL CORD PERIVASCULAR
CELLS FOR PROPHYLAXIS AGAINST
OR TREATMENT OF BIOLOGICAL OR
CHEMICAL AGENTS
TISSUE REGENERATION
THERAPEUTICS, INC.
US
61/046630
21/04/2008
PCT/CA/2009/000528
WO/2009/129616
150
A61K )5010.01(
‫תאים פריווסקולאריים מהודנסים גנטית‬
‫מחבל טבור אנושי למניעה של או טיפול‬
‫בגרומים ביולוגיים או כימיים‬
December 30, 2010-‫כג' בטבת התשע"א‬
11/40/1440
501111
METHODS FOR RADIOLABELLING
MACROMOLECULES
THE AUSTRALIAN NATIONAL
UNIVERSITY
AU
2008902063 24/04/2008
PCT/AU/2009/000508
WO/2009/129577
40/40/1441
‫שיטות לסימון איזוטופי של מקרומלקולות‬
501116
BIOLOGICAL ACTIVE COATING
COMPONENTS, COATINGS, AND
COATED SURFACES
STEVEN C. MCDANIEL
US
60/409102
09/09/2002
/4////10/
40/40/1441
US
PCT/US/2003/028345
WO/2004/112482
11/40/1440
501110
METHODS FOR RADIOLABELLING
SYNTHETIC POLYMERS
THE AUSTRALIAN NATIONAL
UNIVERSITY
AU
2008902064 24/04/2008
PCT/AU/2009/000509
WO/2009/129578
11/40/1440
501111
IMINOPYRIDINE DERIVATIVES AND
USE THEREOF
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
2008JP
23/04/2008
113135
PCT/JP/2009/058434
151
A61K )5010.01(
C12N )5010.01(
‫ ציפויים‬,‫הרכבי ציפוי ביולוגיים פעילים‬
‫ומשטחים מצופים‬
A61K )5010.01(
‫שיטות לסימון איזוטופי של פולימרים‬
‫סינתטיים‬
C07D )5010.01(
‫נגזרות של אימינופירידים ושימוש בהן‬
December 30, 2010-‫כג' בטבת התשע"א‬
WO/2009/131245
4//40/1440
501115
METHODS FOR PROCESSING
ORNAMENTAL DIAMONDS AND
CORRESPONDING ORNAMENTAL
DIAMONDS
E. BROUKMAN DIAMONDS LTD
US
12/103774
16/04/2008
PCT/IB/2009/051461
WO/2009/144594
///40/1441
501112
AN ABSORBING AND SATURATION
DETECTION PAD AND METHODS
THEREOF
WALDHORN JOSHUA
B28D )5010.01(
‫שיטות לעיבוד יהלומי עיטור ויהלומים‬
‫התואמים להם‬
A61F )5010.01(
‫פד לאיתור ספיגה ורוויה ושיטות לכך‬
‫יהושע ולדהורן‬
PCT/IL/2008/000513
WO/2009/144696
///40/1440
501114
COMPOSITIONS COMPRISING
WEAKLY BASIC DRUGS AND
CONTROLLED-RELEASE DOSAGE
FORMS
EURAND INC.
US
61/045170
15/04/2008
PCT/US/2009/040608
WO/2009/129282
10//1/1441
152
501115
A61K )5010.01(
‫הרכבים המכילים תרופות שהן בסיסים‬
‫חלשים וצורות מינון לשחרור מבוקר‬
H04L )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
TRANSMISSION TIME INTERVAL
(TTI) BUNDLING INDICATION TO
NON-SERVING BASE STATION
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL)
US
61/047645
24/04/2008
PCT/SE/2008/051565
WO/2009/131509
1//40/1440
‫ציון אלומת הפרש זמן שידור לתחנת בסיס‬
‫שאינה שרת‬
501111
FLUID COUPLING AND RETAINER
FOR FLUID COUPLING
FUJIKIN INC.
2008JP
22/04/2008
110956
PCT/JP/2009/057884
WO/2009/131105
14/40/1440
///40/1440
G01N )5010.01(
‫שיטות סריקה לפגיעות לפיתוח סובלנות‬
‫איממונית‬
501111
WATER TURBINES WITH MIXERS
AND EJECTORS
FLODESIGN WIND TURBINE
CORPORATION
US
61/124397
16/04/2008
PCT/US/2009/040874
153
‫חיבור נגר ומחזיק עבור חיבור נגר‬
501111
SCREENING METHODS FOR
SUSCEPTIBILTY TO IMMUNE
TOLERANCE DEVELOPMENT
THE UNIVERSITY OF TENNESSEE
RESEARCH FOUNDATION
US
61/071264
18/04/2008
///4144/1
///4//1441
US
////40/40
/4//4/1441
US
PCT/US/2009/041134
WO/2009/146213
F16J )5010.01(
F03B )5010.01(
‫טורבינות מים עם מערבלים ומפלטים‬
December 30, 2010-‫כג' בטבת התשע"א‬
WO/2009/129420
////4/14/4
501116
PROCESS FOR SURFACE
TREATMENT
ACKTAR LTD.
///40/1440
‫תהליך לטיפול שטח‬
‫אקטר בע"מ‬
501110
METHODS OF GENERATING AND
USING PROCOLLAGEN
COLLPLANT LTD
US
61/071267
18/04/2008
////100//
40/41/1441
US
PCT/IL/2009/000419
WO/2009/128076
///40/1440
154
A61K )5010.01(
‫שיטות ליצור ושימוש בפרוקולאגן‬
‫קולפלנט בע"מ‬
501111
INDOLEAMINE 2,3-DIOXYGENASE
BASED IMMUNOTHERAPY
HERLEV HOSPITAL
DK
PA200800565 17/04/2008
PCT/DK/2009/000095
WO/2009/143843
///40/1440
H01G )5010.01(
A61K )5010.01(
‫אימונותראפיה מבוסס על‬
DIOXYGENASE –2,3 INDOLEAMINE
501115
A61K )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
DESIGN AND SYNTHESIS OF
DIRECTED SEQUENCE POLYMER
COMPOSITIONS AND ANTIBODIES
THEREOF FOR THE TREATMENT OF
PROTEIN CONFORMATIONAL
DISORDERS
DECLION PHARMACEUTICALS, INC.
US
61/124689
17/04/2008
/////1///
/4/40/1440
US
PCT/US/2009/002426
WO/2009/128948
///40/1440
501112
INTRUSION WARNING SYSTEM
SHILAT OPTRONICS LTD
US
61/124315
17/04/2008
///141/10
1//41/1440
US
PCT/IL/2009/000417
WO/2009/144707
1//41/1441
501114
CHIMERIC NUCLEIC ACID
CONSTRUCTS AND COMPOSITIONS
COMPRISING SETS OF NUCLEIC
ACID CONSTRUCTS
ENZO LIFE SCIENCES, INC.
US
10/096076
12/03/2002
/1//4/14/4
SYSTEM AND METHOD FOR
ELECTRONIC TIPPING
OMRI ZVIELI
155
501115
‫עיצוב וסינטזה של תכשירי רצף פולימר‬
‫ישיר ונוגדנים הנובעים מכך לטיפול‬
‫בהפרעות בהתאמת חלבון‬
G01B )5010.01(
‫מערכת התראה מפני חדירות‬
‫שילת אופטרוניקה בע"מ‬
C12Q )5010.01(
‫מבני חומצות גרעין כימריים ותרכובות‬
‫הכוללות סדרות של מבני חומצות גרעין‬
‫כימריים‬
G07B )5010.01(
‫שיטה ומערכת להענקת תשר בצורה‬
‫אלקטרונית‬
‫עמרי צביאלי‬
December 30, 2010-‫כג' בטבת התשע"א‬
4//4//1440
501111
TECHNIQUES FOR ENHANCED
BACKHAUL FLOW CONTROL
QUALCOMM INCORPORATED
US
61/052133
09/05/2008
/1/01/01/
4//4//1440
US
PCT/US/2009/043095
WO/2009/137650
/1/4//1440
501111
SELF CALIBRATION OF DOWNLINK
TRANSMIT POWER
QUALCOMM INCORPORATED
US
61/052969
13/05/2008
/1/0/1//0
///4//1440
US
PCT/US/2009/043675
WO/2009/140312
/0/4//1440
501111
A SOLID PHARMACEUTICAL
FORMULATION
OTSUKA PHARMACEUTICAL CO.,
LTD.
2008JP
15/05/2008
128259
PCT/JP/2009/059300
WO/2009/139504
/1/4//1440
FOOD PRODUCT
NESTEC S.A.
156
501116
H04W )5010.01(
‫שיטות לבקרת זרימה מנקודות גישה‬
‫לרשת מרכזית משופרת‬
H04W )5010.01(
‫כיול עצמי של כח שידור בקישור למטה‬
A61K )5010.01(
‫פורמולציה מבוססת של רוקחות‬
A21D )5010.01(
‫מוצר מזון‬
December 30, 2010-‫כג' בטבת התשע"א‬
GB
0810856.5
4114/0/81
GB
PCT/EP/2009/004244
WO/2009/149948
/1//4/14/4
13/06/2008
/1////1441
501160
IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN
14/40/1440
501161
METHOD AND SYSTEM TO
SELECTIVELY SECURE THE
DISPLAY OF ADVERTISEMENT ON
WEB BROWSERS
IBM CORPORATION
EP
08305188.8 21/05/2008
PCT/EP/2009/054645
WO/2009/141201
///4//1440
501165
PROCESS FOR THE PREPARATION
OF AMIDES
SYNGENTA PARTICIPATIONS AG
GB
0808772.8
14/05/2008
4141///84
/0/4//1441
GB
PCT/EP/2009/055651
WO/2009/138375
40/4//1440
157
501162
G06F )5010.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
G06F )5010.01(
‫שיטה וצערכת לאבטחה סלקטיבית של‬
‫תצוגת פרסומות בדפדפני אינטרנט‬
C07D )5010.01(
‫תהליך להכנת אמידים‬
C07D )5010.01(
December 30, 2010-‫כג' בטבת התשע"א‬
NOVEL CLASS OF SPIRO
PIPERIDINES FOR THE TREATMENT
OF NEURODEGENERATIVE
DISEASES
PFIZER INC.
US
61/050423
05/05/2008
PCT/IB/2009/051815
WO/2009/136350
4//4//1440
‫קבוצה חדשה של ספירו פיפרידינים‬
‫לטיפול במחלות עצבים ניווניות‬
501164
ORAL ADMINISTRATION OF
PERIPHERALLY-ACTING OPIOID
ANTAGONISTS
NEKTAR THERAPEUTICS
US
61/126868
07/05/2008
PCT/US/2009/002856
WO/2009/137086
////4/1440
/1//4/14/4
C07K )5010.01(
–‫ לא מנוטרלים ומולטי‬CD2 ‫חומרים קושרי‬
‫ספציפיים‬
501161
AN APPARATUS FOR OPERATING A
COMPUTER USING THOUGHTS OR
FACIAL IMPRESSIONS
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
158
‫מתן פומי של אנטגוניסטים לאופיאויד‬
‫הפועלים היקפית‬
501165
MULTISPECIFIC DEIMMUNIZED CD3BINDERS
MICROMET AG
EP
03023581.6 16/10/2003
PCT/EP/2004/011646
WO/2005/040220
A61K )5010.01(
G06F )5010.01(
‫התקן להפעלת מחשב באמצעות‬
‫מחשבות והבעות פנים‬
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫למחקר ופיתוח‬
December 30, 2010-‫כג' בטבת התשע"א‬
///41/144/
501161
SELF-CALIBRATING SHOOTER
ESTIMATION
BBN TECHNOLOGIES CORP.
US
10/925876
24/08/2004
PCT/US/2005/028604
WO/2006/098755
10/41/144/
10/41/144/
‫הערכת ירייה בכיול עצמי‬
501161
SYSTEMS AND METHODS FOR
DISAMBIGUATING SHOOTER
LOCATIONS
BBN TECHNOLOGIES CORP.
US
10/925875
24/08/2004
///1/410/
11/41/144/
US
PCT/US/2005/030126
WO/2006/096208
A METHOD FOR DETERMINING AN
UNAMBIGUOUS PROJECTILE
TRAJECTORY
BBN TECHNOLOGIES CORP.
159
G01S )5010.01(
‫מערכות ושיטות חד–משמעיות למקומות‬
‫יורים‬
501166
A METHOD AND SYSTEMS FOR
ESTIMATING A SHOOTER RANGE
BBN TECHNOLOGIES CORP.
US
10/925875
24/08/2004
///1/410/
11/41/144/
US
PCT/US/2005/030126
WO/2006/096208
10/41/144/
G01S )5010.01(
501100
G01S )5010.01(
‫שיטה ומערכת להערכת טווח יורה‬
G01S )5010.01(
‫שיטה לקביעה חד משמעית של מסלול‬
‫קליע‬
December 30, 2010-‫כג' בטבת התשע"א‬
US
10/925875
///1/410/
US
PCT/US/2005/030126
WO/2006/096208
10/41/144/
24/08/2004
11/41/144/
501101
A METHOD AND SYSTEM FOR
IDENTIFYING MUZZLE BLAST
BBN TECHNOLOGIES CORP.
US
10/925875
24/08/2004
///1/410/
11/41/144/
US
PCT/US/2005/030126
WO/2006/096208
14/40/1440
501105
AN ELASTIC COMPOSITE HAVING
CROSS-DIRECTIONAL ELASTICITY
AND A SYSTEM AND METHOD FOR
MAKING THE ELASTIC COMPOSITE
DSG TECHNOLOGY HOLDINGS LTD
US
61/124697
18/04/2008
PCT/US/2009/002462
WO/2009/145860
160
G01S )5010.01(
‫שיטה לזיהוי הדף לוע‬
A61F )5010.01(
‫תרכובת אלסטית בעלת אלסטיות‬
‫מוצלבת–כיוונית ומערכת להכנת‬
‫התרכובת האלסטית‬
December 30, 2010-‫כג' בטבת התשע"א‬
NOTICE UNDER SECTION 26 OF THE
PATENTS LAW, 5727-1967
The applications, particulars of which are set
out below, have been accepted pursuant to
Section 17 of the Patents Law. Any person
wishing to oppose the grant of a patent on any
of the applications published here, may,
within three months from the date of this
journal, give to the Commissioner of Patents
notice under Section 30 of the Patents Law, in
the manner prescribed in regulations 57 et seq
of the Patents Regulations, 5728-1968
Particulars of the applications, where
applicable, are given in the following order:
[11] [21] Number of application
[54] Title of invention
[22] Application date
[31] [32] [33] Number and date of foreign
application – convention country.
*[51] Int.Cl.
[61] Application for patent of addition
[62] Divisional application
[71] Applicant
[72] Inventor
[87] International Publication Number
[74] Address for service
[57] Abridgement of invention (in the
language in which the specification is drawn
up)
*Note:, patent applications published in this
journal were classified according to the
International Classification version that was
in force when this journal was prepared.
161
- ‫ לחוק הפטנטים תשכ"ז‬51 ‫הודעה לפי סעיף‬
1611
‫הבקשות שפרטיהן מתפרסמים להלן קובלו‬
‫ כל המעונין‬.‫ לחוק הפטנטים‬11 ‫לפי סעיף‬
‫להתנגד למתן פטנט על פי בקשה מהבקשות‬
‫ תוך שלושה חדשים‬,‫המתפרסמות רשאי‬
‫ להגיש לרשם הפטנטים‬,‫מתאריך יומן זה‬
‫ לחוק‬20 ‫הודעת התנגדות לפי סעיף‬
‫ ואילך‬51 ‫הפטנטים בדרך הקבועה בתקנה‬
.1611 – ‫ תשכ"ח‬,‫לתקנות הפטנטים‬
‫פרטי הבקשות במידה ויישימים מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה‬
‫שם האמצאה‬
‫תאריך הבקשה‬
‫מספר ותאריך של בקשות החוץ – מדינת‬
‫האגוד‬
‫*סיווג בינלאומי‬
‫בקשה לפטנט מוסף‬
‫בקשת חלוקה‬
‫המבקש‬
‫הממציא‬
‫מס' פרסום של בקשה הבינלאומית‬
‫מען למסירת מסמכים‬
)‫תקציר האמצאה (בשפה בה ערוך הפירוט‬
‫ בקשות הפטנטים שפורסמו ביומן‬:‫**הערה‬
‫זה סווגו בהתאם לגרסת הסיווג הבינלאומי‬
‫שהייתה בתוקף בעת הכנת הבקשות‬
.‫לפרסום‬
December 30, 2010-‫כג' בטבת התשע"א‬
]00[]00[
]34[
PROCESS FOR RECOVERING
HETEROLOGOUS
POLYPEPTIDES FROM
BACTERIAL CELLS
]00[
]30[
]30[
]10[
]71[
]14[
21.10.1999
60/106052
]30[ 28.10.1998
Int. Cl.(2010.01) C12P 21//02, 21//08
GENENTECH, INC., U.S.A.
WO/2000/024873
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]31[
162
932241
‫תהליך להשבת פוליפפטידים הטרולוגים מתאי‬
‫חיידקים‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Processes are described for recovering heterologous polypeptide from bacterial cells,
including the periplasm and cytoplasm. One process involves culturing the bacterial
cells, which cells comprise nucleic acid encoding phage lysozyme and nucleic acid
encoding a protein that displays DNA-digesting activity, wherein these nucleic acids
are linked to a first promoter, and nucleic acid encoding the heterologous polypeptide,
which nucleic acid is linked to a second promoter, under certain conditions to produce
a broth lysate; and recovering accumulated heterologous polypeptide from the broth
lysate. Another process entails culturing bacterial cells that comprise nucleic acid
encoding phage lysozyme, gene i(t), and nucleic acid encoding a protein that displays
DNA-digesting activity under the control of a signal sequence for secretion of said
DNA-digesting protein, wherein said nucleic acids are linked to one or more
promoters, and nucleic acid encoding the heterologous polypeptide, which nucleic acid
encoding the heterologous polypeptide is linked to another promoter that is inducible,
under certain conditions to produce a broth lysate; and recovering accumulated
heterologous polypeptide from the broth lysate.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
142989
]34[
NUCLEOTIDE AND PROTEIN
SEQUENCES OF NOGO GENES
AND METHODS BASED
THEREON
]00[
]30[
]30[
]10[
05.11.1999
60/107446
]30[ 06.11.1998
]33[ US
Int. Cl.(2010.01) A61K 38//18, A61P 25//00, C07K 14//435, 14//475, C12N 15//62
UNIVERSITAT ZURICH,
SWITZERLAND
WO/2000/031235
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]71[
]14[
]31[
NOGO ‫רצפי נוקליאוטידים וחלבונים של גן‬
‫ושיטות המבוססות עליהם‬
The present invention relates to the gene, Nogo, its encoded protein products, as well
as derivatives and analogs thereof. Production of Nogo proteins, derivatives, and
antibodies is also provided. The invention further relates to therapeutic compositions
and methods of diagnosis and therapy.
The applications for division
from this application have
not yet been published
0/0141/
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]00[]00[
163
144272
December 30, 2010-‫כג' בטבת התשע"א‬
‫מערכת אלקטרומגנטית חד–צירית לקביעת‬
‫מיקום‬
]34[
ELECTROMAGNETIC POSITION
SINGLE AXIS SYSTEM
]00[
]30[
]30[
]10[
]14[
11.07.2001
09/620316
]30[ 20.07.2000
]33[ US
Int. Cl.(2010.01) A61B 05//00
BIOSENSE WEBSTER INC., U.S.A.
D. KLIGLER I.P. SERVICES LTD,
,‫ קליגלר שירותי קניין רוחני בע"מ‬.‫ד‬
P.O.BOX 33111
‫תל אביב‬22111 .‫ד‬.‫ ת‬,
TEL AVIV 61330
A system for determining the position of a medical device having a sensor comprises a
plurality of field radiators wherein each field radiator has a plurality of radiator
elements. Each radiator element generates a magnetic field such that each magnetic
field is distinct from one another due to the use of a different frequency through
simultaneous energizing of the radiator elements. A signal processor is operatively
connected to the field radiators and the sensor of the medical device for receiving a
sensing signal from the sensor indicative of the magnetic field sensed at the sensor.
Alternative field radiator arrangements are also provided in conjunction with a novel
algorithm utilizing a global convergent technique.
]31[
__________________
]00[]00[
]34[
164
USE OF ALUMINUM FLUORIDE
FOR THE PREPARATION OF
COMPOSITIONS FOR THE
TREATMENT OF ACNE
VULGARIS AND FOLLICULITIS
145751
‫שימוש באלומינום פלואוריד עבור ההכנה של‬
‫תרכובות לטיפול באקנה וולגריס ולדלקת זקיקי‬
‫השיער‬
December 30, 2010-‫כג' בטבת התשע"א‬
]00[
]30[
]10[
]10[
]14[
]31[
04.10.2001
Int. Cl.(2010.01) A61K 08//26, 33//06, 33//16, A61P 17//10
MEDIDERMIS LTD.
‫ א"ת נתניה‬,‫מדידרמיס בע"מ‬
AVI DASCALU
‫אבי דסקלו‬
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
The present invention relates to compositions for the treatment of pilosebaceous gland
inflammations, especially of the hair follicle and its appendages, in particular of Acne
Vulgaris and Folliculitis, comprising as active ingredient AIF or chemical compounds
which finally release AIF. AIF in accordance with the present invention relates to
Aluminum fluoride (Aluminum Trifluoride; Aluminum Fluoride), CAS No 7784-18-1.
EINECS No. 232-051-1, having an empirical formula of AIF3. Said compositions
have, inter alia, pharmaceutical, cosmetic or quasi-cosmetic properties. The present
invention also relates to the use of said compositions in said treatment, and to methods
for the treatment of pilosebaceous gland inflammations with said compositions.
__________________
]00[]00[
146313
‫נגזרות חומצה קרבוקסילית המעכבים קישור‬
‫אינטגרינים לקולטנים שלהם‬
]34[
CARBOXYLIC ACID
DERIVATIVES THAT INHIBIT
THE BINDING OF INTEGRINS TO
THEIR RECEPTORS
]00[
]30[
01.11.2001
707068
]30[ 06.11.2000
]33[ US
013040
2000200220
US
Int. Cl.(2010.01) C07D 21/3/00
ENCYSIVE PHARMACEUTICALS
INC., U.S.A.
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
A method for the inhibition of the binding of α4β1 integrin to its receptors, for example
VCAM-1 (vascular cell adhesion molecule-1) and fibronectin; compounds that inhibit
this binding; pharmaceutically active compositions comprising such compounds; and
to the use of such compounds either a above, or in formulations for the control or
prevention of disease states in which α4β1 is involved.
]30[
]10[
]14[
]31[
165
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
146694
‫שימוש של תמיסה מימית המכילה קומפלקס של‬
‫טלוריום דיאוקסיד בעל פעילות ביולוגית לייצר‬
‫תרופה‬
]34[
USE OF AN AQUEOUS
SOLUTION CONTAINING A
BIOLOGICALLY ACTIVE
COMPLEX OF TELLURIUM
DIOXIDE FOR
MANUFACTURING A
MEDICAMENT
]00[
]30[
]10[
]14[
22.11.2001
Int. Cl.(2010.01) A61K 33//00
BIOMAS LTD.
‫ תל אביב‬,‫ביומס בע"מ‬
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
Use of an aqueous solution comprising at least one species selected from the group
consisting of a 1:1 molar non-covalent complex of TeO2 with a moiety of
]31[
HO-X-OH (A)
in the manufacture of a medicament for stimulating cells to produce cytokines, where
X is an optionally substituted divalent saturated hydrocarbon group containing 2-8
carbon atoms in the chain connecting the two OH groups.
__________________
]00[]00[
]34[
RETRO-INVERSO PEPTIDES
DERIVED FROM LEUKEMIA
INHIBITORY FACTOR
]00[
]30[
16.06.2000
60/139685
166
]30[
16.06.1999
147095
‫פפטידים רטרו אינוורסו שנתקבלו מפקטור‬
‫מעכב לויקמיה‬
]33[
US
December 30, 2010-‫כג' בטבת התשע"א‬
]30[
]10[
]71[
]14[
]31[
Int. Cl.(2010.01) A61K 35//12, 38//10, A61P 25//00, C07K 07//08, 14//435, 14//52
MYELOS CORPORATION, U.S.A.
WO/2000/077029
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
Retro-inverso peptides derived from leukemia inhibitory factor (LIF) having between
18 and about 40 amino acids and including the sequence shown in SEQ ID NO: 1.
These peptides have the same activity as native LIF and also have neurotrophic
activity. Because of the D-amino acid linkage in the peptides, they are less susceptible
to proteolytic degradation in vivo.
__________________
]00[]00[
149046
‫תכשיר הכולל פולינוקליאוטיד המקודד‬
‫ לשימוש באבחון סרטן‬P6D563 ‫לפוליפפטיד‬
P6D563 –‫ושיטת אבחון הקשורה ל‬
]34[
COMPOSITION COMPRISING A
POLYNUCLEOTIDE ENCODING A
36P6D5 POLYPEPTIDE FOR USE
IN DIAGNOSING CANCER AND
DIAGNOSTIC METHOD
RELATED TO 36P6D5
]00[
]30[
]30[
]10[
]71[
]14[
30.10.2000
60/162417
]30[ 28.10.1999
]33[ US
Int. Cl.(2010.01) A61K 38//17, C07K 14//47, C12N 15//12, G01N 33//574
AGENSYS, INC., U.S.A.
WO/2001/031015
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]31[
167
Described is a gene and its encoded secreted tumor antigen, termed 36P6D5, and to
diagnostic and therapeutic methods and compositions useful in the management of
various cancers which express 36P6D5, particularly including cancers of the bladder,
kidney, prostate, breast, colon, ovary and pancreas.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
150163
–5,1[‫תכשירי רוקחות המכילים נגזרי פיראזלול‬
‫]פירימידין ותרכובות חדשות מסוג זה‬a
]34[
PHARMACEUTICAL
COMPOSITIONS COMPRISING
PYRAZOLO[1,5-A]PYRIMIDINE
DERIVATIVES AND SOME
NOVEL SUCH COMPOUNDS
]00[
]30[
23.07.1997
60/023290
]30[ 24.07.1996
]33[ US
270676241
0402100006
US
270700040
0302100001
US
Int. Cl.(2010.01) A61K 31//53, A61P 01//00, 03//00, 09//00, 15//00, 25//00, 29//00,
31//18, 37//00, C07D 48/7/04, C12P 17//18
DIVISION FROM 127871
DUPONT PHARMACEUTICALS
COMPANY, U.S.A.
WO/1998/003510
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Corticotropin releasing factor (CRF) antagonists of formula (I) or (II) and their use in
treating anxiety, depression, and other psychiatric, neurological disorders as well as
treatment of immunological, cardiovascular or heart-related diseases and colonic
hypersensitivity associated with psychopathological disturbance and stress.
]30[
]60[
]10[
]71[
]14[
]31[
168
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
150315
‫בקרת גובה על–קולית במערכת מילוי מחדש‬
‫כימית‬
]34[
ULTRASONIC LEVEL SENSE IN A
CHEMICAL REFILL SYSTEM
]00[
]30[
]30[
]60[
]10[
24.11.1999
201005
]30[ 30.11.1998
]33[ US
Int. Cl.(2009.01) B67D 05/02, C23C 16/44, C30B 25/14, G01F 23/296
DIVISION FROM 133102
AIR PRODUCTS AND CHEMICALS,
INC., U.S.A.
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
'‫א‬51 ‫רחוב הברזל‬
26A HABARZEL ST.,
‫רמת החייל‬
RAMAT HACHAYAL 69710
]14[
]31[
A system for transferring ultrapure chemical from a bulk or source reservoir to a
smaller dispensing vessel or reservoir utilizing non-intrusive level sensing to provide
for an effective or appropriate level of the chemical to be present in the dispensing
vessel by automatic transfer from the source reservoir in response to a signal generated
by the sensing device. Non-intrusive level sensing can accommodate both high and
low viscosity chemicals without using moving parts and without the need for special
fixturing or calibration.
The parent application from which
this application has been divided has
not yet been published
169
/11/41
‫בקשת הורה לבקשה זו שטרם פורסמה‬
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
METHOD FOR IMPROVING DES
HARDWARE THROUGHPUT FOR
SHORT OPERATIONS
]00[
]30[
]30[
]10[
30.04.2001
60/201002
]30[ 01.05.2000
Int. Cl.(2010.01) H04L 09//06
INTERNATIONAL BUSINESS
MACHINES CORPORATION, U.S.A.
WO/2001/084769
IBM ISRAEL,
HAIFA UNIVERSITY - MOUNT
CARMEL
HAIFA 31905
]71[
]14[
]31[
152595
‫ לפעולות‬SED ‫שיטת שיפור תפוקת חומרת‬
‫קצרות‬
]33[
US
- ‫ מחלקת קניין רוחני‬- ‫ ישראל‬IBM
,‫מעבדות מחקר ופיתוח‬
‫קמפוס אוניברסיטת חיפה הר הכרמל‬
‫חיפה‬
A symmetric key cryptographic method is provided for short operations. The method
includes batching a plurality of operation parameters (1503), and performing an
operation according to a corresponding operation parameter (1505). The symmetric
key cryptographic method is a Data Encryption Standard (DES) method. The short
operations can be less than about 80 bytes. The short operations can be between 8 and
80 bytes. The method includes reading the batched parameters from a dynamic random
access memory (1504), and transmitting each operation through a DES engine
according to the operations parameter (1505).
__________________
]00[]00[
170
153308
December 30, 2010-‫כג' בטבת התשע"א‬
‫ תכשירים‬, ‫אנטגוניסטים קולטני תרומבין‬
‫רוקחיים המכילים אותם ושימושיהם להכנת‬
‫תרופה לעיכוב כולתי תרומבין‬
]34[
THROMBIN RECEPTOR
ANTAGONISTS,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF IN
PREPARING MEDICAMENTS FOR
INHIBITING THROMBIN
RECEPTORS
]00[
]30[
]30[
]10[
]71[
]14[
13.06.2001
60/211724
]30[ 15.06.2000
]33[ US
Int. Cl.(2010.01) A61K 31//343, A61P 07//00, C07D 40/5/00, 40/5/08, 40/5/14
SCHERING CORPORATION, U.S.A.
WO/2001/096330
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
Heterocyclic-substituted compounds of formula (I) ]or a pharmaceutically acceptable
salt thereof, are disclosed, wherein: Z is - (CH2)n-; (a) ; (b), wherein R10 is absent; or,
(c) wherein R3 is absent; the single dotted line represents an optional double bond; the
double dotted line represents an optional single bond; n is 0-2; Het is an optionally
substituted mono-, bi- or tricyclic heteroaromatic group; B is -(CH2)n3-, wherein n3 is
0-5, -CH2-O-, -CH2S-, -CH2-NR6-, -C(O)NR6-. -NR6C(O)-, (d), optionally
substituted alkenyl or optionally substituted alkynyl; X is -O- or -NR6- when the
double dotted line represents a single bond, or X is H, -OH or -NHR20 when the bond
is absent; Y is =O, =S, (H, H), (H, OH) or (H, C1-C6 alkoxy) when the double dotted
line represents a single bond, or when the bond is absent, Y is =O, =NOR17, (H, H),
(H, OH), (H, SH), (H, C1-C6 alkoxy) or (H, substituted-amino); R22 and R23 are
independently -OH, -OC(O)R30, OC(O)NR30R31, or optionally substituted alkyl,
alkenyl, alkynyl, heterocycloalkyl, aryl, cycloalkyl, cycloalkenyl, carbonyl, amino,
alkoxy, alkenyloxy, alkynyloxy, heterocycloalkyloxy, cycloalkyloxy, or
cycloalkenyloxy; or R22 and R10, or R23 and R11, can form a carbocyclic or
heterocyclic ring; and the remaining variables are as described in the specification.
Also disclosed are pharmaceutical compositions containing said compounds and their
use as thrombin receptor antagonists and binders to cannabinoid receptors.
]31[
171
__________________
December 30, 2010-‫כג' בטבת התשע"א‬
]00[]00[
153749
‫חיתולים‬
]34[
DIAPERS
]00[
]30[
]10[
]14[
30.12.2002
Int. Cl.(2010.01) A61F 13//58, A61F 13/15
RIVA HAHAM, U.S.A.
DAVID ZEIRA, ADV & NOTARY,
5 TARPHON ST.
BNEI BRAK 51420
]31[
‫חכם ריבה‬
,‫זעירא דוד משרד עורכי דין‬
5 ‫ר' טרפון‬
‫בני ברק‬
Method for dressing a diaper on a wearer's body, said diaper provided with special
fixing means in addition to conventional fastening means, comprising the following
steps:
(a) firstly some sector[s] of the diaper is/are fixed temporarily at the right
place[s] on the wearer’s body by said fixing means,
(b) and subsequently said fastening means are used for conventional joining the
parts of the diaper,
(c) optionally, removing said fixing means after said joining,
(d) and optionally, using special marks on said diaper and/or on said means for
correct and quick dressing.
‫ לתקנות‬1/ ‫פירוט זה נבחן בהתאם לתקנה‬
/0/1 – ‫ תשכ"ח‬0‫הפטנטים‬
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
__________________
]00[]00[
]34[
LOCK ASSEMBLY WITH
COMMON FACEPLATE
]00[
]30[
]10[
30.12.2002
Int. Cl.(2009.01) E05B 09/00
RAV BARIACH SECURITY
PRODUCTS LTD.
EYAL ARTSIELY
APPELFELD ZER FISHER WEILER,
LAW FIRM,
B.S.R TOWER 1, FLOOR 16
2 BEN GURION ST.
]10[
]14[
172
153751
‫מכלול מנעול בעל סרט פנית משותף‬
‫ יבנה‬,‫רב בריח מוצרי בטחון בע"מ‬
‫אייל ארציאלי‬
,‫אפלפלד זר פישר וילר חברת עורכי דין‬
11 ‫ קומה‬.‫ר‬.‫ס‬.‫ מגדל ב‬5 ‫בן גוריון‬
‫ גן‬- ‫רמת‬
December 30, 2010-‫כג' בטבת התשע"א‬
]31[
RAMAT GAN 52573
A method for installing mortise locks comprising:
providing a single, common faceplate attachable to a mortise lock and at least one
auxiliary lock-bolt assembly;
providing a mortise lock comprising a locking mechanism and a plurality of mortise
case lock bolts actuable by said locking mechanism;
providing a plurality of auxiliary lock-bolt assemblies operatively connectable to at
least one of said mortise case lock bolts and comprising an auxiliary lock bolt actuable
by movement of said at least one of said mortise case lock bolts; and
selecting one of said auxiliary lock bolt assemblies and attaching the selected auxiliary
lock bolt assembly and said mortise lock to said single, common faceplate, and
wherein each of said mortise lock and said at least one auxiliary lock bolt assembly
comprises a separate faceplate and said single, common faceplate is attached to the
separate faceplates.
__________________
]00[]00[
]34[
IN VIVO DEVICE FOR
IMPROVING DIASTOLIC
VENTRICULAR FUNCTION
]00[
]30[
]10[
27.01.2003
Int. Cl.(2010.01) A61M 29//00
CORASSIST CARDIOVASCULAR
LTD
PYERNIK RUTMAN,
BEIT ETSION,
]14[
173
154141
‫מתקן לשיפור התפקוד הדיאסטולי של חדרי‬
‫הלב בגוף החי‬
‫קוראסיסט קרדיווסקולר בע"מ‬
,‫פיירניק רוטמן עו"פ‬
61 ‫ רח' הרצל‬,‫בית עציון‬
December 30, 2010-‫כג' בטבת התשע"א‬
]31[
91 HERZL ST.,
‫באר שבע‬10015 .‫ד‬.‫ ת‬,
P.O.B. 10012,
BEER SHEVA
An anatomically-compatible and physiologically-compatible in vivo device for
improving diastolic function of either the left or right ventricle of the heart,
comprising:
at least one elastic component that is capable of being operatively connected to the
external surface of the left or right ventricle of the heart by means of one or more
connecting elements,
wherein said at least one elastic component comprises a plurality of essentially
longitudinal members (12) which are arranged such that the lateral separation between
adjacent longitudinal members may be increased or decreased in response to elastic
deformation of said elastic component and wherein said essentially longitudinal
members are arranged relative to each other such that said elastic component is curved
in both the vertical and horizontal planes, such that the inner surface of said elastic
component may be adapted to the curvature of the external ventricular surface of the
heart, or a portion thereof,
such that said at least one elastic component is capable of exerting both a radially
outward expansive force and a tangentially-directed force on the external surface of
the left ventricular wall to which said component may be connected by means of said
one or more connecting elements.
__________________
]00[]00[
154775
– 51 ,3 – ‫ – הידרוקסי‬15 ‫אנאלוגים של‬
‫( הכנתם‬OP, 6–OH2151( ‫אוקסידופרוגסטרון‬
‫והשימוש בהם‬
]34[
21-HYDROXY- 6,19OXIDOPROGESTERONE (21OH-6,
19OP) ANALOGUES, THEIR
PREPARATION AND USE
]00[
]30[
]30[
]10[
17.09.2001
00119495.0
]30[ 18.09.2000
]33[ EP
Int. Cl.(2010.01) A61K 31//58, A61P 05//46, C07J 71//00
MERCK SERONO S.A.,
SWITZERLAND
GERARDO BURTON, CARLOS P.
LANTOS, ADRIANA SILVIA
VELEIRO
WO/2002/022647
INTERPHARM LABORATORIES
,‫אינטרפארם מעבדות בע"מ‬
LTD.,
11 ‫רחוב הקישון‬
18 HAKISHON ST.,
‫יבנה‬151 .‫ד‬.‫ ת‬,
December 30, 2010-‫כג' בטבת התשע"א‬
]10[
]71[
]14[
174
P.O.B. 151,
YAVNE 81101
]31[
The present invention is related to novel 21-hydroxy-6,19-oxidoprogesterone (21OH6OP) analogues, their use as antiglucocorticoids for the treatment and/or prophylaxis
of diseases associated to an excess of glucocorticoids. In particular, the invention
relates to the use of novel 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) analogues
having the formula FORMULAwherein X is S, SO and SO2, and R is either H or OH,
for treating Cushing's syndrome, iatrogenic hypercortisolism or depression. Also the
present invention is related to methods of preparing the novel 21-hydroxy-6,19oxidoprogesterone (21OH-6OP) analogues.
__________________
]00[]00[
155976
‫תרכובות ללא הלוגן‬
]34[
SUBSTITUTED QUINOLONE
CARBOXYLIC ACID
DERIVATIVES AND
COMPOSITIONS COMPRISING
SAME
]00[
]30[
19.11.2001
2000-352269 ]30[ 20.11.2000
]33[ JP
0220-047700
0202700220
JP
Int. Cl.(2010.01) A61K 31//4375, 31//4439, A61P 31//04, C07D 40/1/10, 40/1/14,
40/5/14, 47/1/12, 49/8/02, 51/3/02
DAIICHI SANKYO COMPANY,
LIMITED, JAPAN
WO/2002/040478
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
'‫א‬51 ‫רחוב הברזל‬
26A HABARZEL ST.,
‫רמת החייל‬
RAMAT HACHAYAL 69710
]30[
]10[
]71[
]14[
175
December 30, 2010-‫כג' בטבת התשע"א‬
]31[
3-(1-Aminocycloalkyl)pyrrolidinyl-substituted-6-dehalogeno(hydrogensubstituted)quinolonecarboxylic acid derivatives having specific substituents as
represented by the following general formula (I), salts thereof and hydrates of the same
exhibit a broad and potent antibacterial activity on gram-negative and gram-positive
bacteria, in particular, resistant bacteria typified by gram-positive cocci including
MRSA, PRSP and VRE. Thus, these compounds are usable as drugs.
__________________
]00[]00[
157203
‫ניהול מערכות כבילה מרובות כבלים‬
]34[
MANAGEMENT OF LARGE
SCALE CABLING SYSTEMS
]00[
]30[
]10[
]10[
31.07.2003
Int. Cl.(2010.01) G06K 01//00
RIT TECHNOLOGIES LTD.
‫ תל אביב‬,‫ריט טכנולוגיות בע"מ‬
DAVID SHALTS, DAEL
‫סגל‬-‫ דעאל גוברין‬,‫דוד שלץ‬
GOVREEN-SEGAL
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
1 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬15111 .‫ד‬.‫ ת‬,
HERZLIYA 46733
Method and system for managing cabling rooms that include a plurality of
communication panels, which are arranged closely to one another. Each cabling room
has a plurality of patch panels, structurally connected to form vertical structures. An
operator is automatically guided to a communication panel or a plurality of
communication panels, in which changes are to be made to modify the connectivity
status or to deal with connectivity problems that may arise for any reason. The system
automatically indicates to an operator optimal ports that are available and optimal
patch cords for connecting them, based on distances between ports and on the
electrical characteristics of the electrical signals that it is intended to pass between the
ports.
]14[
]31[
176
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
157483
‫מערכת להכנה ביתית של סושי‬
]34[
KIT FOR HOME PREPARATION
OF SUSHI
]00[
]30[
]10[
19.08.2003
Int. Cl.(2010.01) A21C 09//06, A23P 01//08, A47J 43//20
VEHUDA YAVETS-CHEN
CHANOCH FARBER
]14[
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
A sushi maker comprising:
a base plate;
a roll-up sheet for holding a seaweed layer, the roll-up sheet being positionable on the
base plate in a substantially flat configuration when held by clamps, rollable into a
cylindrical configuration when released from the clamps;
a cooked-rice container with an opening for depositing a layer of rice on the seaweed
layer when held by the roll-up sheet, the area of the opening being substantially equal
to the area of the seaweed layer; and
a cutting device for separating the deposited layer of rice from rice contained in the
container.
]31[
‫ קיסריה‬,‫חן‬-‫יהודה יעבץ‬
‫ קיסריה‬,‫חנוך פרבר‬
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
1 ‫רחוב שנקר‬
‫הרצליה‬15111 .‫ד‬.‫ ת‬,
__________________
]00[]00[
158491
‫ אימינופירולידין‬1–‫נגזרי‬
]34[
2-IMINOPYRROLIDINE
DERIVATIVES
]00[
]30[
19.04.2002
2001-121829 ]30[ 19.04.2001
]33[ JP
0220-060400
2302000220
JP
Int. Cl.(2010.01) A61K 31//4035, A61P 07//02, 09//00, 11//06, 19//00, 35//00, C07D
20/9/44, 40/1/10, 40/3/10, 41/3/10, 47/1/04, 48/7/04, 49/1/14
EISAI R&D MANAGEMENT CO.,
LTD., JAPAN
SHUICHI SUZUKI, MAKOTO
December 30, 2010-‫כג' בטבת התשע"א‬
]30[
]10[
]10[
177
]71[
]14[
]31[
KOTAKE, MITSUAKI MIYAMOTO,
TETSUYA KAWAHARA, AKIHARU
KAJIWARA, IEHARU HISHINUMA,
KAZUO OKANO, SYUHEI
MIYAZAWA, RICHARD CLARK,
FUMIHIRO OZAKI, NOBUAKI
SATO, MASANOBU SHINODA,
ATSUSHI KAMADA, ITARU
TSUKADA, FUMIYOSHI
MATSUURA, YOSHIMITSU NAOE,
TARO TERAUCHI, YOSHIAKI
OOHASHI, OSAMU ITO, HIROSHI
TANAKA, TAKASHI MUSHA,
MOTOJI KOGUSHI, TSUTOMU
KAWATA, TOSHIYUKI
MATSUOKA, HIROKO
KOBAYASHI, KEN-ICHI CHIBA,
AKIFUMI KIMURA, NAOTO ONO
WO/2002/085855
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
2−Iminopyrrolidine derivatives represented by the general formula (I) or salts
thereof: (I) wherein B is a benzene or pyridine ring, or the like; R 101 to R103 are
each hydrogen, halogeno, C1−6 alkyl, or the like; R5 is hydrogen, C1−6 alkyl, C1−6
alkoxy C1−6 alkyl, or the like; R6 is hydrogen, C1−6 alkyl, C1−6 alkyloxycarbonyl,
or the like; Y1 is a single bond, −CH2−, or the like; Y2 is a single bond, −CO−, or the
like; and Ar is hydrogen, a group represented by the general formula (II): (II) (wherein
R10 to R14 are each hydrogen, C1−6 alkyl, hydroxyl, C1−6 alkoxy, or the like, or R11 and
R12 or R12 and R13 may be united to form a 5− to 8−membered heterocycle), or the like.
__________________
]00[]00[
178
159376
December 30, 2010-‫כג' בטבת התשע"א‬
‫מכשיר לטיפול בפצעי בגרות‬
]34[
APPARATUS FOR ACNE
TREATMENT
]00[
]30[
]10[
]10[
]71[
]14[
27.06.2001
Int. Cl.(2010.01) A61B 18//18
RADIANCY, INC., U.S.A.
PINCHAS SHALEV, ZION AZAR
WO/2003/002009
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
]31[
‫ ציון עזר‬,‫פנחס שלו‬
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
‫רמת גן‬
A method and apparatus (100) are provided for treating acne using pulsed radiant
energy (246) to destroy or partially destroy one or more hairs (112), without damaging
the skin, or, alternatively, to destroy or partially destroy one or more acne-related
structures without damaging either skin or hair.
__________________
]00[]00[
]34[
SOLAR ENERGY CONVERTER
USING A SOLAR CELL IN A
SHALLOW LIQUID LAYER
]00[
]30[
31.05.2002
09/887416
]30[ 22.06.2001
020034667
0002300220
Int. Cl.(2010.01) H01L 31//052
KUNIHIDE TANAKA, U.S.A.
WO/2003/001610
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
]30[
]10[
]71[
]14[
179
159480
‫ממיר אנרגיה סולרית שמשתמש בתא סולרי‬
‫בשכבת נוזל רדודה‬
]33[
US
US
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
December 30, 2010-‫כג' בטבת התשע"א‬
1 ‫רחוב שנקר‬
‫הרצליה‬15111 .‫ד‬.‫ ת‬,
P.O.B. 12688,
HERZLIYA 46733
]31[
Solar cells (1010) operating in liquid (1016) have an increased operating efficiency
resulting from two independent physical phenomena, an increase in output current
from the solar cells (1010) simply by wetting the front and back of the solar cells
(1010) using a mounting table (1002), and enhanced collection of light through
refraction and inner reflection of light in the liquid (1016). Dielectric liquids (1016) are
found to increase output power efficiency of n/p junction solar cells (1010) and also
function as a medium for optical concentration. The properties of dielectric liquid
(1016) permit the construction of a solar cell panel (1000) with a suitable geometry for
functioning as an optical concentrator.
__________________
]00[]00[
159671
‫פפטיד לטרום השתלה‬
]34[
PREIMPLANTATION FACTOR
PEPTIDE
]00[
]30[
]30[
]10[
]71[
]14[
28.06.2002
60/302607
]30[ 02.07.2001
]33[ US
Int. Cl.(2010.01) C07K 07//00, 07//06, 07//08, 14//47
BIOINCEPT, INC., U.S.A.
WO/2003/004601
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
]31[
180
The present invention relates to assay methods used for detecting the presence of PIF,
and to PIF peptides identified using this assay. In particular, the present invention
relates to flow cytomery assays for detecting PIF. It is based, at least in part, on the
observation that flow cytometry using fluorescently labeled antilymphocyte and antiplatelet antibodies demonstrated an increase in rosette formation in the presence of
PIF. It is further based on the observation that flow cytometry demonstrated that
monoclonal antibody binding to CD2 decreased in the presence of PIF. The present
invention further relates to PIF peptides which, when added to Jurkat cell cultures,
have been observed to either (I) decrease binding of anti-CD2 antibody to Jurkat cells;
December 30, 2010-‫כג' בטבת התשע"א‬
(ii) increase expression of CD2 in Jurkat cells; or (iii) decrease Jurkat cell viability. In
additional embodiments, the present invention provides for ELISA assays which detect
PIF by determining the effect of a test sample on the binding of anti-CD2 antibody to a
CD2 substrate.
The applications for division
from this application have
not yet been published
0140/40014001/01400/10/00//4
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]00[]00[
]34[
IMAGING SYSTEM AND
METHODOLOGY EMPLOYING
RECIPROCAL SPACE OPTICAL
DESIGN
]00[
]30[
03.07.2002
09/900218
]30[ 06.07.2001
020066031
0202600220
020070306
2002100220
Int. Cl.(2010.01) G02B 27//40
PALANTYR RESEARCH, LLC,
U.S.A.
HIMANSHU S. AMIN, U.S.A.
DANIEL B. BORTNICK, U.S.A.
GREGORY TUROCY, U.S.A.
ANGKOR TECHNOLOGY, LLP,
U.S.A.
WO/2003/005446
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]30[
]10[
]71[
]14[
]31[
181
159700
‫מערכת הדמיה ושיטה המשתמשת בתיכנון‬
‫אופטי מרחבי בעל ערך הופכי‬
]33[
US
US
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
An imaging system (10) and methodology (600) is provided to facilitate optical
imaging performance. The system (10) includes a sensor (20) having one or more
receptors and an image transfer medium (30) to scale the sensor and receptors to an
object field of view (54). A computer (824), memory (864), and/or display (864)
associated with the sensor (20) provides storage and/or display of information relating
to output from the receptors to produce and/or process an image, wherein a plurality of
illumination sources (60) can also be utilized in conjunction with the image transfer
medium (30). The image transfer medium (30) can be configured as a k-space filter
(110) that correlates a pitch (116) associated with the receptors to a diffraction-limited
December 30, 2010-‫כג' בטבת התשע"א‬
spot (50) within the object field of view (54), wherein the pitch (116) can be unitmapped to about the size of the diffraction- limited spot (50) within the object field of
view (54).
__________________
]00[]00[
160265
‫מערכת מוטסת לצילום לייזר בטווח רחוק‬
]34[
AIRBORNE LONG- RANGE
LASER IMAGING SYSTEM
]00[
]30[
]10[
05.02.2004
Int. Cl.(2010.01) G01S 17//89
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
]10[
]14[
UZI LANDAU
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
An airborne long-range laser imaging system, for obtaining an image showing high
resolution details of a specific object having dimensions in the order of several meters,
comprising:
(a) a laser source (212) and focal plane array sensing detector (230), both being
mounted on a same gimbals platform (221);
(b) a pulse generator (211) for providing a series of pulses to said laser source during a
step-scanning period, thereby activating laser illumination by said laser source during
each of said pulses, the laser source being characterized in that the width of the
illumination beam is in the range of 0.1mrad to 0.3mrad so that it produces an
illumination spot that covers only a portion of said object having dimensions of up to
several meters and located at a long range;
(c) a scanning unit (235) for receiving a line of sight direction to said object, and for
providing to the gimbals a scanning signal for effecting a stepping-image capturing
]31[
182
,‫רפאל מערכות לחימה מתקדמות בע"מ‬
‫חיפה‬
‫עוזי לנדאו‬
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
December 30, 2010-‫כג' בטבת התשע"א‬
sequence in such a manner as to scan the object and the area in which said object is
included, wherein said area having dimensions in the order of up to a few tens of
meters;
(d) a motion compensation unit (235) for providing to said gimbals, in addition to said
scanning signal a motion compensation signal for compensating for the aircraft
motion and for the aircraft vibrations;
(e) a timing unit (215) for:
(i) activating, in coordination with the said scanning unit, said pulse generator during
the scanning period, in order to produce over the target a plurality of illumination
spots, each relating to one of said laser pulses, and wherein each of said spots
overlaps at least a portion of one or more adjacent spots; and
(ii) activating said focal plane array sensing detector during the illumination of the
target by each specific pulse in order to capture a plurality of distinct spot-images,
each relating to a single illumination pulse;
(f) a memory unit (240) for receiving from said focal plane array sensing detector the
captured spot-images, and for storing them;
(g) a correlating unit (241) for correlating images stored in said memory by finding
similarity between features of overlapping portions of neighboring spot-images; and
(h) a combining unit (242) receiving information from said correlating unit for
combining the spot-images to form a complete image of the scanned area.
__________________
]00[]00[
]34[
183
COMPOUNDS AND
COMPOSITION FOR
ACTIVATING PEROXISOME
PROLIFERATORS-RESPONSIVE
RECEPTOR
160304
‫תרכובות ותכשיר המשפעילים לקולתן המגיב‬
‫לריבוי פראוקסיזום‬
December 30, 2010-‫כג' בטבת התשע"א‬
]00[
]30[
]30[
]10[
]71[
]14[
]31[
02.08.2002
2001-243734 ]30[ 10.08.2001
]33[ JP
Int. Cl.(2010.01) A61K 31//4164, 31//421, 31//426, 31//44, A61P 03//00, 09//00,
35//00, 43//00, C07D 23/3/64, 26/3/30, 27/7/20, 40/1/02, 40/1/14, 40/5/04, 40/9/04,
41/3/02, 41/7/02
NIPPON CHEMIPHAR CO., LTD.,
JAPAN
WO/2003/016291
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
A compound represented by the following general formula (I) : (wherein R1 represents
optionally substituted phenyl; R2 represents C1−8 alkyl; A represents oxygen; X
represents a C1−8 alkylene chain; Y represents C(=O); R3, R4, and R5 each represents
hydrogen, C1−8 alkyl; B represents CH; Z represents oxygen or sulfur 1R d a 6a ;
o go d ed eidorp , gordyd d eeRe Re 7 Rde o go d ed eidorp ; R d a
orp o ro R dR e rt ee drogrn d; yd re eid 3R d a ,4a ,3 Rde r rt a
d eR RdeydRero deyde dr eRy d ee drogrn d ro dR e Rd ee −R d R ddna
0Rdeyd y po dy e
__________________
]00[]00[
]34[
ARP PEPTIDE AND USES
THEREOF
]00[
]30[
]10[
12.02.2004
Int. Cl.(2010.01) A61K 38//43, 38//46
YISSUM RESEARCH
DEVELOPMENT COMPANY OF
THE HEBREW UNIVERSITY OF
JERUSALEM LTD.
THE MEDICAL RESEARCH,
INFRASTRUCTURE, AND HEALTH
184
160376
‫ ושימושים שלו‬ARP ‫פפטיד‬
‫יישום חברה לפיתוח המחקר של‬
,‫האוניברסיטה העברית בירושלים בע"מ‬
‫ירושלים‬
‫קרן מחקרים ופיתוח תשתיות שליד המרכז‬
‫ תל אביב‬,‫הרפואי תל אביב ע"ש סוראסקי‬
December 30, 2010-‫כג' בטבת התשע"א‬
]10[
]14[
]31[
SERVICES FUND OF THE TELAVIV MEDICAL CENTER
HERMONA SOREQ, CHAVA
PERRY, DANI GRISARU,
MARJORIE PICK, VARDA
DEUTSCH
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
‫ מרג'ורי‬,‫ דני גריסרו‬,‫ חוה פרי‬,‫חרמונה שורק‬
‫ ורדה דוייטש‬,‫פיק‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Use of an acetylcholinesterase (AChE)-derived peptide in the preparation of a
pharmaceutical composition for the induction of the production of granulocytes,
wherein said peptide is ARP and is denoted by SEQ ID NO.1.
__________________
]00[]00[
]34[
UNIT AND PROCESS FOR
CARRYING OUT HIGH CELL
DENSITY FERMENTATION
]00[
]30[
]30[
]10[
29.08.2002
60/316837
]30[ 31.08.2001
Int. Cl.(2010.01) C12M 03//00, 03//02
BAYER SCHERING PHARMA AG,
GERMANY
WO/2003/020919
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]71[
]14[
]31[
185
160445
‫יחידה ותהליך לביצוע תסיסה בתא בעל צפיפות‬
‫גבוהה‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to a continuous process for high cell density cultivation
of suspended animal or plant cell lines with the aim of efficiently producing biological
products. The invention also relates to units and apparatuses in which the process
according to the invention for cultivating suspended animal or plant cell lines can be
carried out.
__________________
December 30, 2010-‫כג' בטבת התשע"א‬
]00[]00[
]34[
METHOD OF FORMING BARBS
ON A SUTURE AND APPARATUS
FOR PERFORMING SAME
]00[
]30[
]30[
]10[
]71[
]14[
29.08.2002
09/943733
]30[ 31.08.2001
Int. Cl.(2010.01) A61B 17//06
QUILL MEDICAL, INC., U.S.A.
WO/2003/017850
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]31[
160496
‫שיטת יצירה של קרסים בתפר ומתקן לעיצובם‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A method of making a barbed suture by varying the blade geometry and/or the
movement of the blade when cutting a suture is disclosed. The method can also be
accomplished with a cutting device to create a plurality of barbs on the exterior of
surgical suture. The barbs produced using the method with the cutting device can be
the same or random configurations.
__________________
]00[]00[
161178
]34[
METHOD FOR PREPARING
MODIFICATIONS OF SOLID 3-SNPHOSPHOGLYCERIDES AND
COMPOSITIONS CONTAINING
THEM
]00[
]30[
]30[
11.10.2002
60/328660
]30[ 11.10.2001
]33[ US
Int. Cl.(2010.01) A61K 31//661, 47//00, 47//24, A61P 11//00, C07F 09//10, C12P
09//00
BIOMOLECULAR PRODUCTS, INC.,
]10[
186
–sn–6–‫שיטה להכנת שינויים מבניים ב‬
‫פוספוגליצרידים מוצקים ותכשירים המכילים‬
‫אותם‬
December 30, 2010-‫כג' בטבת התשע"א‬
]71[
]14[
]31[
U.S.A.
WO/2003/031593
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
,'‫זליגסון גבריאלי ושות‬
21 ‫רח' יבנה‬
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
Methods for hydrolyzing solid ungranulated lysophosphatidylcholine with
phospholipase A2 are provided. Also disclosed are methods for making a lipid matrix
of lysophosphatidylcholine, monoglyceride and fatty acid, and lipid matrices of
particular structure.
__________________
]00[]00[
]34[
OUTLET WITH ANALOG
SIGNAL ADAPTER, METHOD
FOR USE THEREOF AND A
NETWORK USING SAID
OUTLET
]00[
]30[
]10[
11.10.2001
Int. Cl.(2010.01) H04L 12//56
MOSAID TECHNOLOGIES
INCORPORATED, CANADA
WO/2003/039150
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]71[
]14[
]31[
187
161190
‫שקע שכולל מתאם עבור אותות אנלוגים שיטה‬
‫לשימוש בו ורשת המשתמשת בו‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
An outlet (70, 75, 76, 78, 79) for a Local Area Network (LAN), containing an
integrated adapter (21, 25) that converts digital data to and from analog video signal.
December 30, 2010-‫כג' בטבת התשע"א‬
Such an outlet allows using analog video units in a digital data network (80),
eliminating the need for a digital video units or external adapter. The outlet may
include a hub (31, 41) that allows connecting both an analog video signal via an
adapter, as well as retaining the data network connection, which may be accessed by a
network jack (73). The invention may also be applied to a telephone line-based data
networking system. In such an environment, the data networking circuitry as well as
the analog video adapters are integrated into a telephone outlet, providing for regular
telephone service, analog video connectivity, and data networking as well. In such a
configuration, the outlet would have a standard telephone jack (71), an analog video
jack (72) and at least one data networking jack (73). Outlets according to the invention
can be used to retrofit existing LAN and in-building telephone wiring, as well as
original equipment in new installation
__________________
]00[]00[
161686
‫שימוש בנוגדן מונוקלוני נמס המקשר באופן‬
‫ בייצור תכשירי‬DR5 ‫ רצפטור‬TRAIL ‫ספציפי‬
DR5 ‫רוקחי מיועדים לתאים מבטאים‬
]34[
USE OF A SOLUBLE
MONOCLONAL ANTIBODY THAT
SPECIFICALLY BINDS TRAIL
RECEPTOR DR5 IN THE
MANUFACTURE OF
PHARMACEUTICAL
COMPOSITIONS TARGETING
CELLS EXPRESSING DR5
]00[
]30[
25.10.2002
60/346402
]30[ 01.11.2001
]33[ US
620300417
0402600220
US
Int. Cl.(2010.01) A61K 39//395, A61P 19//02, 35//00, 37//06, C07K 16//28
UAB RESEARCH FOUNDATION,
U.S.A.
TONG ZHOU, KIMIHISA
ICHIKAWA, ROBERT P.
]30[
]10[
]10[
188
December 30, 2010-‫כג' בטבת התשע"א‬
]71[
]14[
]31[
KIMBERLY, WILLIAM J.
KOOPMAN, JUN OSHUMI, ALBERT
F. LOBUGLIO, DONALD J.
BUCHSBAUM
WO/2003/038043
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
An antibody of the invention interacts with human DR5 or with human DR4 to
produce agonistic or antagonistic effects downstream of the receptor including
inhibition of cell proliferation and apoptosis. Methods and uses for the antibodies,
optionally in combination with various therapeutic agents, are detailed, including
treatment of apoptosis-related disease and treatment of dysregulated cell growth.
0
__________________
]00[]00[
162022
‫ מכסה של מיכל‬,‫ או בתוך‬,‫אמצעי הידוק עבור‬
]34[
LOCKING MEANS FOR, OR IN,
COVER OF CONTAINER
]00[
]30[
]10[
17.05.2004
Int. Cl.(2010.01) A01G 07//00, A47G 07//00, B65D 55//02, E05B 65//52
EFRAIM MOLEK
‫ פתח תקווה‬,‫אפרים מולק‬
TZADOK LEVY
‫ פתח תקווה‬,‫צדוק לוי‬
]14[
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A lock (10) for locking a cover (40) to a container (60), said lock including:
a head portion (18) configured for insertion into an opening (44) formed in the cover
associated with and fitted to the container; and
a bottom portion (16) formed integrally with said head portion constructed of a
resilient material, said bottom portion including at least one wing (19, 19') having a
leaf-like construction and at the end of each of said at least one wing is a curved
upward projecting region (20) which contacts the surface of the container on which a
compressive force is exerted, the compressive force holding the container securely
against the cover, thereby to lock the cover to the container.
]31[
189
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
METHODS FOR OBTAINING
ISLET CELLS FROM HUMAN
EMBRYONIC STEM CELLS
]00[
]30[
]30[
]10[
]71[
]14[
06.12.2002
60/338885
]30[ 07.12.2001
Int. Cl.(2010.01) C12N 05//076
GERON CORPORATION, U.S.A.
WO/2003/050249
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]31[
190
162131
‫שיטות להפקת איים מתאי גזע עובריים‬
‫אנושיים‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
This disclosure provides a system for producing pancreatic islet cells from embryonic
stem cells. Differentiation is initiated towards endoderm cells, and focused using
reagents that promote emergence of islet precursors and mature insulin-secreting cells.
High quality populations of islet cells can be produced in commercial quantities for
use in research, drug screening, or regenerative medicine.
December 30, 2010-‫כג' בטבת התשע"א‬
The applications for division
from this application have
not yet been published
0/110/1
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]00[]00[
]34[
SEMICONDUCTOR TEXTURING
PROCESS
]00[
]30[
]30[
]10[
29.11.2002
PCT/AU01/01546 ]30[ 29.11.2001
Int. Cl.(2010.01) H01L 21//302, 31//0236
ORIGIN ENERGY SOLAR PTY.LTD.,
AUSTRALIA
WO/2003/047004
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]71[
]14[
]31[
191
162190
‫תהליך יצירת מרקם של מוליך למחצה‬
]33[
WO
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The invention provides a process for texturing a surface of a semiconductor material,
the process comprising: applying a layer of a protective substance on said surface
wherein said layer is sufficiently thin that it has a plurality of apertures therethrough;
and contacting said layer and said semiconductor material with an etchant capable of
etching said semiconductor material faster than said protective substance, said etchant
making contact with said semiconductor material at least through said apertures, for a
time and under conditions in which said semiconductor material is etched by said
etchant in the vicinity of said apertures to produce a textured surface on said
semiconductor material, but said protective substance is substantially unetched.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
162357
]34[
CHIMERIC TNF LIGAND/CD154
MOLECULES
]00[
]30[
]30[
]10[
05.12.2002
10/006305
]30[ 06.12.2001
]33[ US
Int. Cl.(2010.01) C07K 14//525, 19//00, C12N 15//19
THE REGENTS OF THE
UNIVERSITY OF CALIFORNIA,,
U.S.A.
WO/2003/050254
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]71[
]14[
]31[
192
CD154 ‫ ו‬TNF ‫מולקולות כימריות של ליגנד‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention is directed to an isolated polynucleotide sequence encoding a
chimeric TNFalpha, comprising a first nucleotide sequence encoding a domain or
subdomain of a tumor necrosis factor ligand other than TNFalpha, wherein the
encoded domain or subdomain replaces a cleavage site of native TNFalpha, and a
second nucleotide sequence encoding a domain or subdomain of native TNFalpha that
binds to a TNFalpha receptor. The encoded chimeric TNFalpha is significantly less
susceptible to cleavage from the cellular surface and, as a result can increase the
concentration of a ligand capable of binding to a TNFalpha receptor on the surface of a
cell. The chimeric TNFalpha is therefore useful in methods for inducing apoptosis of a
cell expressing a TNFalpha receptor, inducing activation of an immune system cell and
treating neoplastic cells, by introducing into the cell of interest an isolated
polynucleotide sequence encoding a chimeric TNFalpha; that is expressed on the
surface of the cell.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
SYSTEM AND METHOD FOR
FILTERING AND ORGANIZING
ITEMS BASED ON COMMON
ELEMENTS
]00[
]30[
]30[
]10[
15.05.2003
10/403341
]30[ 27.03.2003
Int. Cl.(2010.01) G06F 07//00, 17//30
MICROSOFT CORPORATION,
U.S.A.
WO/2004/097682
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]71[
]14[
]31[
193
162694
‫מערכת ושיטה לסינון וארגון פריטים המבוססת‬
‫על גופים משותפים‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A system (600) and method for filtering (620) and organizing items from computer
memories based on common elements (SB). In accordance with one aspect of the
invention, filters (621) are a set of items. In one embodiment, the filters (621) are
dynamically generated based on the properties of separate items (651, 652, 654). The
system (600) utilizes virtual folders. Virtual folders expose regular files (651, 652,
654) and folders to users in different views based on their metadata instead of the
actual physical underlying file system structure on the disk. In accordance with another
aspect of the invention, quick links are provided. In one embodiment, quick links are a
set of predefined links (e.g. located on the left side of the display (600) that can be
clicked on to generate useful views of the sets of items. In accordance with another
aspect of the invention, libraries (641) are provided. Libraries consist of large groups
of usable types of items (644) that can be associated together.
__________________
December 30, 2010-‫כג' בטבת התשע"א‬
]00[]00[
]34[
METHOD OF USING RIBOZYMES
IN THE DETECTION OF
ADVENTITIOUS AGENTS
]00[
]30[
]30[
]10[
26.02.2003
60/360370
]30[ 28.02.2002
Int. Cl.(2010.01) C12Q 01//04, 01//68
ONCOLYTICS BIOTECH INC.,
CANADA
WO/2003/072811
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]71[
]14[
]31[
163343
‫שיטת שימוש בריבוזימים לגילוי גורמים לא‬
‫צפויים‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention provides a method of detecting adventitious agents in a
composition comprising a microorganism by using ribozyme−expressing indicator
cells, as well as indicator cells useful in such detection.
__________________
]00[]00[
163613
‫אגוניסטים מלאים או חלקיים של קולטן אדנוזין‬
‫ ותכשירים רוקחיים המכילים אותם‬A1
]34[
PARTIAL OR FULL AGONISTS OF
A1 ADENOSINE RECEPTORS AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME
]00[
]30[
]30[
]10[
]71[
]14[
19.02.2003
60/357961
]30[ 19.02.2002
]33[ US
Int. Cl.(2010.01) A61K 31//70, A61P 35//00, C07H 19//16
GILEAD PALO ALTO, INC., U.S.A.
WO/2003/070739
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]31[
194
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Disclosed are novel compounds that are partial and full A1 adenosine receptor
December 30, 2010-‫כג' בטבת התשע"א‬
agonists, useful for treating various disease states, in particular tachycardia and atrial
flutter, angina, myocardial infarction and hyperlipidemia.
__________________
]00[]00[
163825
‫–אזאסטרואיד לויסות‬4 ‫נגזרות פלואור של‬
‫התווך ע"י רצפטור של אנדרוגן‬
]34[
FLUORINATED 4-AZASTEROID
DERIVATIVES FOR
MODULATING A FUNCTION
MEDIATED BY THE ANDROGEN
RECEPTOR
]00[
]30[
]30[
07.03.2003
60/363822
]30[ 13.03.2002
]33[ US
Int. Cl.(2010.01) A61K 45//06, C07D 21/5/14, 40/1/10, 40/5/10, 40/7/10, 41/7/10,
C07J 71//00
MERCK SHARP & DOHME CORP.,
U.S.A.
WO/2003/077919
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
]10[
]71[
]14[
]31[
Compounds of structural formula I are modulators of the androgen receptor (AR) in a
tissue selective manner. They are useful as agonists of the androgen receptor in bone
and/or muscle tissue while antagonizing the AR in the prostate of a male patient or in
the uterus of a female patient. These compounds are therefore useful in the treatment
of conditions caused by androgen deficiency or which can be ameliorated by androgen
administration, including osteoporosis, osteopenia, glucocorticoid-induced
osteoporosis, periodontal disease, bone fracture, bone damage following bone
reconstructive surgery, sarcopenia, frailty, aging skin, male hypogonadism,
postmenopausal symptoms in women, atherosclerosis, hypercholesterolemia,
hyperlipidemia, obesity, aplastic anemia and other hematopoietic disorders,
inflammatory arthritis and joint repair, HIV-wasting, prostate cancer, cancer cachexia,
muscular dystrophies, premature ovarian failure, and autoimmune disease, alone or in
combination with other active agents.
__________________
195
December 30, 2010-‫כג' בטבת התשע"א‬
]00[]00[
164240
‫תכשירים המכילים‬,‫ – טריאזיניות‬1,6,5 ‫תולדות‬
‫אותן ושימושים בהן להכנת תרופות לטיפול‬
‫במחלת הפרקינסון‬
]34[
1,3,5 - TRIAZINE DERIVATIVES,
COMPOSITIONS COMPRISING
THEM AND USES THEREOF IN
THE MANUFACTURE OF
MEDICAMENTS FOR THE
TREATMENT OF PARKINSON'S
DISEASE
]00[
]30[
]30[
28.05.2003
02077310.7
]30[ 30.05.2002
]33[ EP
Int. Cl.(2010.01) A61K 31//53, A61P 25//00, 29//00, 43//00, C07D 25/1/42, 25/1/50,
40/1/00, 40/1/04, 40/1/12, 40/5/04, 40/5/12, 40/7/10, 40/7/12, 41/3/10, 41/3/12,
41/3/14
SOLVAY PHARMACEUTICALS
B.V., THE NETHERLANDS
ARQULE, INC., U.S.A.
WO/2003/101980
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]10[
]71[
]14[
]31[
The invention relates to a group of novel triazine derivatives which are ligands for
human adenosine-A3 receptors, as well as to pharmaceutical compositions containing
a pharmacologically active amount of at least one of these compounds as an active
ingredient. The invention relates to compounds of the general formula (1) wherein Y
represents a group of the general formula (A), (B) or (C) and all other symbols have
the meanings as given in the description.
__________________
196
December 30, 2010-‫כג' בטבת התשע"א‬
]00[]00[
164388
‫שימוש ברנולאזין להכנת תרופה לטיפול‬
‫בהפרעת קצב‬
]34[
USE OF RANOLAZINE FOR THE
PREPARATION OF A
MEDICAMENT FOR THE
TREATMENT OF ARRHYTHMIAS
]00[
]30[
04.04.2003
60/408292
]30[ 05.09.2002
]33[ US
620400370
3200200220
US
620312032
2402400223
US
Int. Cl.(2010.01) A61K 31//495, A61P 09//06, C07D 29/5/15, 40/5/12
GILEAD PALO ALTO, INC., U.S.A.
WO/2003/086401
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]30[
]10[
]71[
]14[
]31[
Methods are provided for treating arrhythmias including tachycardias, such as
idiopathic ventricular tachycardia, ventricular fibrillation, and Torsade de Pointes
(TdP) in a manner that minimizes undesirable side effects.
0/0/04/
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]00[]00[
]34[
DRUM FOR A PRODUCTION
UNIT FOR A NON-WOVEN
MATERIAL, METHOD FOR
PRODUCTION OF A NON-WOVEN
MATERIAL AND NON-WOVEN
MATERIAL OBTAINED THUS
]00[
]30[
]30[
]10[
08.04.2003
0204604
]30[ 12.04.2002
Int. Cl.(2010.01) D04H 01//46
RIETER PERFOJET, FRANCE
197
164472
‫ שיטה ליצור‬,‫תוף ליחידת יצור לחומר לא ארוג‬
‫ וחומר לא ארוג המושג כך‬,‫חומר לא ארוג‬
]33[
FR
December 30, 2010-‫כג' בטבת התשע"א‬
]10[
]71[
]14[
]31[
FREDERIC NOELLE
WO/2003/087455
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
‫רמת גן‬
The invention relates to a production unit for non-woven material, comprising a
spunbond tower (21), the conveyor (22) of which supplies the non-woven material
preform to a drum (24) with a compartment (26) for aspirating said preform and
applying the same to the lateral surface of the drum before the preform is hydraulically
tangled by injectors (25). Said method permits the production of non-woven materials
with uniform properties.
__________________
]00[]00[
]34[
PROCESS FOR
HYDROGENATING
UNACTIVATED IMINES USING
RUTHENIUM COMPLEXES AS
CATALYSTS
]00[
]30[
]30[
]10[
15.05.2003
60/380256
]30[ 15.05.2002
Int. Cl.(2010.01) C07B 35//00
KAMALUDDIN ABDUR-RASHID,
CANADA
WO/2003/097571
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]71[
]14[
]31[
198
164915
‫תהליך לממנון אמינים לא פעילים באמצעות‬
‫שימוש בקומפלקסי רותיניום כזרזים‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A process is provided for the hydrogenation or asymmetric hydrogenation of dialkyl,
alkylalkenyl and dialkenyl imines of formula (II) to provide amines of formula (III),
wherein, (i) R1 and R2 are optionally substituted cyclic, linear or branched alkyl or
December 30, 2010-‫כג' בטבת התשע"א‬
alkenyl; R3 is a hydrogen atom, a hydroxy radical, optionally substituted C 1 to C8
cyclic, linear or branched alkyl or alkenyl, optionally substituted aryl; or (ii) R 1 is alkyl
or alkenyl, R2 is alkyl or alkenyl and the two are linked together or with R3 to form one
or more rings; using a catalytic system comprising a base and a ruthenium complex
containing (1) a diamine and (2) a diphosphine ligand or monodentate phosphine
ligands in hydrogenation and asymmetric hydrogenation processes.
__________________
]00[]00[
165566
]34[
SPEEDY SELF-COOLING
BEVERAGE CONTAINER
]00[
]30[
]10[
]14[
06.12.2004
Int. Cl.(2010.01) B65D 81//18, F25D 03//10
MESHALI SHALOM
MESHALI SHALOM,
HOMA VE MIGDAL 16
]31[
199
‫מיכל משקה בעל מנגנון קירור עצמי מהיר‬
‫ תל אביב‬,‫שלום משעלי‬
,‫שלום משעלי‬
11 ‫חומה ומגדל‬
‫תל אביב‬
A speedy self cooling beverage container consisting of a modified beverage can in a
way that a vaporizing cavity is added to the base of the beverage can, extending to the
middle of the can with an opening at the bottom;
a refrigerant chamber with a cone shaped neck and a niche on the inner side of one
wall is attached to the bottom wall of the beverage can in a way that leaves release
openings from where the refrigerant releases to the open air and said chamber can be
rotated; and
a cone shaped regulator that seals the chamber with rubber band connects to the
vaporizing cavity with a clip and made of tubes of specific length and diameter,
designed to control the refrigerant release speed and the evaporation location.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
165843
‫צורת מתן פומי קופצת‬
]34[
POPPING ORAL
ADMINISTRATION FORM
]00[
]30[
]30[
]10[
]71[
]14[
18.06.2003
173814
]30[ 19.06.2002
]33[ US
Int. Cl.(2010.01) A61K 09//00, 09//10, 09//20, 47//46
CTS CHEMICAL INDUSTRIES LTD.
‫ קרית מלאכי‬,‫כצט תעשיות כימיות בע"מ‬
WO/2004/000283
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]31[
Disclosed are popping pharmaceutical oral administration forms, which comprise an
active ingredient, and pressurized gas trapped within cavities in a pharmaceutically
acceptable material in a manner that allows the gas to escape from the administration
form upon dissolution or shattering of said form. Such an oral administration form may
be popular with children that will prefer it on other ones, which do not pop. Methods
for preparation of such oral administration forms are also disclosed.
__________________
200
December 30, 2010-‫כג' בטבת התשע"א‬
]00[]00[
165852
‫מערכת ושיטה לשיפור תצוגת דמות‬
]34[
SYSTEM AND METHOD FOR
IMAGE DISPLAY
ENHANCEMENT
]00[
]30[
19.12.2004
Int. Cl.(2010.01) G06T 05//00, 05//50, G09G 05//18, 05//377, H04N 01//387, 01//58,
05//14
RAFAEL ADVANCED DEFENSE
,‫רפאל מערכות לחימה מתקדמות בע"מ‬
SYSTEMS LTD.
‫חיפה‬
]10[
]14[
]31[
201
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
A method for displaying digital images on a display device. The method includes
obtaining an input image set including one or more input images, processing the input
image set to generate an output image set including a number of output images,
displaying the output image set in a sequence on the display device at a frame rate in
excess of five frames per second the first and second image-processing
transformations and the sequence being chosen such that a time-integrated average
luminance in each region of the display over successive frames approximates the
luminance distribution of a corresponding region of the input image set.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
RATE CONTROL FOR MULTICHANNEL COMMUNICATION
SYSTEMS
]00[
]30[
20.06.2003
10/176567
202
]30[
20.06.2002
165866
‫שליטה על קצב עבור מערכות תקשורת רב‬
‫ערוצים‬
]33[
US
December 30, 2010-‫כג' בטבת התשע"א‬
]30[
]10[
]71[
]14[
]31[
Int. Cl.(2010.01) H04B 07//06, H04J 11//00, H04L 01//00, 12//56, H04W 28//22
QUALCOMM INCORPORATED,
U.S.A.
WO/2004/001545
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Techniques to determine a set of rates for a set of data streams to be transmitted in a
multi-channel communication system. A group of transmission channels to be used for
each data stream is initially identified. An equivalent system for each group is then
defined to have an AWGN (or flat) channel and a spectral efficiency equal to the
average spectral efficiency of the transmission channels in the group (216). A metric
for each group is then derived based on the associated equivalent system, e.g., set to
the SNR needed by the equivalent system to support the average spectral efficiency
(218). A rate for each data stream is then determined based on the metric associated
with the data stream. The rate is deemed to be supported by the communication system
if the SNR required to support the data rate by the communication system is less than
or equal to the metric (226).
__________________
]00[]00[
165935
‫מעכבי ואזופפטידאז‬
]34[
VASOPEPTIDASE INHIBITORS
]00[
]30[
]30[
]10[
13.06.2003
10229180.2
]30[ 28.06.2002
]33[ DE
Int. Cl.(2010.01) A61K 08//00, 31//55, A61P 05//04, 07//10, 09//00, C07D 47/1/04
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2004/002492
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
1 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬15111 .‫ד‬.‫ ת‬,
HERZLIYA 46733
]71[
]14[
]31[
203
The invention describes the use of vasopeptidase inhibitors of the formula (I) for the
treatment and/or prophylaxis of nephropathy in diabetic or non-diabetic patients,
including diabetic or non-diabetic nephropathy, glomerulonephritis, glomerular
sclerosis, nephrotic syndome, hypertensive nephrosclerosis, microalbuminuria or end
stage renal disease, or insulin resistence or of metabolic diseases associated with
advanced glycation end-products, such as diabetic complications, diabetic neuropathy,
diabetic nephropathy, diabetic retinopathy, cataracts, myocardial infarction and/or
December 30, 2010-‫כג' בטבת התשע"א‬
diabetic cardiomyopathy, or atherosclerosis or endothelial dysfunction.
__________________
]00[]00[
166113
‫מערכת ושיטה לחישת מתח ולחץ תוך גופיים‬
]34[
SYSTEM AND METHOD FOR
SENSING IN-VIVO STRESS AND
PRESSURE
]00[
]30[
03.07.2003
60/393300
]30[ 03.07.2002
]33[ US
620433363
0300000220
US
Int. Cl.(2010.01) A61B 05//00, 05//103, 05//117
GIVEN IMAGING LTD.
ZVIKA GILAD, GAVRIEL J. IDDAN
WO/2004/004540
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]30[
]10[
]10[
]71[
]14[
]31[
204
‫ יקנעם‬,‫גיוון אימג'ינג בע"מ‬
‫ עידן‬.‫ גבריאל י‬,‫צביקה גלעד‬
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
A device (4440), system and method may sense and/or analyze in-vivo pressure or
stress, and may in addition sense other data, such as for example, image data. An invivo device (4440) may include a stress or pressure sensor (4443), and possibly an
additional sensor, such as an image sensor, a pH sensor, etc. In one example the stress
or pressure sensor (4443) is connected to a shell (4444) of the device.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
166191
)‫נגזרות חדשות של פירידילאתנול (פנילאתיל‬
,‫אמינים כמעכבי ביוסינתזה של כולסטרול‬
‫תהליך להכנתן ותכשירי רוקחות המכילים אותן‬
]34[
DERIVATIVES OF
PYRIDYLETHANOL
(PHENYLETHYL) AMINES AS
INHIBITORS OF CHOLESTEROL
BIOSYNTHESIS, PROCESSES FOR
THEIR PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM
]00[
]30[
09.07.2003
P-200200177 ]30[ 17.07.2002
]33[ SI
P-200200287
0700000220
SI
Int. Cl.(2010.01) A61K 31//44, A61P 03//06, 43//00, C07D 21/3/38
LEK PHARMACEUTICALS D.D.,
SLOVENIA
WO/2004/007456
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
]30[
]10[
]71[
]14[
]31[
205
The novel derivatives of pyridylethanol (phenylethyl) amines of formula I are
described wherein n is an integer from 1 to 4, R1 is a hydrogen atom, hydroxyl group
or lower C1-6 alkoxy group R2 is a hydrogen atom or a straight or branched lower C1-6
alkyl group X, is hydrogen, fluorine, chlorine, bromine, hydroxyl group,
trifluoromethyl group, 3,4-di-CI,2,4-di-CI or lower C1-6 alkoxy group, the enantiomers,
diastereoisomers or racemates thereof or the physiologically acceptable acid addition
salts thereof which are ligands of sigma receptors for inhibiting cholesterol
biosynthesis and are thus appropriate for the treatment of hypercholesterolemia and
hyperlipemia in humans. The greatest lowering of cholesterol was observed by 1-(dDecember 30, 2010-‫כג' בטבת התשע"א‬
pyridyl)-2-(N-(2-(3,4-dicholorophenyl)ethyl-N-propylamino)ethanol in the form of
dihydrobromide salt (signature BK-35. 2HBr).
__________________
]00[]00[
]34[
METHOD AND APPARATUS FOR
MULTI-SENSORY SPEECH
ENHANCEMENT ON A MOBILE
DEVICE
]00[
]30[
]30[
]10[
25.01.2005
785768
]30[ 24.02.2004
Int. Cl.(2010.01) H04B 01//10
MICROSOFT CORPORATION,
U.S.A.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]31[
206
166473
‫שיטה והתקן למגביר קול רב–חושי על התקן‬
‫נייד‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A mobile hand-held device comprising:
an air conduction microphone (804) that converts acoustic waves into an electric
microphone signal indicative of a frame of speech;
at least one alternative sensor (807) other than an air conduction microphone that
provides an electric alternative sensor signal indicative of the frame of speech based on
contact between a user and at least one of at least two contact points coupled to the at
least one alternative sensor wherein the the two contact points are provided on
opposite sides of a speaker (800) in the hand-held device, wherein the at least one
alternative sensor comprises a second alternative sensor (806) that provides a second
alternative sensor signal and wherein the alternative sensor and the second alternative
sensor comprise bone conduction sensors; and
a processor (820) that uses the microphone signal and the alternative sensor signal to
estimate a clean speech value for the frame of speech.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
APPARATUS AND METHOD FOR
CHEMICALLY REDUCING
WASTE MATERIALS
]00[
]30[
]30[
]60[
]10[
]71[
]14[
01.10.2003
263043
]30[ 02.10.2002
Int. Cl.(2010.01) B09B 03//00
150887
DIGESTOR, LLC, U.S.A.
WO/2004/091820
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]31[
207
167649
‫התקן ושיטה להפחתה באופן כימי של חומר זבל‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
In accordance with the present invention, a system, method and apparatus is provided
for chemically reducing waste. The apparatus includes a substantially alkaline-resistant
vessel having a temperature sensor positioned in thermal communication therewith, a
heater in thermal communication with the vessel, a substantially alkaline-resistant
magnetic stir rod adapted to be positioned within the vessel, and a magnetic stirrer
adapted to produce a rotating magnetic field within the vessel capable of spinning a
magnetic stir rod positioned therein. The apparatus further includes a water inlet valve
operationally connected to the vessel and a water outlet valve operationally connected
to the vessel. An electronic controller is connected in electric communication to the
heater, to the magnetic stirrer, to the water inlet valve, to the water outlet valve, and to
the temperature sensor and is adapted to maintain the temperature of the substantially
alkaline resistant vessel substantially at a predetermined value.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
METHOD AND APPARATUS FOR
ENABLING ASSOCIATED
PORTLETS OF A WEB PORTAL
TO COLLABORATE FOR
SYNCHRONIZED CONTENT
DISPLAY
]00[
]30[
]30[
]10[
]71[
]14[
01.10.2003
2406569
]30[ 04.10.2002
Int. Cl.(2010.01) G06F 15//16, 17//30
IBM CORPORATION, U.S.A.
WO/2004/031985
IBM LABORATORIES,
HAIFA UNIVERSITY,
HAIFA 31905
]31[
167738
‫שיטה ומערכת המאפשרים שיתוף פעולה בין‬
‫פורטלים המשויכים לאותו אתר בית על מנת‬
‫להציג תוכן מסונכרן‬
]33[
CA
,‫מעבדות יבמ מחלקת קנין רוחני‬
‫אוניברסיטת חיפה הר הכרמל‬
‫חיפה‬
The invention provides method and apparatus for collaboration between a plurality of
associated portlets in a portal server comprising: associating each portlet with a portlet
descriptor describing context names; forming collaboration groups of portlets having
corresponding context names for sychronized contents.
__________________
]00[]00[
]34[
208
REDUCED DIAMETER IMAGING
DEVICE
167755
‫מתקן דימות בעל קוטר מופחת‬
December 30, 2010-‫כג' בטבת התשע"א‬
]00[
]30[
]30[
]10[
]10[
]71[
]14[
]31[
30.09.2003
60/414414
]30[ 30.09.2002
]33[
Int. Cl.(2010.01) A61B 01//00, 01//05, 01//06
GIVEN IMAGING LTD.
GAVRIEL J. IDDAN, ZVIKA GILAD
WO/2004/028336
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
US
‫ יקנעם‬,‫גיוון אימג'ינג בע"מ‬
‫ צביקה גלעד‬,‫ עידן‬.‫גבריאל י‬
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
A reduced diameter in vivo imaging device, such as a swallowable imaging capsule.
The imaging device includes a first circuit board (107) configured for accommodating
at least an image sensor (107), and a second circuit board (112), which is in electrical
communication with the first circuit board and which extends substantially
perpendicularly from the bottom surface of the first circuit board.
__________________
]00[]00[
167943
]34[
BOTULINUM NEUROTOXIN B
RECEPTORS AND USE THEREOF
]00[
]30[
28.10.2003
60/422951
]30[ 31.10.2002
]33[ US
620407007
0102700223
US
Int. Cl.(2010.01) C07K 14//435, 14//47, 14//705
WISCONSIN ALUMNI RESEARCH
FOUNDATION, U.S.A.
WO/2005/016233
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]30[
]10[
]71[
]14[
209
‫ של בוטולינום ושימושם‬B ‫קולטני רעלן העצבים‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
December 30, 2010-‫כג' בטבת התשע"א‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
]31[
It is disclosed here that synaptotagmin I (syt I) and synaptotagmin II (syt II) are the
cellular receptors for botulinum neurotoxin B (BoNT/B) that mediate the cellular entry
and toxicity of BoNT/B. The BoNT/B binding domains of syt I and II are also
disclosed. While syt I needs gangliosides for BoNT/B binding, syt II can bind to
BoNT/B in the absence of gangliosides. Various nucleic acids and polypeptides that
relate to the BoNT/B binding domain of syt I or II are disclosed. Further disclosed are
methods of reducing BoNT/B toxicity, methods of identifying agents that can block
the binding between BoNT/B and syt I or II, methods of identifying agents that can
bind to the BoNT/B binding domain of syt I or II, and methods of detecting BoNT/B
or Clostridium botulinum.
__________________
]00[]00[
]34[
PROCESS FOR THE
PREPARATION OF
ROFLUMILAST
]00[
]30[
]30[
]10[
]71[
]14[
08.03.2004
03005245.0
]30[ 10.03.2003
Int. Cl.(2010.01) C07D 21/3/75
NYCOMED GMBH, GERMANY
WO/2004/080967
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]31[
210
168170
‫תהליך להכנת רופלומילסט‬
]33[
EP
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
The invention relates to novel processes for the preparation of high-purity roflumilast.
The process involves reacting the anion of 4 - armino -3,5 dichloropyridine (I), with an
activated derivative of 3-cyclopropylmethoxy-4-difluoromethoxybenzoic acid (II),
characterized in that the molar ratio of the employed anion of 4-amino-3,5
dichloropyridine to the activated derivative of 3-cyclopropylmethoxy-4difluoromethoxybenzoic acid is at least 1.5 and at most 3, preferably at least 1.8 and at
most 2.7 particularly preferably at least 2 and at most 2.5 and very particularly
December 30, 2010-‫כג' בטבת התשע"א‬
preferably 2.2
__________________
]00[]00[
168307
]34[
COMPOSITIONS CONTAINING
ROFLUMILAST AND (R,R)FORMOTEROL
]00[
]30[
]30[
]10[
]71[
]14[
26.11.2003
02026504.7
]30[ 27.11.2002
]33[ EP
Int. Cl.(2010.01) A61K 31//167, 31//44, A61P 11//00
NYCOMED GMBH, GERMANY
WO/2004/047828
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]31[
–) R, R( ‫תכשירים המכילים רופלומילסט ו‬
‫פורמוטירול‬
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
The invention relates to the combined administration of roflumilast and R,Rformoterol for the treatment of respiratory tract disorders.
__________________
]00[]00[
168584
‫חיסון נגד נגיף הנילוס המערבי‬
]34[
WEST NILE VIRUS VACCINE
]00[
]30[
]30[
]10[
13.11.2003
60/426592
]30[ 15.11.2002
]33[ US
Int. Cl.(2010.01) A61K 39//295, C07K 14//18, C12N 07//01, 07//04, 15//40
SANOFI PASTEUR BIOLOGICS CO.,
U.S.A.
WO/2004/045529
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
]71[
]14[
]31[
211
The invention provides chimeric flavivirus vaccines against West Nile virus and
methods of using these vaccines to prevent or treat West Nile virus infection.
December 30, 2010-‫כג' בטבת התשע"א‬
01410/1
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]00[]00[
169045
‫צמדים חיסוניים‬
]34[
IMMUNOCONJUGATES
]00[
]30[
]30[
]10[
]71[
]14[
15.12.2003
60/433017
]30[ 13.12.2002
]33[
Int. Cl.(2010.01) A61K 47//48, A61P 35//00
IMMUNOMEDICS, INC., U.S.A.
WO/2004/054622
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]31[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to therapeutic conjugates with improved ability to target various
cancer cells containing a targeting moiety and a therapeutic moiety. The targeting and
therapeutic moieties are linked via an acid cleavable linkage that increases therapeutic
efficacy of the immunoconjugate.
__________________
]00[]00[
169096
‫תהליך ייצור של גמא–ציהלותרין ותרכובת‬
‫ביניים‬
]34[
PRODUCTION PROCESS OF
GAMMA-CYHALOTHRIN AND
INTERMEDIATE
]00[
]30[
]30[
]10[
09.12.2003
0229803.2
]30[ 20.12.2002
]33[ GB
Int. Cl.(2010.01) C07C 25/3/08, 25/3/30, 25/3/34, 25/5/39
SYNGENTA LIMITED, UNITED
KINGDOM
WO/2004/056752
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
]71[
]14[
212
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
December 30, 2010-‫כג' בטבת התשע"א‬
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
P.O.B. 5352,
BEER-SHEVA 84152
]31[
A process for the preparation of gamma-cyahlothrin comprising a) chlorinating 1R cisZ 3-(2-chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethyl cyclopropanecarboxylic acid to
give 1R cis-Z 3-(2-chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethyl
cyclopropanecarboxylic acid chloride; b) esterifying 1R cis-Z 3-(2-chloro-3,3,3trifluoro-1-propenyl)-2,2-dimethyl cyclopropanecarboxylic acid chloride with 3phenoxy benzaldehyde in the presence of a source of cyanide to form a
diastereoisomeric mixture of cyhalothrin isomers and c) epimerising the
diastereoisomeric mixture under conditions in which the least soluble diastereoisomer
crystallises from solution.
__________________
]00[]00[
]34[
STABLE TOPICAL DRUG
DELIVERY COMPOSITIONS
]00[
]30[
]30[
]10[
31.12.2003
60/437279
]30[ 31.12.2002
Int. Cl.(2010.01) A61F 13//00
TRANSDERMAL
BIOTECHNOLOGY, INC., U.S.A.
WO/2004/060315
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]71[
]14[
]31[
169169
‫תכשירים יציבים למתן מקומי של תרופות‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A stable composition of a drug comprising a carrier having a phosphatidylcholine
component which entraps the drug is applied to the skin for transdermal delivery of the
drug.
__________________
]00[]00[
]34[
213
STERILE OPHTHALMIC
FORMULATION, AN OCULAR
169287
‫ התקן עיני להחדרתו‬,‫תכשיר סטרילי לעיניים‬
‫ושימושים בתכשיר‬
December 30, 2010-‫כג' בטבת התשע"א‬
INSERT FOR DELIVERY OF
SAME AND THE USE OF THE
FORMULATION
]00[
]30[
]30[
]10[
]71[
]14[
]31[
22.12.2003
60/435849
]30[ 20.12.2002
]33[ US
620326414
0602000223
US
Int. Cl.(2010.01) A61K 31//195, 31//4172, 45//06, 47//00, A61P 39//04
CHAKSHU RESEARCH INC., U.S.A.
WO/2004/058289
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
An ophthalmic formulation is provided for the prevention and treatment of adverse
ocular conditions, including presbyopia, arcus senilis, age-related macular
degeneration, and other conditions associated with aging. The formulation is also
useful in the prevention and treatment of other adverse ocular conditions such as those
associated with oxidative and/or free radical damage within the eye; these conditions
can involve a condition, disease, or disorder of the cornea, retina, lens, sclera, anterior
segment, or posterior segment of the eye. In one embodiment, the formulation contains
at least 0.6 wt. % of a biocompatible chelating agent, an effective permeation
enhancing amount of an ophthalmic permeation enhancer such as
methylsulfonylmethane (MSM), an anti-AGE agent, i.e., a compound that serves to
reduce the presence of advanced glycation endproducts (AGEs) in the eye, and a
pharmaceutically acceptable ophthalmic carrier suited to the particular formulation
type (e.g., eye drops or ointments). Preferred components of the formulation are
multifunctional and naturally occurring.
__________________
]00[]00[
]34[
SURGICAL DEVICE FOR
EXTRACTING A FOREIGN
OBJECT AND METHOD FOR
MANUFACTURING THEREOF
]00[
]30[
]10[
]71[
]14[
23.12.2002
Int. Cl.(2010.01) A61B 17//22
LITHOTECH MEDICAL LTD.
WO/2004/056275
REINHOLD COHN AND
214
169319
‫התקן כירורגי להוצאת גוף זר ושיטה לייצורו‬
‫ קצרין‬,‫ליתוטק מדיקל בע"מ‬
,‫ריינהולד כהן ושותפיו‬
December 30, 2010-‫כג' בטבת התשע"א‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]31[
A surgical device for removing a foreign object from a body along with a method for
manufacturing the surgical device and a retrieval basket of the device are described.
The retrieval basket is adapted for entrapping and retaining the object located in the
body. The basket comprises a structure having a proximal end and a distal end. The
structure is formed by a plurality of filaments fabricated from a single or several wires.
The filaments extend from the proximal end towards the distal end. At least a part of
the filaments are overlapped and/or interlaced so as to define a net, and thereby impart
structural rigidity and dilatation ability to the basket when opened. The process of
manufacturing the retrieval basket includes selecting at least one wire; weaving the
basket from the wire by overlapping and/or interlacing the filaments so that to form a
net at least in the vicinity of the distal end; and binding the filaments for forming a
shape of the retrieval basket.
__________________
]00[]00[
169448
‫תרכובת הספגה למוצר בד‬
]34[
IMPREGNATION COMPOUND
FOR A FABRIC PRODUCT
]00[
]30[
]30[
]10[
]71[
]14[
05.02.2004
60/445940
]30[ 07.02.2003
]33[ US
Int. Cl.(2010.01) B32B 27//00, 27//02, 27//04, 27//40, D06N 07//00
RAYTHEON COMPANY, U.S.A.
WO/2004/072359
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
]31[
215
A high strength, high modulus structural fabric product and the method of
December 30, 2010-‫כג' בטבת התשע"א‬
manufacturing the product are disclosed. The incorporation of a specific fiber/fabric
treatment coupled with a resin impregnation and coating process produces a composite
material. This composite material comprises high strength and modulus fibers
embedded in and linked to a matrix. The resulting fabric product is useable in the
formation of seamed structures, which carry and distribute high-level loads under
extreme environmental conditions.
__________________
]00[]00[
]34[
SYSTEMS AND METHODS FOR
FINE GRAINED ACCESS
CONTROL OF DATA STORED IN
RELATIONAL DATABASES
]00[
]30[
26.07.2004
60/557239
]30[ 29.03.2004
020717030
0702600224
Int. Cl.(2010.01) G06F 17//30, 21//00
MICROSOFT CORPORATION,
U.S.A.
WO/2005/103879
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]30[
]10[
]71[
]14[
]31[
216
169467
‫מערכות ושיטות לבקרת כניסה מאובטחת של‬
‫מידע המאוחסן במאגרי נתונים בעלי זיקה זה‬
‫לזה‬
]33[
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A system and method for facilitating secure access to database(s) (fig. 1, 120) is
provided. The system relates to authorizing discriminatory access (fig. 4, 400) to
relational database data (120). More particularly, the invention provides for an
innovative technique of defining secured access to rows (fig. 2, 220) in relational
database tables (fig. 2, 200) in a way that cannot be spoofed while preserving various
optimization (fig. 4, 410) techniques. The invention affords a persistent scheme via
providing for a security architecture whereby discriminatory access policies (fig. 3,
December 30, 2010-‫כג' בטבת התשע"א‬
300) on persistent entities can be defined and enforced while preserving set based
associative query capabilities (700, 710, 714). With respect to one particular
implementation of the invention, creation, modification and deletion of access control
lists called security descriptors (fig. 4, 130, 300) is provided. The security descriptors
(130, 300) can be provisioned independent of rows (220) in tables (200) of the
database (120) and can be shared and embody the policy on what permissions are
granted (720) to whom when associated with a row (200).
__________________
]00[]00[
]34[
600 BPS MIXED EXCITATION
LINEAR PREDICTION
TRANSCODING
]00[
]30[
]30[
]10[
]71[
]14[
29.01.2004
10/355164
]30[ 31.01.2003
Int. Cl.(2009.01) G10L 19/08
HARRIS CORPORATION, U.S.A.
WO/2004/070541
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]31[
217
169947
366 ‫חיזוי הצפנת טרנס בעירור לינארי מעורב‬
BPS
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Vector quantization techniques reduce the effective bit rate to 600 bps while
maintaining intelligible speech. Four frames of speech are combined into one frame
(104). The system uses mixed excitation linear prediction speech model parameters to
quantized the frame and achieve a fixed rate of 600 bps (104). The system allows voice
communication over bandwidth constrained channels.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
TRANSDERMAL THERAPEUTIC
SYSTEM SUITABLE FOR HEAT
APPLICATION FOR PROMOTING
THE PERMEATION OF ACTIVE
SUBSTANCES AND THE USE
THEREOF
]00[
]30[
03.02.2004
10304989.4
]30[ 07.02.2003
02022422300406
0002000224
Int. Cl.(2010.01) A61K 09//70
LTS LOHMANN THERAPIE-SYSTEME
AG, GERMANY
WALTER MULLER
WO/2004/069286
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]30[
]10[
]10[
]71[
]14[
]31[
218
170045
‫מערכת רפואית לטיפול דרך העור המתאימה‬
‫לאפלקציות חום לסיוע בחדירות של חומר‬
‫ והשימוש בה‬,‫פעיל‬
]33[
DE
DE
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
The invention relates to a transdermal therapeutic system (TTS) comprising at least
one pharmacological active substance, which is suitable for heating up to a temperature
above skin temperature, thereby promoting the permeation rate of the active substance.
The transdermal therapeutic system comprises at least one layer containing the active
substance and one peelable backing layer, and is characterized in that the layer
containing the active substance mainly consists of a polysiloxane in which the active
substance is partially dissolved.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
170081
‫חגורה להתעמלות שרירי הבטן‬
]34[
EXERCISE BELT FOR
STOMACH MUSCLES
]00[
]30[
]10[
]14[
04.08.2005
Int. Cl.(2010.01) A61H 11//00, A63B 23//02
SHMUEL COHEN
‫ציון‬-‫ מבשרת‬,‫שמואל כהן‬
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A mechanical device for stimulating stomach muscles, comprising a belt-like element
sized to be worn with a section thereof adjacent the stomach muscles of the wearer,
said belt being associated with a motor and a power element for driving said motor,
said motor being mechanically linked to means for intermittently tensioning at least
said section to repeatedly intermittently press against the stomach muscles of the
wearer in order to stimulate said muscles to contract as a reaction and in anticipation
of said repeated intermittent contact, wherein said belt is provided with further
segments having a plurality of spaced-apart sequential apertures, and said motor is
attached to a sprocket wheel positioned to engage said sequential apertures in said
further segments of said belt, the arrangement being such that said belt is repeatedly,
intermittently displaceable between a first relaxed position and a second tensioned
position by repeated clockwise and counter-clockwise rotation of said sprocket wheel.
]31[
__________________
219
December 30, 2010-‫כג' בטבת התשע"א‬
]00[]00[
‫לולאת משוב למניעת הצפת רשת האינטרנט‬
‫בדואר אלקטרוני בלתי רצוי‬
]34[
FEEDBACK LOOP FOR SPAM
PREVENTION
]00[
]30[
]30[
]10[
25.02.2004
10/378463
]30[ 03.03.2003
Int. Cl.(2010.01) H04L 12//58
MICROSOFT CORPORATION,
U.S.A.
WO/2004/079514
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]71[
]14[
]31[
170115
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The subject invention provides for a feedback loop system and method that facilitate
classifying items in connection with spam prevention in server and/or client-based
architectures. The invention makes uses of a machine-learning approach as applied to
spam filters, and in particular, randomly samples incoming email messages so that
examples of both legitimate and junk/spam mail are obtained to generate sets of
training data. Users which are identified as spam-fighters are asked to vote on whether
a selection of their incoming email messages is individually either legitimate mail or
junk mail. A database stores the properties for each mail and voting transaction such as
user information, message properties and content summary, and polling results for
each message to generate training data for machine learning systems. The machine
learning systems facilitate creating improved spam filter(s) that are trained to
recognize both legitimate mail and spam mail and to distinguish between them.
The applications for division
from this application have
not yet been published
014//1/
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]00[]00[
220
170217
December 30, 2010-‫כג' בטבת התשע"א‬
‫שיטות לקביעת טיפול כמותרפי המבוססות על‬
‫אובדן ההטרוזגוטיות באתר הגנטי של‬
‫התימידילאט סינתאז‬
]34[
METHODS OF DETERMINING A
CHEMOTHERAPEUTIC
REGIMEN BASED ON LOSS OF
HETEROZYGOSITY AT THE
THYMIDYLATE SYNTHASE
LOCUS
]00[
]30[
]30[
]10[
]71[
]14[
20.02.2004
10/373752
]30[ 27.02.2003
]33[
Int. Cl.(2010.01) C12Q 01//68, G01N 33//574
RESPONSE GENETICS, INC., U.S.A.
WO/2004/075833
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]31[
US
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
The present invention is directed to a method of predicting a response to a
chemotherapeutic regimen based on loss of heterozygosity at the thymidylate synthase
locus in cancer tissue. This method comprises determining normal tissue genotype for
thymidylate synthase of a patient; determining tumor tissue genotype for thymidylate
synthase of said patient; comparing the normal tissue genotype with the tumor tissue
genotype; determining whether a loss of heterozygosity at the thymidylate synthase
locus has occurred in the tumor tissue based on the comparison of the genotypes; and
predicting a response to the chemotherapeutic regimen based on the loss of
heterozygosity in the tumor sample.
__________________
]00[]00[
170468
‫–(דיאזה–ביצקלו–אלקיל)– פירימידון‬1 ‫נגזרות‬
‫מותמרות‬
]34[
SUBSTITUTED 2-(DIAZABICYCLO-ALKYL)-PYRIMIDONE
DERIVATIVES
]00[
]30[
05.03.2004
03290570.5
]30[ 07.03.2003
]33[ EP
2300231003
2102300223
EP
Int. Cl.(2010.01) A61K 31//40, 31//435, C07D 47/1/08, 48/7/08
MITSUBISHI TANABE PHARMA
CORPORATION, JAPAN
SANOFI-AVENTIS, FRANCE
WO/2004/078759
]30[
]10[
]71[
221
December 30, 2010-‫כג' בטבת התשע"א‬
]14[
]31[
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
The invention relates to a 2-(diaza-bicyclo-alkyl)-pyrimidone derivative represented by
formula (I) or a salt thereof: wherein: R1 represents a hydrogen atom, a C1-6 alkyl
group or a halogen atom; R2 represents a hydrogen atom, a C1-6 alkyl group optionally
substituted; a C 1-2 perhalogenated alkyl group, a benzyl group, a phenethyl group, a
benzyloxycarbonyl group, a C 1-4 alkoxy carbonyl group, a benzene ring, a naphthalene
ring, a quinoline ring, a phthalazine ring, a 5,6,7,8-tetrahydronaphthalene ring, a
pyridine ring, an indole ring, a pyrrole ring, a thiophene ring, a benzenesulfonyl group,
a benzoyl group, a pyridazine ring, a furan ring or an imidazole ring; the benzyl group,
the phenethyl group, the benzyloxycarbonyl group, the benzenesulfonyl group, the
benzoyl group and the rings being optionally substituted; R3 represents a 2, 4 or 5pyrimidine ring or a 2, 3 or 4-pyridine ring, the rings being optionally substituted; R4
represents a C 1-4 alkyl group and n represents 1 or 2. The invention relates also to a
medicament comprising the said derivative or a salt thereof as an active ingredient
which is used for preventive and/or therapeutic treatment of a neurodegenerative
disease caused by abnormal activity of GSK3&bgr;, such as Alzheimer disease.
__________________
]00[]00[
170581
]34[
CUSTOMIZED EXECUTION
ENVIRONMENT AND
OPERATING SYSTEM CAPABLE
OF SUPPORTING SAME
]00[
]30[
04.03.2004
60/451848
]30[ 04.03.2003
]33[
620401712
0302700223
020170173
0102000224
020104003
2402300224
Int. Cl.(2010.01) G06F 01//00, 09//46, 09//50
SECURE64 SOFTWARE
CORPORATION, U.S.A.
]30[
]10[
222
‫סביבת ביצוע מותאמת ומערכת הפעלה‬
‫המסוגלת לתמוך בה‬
US
US
US
US
December 30, 2010-‫כג' בטבת התשע"א‬
]71[
]14[
]31[
WO/2004/079547
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
,'‫ד"ר שלמה כהן ושות‬
154 ‫אבן גבירול‬
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
Methods and techniques for implementing a custom execution environment (CE 2) a
related loader, and an operating system for supporting CE 2s are provided. According to
one embodiment, a determination is made with respect to which system resources of a
computer system, if any, are to remain under control of a resident operating system of
the computer system and which of the system resources are to be placed under control
of on or more CE2s. The system resources are then partitioned among the resident
operating system and the one or more CE2s by associating one or more partitions of the
system resources with the one or more CE2s. According to one embodiment, a CE2
includes code and data sections of an application and code and data sections of a set of
system services. The set of system services has direct and full control of a set of
hardware resources of a computer system containing one or more processors
implementing a parallel protected architecture.
__________________
]00[]00[
170642
‫מערכת ושיטה לאספקת מסך הדודי בהתקן‬
‫אלחוטי בהידוד עם שרת‬
]34[
SYSTEM AND METHOD FOR
PROVIDING AN INTERACTIVE
SCREEN ON A WIRELESS
DEVICE INTERACTING WITH A
SERVER
]00[
]30[
]30[
31.01.2003
10/061635
]30[ 31.01.2002
]33[ US
Int. Cl.(2010.01) G06F 13//00, H04B 07//26, H04L 29//08, H04M 01//725, H04W
08//24, 76//02
DIVISION FROM 163186
QUALCOMM INCORPORATED,
]60[
]10[
223
December 30, 2010-‫כג' בטבת התשע"א‬
]71[
]14[
]31[
U.S.A.
WO/2003/065743
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A system and method for displaying an interactive screen, such as an end-user license
agreement or verification form, on the graphic display (13) of a wireless device (12)
when the wireless device connects to a network server (26) on a wireless network (14)
and attempts to access or download software applications and data. The user of the
wireless device (12) must then affirmatively interact with the interactive screen in
order to access or download a software application or data from the network server.
The interactive screen can be transmitted from the network server (26) where the
wireless device seeks to access or download an application or data, or can be
transmitted from a separate server to the wireless device (12). The records of the
wireless device-server interactions can be stored on a network server or other data
stores on the wireless network.
__________________
]00[]00[
]34[
]00[
224
SYSTEM AND METHOD FOR
LOCATING A TARGET AND
GUIDING A VEHICLE TOWARD
THE TARGET
170679
‫מערכת ושיטה למקם מטרה להדריך כלי רכב‬
‫בכיוונו של המטרה‬
07.04.2004
December 30, 2010-‫כג' בטבת התשע"א‬
]30[
]30[
]10[
]71[
]14[
]31[
10/448869
]30[ 30.05.2003
Int. Cl.(2010.01) G01S 11//08, 13//87
RAYTHEON COMPANY, U.S.A.
WO/2005/050248
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A vehicle guidance system (10). The system (10) includes a first mechanism (34, 38,
40) for tracking a vehicle (20) based on time-of-arrival information associated with
energy (54) emanating from the vehicle (20) and providing vehicle position
information in response thereto. A second mechanism (40, 46) steers the vehicle (20)
based on the vehicle position information. In a specific embodiment, the system (10)
of further includes a third mechanism (24, 28, 36, 38) for locating the target (22) based
on time-of-arrival information associated with energy (52) radiating from the target
(22) and providing target location information in response thereto. The second the
second mechanism steers the vehicle (20) based on the target location information and
the vehicle position information.
__________________
]00[]00[
171093
‫ – אמינופיקולינאטים‬4 – ‫ – אלקיל או אלקניל‬3
‫לשימושם כקוטלי צמחים‬
]34[
6-ALKYL OR ALKENYL-4AMINOPICOLINATES FOR USE
AS HERBICIDES
]00[
]30[
]30[
]10[
]10[
02.04.2004
60/459892
]30[ 02.04.2003
]33[ US
Int. Cl.(2010.01) A01N 43//40, C07D 21/3/79, C07F 07//10, 09//547
DOW AGROSCIENCES LLC, U.S.A.
TERRY WILLIAM BALKO, ANN
MARIE BUYSSE, STEPHEN CRAIG
FIELDS, NICHOLAS MARTIN
225
December 30, 2010-‫כג' בטבת התשע"א‬
]71[
]14[
]31[
IRVINE, WILLIAM CHI-LEUG LO,
CHRISTIAN THOMAS LOWE, JOHN
SANDERS RICHBURG III, PAUL
RICHARD SCHMITZER
WO/2004/089906
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
4-Aminopicolinic acids of Formula (I): X represents H or F; Y represents C 1-C4 alkoxy
substituted C1-C4 alkyl, C1-C4 thioalkoxy substituted C1-C4 alkyl, or C2-C3 alkenyl;
and W represents -NO2, -N3, -NR1R2, -N=CR3R4 or -NHN=CR3R4 and their amine and
acid derivatiey are potent herbicides demonstrating a broad spectrum of weed control.
__________________
]00[]00[
]34[
PREPARATION OF FLUID
DOUGH
]00[
]30[
]30[
]10[
]71[
]14[
27.05.2004
03012746.8
]30[ 04.06.2003
Int. Cl.(2010.01) A21D 06//00
NESTEC S.A., SWITZERLAND
WO/2004/107866
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]31[
226
171302
‫הכנה של בצק נוזלי‬
]33[
EP
,‫ד"ר יצחק הס ושותפיו‬
516 ‫רחוב הירקון‬
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
Liquid dough whose Aw is less than 0.9 and which comprises 10 to 40% flour, from
20 to 30% fat, from 10 to 30% water, up to 2% salt and a mixture of at least one
carbohydrate with low or zero sweetening power in a sufficient quantity to reduce the
Aw of said dough to a desired value of less than 0.9. The dough substantially contains
no carbohydrate having a substantially perceptible sweetening power and as a result
does not have a sweet taste. This dough allows the production of savory bakery
products such as fruit cakes with olives, lardoons or cheese for example. The dough
can be preserved for several weeks in the refrigerated state and exists in liquid or fluid
form which makes it possible to pour it directly into baking molds. Process for the
manufacture of such a dough.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
171355
‫תרכובות ליפידיות קטיוניות המכוונות לתאים‬
‫אנגיוגנים אנדותליאליים‬
]34[
CATIONIC LIPID
COMPOSITIONS TARGETING
ANGIOGENIC ENDOTHELIAL
CELLS
]00[
]30[
]30[
]60[
]10[
12.03.1998
08/820337
]30[ 12.03.1997
]33[ US
Int. Cl.(2010.01) A61K 09//127, 47//48, 49//00, C12N 15//88
DIVISION FROM 131697
THE REGENTS OF THE
UNIVERSITY OF CALIFORNIA,
U.S.A.
WO/1998/040052
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]71[
]14[
]31[
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Angiogenic endothelial cells are selectively targeted with lipid/DNA complexes or
cationic liposomes containing a substance which affects the targeted cells by inhibiting
or promoting their growth. A site of angiogenesis can be precisely located by
administering cationic liposomes containing a detectable label. The complexes may
comprise nucleotide constructs which are comprised of promoters which are
selectively and exclusively activated in the environment of an angiogenic endothelial
cell.
__________________
]00[]00[
]34[
METHOD FOR THE
PRODUCTION OF FATTY ACIDS
HAVING A LOW TRANS-FATTY
ACID CONTENT
]00[
]30[
]30[
10.06.2004
60/477043
]30[ 10.06.2003
Int. Cl.(2010.01) C11C 01//04
227
171704
‫שיטה להכנת חומצות שומן בעלות תכולה נמוכה‬
‫של חומצות שומן טרנס‬
]33[
US
December 30, 2010-‫כג' בטבת התשע"א‬
]10[
]71[
]14[
]31[
KAO CORPORATION, JAPAN
WO/2004/111164
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
This invention relates to a method of hydrolyzing glycerol fatty acid ester-containing
composition, such as a fat and/or an oil, to produce fatty acids having a low proportion
of trans-isomer fatty acids. Specifically, the present invention relates to a process for
the hydrolyzing the glycerol fatty acid ester-containing compositions under conditions
resulting in a low proportion of trans-isomer fatty acids.
__________________
]00[]00[
171769
‫ ושימושן‬,‫ תהליך להכנתן‬,‫נגזרות של בנזותיאזול‬
‫בהכנת תרופות לטיפול במחלות הקשורות‬
‫ של אדנוזין ותרופות המכילות‬A2A ‫לקולטן‬
‫הנגזרות האמורות‬
]34[
BENZOTHIAZOLE DERIVATIVES,
PROCESS FOR THEIR
PREPARATION, USE THEREOF IN
THE MANUFACTURE OF
MEDICAMENTS FOR THE
TREATMENT OF DISEASES
RELATED TO THE ADENOSINE
A2A RECEPTOR AND
MEDICAMENTS COMPRISING
SAID DERIVATIVES
]00[
]30[
]30[
21.05.2004
03012118.0
]30[ 30.05.2003
]33[ EP
Int. Cl.(2010.01) A61K 31//428, A61P 09//10, 11//06, 21//02, 25//00, 43//00, C07D
41/7/04
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2004/105755
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
]10[
]71[
]14[
]31[
228
Compounds of the general formula (I) and pharmaceutically acceptable acid addition
salts thereof for the treatment of diseases, related to the A2A receptor.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
OPTICAL METHOD AND SYSTEM
FOR ENHANCING IMAGE
RESOLUTION
]00[
]30[
]30[
]10[
]71[
]14[
13.05.2004
60/469816
]30[ 13.05.2003
Int. Cl.(2010.01) H04N 05//335
XCEED IMAGING LTD
WO/2004/102958
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]31[
229
171853
‫מערכת ושיטה אופטית להגברת רזולוציה של‬
‫דמות‬
]33[
US
‫ ראש העין‬,‫אקסיד אימג'ינג בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A method and system are presented for imaging an object with image resolution for at
least a part of the object exceeding by a predetermined factor a geometrical resolution
defined by a detector pixel array. A predetermined aperture coding is applied to the
wavefront of a light signal indicative of at least a part of the object to be imaged with
the enhanced resolution, while propagating towards the detector pixel array. The
aperture coding is predetermined in accordance with aliasing occurring in the detector
plane and such as to provide orthogonality of spectral data indicative of a sampled
output of the detector, to thereby enable using the aperture code to reconstruct the
image of said at least part of the object with the resolution enhanced by said factor.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
171926
]34[
GLP-1 ANALOG FUSION
PROTEINS
]00[
]30[
]30[
]10[
]71[
]14[
10.06.2004
60/477880
]30[ 12.06.2003
]33[ US
Int. Cl.(2010.01) A61K 38//26, A61P 03//10, C07K 14//435, 14//605, 19//00
ELI LILLY AND COMPANY, U.S.A.
WO/2005/000892
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
]31[
GLP–1 ‫חלבוני התכה של אנלוג‬
The invention provides specific GLP-1 analogs fused to specific IgG4-Fc derivatives.
These fusion proteins have an increased half-life, decreased immunogenicity, and
reduce effector activity. The fusion proteins are useful in treating diabetes, obesity,
irritable bowel syndrome and other conditions that would be benefited by lowering
plasma glucose, inhibiting gastric and/or intestinal motility and inhibiting gastric
and/or intestinal emptying, or inhibiting food intake.
__________________
]00[]00[
171930
‫ תרופה‬,‫ תהליך להכנתן‬,‫תולדות של אימידזול‬
‫המכילה אותן ושימושן לייצורתרופה לטיפול‬
‫ולמניעה של הפרעות הקשורות הקשורות‬
mGlu5 ‫לקולטן‬
]34[
IMIDAZOLE DERIVATIVES,
PROCESS FOR THEIR
PREPARATION , MEDICAMENTS
CONTAINING THEM AND USE
THEREOF FOR THE
MANUFACTURE OF
MEDICAMENTS FOR THE
TREATMENT AND PREVENTION
OF MGLU5 RECEPTOR
MEDIATED DISORDERS
]00[
]30[
]30[
01.06.2004
03012200.6
]30[ 05.06.2003
]33[ EP
Int. Cl.(2010.01) A61K 31//4439, A61P 13//00, 25//00, 43//00, C07D 40/1/06,
40/1/14, 41/3/14, 41/7/14
December 30, 2010-‫כג' בטבת התשע"א‬
230
]10[
]71[
]14[
]31[
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2004/108701
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
The present invention relates to imidazole derivatives which are mGluR5 receptor
antagonists and which are represented by the general formula (I): wherein R1, R 2 , R3
and R4 are as defined in the specification, to a process for the manufacture thereof, as
well as to pharmaceutically acceptable salts thereof for the manufacture of a
medicament for the treatment or prevention of mGluR5 receptor mediated disorders,
such as acute and/or chronic neurological disorders.
__________________
]00[]00[
171987
‫השימוש בנגזרות חומצה פומרית להכנת תרופה‬
‫ אוטם‬,‫לטיפול באי–ספיקת הלב או מניעתו‬
‫שריר הלב ותעוקת הלב‬
]34[
USE OF FUMARIC ACID
DERIVATIVES FOR PREPARING
A DRUG FOR TREATING OR
PREVENTION OF CARDIAC
INSUFFICIENCY, MYOCARDIAL
INFARCT AND ANGINA
PECTORIS
]00[
]30[
03.09.2004
10341530.0
]30[ 09.09.2003
]33[ DE
0236276000
0300000223
DE
Int. Cl.(2010.01) A61K 31//231, 38//00, A61P 09//00, 11//06, C07C 69//60
FUMAPHARM AG, SWITZERLAND
WO/2005/023241
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
]30[
]10[
]71[
]14[
231
December 30, 2010-‫כג' בטבת התשע"א‬
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
P.O.B. 1426,
TEL AVIV 61013
]31[
According to a first aspect the invention relates to the use of fumaric acid derivatives
selected from the group consisting of dialkyl fumarates, monoalkyl hydrogen
fumarates, fumaric acid monoalkyl ester salts, fumaric acid monoamides, monoamido
fumaric acid salts, fumaric acid diamides, monoalkyl monoamido fumarates,
carbocyclic and oxacarbocyclic oligomers of these compounds and mixtures thereof
for preparing a drug for the treatment or prevention of cardiac insufficiency, in
particular left ventricular insufficiency, myocardial infarction and angina pectoris.
According to a second aspect the invention relates to the use of fumaric acid
derivatives, selected from the group consisting of dialkyl fumarates, monoalkyl
hydrogen fumarates, fumaric acid monoaklyl ester salts, fumaric acid monoamido
fumaric acid salts, fumaric acid diamides, monoalkyl monoamido fumarates,
carbocyclic and oxacarbocyclic oligomers of these compounds and mixtures thereof
for preparing a drug for the treatment of asthma and chronic obstructive pulmonary
diseases, especially asthma caused by allergies, infections, analgesics, job conditions
or physical effort, mixed forms of asthma, or asthma cardiale.
__________________
]00[]00[
172119
‫שיטה לזיהוי הפעילות של גמא–סקרטאז ע"י‬
‫שימוש בחלבון איחוי‬
]34[
METHOD FOR THE DETECTION
OF THE ACTIVITY OF GAMMASECRETASE USING A FUSION
PROTEIN
]00[
]30[
]30[
]10[
29.04.2004
03011807.9
]30[ 26.05.2003
]33[ EP
Int. Cl.(2010.01) C12N 09//64, 15//57, 15//62, 15//79, G01N 33//50
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2004/104037
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
]71[
]14[
]31[
232
The invention relates to an improved process for the determination of the gammasecretase activity, individual components of the process and the use of the process. The
present invention relates to an improved process for the determination of the gammasecretase activity and for the detection of gamma-secretase, a subunit protein of
gamma-secretase, or a gamma -secretase-like proteinase; particular embodiments of
the process relate on the one hand to processes for the identification of a gammaDecember 30, 2010-‫כג' בטבת התשע"א‬
secretase or of a cDNA which codes for a gamma-secretase, a subunit protein of
gamma-secretase, or a gamma-secretase-like proteinase, and on the other hand to
processes for the identification of substances which can inhibit the activity of a
gamma-secretase, a subunit protein of gamma-secretase, or a gamma-secretase-like
proteinase. Such substances have particular importance, as they can be used, e.g., as
pharmaceutical active compounds, e.g., for the treatment of Alzheimer's disease.
__________________
]00[]00[
]34[
SYSTEM AND METHOD OF
PROCESSING RADAR
INFORMATION
]00[
]30[
]10[
15.12.2005
Int. Cl.(2010.01) G01S 07//36
ISRAEL AEROSPACE
INDUSTRIES LTD.
JACOB ILAN
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]10[
]14[
]31[
233
172591
‫מערכת ושיטה לעיבוד מידע מכ"ם‬
‫ לוד‬,‫התעשייה האוירית לישראל בע"מ‬
‫יעקב אילן‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A system for training a user of a radar system (140) in connection with EW
actions, comprising:
(a) an analyzer (110);
(b) a first interface (180) operatively coupled to the analyzer and adapted to obtain
data representative of at least one radar image indicative of a target spatial
position as measured by the radar, wherein at least a portion of said image is
affected by an EW (electronic-warfare) action; and
(c) a second interface (130) operatively coupled to the analyzer and adapted to
obtain from a radar-independent source data indicative of at least the spatial
position of the target;
wherein the analyzer is adapted to provide data usable for displaying the obtained
radar image and/or derivatives thereof in a manner indicative of a discrepancy
with the spatial position obtained from said radar-independent source, thereby to
facilitate training the user at least with respect to the effect of EW action on the
radar imaging indicative of the target spatial position, said displaying comprises
superimposing an image indicative of the portion of the radar information
modified in response to an EW action onto an image corresponding to the position
of the target with respect to the radar system.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
172773
‫הרכבים לטיפול במצבי דלקת פרקים‬
]34[
FORMULATIONS FOR THE
TREATMENT OF ARTHRITIS
CONDITIONS
]00[
]30[
]30[
01.06.2004
MI2003A001311 ]30[ 27.06.2003
]33[ IT
Int. Cl.(2010.01) A61K 31//045, 31//10, 31//353, 31//7008, 36//185, 36//324, 36//76,
36//87, C07D 31/1/00
INDENA S.P.A., ITALY
WO/2005/002611
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]10[
]71[
]14[
]31[
234
The present invention relates to formulations comprising combinations of
analgesic/anti-inflammatory, immunomodulating and cartilage-reconstructing agents in
particular comprising saligenig, boswellic acid, procyanidins, N-acetyl-glucosamine
and either glucoronic acid or glucoronolactone, for the treatment of rheumatoid
arthritis and, more generally, of arthritis conditions 0
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
DISPENSING CONTAINER
]00[
]30[
]10[
24.06.2003
Int. Cl.(2010.01) G01F 11//26
SUTTER FINANZIARA S.P.A.,
ITALY
ALDO SUTTER
WO/2004/113850
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
]10[
]71[
]14[
]31[
173285
‫מיכל חלוקה‬
,‫ד"ר מרק פרידמן בע"מ‬
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
A dispensing container (1) comprising; a main bottle (2) having an outlet port (6) for
the fluid product located at the bottom (21); thereof; a metering receptacle (3), having
a side port (7; 70) for inletting the fluid product and a top opening (8) for outwardly
dispensing the fluid product; and a duct (4), having an internal lumen (12) connecting
the outlet port (6) of the main bottle (2) to the inlet port (7) of the metering receptacle
(3), wherein the main bottle (2) is of the type apt to be deformed to express the fluid
product into the metering receptacle (3) through the duct (4), and wherein the internal
lumen (12) of the duct (4) comprises, at the inlet port (7) of the metering receptacle
(3), an end portion (121, 1210) having a frustum of cone development and a cross
section increasing toward the inlet port (7).
__________________
235
December 30, 2010-‫כג' בטבת התשע"א‬
]00[]00[
173294
– 5 ' ,5 [ ( – 4 [ – 7( ‫פולימורף גבישי של‬
1 – ]‫– פיפראזיניל‬5 – )‫ – יל – מתיל‬6 – ]‫ביפניל‬
‫ תהליך‬,‫) – בנזוקסזולון מונומתאנסולפונאט‬H6(
‫להכנתו ותכשירי רוקחות המכילים אותו‬
]34[
CRYSTALLINE POLYMORPH OF
(7 - [4 - ([1,1'- BIPHENYL] - 3 YLMETHYL) - 1 - PIPERAZINYL] 2 (3H) - BENZOXAZOLONE
MONOMETHANESULFONATE,
PROCESS FOR ITS PREPARATION
AND PHARMACEUTICAL
COMPOSITIONS COMPRISING IT
]00[
]30[
18.08.2004
03102573.7
]30[ 18.08.2003
]33[ EP
620403127
0702700223
US
Int. Cl.(2010.01) A61K 31//4985, A61P 25//00, C07D 41/3/04
SOLVAY PHARMACEUTICALS
B.V., THE NETHERLANDS
WO/2005/016898
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]30[
]10[
]71[
]14[
]31[
The invention relates to a stable polymorphic form of the compound 7-[4-([1,1'biphenyl] -3-ylmethyl)-l -piperazinyl]2(3H)-benzoxazolone monomethanesulfonate
(INNM bifeprunox mesylate), a method for the preparation of said polymorphic form
and its use in pharmaceutical products, especially in pharmaceutical products for the
treatment of psychotic disorders and Parkinson's disease.
__________________
]00[]00[
173445
– 4 – )‫ – דיפלואורואלקיל‬5,5 ( – 3
‫אמינופיקולינטים לשימושם כקוטלי עשב‬
]34[
6-(1,1-DIFLUOROALKYL)-4AMINOPICOLINATES FOR USE
AS HERBICIDES
]00[
]30[
]30[
]10[
]10[
04.08.2004
60/493555
]30[ 04.08.2003
]33[ US
Int. Cl.(2010.01) A01N 43//40, C07D 21/3/79, C07F 07//10, 09//547
DOW AGROSCIENCES LLC, U.S.A.
STEPHEN CRAIG FIELDS, TERRY
WILLIAM BALKO, PAUL RICHARD
SCHMITZER, NICHOLAS MARTIN
236
December 30, 2010-‫כג' בטבת התשע"א‬
]71[
]14[
]31[
IRVINE, CHRISTIAN THOMAS
LOWE
WO/2005/016887
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
4-Aminopicolinic acids of formula (I) wherein Y represents -CF2(C1-C3 alkyl); and W
represents -NO2, -N3, -NR1R2, -N=CR3R4 or -NHN=CR3R4 having (1,1-difluoroalkyl)
substituents in the 6-position and their amine and acid derivatives are potent herbicides
demonstrating a broad spectrum of weed control.
__________________
]00[]00[
]34[
SIMPLIFIED SCRAMBLING
SCHEME FOR SATELLITE
BROADCASTING SYSTEMS
]00[
]30[
]30[
]10[
]71[
]14[
27.08.2004
60/498824
]30[ 29.08.2003
Int. Cl.(2010.01) H04L 25//03, 27//36
DTVG LICENSING, INC.
WO/2005/022758
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]31[
237
173491
‫סכימת ערבול מופשטת למערכות שידור לוויניות‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A simplified scrambling scheme that unifies all signals of a satellite broadcasting
system, including frame header (404), frame body (402) and pilot symbols (408) with
a common reference phase. This results in the simplification and increased flexibility
of the receiver front-end design without affecting the overall system performance. In
December 30, 2010-‫כג' בטבת התשע"א‬
many current communications systems with frame headers and pilot symbols, the
phases of frame headers and pilot syrnbols are not designed to be aligned with any
constellation points of the modulated data from the frame body. This scrambling
scheme takes into account possible impact due to irregular phase changes between
frame headers/pilot symbols and modulated data.
__________________
]00[]00[
173834
]34[
METHOD AND APPARATUS FOR
PROCESSING DATA BLOCKS
DURING SOFT HANDOVER
]00[
]30[
02.11.2004
60/517779
]30[ 05.11.2003
]33[
020030036
0202000224
Int. Cl.(2010.01) H04W 36//00, 36//02, 36//18
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2005/048465
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]30[
]10[
]71[
]14[
]31[
238
‫שיטה והתקן לעיבוד יחידות מידע במהלך‬
‫העברה רכה‬
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A method and apparatus for processing data blocks during soft handover. The
apparatus may be a wireless communication system including at least two enhanced
uplink soft handover (EU-SHO) Node-B’s and a radio network controller (RNC) as
shown in figure 1. Each Node-B decodes a received data block and forwards the
decoded data block to the RNC. If the RNC receives at least one copy of a successfully
decoded data block, the RNC uses a re-ordering function entity to process the copy of
the successfully decoded data block to support in-sequence delivery to higher protocol
layers. If the RNC receives more than one copy of a successfully decoded data block,
the RNC discards the extra successfully decoded data block copies. The RNC is either
a serving-RNC (S-RNC) or a controlling-RNC (C-RNC). Each Node-B includes a
medium access control (MAC) entity that handles enhanced uplink dedicated channel
December 30, 2010-‫כג' בטבת התשע"א‬
(EU-DCH) functionalities.
__________________
]00[]00[
]34[
IRRIGATION DRIPPER WITH
PIPE
]00[
]30[
]30[
]10[
]10[
22.02.2006
11/062739
]30[ 23.02.2005
Int. Cl.(2010.01) B05B 01//20
NETAFIM LTD.
JAMES WALLACE BELFORD,
JAKOB- DAN RETTER, RON KEREN
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]31[
239
173874
‫טפטפת וצינור השקיה‬
]33[
US
‫ אביב‬-‫ תל‬,‫נטפים בע"מ‬
‫ רון קרן‬,‫ דן רטר‬-‫ יעקב‬,‫ג'ימס וולס בלפורד‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A dripper (10) adapted to be bonded to an interior of an irrigation pipe (25) during
manufacture and to be associated with an outlet opening (38) in said pipe, the dripper
comprising:
an outwardly facing surface (14) adapted for the bonding, an outlet area (22)
associated with said outwardly facing surface, and at least one element movable from a
first position in which the at least one element does not project above the outwardly
facing surface to a second position in which the at least one element projects above the
outwardly facing surface, said element constituting a bulge (20), when in said second
position, near said outlet area, said bulge defining an outermost portion of said
outwardly facing surface at least during manufacture of the pipe, and being adapted to
form, when the dripper is bonded to said pipe, a raised outlet region (35) in pipe
associated with said bulge, the bulge and said outlet area being designed so as to form
said raised outlet region suitable for at least a part of said outlet opening being formed
in said raised outlet region and being defined by the material of the pipe.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
METHOD FOR ACCEPTING
DEVICES AND ARRANGEMENT
AND EQUIPMENT USED
THEREFOR
]00[
]30[
]30[
]10[
02.09.2004
03405636.6
]30[ 02.09.2003
Int. Cl.(2010.01) G06Q 10//00
GFK TELECONTROL AG,
SWITZERLAND
WO/2005/022421
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]71[
]14[
]31[
240
173928
‫שיטה לקבלת התקנים וסידור וציוד לשימושה‬
]33[
EP
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
Disclosed is an arrangement for determining a chronological acceptance of spacedapart devices (1a-c), comprising at least one transmitter unit (3a-c) which is disposed
on each device (1a-c) and from which a signal (5a-c) that identifies said device (1a-c)
and has a predefined range (17a-c) can be transmitted. Several personal apparatuses
(7a-d) are provided that are to be carried by one respective person (6a-c) and are fitted
with a receiver (4a-d) for the signals and a device memory for storing data contents of
the emitted signals (5a-c) during a given interval. The range of each transmitter unit
(3a-c) defines a respective transmission range (9a-c). The transmission range (9a-c)
and a receive sensitivity of the receiver (4a-d) are adjusted to each other in such a way
that no data can be received if the device (1a-c) is located outside a typical zone of
attention or perception of humans relative to the personal apparatus (7a-d) carried by
the person (6a-c).
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
174035
‫התקן לניקוי ארובת גז המכיל התקן מחמצן‬
‫משופר בצינור ניקוז הנוזלים המקרצף‬
]34[
FLUE GAS PURIFICATION
DEVICE HAVING AN IMPROVED
OXIDATION DEVICE IN THE
SCRUBBING LIQUID SUMP
]00[
]30[
]30[
]10[
]14[
01.03.2006
05005920.3
]30[ 18.03.2005
]33[
Int. Cl.(2010.01) B01D 53//50, B01F 13//02
LENTJES GMBH, GERMANY
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]31[
EP
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A flue gas purification device comprising a receptacle, which has a scrubbing liquid
sump comprising an oxidation device for introducing oxygen, wherein the introduction
of oxygen is realized by at least one plate aerator.
__________________
]00[]00[
]34[
ULTRASONIC FOG
GENERATOR
]00[
]30[
]10[
05.03.2006
Int. Cl.(2010.01) B05B 17//06
ZVI LEVI
241
174109
‫מחולל ערפל אולטראסוני‬
‫ רחובות‬,‫צבי לוי‬
December 30, 2010-‫כג' בטבת התשע"א‬
,‫דקל פטנט בע"מ‬
51 ‫חדר‬, 11 ‫מנוחה ונחלה‬
‫רחובות‬
]14[
DEKEL PATENT LTD.,
18 MENUHA VENAHALA ST.,
REHOVOT 76209
]31[
An ultrasonic fog generator comprising:
a container inside an enclosure, the container comprising therein an ultrasonic
nebulizer and a liquid, said ultrasonic nebulizer operative to vibrate at very high
frequencies and thereby break down the liquid into a fog comprising tiny vapor
particles, said container having an exit opening for said fog to pass therethrough; and
a driver inside said enclosure and outside said container, and a driving fluid, said
driver being operative to cause said driving fluid to flow past the exit opening and
draw out said fog through the exit opening without said driving fluid substantially
entering said container, wherein said driver uses positive pressure to drive the driving
fluid past the exit opening and drive the fog out of the container.
__________________
]00[]00[
]34[
ADHESIVE BINDING METHOD
AND DEVICE FOR CARRYING
OUT THIS METHOD
]00[
]30[
]30[
]10[
]71[
]14[
09.09.2004
10341493.2
]30[ 09.09.2003
Int. Cl.(2010.01) B42C 09//00, 19//00
PETER SCHMIDKONZ, GERMANY
WO/2005/023555
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]31[
242
174157
‫שיטת כריכה בהדבקה והתקן לביצוע שיטה זו‬
]33[
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
In order to produce an adhesive binding for bookbinding, in which the sheets, in quarto
format, are perforated on the folding edge, folded, provided with adhesive on the
folding edge and assembled to form an inner book, the perforating process is carried
out on the folding edge in such a manner that two interrupted perforation lines (12, 13)
are punched, these perforation lines being parallel at a short distance from one another,
offset in a longitudinal direction, and forming a widened folding edge (14). The punch
locations of both perforation lines (12, 13) are, along the folding edge (14), offset by
the length of one perforating tooth. The quarto format sheets, which are folded on the
folding edge (14) and which are assembled and squeezed to form an inner book, are
provided with the application of adhesive on surfaces, which are formed by the double
perforating and which are assigned to one another, between full locations of one
perforation line (12) and full locations of the other perforation line (13).
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
174286
‫ פענוח רב–ערוצי מתאים‬/‫הצפנה‬
]34[
COMPATIBLE MULTI-CHANNEL
CODING/DECODING
]00[
]30[
]30[
]10[
30.09.2004
10/679085
]30[ 02.10.2003
]33[ US
Int. Cl.(2010.01) G10L 19//00, H04S 03//00, 03//02
FRAUNHOFER-GESELLSCHAFT
ZUR FORDERUNG DER
ANGEWANDTEN FORSCHUNG
E.V., GERMANY
WO/2005/036925
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
]71[
]14[
]31[
243
,'‫זליגסון גבריאלי ושות‬
21 ‫רח' יבנה‬
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
In processing a multi-channel audio signal having at least three original channels, a
first downmix channel and a second downmix channel are provided (12), which are
derived from the original channels. For a selected original channel of the original
channels, channel side information are calculated (14) such that a downmix channel or
a combined downmix channel including the first and the second downmix channels,
when weighted using the channel side information, results in an approximation of the
selected original channel. The channel side information and the first and second
downmix channels form output data (20) to be transmitted to a decoder, which, in case
of a low level decoder only decodes the first and second downmix channels or, in case
of a high level decoder provides a full multi-channel audio signal based on the
downmix channels and the channel side information. Since the channel side
information only occupy a low number of bits, and since the decoder does not use
dematrixing, an efficient and high quality multi-channel extension for stereo players
and enhanced multi-channel players is obtained.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
APERTURED SLEEVES FORMED
WITH NON-PERFORATING
PATTERNS, A MACHINE AND A
PROCESS FOR MAKING SUCH
APERTURED SLEEVES
]00[
]30[
]30[
]10[
]10[
]71[
]14[
14.09.2004
0310974
]30[ 18.09.2003
Int. Cl.(2010.01) D06C 23//00
RIETER PERFOJET, FRANCE
FREDERIC NOELLE
WO/2005/028728
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
]31[
244
174348
‫שרוולים מחוררים המיוצרים בדפוסים לא‬
‫ מכונה ותהליך לייצור שרוולים‬,‫מנוקבים‬
‫מחוררים שכאלו‬
]33[
FR
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
‫רמת גן‬
The invention relates to a machine for forming a pattern on a non-woven cloth
comprising a rotatable drum (29) encompassed by an apron (30) which is coated with a
nickel or copper layer.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
174410
‫הכנה בקנה מידה גדול של מעכב פרוטאינז‬
‫ ושימוש בו‬5–‫אלפא‬
]34[
LARGE SCALE PREPARATION
OF ALPHA-1 PROTEINASE
INHIBITOR AND USE THEREOF
]00[
]30[
22.09.2004
158053
]30[ 22.09.2003
]33[ IL
620323020
0002000223
US
Int. Cl.(2010.01) A61K 38//17, A61P 11//00, 17//06, C07K 01//18, 14//81, C12P
21//02
KAMADA LTD.
‫ רחובות‬,‫קמהדע בע"מ פארק המדע‬
SHABTAI BAUER
‫שבתאי באור‬
WO/2005/027821
WEBB & CO.,
,'‫ד"ר וב ושות‬
2 PEKERIS ST., P.O.B. 2189,
5 ‫רח' פקריס‬
REHOVOT 76121
‫רחובות‬5116 .‫ד‬.‫ ת‬,
]30[
]10[
]10[
]71[
]14[
]31[
The present invention provides a process suitable for processing scaled-up amounts of
source material in the range of tens of kilograms for the purification of alpha-1
proteinase inhibitor (API) from a mixture of unpurified proteins. More particularly, the
present invention relates to a process for the purification of API from blood plasma or
from plasma fractions to obtain pharmaceutical grade API on a commercial scale. The
API produced by the process of the present invention is highly pure (at least 90% API
out of the total protein) and highly active (at least 90% active API). The present
invention also relates to pharmaceutical compositions comprising the purified API and
methods of using same.
__________________
]00[]00[
]34[
AIR CONDITIONING SYSTEM
WITH ABSORPTION
COMPRESSOR
]00[
]30[
26.03.2006
Int. Cl.(2010.01) F25B 17//00, 27//02
245
174548
‫מערכת מיזוג אוויר עם מדחס ספיגה‬
December 30, 2010-‫כג' בטבת התשע"א‬
]10[
]14[
]31[
VLADIMIR POGADAEV
‫ ירושלים‬,‫ולדימיר פוגדייב‬
VLADIMIR POGADAEV,
,‫ולדימיר פוגדייב‬
206/14 ABA AHIMEIR ST.
501/14 ‫אבא אחימאיר‬
NEVE YAAKOV
‫ירושלים‬
JERUSALEM 97350
Air conditioning system with an absorption compressor designed for cooling car
cabin. The system i utilizes heat energy from a vehicle exhaust gas. The absorption
compressor is an oil-Freon absorption device and it works in parallel with the
conventional mechanical compressor.
__________________
]00[]00[
174680
‫שיטה להשגת אטימת וואקום למשטח קרמי‬
‫שטוח‬
]34[
METHOD OF ACHIEVING A
VACUUM SEAL OF A CLOSURE
MEMBER TO A PLANAR
CERAMIC SURFACE
]00[
]30[
]30[
]60[
]10[
]71[
]14[
15.08.2001
652516
]30[ 31.08.2000
Int. Cl.(2010.01) H01J 01//62
DIVISION FROM 154517
INTEVAC, INC., U.S.A.
WO/2002/019365
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]31[
A method of achieving a vacuum seal of a closure member to a planar ceramic surface
bounded by an outward peripheral lateral ceramic lip and an inwardly disposed
aperture, comprising:
246
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
December 30, 2010-‫כג' בטבת התשע"א‬
laminating a structure comprising a base ceramic layer and a plurality of planar
ceramic layers, the plurality of planar layers comprising at least three planar layers, the
at least three planar layers each comprising an aperture having a respective area, the at
least three planar layers positioned serially to define a cavity in the laminated
structure, the at least three aperture areas varying non-monotonically in the series to
form an electrical isolator, one of the plurality of planar layers being the planar
ceramic surface bounded by the outward peripheral lateral ceramic lip and the
inwardly disposed aperture;
positioning and bonding a microelectronic device on a surface of the base layer;
positioning and bonding a photocathode on a surface of the closure member;
metallizing said planar ceramic surface with a metallization for which a selected low
melting point metal exhibits a relatively high wettability,
applying a preformed gasket of said low melting point metal to said metallized planar
surface surrounding said aperture where a seal is desired and wetting said surface with
said metal in the fluid state thereof;
urging said closure member against said metal with sufficient force in a range to cause
cold flow of said metal outwardly around said outer lip and to limit said cold flow
inwardly to said aperture, whereby a parallel relation of said planar surface with said
closure member is facilitated; and
relaxing said force.
__________________
]00[]00[
174879
‫רשת מקומית המשלבת העברת אינפורמציה‬
‫ואנרגיה על אותו כבל תקשורת‬
]34[
LAN (LOCAL AREA NETWORK)
WITH INTEGRATED ENERGY
AND INFORMATION
TRANSMISSION OVER THE
SAME LINE
]00[
]30[
]30[
14.10.2004
60/512362
]30[ 16.10.2003
]33[ US
Int. Cl.(2010.01) G06F 01//26, H04L 12//10, 29//06
247
December 30, 2010-‫כג' בטבת התשע"א‬
]10[
MICROSEMI CORP - ANALOG
MIXED SIGNAL GROUP LTD
]10[
YAIR DARSHAN, ALON FERENTZ,
DAN ADMON, YOSSI SHANAVA,
RONI BLAUT, POLDI RIMBOIM
WO/2005/036374
MICROSEMI CORP - ANALOG
MIXED SIGNAL GROUP LTD,
HANAGAR 1
P.O.BOX 7220
HOD HASHARON 45421
]71[
]14[
]31[
‫ אנאלוג מיקסד סינגל‬- ‫מיקרוסמי קורפ‬
‫ הוד השרון‬,‫גרופ בע"מ‬
,‫ יוסי שנבה‬,‫ דן אדמון‬,‫ אלון פרנץ‬,‫יאיר דרשן‬
‫ פולדי רימבוים‬,‫רוני בלאוט‬
‫ אנאלוג מיקסד סינגל‬- ‫מיקרוסמי קורפ‬
,‫גרופ בע"מ‬
1550 .‫ד‬.‫ ת‬1 ‫הנגר‬
‫הוד השרון‬
A method for communicating multi-bit data from a powered device being powered
over communication cabling to power sourcing equipment, the method comprising:
exhibiting a signature indicative of a device to be powered over communication
cabling; sensing a voltage level indicative of remote powering over communication
cabling; prior to connecting power to operational circuitry, transmitting first multi-bit
information; subsequently to the transmitting first multi-bit information, connecting
power received over the communication cabling to the operational circuitry; receiving
information from the operational circuitry; subsequent to receiving the information
disconnecting the received power from the operational circuitry; subsequent to the
disconnecting, transmitting second multi-bit information associated with the
operational circuitry, the second multi-bit information comprising at least one bit being
a function of the received information; and re-connecting power received over the
communication cabling to the operational circuitry.
__________________
]00[]00[
]34[
WEAR RESISTANT POLYMERS
]00[
]30[
]10[
10.10.2003
Int. Cl.(2010.01) C08K 03//20
COMMONWEALTH SCIENTIFIC
AND INDUSTRIAL RESEARCH
ORGANISATION, AUSTRALIA
WO/2005/035642
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
]71[
]14[
248
174899
‫פולימרים עמידים בפני שחיקה‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
December 30, 2010-‫כג' בטבת התשע"א‬
RAMAT HACHAYAL 69710
]31[
A method of improving the wear resistance of a polymer is disclosed comprising the
steps of evenly dispersing an ultrafine inorganic particulate material in the polymer at
a loading rate of 0.01 to 20wt% of the total weight of the particulate polymer
composite. The mixing or dispersing is preferably carried out under sub-atmospheric
pressure conditions to ensure little or no bubbles form in the mixture prior to curing.
__________________
]00[]00[
]34[
FILTER JUG WITH REPLACEABLE
CARTRIDGE AND METHOD OF
MONITORING AND CONTROLLING
THE EFFICIENCY OF A FILTER
CARTRIDGE IN A REPLACEABLE
CARTRIDGE FILTER DEVICE
]00[
]30[
]30[
]10[
]71[
]14[
16.09.2004
PD2003A000262 ]30[ 28.10.2003
Int. Cl.(2010.01) C02F 01//00
LAICA S.P.A., ITALY
WO/2005/047189
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]31[
249
175066
‫קנקן פילטר עם מחסנית הניתנת להחלפה‬
‫ושיטה לבקרה ופיקוח על יעילותה של‬
‫מחסנית פילטר במכשיר המכיל מחסנית‬
‫פילטר הניתנת להחלפה‬
]33[
IT
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
Replaceable cartridge filtering jug comprising means for counting and displaying the
filtering cycles performed by the cartridge to indicate that the cartridge is exhausted at
the end of a period corresponding to its efficient useful life, in which auxiliary
counting and display means capable of counting the filtering cycles performed in a
subsidiary period of the period to indicate an item of data representing the temporary
December 30, 2010-‫כג' בטבת התשע"א‬
efficiency of the cartridge in the subsidiary period are provided.
__________________
]00[]00[
175171
‫תהליך ומכשיר לקירור ולפירוק לחלקיקים של‬
‫חומרים נוזליים או דמוי בצקיים‬
]34[
PROCESS AND APPARATUS FOR
COOLING AND ATOMIZING
LIQUID OR PASTY-LIKE
SUBSTANCES
]00[
]30[
]30[
]10[
27.10.2004
03104024.9
]30[ 30.10.2003
]33[
Int. Cl.(2010.01) B01J 02//04, F25C 01//00
MESSER ITALIA S.P.A, ITALY
MERCK SERONO S.A.,
SWITZERLAND
MARIO MAIO, DANIELA CHICCO,
LUCA DONATI, PIERANDREA
ESPOSITO, LEONARDO GALLI,
MAURO MENEGOLI
WO/2005/049192
INTERLAB LTD.,
18 HAKISHON ST.
YAVNE 81220
]10[
]71[
]14[
]31[
250
EP
,‫אינטר לאב בע"מ‬
11 ‫הקישון‬
‫יבנה‬
A process and an apparatus for the rapid cooling and atomization of liquid or pasty
substances, in particular even relatively small amounts of liquid or pasty substances
being able to be cooled and atomized economically. Both process and apparatus are
particularly useful in the pharmaceutical industry for preparing injectable
microparticles of polymer or lipid matrices suitable for the incorporation of active
ingredients.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
VEHICLE-BORNE SYSTEM AND
METHOD FOR COUNTERING AN
INCOMING THREAT
]00[
]30[
]30[
]10[
]10[
]71[
]14[
28.10.2004
10/698500
]30[ 31.10.2003
Int. Cl.(2010.01) F41G 07//22
RAYTHEON COMPANY, U.S.A.
RICHARD M. LLOYD
WO/2005/111531
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]31[
251
175201
‫מערכת ושיטה נגד איום המתקרב הנשאות על‬
‫כלי–רכב‬
]33[
US
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
A vehicle-borne system for countering an incoming threat, the system including a
sensing device configured to sense an incoming threat, and an active protection system
including a maneuverable interceptor incorporating a plurality of kinetic energy rods
and an aimable explosive charge configured to deploy the kinetic energy rods in a
predetermined direction; the active protection system further including a detection
subsystem configured to maneuver the interceptor to intercept the incoming threat, the
detection subsystem further configured to determine if the interceptor will miss the
threat, and then initiate the explosive charge to aim the kinetic energy rods into a
disbursed cloud in the trajectory path of the incoming threat and between the incoming
threat and the vehicle.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
175564
]34[
AIR TRANSPORTABLE ISO
CONTAINER
]00[
]30[
]30[
]10[
]71[
]14[
10.11.2004
60/519977
]30[ 14.11.2003
]33[
Int. Cl.(2010.01) B65D 88//12, 88//14, 90//12
AAR CORP., U.S.A.
WO/2005/049431
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]31[
‫ להובלה אווירית‬ISO ‫מיכל‬
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
A transport device includes a base, a plurality of movable ISO corner blocks movably
coupled to the base, and a plurality of adjustment mechanisms. Each adjustment
mechanism is adapted to couple a respective corner block to the base and to selectively
move the corner block with respect to the base between an air transport position,
wherein the bottom surface of the corner block does not extend beyond the bottom
surface of the base, and a surface transport position wherein the bottom surface of the
corner block is located below the bottom surface of the base.
__________________
]00[]00[
]34[
252
METHOD FOR TREATING
FLUIDS BY COAGULATION ON
MEMBRANES
175707
‫שיטה לטיפול בנוזלים באמצעות קואגלציה על‬
‫ממברנות‬
December 30, 2010-‫כג' בטבת התשע"א‬
]00[
]30[
]30[
]10[
]71[
]14[
]31[
24.11.2004
0314917
]30[ 18.12.2003
Int. Cl.(2010.01) C02F 01//52
DEGREMONT, FRANCE
WO/2005/068376
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a method for treating fluids, in particular waste waters
involving coagulation/flocculation, clarification by filtration or flotation stages and a
stage of filtration through micro-, ultra, and nanomembranes or of hyperfiltration. The
inventive method consists in injecting two times several coagulating reagents in a
quantity ranging from 75 to 125 % of an optimal coagulation dose or a dose cancelling
a Zeta potential (pz) in an area (area n°1) situated upstream of the clarification stage
(2) and from 0.1 to 25 % of an optimal dose cancelling the pz in a second area (area
n°2) situated upstream of the stage of membrane filtration (4).
__________________
]00[]00[
175713
]34[
METHOD FOR PRODUCING 3PHENYL (THIO) URACILS AND 3PHENYLDITHIOURACILS
]00[
]30[
]30[
]10[
]71[
]14[
01.12.2004
10356474.8
]30[ 03.12.2003
]33[
Int. Cl.(2010.01) C07D 23/9/54, 23/9/56
BASF SE, GERMANY
WO/2005/054208
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
253
–6–‫–פניל (תיאו) אורצילים ו‬6 ‫שיטה ליצור‬
‫פנילדיתיאואורצילים‬
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
December 30, 2010-‫כג' בטבת התשע"א‬
‫רמת החייל‬
]31[
The invention relates to a method for producing 3-phenyl(thio)uracils or 3phenyldithiouracils of formula (I), by reacting a phenyliso(thio)cyanate of formula (II)
with an enamine of formula (III) and optionally reacting in an additional step the 3phenyl(thio)uracil or 3-phenyldithiouracil of formula (I) with R1 = R1a, if R1 is
hydrogen, with an aminating agent of formula (IV) to give 3-phenyl(thio)uracils or 3phenyldithiouracils of formula (I) with R1 = amine, wherein the variables R1, R1a, R2,
R3, R4, X1, X2, X3, Ar, A and L1 are defined as in claim 1.
__________________
]00[]00[
175783
‫תקשורת פקסימיליה בזמן – אמת באופן התלוי‬
‫בסוג האות‬
]34[
SIGNAL-TYPE DEPENDENT
REAL-TIME FAX RELAY
]00[
]30[
]30[
]10[
]10[
]14[
18.05.2006
11/136933
]30[ 25.05.2005
]33[
Int. Cl.(2010.01) H04L 12//66, H04N 01//00
AUDIOCODES LTD.
ULYBIN VLADIMIR
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]31[
254
US
‫ לוד‬,‫אודיוקודס בע"מ‬
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
In order to enable V.34 fax relay communications over IP ("FoIP") without increasing
a gateway complexity, the gateway (100) relays all types of fax control signals in
demodulated form and transfers fax image type signals either as demodulated or as
PCM encoded signal, based on a predetermined condition. The PCM data type is
added to FoIP protocol to allow transferring PCM encoded fax image signals without
exiting from FoIP mode of operation until the completion of a fax call. During a FoIP
call, the communicating gateway (100) determines whether the input fax signal is a
"fax control signal" or a "fax image" type signal. If the gateway (100) determines that
the input signal is a fax control signal or supported fax image signal, it handles it in a
traditional fax relay manner. However, if the gateway (100) determines that the input
fax image type signal cannot be demodulated, it outputs the fax signal to the IP
network as PCM encoded signal and without performing demodulation.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
175933
–4–‫–כלורו‬6(–4 ‫צורה גבישית למלח של‬
–)‫(ציקלופרופילאמינוקרבוניל)אמינופנוקסי‬
‫–קינולינקרבוקסאמיד או‬3–‫–מתוקסי‬7
‫ממסת המלח תכשיר המכיל אותה ותהליך‬
‫להכנתן‬
]34[
CRYSTALLINE FORM OF THE SALT OF 4-(3-CHLORO4(CYCLOPROPYLAMINOCARBONYL)AMINOPHENOXY)7-METHOXY-6-QUINOLINECARBOXAMIDE OR THE
SOLVATE OF THE SALT, A PHARMACEUTICAL
COMPOSITION COMPRISING THE SAME AND A
PROCESS FOR PREPARING THE SAME
]00[
]30[
]30[
]10[
]10[
22.12.2004
P2003-430939
]30[
25.12.2003
]33[ JP
Int. Cl.(2010.01) A61K 31//47, A61P 09//00, 17//00, 27//00, 29//00, 35//00, 43//00, C07D 21/5/48
EISAI R&D MANAGEMENT CO., LTD., JAPAN
TOMOHIRO MATSUSHIMA, ITARU ARIMOTO, ATSUSHI
KAMADA, KAZUHIRO YOSHIZAWA, TAIJU NAKAMURA,
255
December 30, 2010-‫כג' בטבת התשע"א‬
]71[
]14[
]31[
YUSUKE AYATA, NAOKO SUZUKI, TAKAHISA
SAKAGUCHI, MASAHARU GOTODA
WO/2005/063713
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
Crystals of the hydrochloride, hydrobromide, p-toluenesulfonate, sulfate, methanesulfonate, or
ethanesulfonate of 4-(3-chloro-4-(cyclopropylamino-carbonyl)aminophenoxy)-7-methoxy-6quinolinecarboxamide or crystals of a solvate of any of these.
__________________
]00[]00[
175984
‫תהליך הפיכה לאיזומרים של ציקלוהקסניל‬
‫אלקיל או אלקניל קטון‬
]34[
PROCESS FOR THE
ISOMERISATION OF A
CYCLOHEXENYL ALKYL OR
ALKENYL KETONE
]00[
]30[
30.11.2004
PCT/IB03/06118 ]30[ 16.12.2003
]33[
2320006602
0700000223
Int. Cl.(2010.01) C07C 45//67, 49//543, 49//557
FIRMENICH SA, SWITZERLAND
DENIS JACOBY, BESSAA NEFFAH,
CHRISTIAN CHAPUIS
WO/2005/061426
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]30[
]10[
]10[
]71[
]14[
]31[
IB
EP
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
The present invention relates to a process for the carbon-carbon double bond
isomerisation of a 2-alkyl-cyclohex-3-enyl alkyl or alkenyl ketone into a mixture
comprising the corresponding 2-alkyl-cyclohex-2-enyl ketones and the corresponding
2-alkylene-cyclohexyl ketones, using as catalyst a ruthenium complex obtainable by
the reaction of an appropriate ruthenium organometallic precursor and an acid.
__________________
256
December 30, 2010-‫כג' בטבת התשע"א‬
]00[]00[
175987
‫תאי גזע עובריים מבודדים מאדם הנושאים‬
‫מוטציות והשימוש בם לזיהוי חומרים לטיפול‬
‫במחלות גנטיות הקשורות למוטציות‬
]34[
ISOLATED EMBRYONIC STEM
CELLS CARRYING DISEASECAUSING MUTATIONS AND
METHODS OF USING SAME FOR
IDENTIFICATION OF AGENTS
FOR TREATING GENETIC
DISORDERS ASSOCIATED WITH
THE MUTATIONS
]00[
]30[
]30[
]10[
15.11.2004
60/525883
]30[ 01.12.2003
]33[ US
Int. Cl.(2010.01) C12N 05//074, 15//63, C12Q 01//68
TECHNION RESEARCH AND
‫ חיפה‬,‫מוסד הטכניון למחקר ופתוח בע"מ‬
DEVELOPMENT FOUNDATION
LTD.
MICHAL AMIT, JOSEPH
‫אלדור‬-‫ יוסף איצקוביץ‬,‫מיכל עמית‬
ITSKOVITZ-ELDOR
WO/2005/053601
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
]10[
]71[
]14[
]31[
Stem cells, stem cell lines and differentiated cells, tissues and organs which carry
disease-causing mutations are provided. There is also provided a method of identifying
agents suitable for treating disorders associated with at least one disease-causing
mutations such as myotonic dystrophy and van Waardenburg syndrome.
__________________
]00[]00[
176280
]34[
L-(-)- MOPROLOL L-(+)-TARTRATE
]00[
]30[
]30[
]10[
14.01.2005
MI2004A000145 ]30[ 30.01.2004
]33[ IT
Int. Cl.(2010.01) A61K 31//133, A61P 27//02, C07C 21/7/34, 51//41, 59//255
AZIENDE CHIMICHE RIUNITE
ANGELINI FRANCESCO A.C.R.A.F.
S.P.A., ITALY
257
‫) טרטאראט‬+(– L ‫ – (–) מופרולול‬L
December 30, 2010-‫כג' בטבת התשע"א‬
]71[
]14[
]31[
WO/2005/075408
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
L-(-)-moprolol L-(+)-tartrate salt (2:1), method for preparing it and pharmaceutical
composition comprising it.
__________________
]00[]00[
176417
‫תהליך להכנת שמן או חומצת שומן בלתי–רוויה‬
‫) ומכשיר לייצורם מתאים‬PUFA(
‫מיקרוביאליים‬
]34[
PROCESS FOR PRODUCING AN
OIL OR A POLYUNSATURATED
FATTY ACID (PUFA) AND
APPARATUS FOR PRODUCING
THE SAME FROM MICROBIAL
CELLS
]00[
]30[
]30[
]10[
28.12.2004
03258249.6
]30[ 30.12.2003
]33[ EP
Int. Cl.(2010.01) C11B 01//00, 01//10, C12M 01//04, C12P 07//64
DSM IP ASSETS B.V., THE
NETHERLANDS
WO/2005/063999
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
]71[
]14[
]31[
A process for producing an oil, or a polyunsaturated fatty acid (PUFA), is described
where an aqueous liquid comprising cells is deaerated, and the oil or PUFA is obtained
from the cells. Deaeration can be performed by a wide variety of techniques, including
the application of a vacuum (or reduced pressure), mechanical deaeration or degassing
by reduced stirring or subjecting the broth to centrifugal forces, reducing viscosity (by
dilution or heating), reduction in the supply of oxygen or air during fermentation or a
reduction in stirring rate, lowering the pH (to lower the solubility of CO 2), filtration
using PTFE capillaries, gas displacement (by bubbling in nitrogen or helium) or
chemical deaeration (using oxygen scavengers).
__________________
258
December 30, 2010-‫כג' בטבת התשע"א‬
]00[]00[
]34[
PROCESS FOR PRODUCTION OF
GLYCINE ENRICHED SODIUM
CHLORIDE CRYSTALS WITH
IMPROVED FLOW
]00[
]30[
]10[
24.12.2003
Int. Cl.(2010.01) C01D 03//06
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH, INDIA
HINDUSTAN LEVER LIMITED,
INDIA
WO/2005/066075
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]71[
]14[
]31[
176542
‫תהליך ליצור גבישי נתרן כלוריד מועשרים‬
‫בגליצין ובעלי זרימה משופרת‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to a simple, economical, and efficient cyclic process for
producing rhombic dodecahedron shaped glycine enriched, free flowing common salt
from brine, said process comprising steps of adding glycine of concentration ranging
between 10 to 25% to the saturated brine, evaporating the saturated brine containing
glycine to obtain crystals having high content of glycine, with mother liquor, washing
the crystals with saturated brine to obtain rhombic dodecahedron shaped glycine
enriched common salt having glycine content ranging between 0.5 to 1.0% and a
washed brine, combining the mother liquor and the washed brine to obtain resulting
brine, subjecting the resultant brine to solar evaporation, and repeating the steps of (iii)
to (v) to obtain rhombic dodecahedron shaped glycine enriched common salt from
brine with glycine concentration ranging between 0.5 to 1.0%.
__________________
]00[]00[
]34[
STRUCTURAL GROUNDING
PLANT FOR DIGITAL
ELECTRONICS TO ATTAIN
VERY HIGH RESOLUTION
]00[
16.07.2006
259
176867
– ‫מיתקן הארקה מיבני עבור מיכשור אלקטרוני‬
‫דיגיטלי להשגת רזולוציה גבוהה מאוד‬
December 30, 2010-‫כג' בטבת התשע"א‬
‫‪Int. Cl.(2010.01) H01R 04//66‬‬
‫‪A. ALLWEIL‬‬
‫‪A. ALLWEIL,‬‬
‫‪48 LEVI ESHKOL ST.‬‬
‫‪TEL AVIV 69361‬‬
‫אברהם אלואיל‪ ,‬תל‪ -‬אביב‬
‫אברהם אלואיל‪,‬‬
‫לוי אשכול ‪41‬‬
‫תל‪ -‬אביב‬
‫מתבקשת הגנה על אמצאה הנוגעת להארקה באמצעות מיכלול המורכב ממעטפת צינורית שחלקה העליון באוויר‪ ,‬ממתכת‬
‫בעלת פוטנציאל תיקני שלילי‪ ,‬וחלק התחתון מחומר מבודד הנתון במי תהום‪ ,‬המכילה לכל אורך בטון ספוגי‪ ,‬בתוכו מוטבע‬
‫מוט מתכת בעל פוטנציאל תיקני חיובי‪ ,‬שקצהו העליון מחובר בחוט מוליך לאנטנה או לשסי של מיתקן אלקטרוני דיגיטלי‪,‬‬
‫כאשר חלקה העליון של המעטפת הנ"ל מחובר בחוט מוליך למוט ממתכת בעלת פוטנציאל תיקני חיובי‪ ,‬המטבע בגוש בטון‬
‫נפרד הנתון במי תהום‪0‬‬
‫[‪]30‬‬
‫[‪]10‬‬
‫[‪]14‬‬
‫[‪]31‬‬
‫__________________‬
‫‪177088‬‬
‫שימוש בתולדות ‪ 5,1,6‬אינדוליזין מותמרות‬
‫להכנת תרופות לטיפול במחלות הקשורות‬
‫באנגיוגנזה כורוידאלית פתלוגית‬
‫[‪]00[]00‬‬
‫‪USE OF SUBSTITUTED 1,2,3‬‬
‫‪INDOLIZINE DERIVATIVES FOR‬‬
‫‪THE PREPARATION OF‬‬
‫‪MEDICAMENTS FOR TREATING‬‬
‫‪DISEASES ASSOCIATED WITH A‬‬
‫‪PATHOLOGICAL CHOROIDAL‬‬
‫‪ANGIOGENESIS‬‬
‫[‪]34‬‬
‫‪04.02.2005‬‬
‫‪0401094‬‬
‫‪]30[ 05.02.2004‬‬
‫‪]33[ FR‬‬
‫‪Int. Cl.(2010.01) A61K 31//437, A61P 35//00, C07D 47/1/00, 47/1/04‬‬
‫‪SANOFI-AVENTIS, FRANCE‬‬
‫‪WO/2005/082457‬‬
‫‪SANFORD T.COLB & CO.,‬‬
‫סנפורד ט‪ .‬קולב ושות'‪,‬‬
‫‪P.O.B. 2273,‬‬
‫שער הגיא ‪ ,4‬מרמורק‬
‫‪REHOVOT 76122‬‬
‫‪ ,‬ת‪.‬ד‪5512 .‬רחובות‬
‫[‪]00‬‬
‫[‪]30‬‬
‫[‪]30‬‬
‫[‪]10‬‬
‫[‪]71‬‬
‫[‪]14‬‬
‫‪The invention relates to the use of substituted 1,2,3 indolizine derivatives for the‬‬
‫‪preparation of medicaments that are useful in treating diseases associated with a‬‬
‫‪pathological choroidal angiogenesis. The derivatives correspond to general formula (I).‬‬
‫כג' בטבת התשע"א‪December 30, 2010-‬‬
‫[‪]31‬‬
‫‪260‬‬
__________________
]00[]00[
177169
]34[
USE OF N-(2-ARYL- PROPIONYL)SULFONAMIDES FOR THE
PREPARATION OF
MEDICAMENTS FOR THE
TREATMENT OF SPINAL CORD
INJURY
]00[
]30[
]30[
]10[
]71[
]14[
17.03.2005
04007177.1
]30[ 25.03.2004
]33[ EP
Int. Cl.(2010.01) A61K 31//18, A61P 25//00, C07C 31/1/51
DOMPE PHA.R.MA S.P.A., ITALY
WO/2005/092315
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]31[
– )‫ – אריל – פרופיוניל‬N – (2 –‫שימוש ב‬
‫סולפונאמידים להכנת תרופות לטיפול בפציעה‬
‫בעמוד השדרה‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
N-(2-aryl-propionyl)-sulfonamides of general formula (I) are useful in the treatment of
spinal cord injury.
__________________
]00[]00[
]34[
261
METHOD FOR IDENTIFICATION
OF A CHEMICAL COMPOUND
WHICH MODULATES THE
ACTIVITY OF A MAMMALIAN
GLYCOSYL-PHOSPHATIDYLINOSITOL SPECIFIC
PHOSPHOLIPASE C
177257
‫שיטה לזיהוי תרכובת כימית המווסתת את‬
‫ ספציפי של‬C ‫הפעולות של פוספוליפאז‬
‫גילקוזיל – פוספאטידיל – אינוזיטול של יונק‬
December 30, 2010-‫כג' בטבת התשע"א‬
]00[
]30[
]30[
]10[
]71[
]14[
]31[
16.02.2005
04003897.8
]30[ 20.02.2004
Int. Cl.(2010.01) C12Q 01//34
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2005/080587
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]33[
EP
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
The present invention refers to a method for identification of a chemical compound
which modulates the activity of mammalian GPI-PLC wherein a] a mammalian cell is
incubated with glimepiride; b] hcDlGs of the cells of a] are prepared; c] the hcDlGs
from b] are incubated with a chemical compound; d] the activity of the GPI-PLC from
the hcDlGs of c] is determined.
The applications for division
from this application have
not yet been published
0141/000141/01
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]00[]00[
177311
‫שיטה ומערכת לקביעת מיקום גיאוגרפי‬
‫באמצעות ניהול שיחה במיתוג קצר‬
]34[
METHOD AND APPARATUS FOR
PERFORMING POSITION
DETERMINATION WITH A
SHORT CIRCUIT CALL FLOW
]00[
]30[
]30[
]10[
04.02.2005
60/542496
]30[ 05.02.2004
]33[ US
Int. Cl.(2010.01) G01S 19//03, H04L 12//26, H04W 04//02, 28//04
QUALCOMM INCORPORATED,
U.S.A.
WO/2005/079002
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
]71[
]14[
]31[
262
For a call flow to perform position determination, a network (100) sends to a user
equipment (UE) (120) an indication (e.g., a request for permission) to perform a
position fix for the UE (120). The UE (120) responds by sending to the network an
acknowledgment (e.g., a grant of permission) to perform the position fix. The UE
(120) selectively sends a position estimate for itself to the network (100), typically
December 30, 2010-‫כג' בטבת התשע"א‬
along with the acknowledgment. The network (100) may initiate location processing if
(1) a position estimate is not received from the UE (120) or (2) a position estimate is
received from the UE (120) but the network (100) decides not to use this position
estimate. In this case, the network (100) and the UE (120) perform location processing
to obtain a position fix for the UE (120). However, if a position estimate is received
from the UE (120) and the network (100) decides to use the position estimate, then the
location processing is bypassed or short circuited.
__________________
]00[]00[
]34[
METHOD FOR ANODIZING
METALLIC SURFACES AND
COMPOSITIONS THEREFOR
]00[
]30[
]30[
]10[
16.02.2005
10/781973
]30[ 18.02.2004
Int. Cl.(2010.01) C25D 11//02
ALONIM HOLDINGS
AGRICULTURAL COOPERATIVE
SOCIETY LTD
ILYA OSTROVSKY
WO/2005/078164
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
]10[
]71[
]14[
]31[
263
177412
‫שיטה לאינוד משטחים מתכתיים ותרכובות‬
‫עבורה‬
]33[
US
‫ קיבוץ‬,‫אלונים אחזקות אגש"ח בע"מ‬
‫אלונים‬
‫איליה אוסטרובסקי‬
,‫ד"ר מרק פרידמן בע"מ‬
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
A method of treating metallic workpieces with an anodizing solution is disclosed.
During this method, a non-conductive polymer containing layer is generated on the
metallic surface that provides an essential contribution in the initiation of the formation
of micro-plasma arcs. This layer is transformed to a gel layer in which gel micelles are
oriented according to the electromagnetic field.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
177461
‫מיצוי נוזלים למשקאות קלים עם‬/‫מנפק רכז‬
‫מיצוי נוזלים‬/‫מחסנית להחלפה מכילה רכז‬
]34[
LIQUID
CONCENTRATE/EXTRACT
BEVERAGE DISPENSER WITH
REPLACEABLE
CONCENTRATE/EXTRACT
CARTRIDGE
]00[
]30[
11.02.2005
60/544379
]30[ 13.02.2004
]33[
620602030
0000200224
620640300
2102000223
Int. Cl.(2010.01) A47J 31//40, B67D 01//08
INTELLIGENT COFFEE COMPANY.
L.L.C., U.S.A.
WO/2005/079361
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]30[
]10[
]71[
]14[
]31[
264
US
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A beverage dispenser for dispensing a beverage into a container is provided. The
dispenser includes a housing having a dispensing area. A pump or a control valve is in
communication with a source of diluent which is to be dispensed into the dispensing
area. A cartridge receiving area and a dispensing actuator are located in the housing. A
concentrate/extract cartridge is removably insertable into the cartridge receiving area
in a position to be actuated by the dispensing actuator, the concentrate/extract cartridge
being adapted to hold a beverage concentrate/extract and including a dispensing
aperture for dispensing a beverage concentrate/extract into the dispensing area upon
placement of the concentrate/extract cartridge in the cartridge receiving area. A
controller is located in the housing to control the actuator to discharge
concentrate/extract into the dispensing area. A method of dispensing a selected
beverage made from concentrate/extract and a diluent is also provided.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
INSERTING BITS WITHIN A
DATA WORD
]00[
]30[
]30[
]10[
]71[
]14[
03.08.2004
0405407.8
]30[ 10.03.2004
Int. Cl.(2010.01) G06F 09//308
ARM LIMITED, UNITED KINGDOM
WO/2005/088441
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]31[
265
177507
‫הכנסה של ביטים לתוך מילה נתונה‬
]33[
GB
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A data processing system (2) is provided which supports shift-and-insert instructions
SLI, SRI which serve to shift a source data value by a specified shift amount and then
insert bits from that shifted value other than the shifted-in bits into a destination value
with the remaining bits within that destination value being unaltered.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
BENZIMIDAZOLE DERIVATIVES,
THEIR PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM
]00[
]30[
23.02.2005
2004-048928 ]30[ 25.02.2004
000230231
2102000223
Int. Cl.(2010.01) C07D 41/3/00
TAKEDA PHARMACEUTICAL
COMPANY LIMITED, JAPAN
WO/2005/080384
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]30[
]10[
]71[
]14[
]31[
177533
‫ הכנתן ותכשירים‬,‫תולדות בנזאימידאיזול‬
‫פרמצפטים שכוללים אותן‬
]33[
JP
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The present invention relates to a compound represented by the formula (I) wherein R 1
is a group represented by the formula wherein R2, R3, R4, R5, R6, R7 and R8 are each
independently a hydrogen atom or a C6 - 1 alkyl, or a salt thereof. The compound of the
present invention is useful as an agent for the prophylaxis or treatment of circulatory
diseases such as hypertension and the like and metabolic diseases such as diabetes and
the like.
__________________
]00[]00[
]34[
266
OLIGOSACCHARIDES,
PREPARATION METHOD AND
177535
‫ שיטת הכנה והשימוש בהם‬,‫אוליגוסכרידים‬
‫ותכשירים פרמצבטיים המכילים אותם‬
December 30, 2010-‫כג' בטבת התשע"א‬
USE THEREOF AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
SAME
]00[
]30[
]30[
]10[
]71[
]14[
]31[
23.02.2005
0401810
]30[ 24.02.2004
]33[ FR
Int. Cl.(2010.01) A61K 31//702, 31//727, C08B 37//00
AVENTIS PHARMA S.A., FRANCE
WO/2005/090591
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The invention relates to oligosaccharides, the preparation method and use thereof, and
pharmaceutical compositions containing same. More specifically, the invention relates
to oligosaccharides which can be used for the treatment of cancer and, in particular, to
prevent and inhibit the formation of metastases. The inventive oligosaccharides can be
used, for example, during early breast, lung, prostate, colon or pancreatic cancer. The
oligosaccharides can be administered subcutaneously, orally or intravenously.
Moreover, said oligosaccharides can be used alone or together with other anticancer
agents, e.g. cytotoxics such as docetaxel or paclitaxel.
__________________
]00[]00[
]34[
AUTOMATIC RESET DEVICE
PARTICULARLY FOR RESIDUAL
CURRENT-OPERATED CIRCUIT
BREAKERS AND THE LIKE
]00[
]30[
]30[
]10[
]71[
]14[
25.02.2005
04425125.4
]30[ 27.02.2004
Int. Cl.(2010.01) H02H 03//33
GEWISS S.P.A., ITALY
WO/2005/086310
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]31[
267
177567
‫מתקן איפוס אוטומטי במיוחד למיתוג המופעל‬
‫על–ידי זרם עודף ודומיו‬
]33[
EP
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
An automatic reset device, particularly for residual current-operated circuit breakers
and the like, comprising an actuator (10) for automatically resetting a residual currentDecember 30, 2010-‫כג' בטבת התשע"א‬
operated circuit breaker (2) that is connected to an electrical line (8, 9), upstream of a
load; control means (1) for actuating the actuator (10), the control means being
connected upstream of the residual current-operated circuit breaker and downstream of
the residual current-operated circuit breaker, upstream of the load, in order to bypass
the residual current-operated circuit breaker when the residual current-operated circuit
breaker is released, the control means including a circuit (20) for checking the
connection of the reset device to the electrical line and a circuit (23) for detecting
leakage current, in order to check for the presence of a leakage current, before
actuating the actuator to automatically reset the residual current-operated circuit
breaker.
__________________
]00[]00[
]34[
APPARATUS FOR TREATING AN
AREA OF BIOLOGIC TISSUE
]00[
]30[
]30[
]10[
18.02.2005
10/784088
]30[ 19.02.2004
Int. Cl.(2010.01) A61N 01//30
VOMARIS INNOVATION, INC.,
U.S.A.
JEFFRY B. SKIBA, LAWRENCE A.
SCHNEIDER
WO/2005/079913
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
]10[
]71[
]14[
]31[
268
177587
‫מתקן לטיפול בשטח של רקמת תאים‬
]33[
US
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
‫רמת גן‬
An apparatus includes multiple first reservoirs and multiple second reservoirs joined
with a substrate. Selected ones of the multiple first reservoirs include a reducing agent,
and first reservoir surfaces of selected ones of the multiple first reservoirs are
proximate to a first substrate surface. Selected ones of the multiple second reservoirs
December 30, 2010-‫כג' בטבת התשע"א‬
include an oxidizing agent, and second reservoir surfaces of selected ones of the
multiple second reservoirs are proximate to the first substrate surface.
__________________
]00[]00[
177733
]34[
GEOPHONE BASED ON HALL
SENSORS
]00[
]30[
]10[
]10[
]14[
29.08.2006
Int. Cl.(2010.01) E21B 47//00, G08B 05//02
VLADIMIR GERTSENOV
VLADIMIR GERTSENOV
VLADIMIR GERTSENOV,
2/72 ESHKOLOT ST., NESHER
]31[
269
‫גאופון מבוסס על חיישני הול‬
‫ נשר‬,‫ולדימיר גרצנוב‬
‫ולדימיר גרצנוב‬
,‫ולדימיר גרצנוב‬
5/15 ‫אשכולות‬
‫נשר‬
Measuring unit-converter to a geophone, containing non magnetic case, a pendulum
with a permanent magnet, a spring , three of location based on Hall's effect, notable
for the feature that in the transformation of mechanical oscillations into electric ones
occurs due to Hall's gauges, and external influences are reflected either by oscillations
of spring with Hall's gauge in vertical plane, or by a magnet suspended on not
stretched thread in two planes X or Y.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
177760
‫מוצרי מגבונים ומגבות מקופלים ורטוביים בעלי‬
,‫ מוגבה ויחס מתיחות נמוך‬CD ‫ערך מתיחות‬
‫עשויים עם תהליך בד קרפ בשיעור מוצקים גבוה‬
]34[
WET-PRESSED TISSUE AND
TOWEL PRODUCTS WITH
ELEVATED CD STRETCH AND
LOW TENSILE RATIOS MADE
WITH A HIGH SOLIDS FABRIC
CREPE PROCESS
]00[
]30[
]30[
]10[
12.04.2005
60/562025
]30[ 14.04.2004
]33[ US
Int. Cl.(2010.01) B31F 01//12, D21F 11//02, D21H 11//20, 27//00
FORT JAMES CORPORATION,
U.S.A.
WO/2005/106117
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
]71[
]14[
270
December 30, 2010-‫כג' בטבת התשע"א‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
REHOVOT 76122
]31[
An absorbent sheet of cellulosic fibers includes a mixture of hardwood fibers and
softwood fibers arranged in a reticulum having: (i) a plurality of pileated fiber enriched
regions of relatively high local basis weight interconnected by way of (ii) a plurality of
lower local basis weight linking regions whose fiber orientation is biased along the
machine direction between pileated regions interconnected thereby, wherein the sheet
exhibits a % CD stretch which is at least about 2.75 times the dry tensile ratio of the
sheet. Tensile ratios of from about 0.4 to about 4 are readily achieved.
The applications for division
from this application have
not yet been published
014110/
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]00[]00[
177800
‫שיטה והתקן לתקשורת אל–חוטית לדיווח מידע‬
‫אודות מדדית נפח תנועה לתמיכה בהעברת מידע‬
‫מוגברת ללוויין‬
]34[
WIRELESS COMMUNICATION
METHOD AND APPARATUS FOR
REPORTING TRAFFIC VOLUME
MEASUREMENT INFORMATION
TO SUPPORT ENHANCED
UPLINK DATA TRANSMISSIONS
]00[
]30[
07.03.2005
60/557974
]30[ 31.03.2004
]33[ US
020033313
0002000224
US
Int. Cl.(2010.01) H04L 12//56, H04W 24//00, 28//14, 48//08, 72//08, 72//12, 72//14,
84//04
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2005/104461
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
December 30, 2010-‫כג' בטבת התשע"א‬
]30[
]10[
]71[
]14[
271
]31[
A wireless communication method and apparatus for reporting traffic volume
measurement (TVM) information used to support enhanced uplink (EU) data
transmissions between a wireless transmit/receive unit (WTRU), i.e., a mobile station,
and a Node-B. After storing EU data in a buffer, the WTRU sends an initial TVM
information request message to the Node-B indicating that the WTRU has EU data
available to send to the Node-B. In response, the Node-B schedules one or more
allowed EU data transmissions. The WTRU transmits at least a portion of the stored
EU data to the Node-B via the allowed EU data transmissions. In one embodiment, the
initial TVM information request message is sent by the WTRU only after the quantity
of EU data stored in the buffer of the WTRU exceeds an established threshold.
Otherwise, all of the stored EU data is transferred to the Node-B without requiring
scheduling by the Node-B.
__________________
]00[]00[
]34[
COMMUNICATION SERVER,
METHOD AND SYSTEMS FOR
REDUCING TRANSPORTATION
VOLUMES OVER
COMMUNICATION NETWORKS
]00[
]30[
]30[
]10[
]71[
]14[
02.03.2005
60/548855
]30[ 02.03.2004
Int. Cl.(2010.01) H04L 29//06
IPORTENT LTD.
WO/2005/086415
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]31[
272
177855
‫ שיטה ומערכות להקטנת נפחי‬,‫שרת תקשורת‬
‫תנועה במערכות תקשורת‬
]33[
US
‫ אביב‬-‫ תל‬,‫איפורטנט בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Method for delivering data streams over communication networks is disclosed, the
method comprising determining reference points in a stream of data being locations in
the stream where predefined number of characters fulfill a predetermined criterion;
registering digital signatures being values returned from a predetermined function
December 30, 2010-‫כג' בטבת התשע"א‬
taken over predefined ranges of content, the ranges are in correlation with the
reference points; using the digital signatures to locate locally stored content, and using
the reference points or creating a dictionary and using it to synchronize between
currently received pieces of data and between locally stored matching content.
Communication server implementing the method is also disclosed, and further
disclosed are communication systems comprising at least one said server.
__________________
]00[]00[
177967
‫תכשירים המכילים תאים כלואים בעלי יכולת‬
‫ אשר יוצרים חומרים מעכבי‬,‫גידול מואץ‬
‫התרבות ושימוש בם‬
]34[
COMPOSITIONS OF RESTRICTED
CELLS CAPABLE OF RAPID
GROWTH WHICH PRODUCE
PROLIFERATION SUPPRESSIVE
MATERIALS AND USES
THEREOF
]00[
]30[
]30[
]60[
]10[
]71[
]14[
09.11.1999
09/188476
]30[ 09.11.1998
]33[ US
Int. Cl.(2009.01) A61K 35/12, A61P 17//02, C12N 05//00
DIVISION FROM 139704
THE ROGOSIN INSTITUTE, U.S.A.
WO/2000/027207
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]31[
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Biocompatible, proliferation-restrictive, selectively-permeable structures which
contain restricted, highly proliferative cells from a species as a subject in need of
suppressing proliferation of cells, for use in suppressing proliferation of cells in said
subject, wherein said restricted cells produce a material having a molecular weight of
at least 30 kd which suppresses cell proliferation, in an amount sufficient to suppress
cell proliferation in a subject. wherein said suppressive material diffuses through said
structures.
__________________
273
December 30, 2010-‫כג' בטבת התשע"א‬
]00[]00[
178301
‫שיטות והתקן המאפשרים קבלה בררנית של‬
‫ערוצי איתות מלווין‬
]34[
METHOD AND APPARATUS FOR
SELECTIVELY ENABLING
RECEPTION OF DOWNLINK
SIGNALING CHANNELS
]00[
]30[
]30[
]10[
06.04.2005
60/566620
]30[ 29.04.2004
]33[ US
Int. Cl.(2010.01) H04L 01//16, H04W 52//00, 74//00, 88//02
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2005/112481
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]71[
]14[
]31[
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
In a wireless communication system (100) including a wireless transmit/receive unit,
WTRU (102) and at least one node-B (104),at least one downlink channel, DL (110) is
selectively established between the WTRU (102) and the node-B (104) by means of
uplink signaling channel, UL (108). WTRU (102) monitors and consolidates DL
signaling channels (110) in accordance with one established standard procedure.
__________________
]00[]00[
]34[
SYSTEM AND METHOD FOR
TRANSMISSION AND
RECEPTION OF QAM SIGNALS
AT LOW SIGNAL TO NOISE
RATIO
]00[
]30[
30.03.2004
Int. Cl.(2010.01) H04L 05//04, 27//36
274
178363
QAM ‫מערכת ושיטה לשידור וקבלה של אותות‬
‫רעש נמוך‬/‫ביחס אות‬
December 30, 2010-‫כג' בטבת התשע"א‬
]10[
]71[
]14[
]31[
MODESAT COMMUNICATIONS
OU, ESTONIA
WO/2005/096539
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The system for transmission and reception of QAM signals for use in
telecommunication networks for any data rates at SNR (signal to noise ratio) of below
0 dB comprises two devices. The first device may be used for transmission. Units (1)(4) transform input bit information sequence (17) with the clock frequency ft (18) into
two parallel m-level sequences with the clock frequency (a) forming the first and
second channels, where k=log2(m). Unit (5) forming additional signals (b),(c), where
&ohgr;t= 2&pgr;ft. Units (6), (7) multiply m-level sequences of the first and second
channels with signal (b) for removal phase ambiguity at reception end, and units (8),
(9) adding with signal (c), defining level of the additional pilot-signal in output
spectrum. Filters (10), (11) forming baseband QAM signal spectrum and units (12)(16) shift of spectrum at intermediate or carrier frequency. The second device may be
used for reception. Restoration of the carrier and clock frequencies at reception end
performing with used two PLL (phase lock loop) systems using availability in signal
spectrum additional pilot-signal. This is allow set up synchronization for signal to
noise ratio below 0 dB. In this case additional losses amounts 0.3-0.7 dB.
__________________
]00[]00[
178478
]34[
PHARMACEUTICAL
COMPOSITIONS CONTAINING
ANTI-CD-3 ANTIBODIES
]00[
]30[
]30[
]10[
]71[
]14[
06.04.2005
60/559944
]30[ 06.04.2004
]33[ US
Int. Cl.(2010.01) A61K 39//395, A61P 37//00, C07K 16//28
NOVIMMUNE S.A., SWITZERLAND
WO/2005/099755
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
275
CD3–‫תכשירי רוקחות המכילים נוגדים אנטי‬
,‫ ברגמן וגולר‬,‫וולף‬
December 30, 2010-‫כג' בטבת התשע"א‬
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]31[
This invention provides method of treatment of autoimmune diseases and/or
inflammatory disorders, using an antibody to CD3.
0140111
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]00[]00[
]34[
METHOD AND SYSTEM FOR
LINKING CERTIFICATES TO
SIGNED FILES
]00[
]30[
]30[
]10[
]71[
]14[
02.03.2005
04368024.8
]30[ 08.04.2004
Int. Cl.(2010.01) H04L 09//32
IBM CORPORATION, U.S.A.
WO/2005/098566
IBM LABORATORIES,
HAIFA UNIVERSITY,
HAIFA 31905
]31[
276
178482
‫שיטה ומערכת לקישור תעודות לקבצים חתומים‬
]33[
EP
,‫מעבדות יבמ מחלקת קנין רוחני‬
‫אוניברסיטת חיפה הר הכרמל‬
‫חיפה‬
A method and systems for linking the certificate to the signed file to which it is
associated is disclosed. According to the method and systems of the invention, the
address or URL wherein the certificate is stored is encoded in the filename of the
signed file so as to be transmitted jointly with the file. When receiving such a signed
file, a first step consists in extracting and decoding the certificate address from the
filename. Using the certificate address, the certificate can be accessed and checked
before opening and authenticating the signed file. In a preferred embodiment, the
signature of a signed file is based on the file content and on a private key while the
corresponding certificate comprises at least the corresponding public key.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
178513
‫תהליך לייצור תאים אפיתלאלים בתרבית‬
‫ומכשיר עיבוד לייצורם‬
]34[
PROCESS FOR THE GENERATION
OF EPITHELIAL CELLS IN
CULTURE AND A CULTIVATION
DEVICE FOR MAKING THE SAME
]00[
]30[
]30[
]10[
01.04.2005
102004017476.8 ]30[ 08.04.2004
]33[ DE
Int. Cl.(2010.01) A61K 35//24, 35//26, C12M 03//04, C12N 05//00
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V., GERMANY
WO/2005/097974
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
]71[
]14[
]31[
277
Disclosed is a method for forming epithelial cells. Said method comprises the steps of
aggregating stem cells from differentiated exocrine gland tissue to obtain an organoid
body and differentiating at least one portion of the organoid body or a tissue body
grown therefrom to obtain epithelial cells. Also disclosed is a cultivation device,
particularly for forming differential epithelial cells.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
178586
‫התקן ראש מדפסת מודולרי בעל מודולים של‬
‫ראש מדפסת המסודרים בצורה סריאלית‬
]34[
MODULAR PRINTHEAD
ASSEMBLY WITH SERIALLY
ARRANGED PRINTHEAD
MODULES
]00[
]30[
]30[
]60[
]10[
07.12.2000
PQ4559
]30[ 09.12.1999
]33[ AU
Int. Cl.(2010.01) B41J 02//01, 02//14, 02//145, 02//16
DIVISION FROM 165538
SILVERBROOK RESEARCH
PTY.LTD., AUSTRALIA
WO/2001/042020
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]71[
]14[
]31[
278
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
A component for a printhead module (12) includes a printhead chip (18) and a flexible
printed circuit board (PCB, 54) on which the chip (18) is mounted. A carrier having
fluid communication channels (72) defined therein supplies ink to the chip (18). The
PCB (54) is bonded to the carrier in a liquid tight manner so that the PCB (54) forms a
wall of an ink supply chamber (30) of the printhead module (12).
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
178601
‫שיטות וכלים לבחירה בן ריבוי ספקים‬
‫המתבססים על מידות אנרגיה אותות‬
]34[
METHODS AND APPARATUS FOR
SELECTING BETWEEN
MULTIPLE CARRIERS BASED ON
SIGNAL ENERGY
MEASUREMENTS
]00[
]30[
15.10.2004
60/562900
]30[ 15.04.2004
]33[ US
020710614
0002600224
US
020064046
0400200224
US
Int. Cl.(2010.01) H04J 13//02, H04L 27//26, H04W 36//08, 36//30, 72//00
QUALCOMM INCORPORATED,
U.S.A.
WO/2005/109657
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
]30[
]10[
]71[
]14[
]31[
279
Carrier frequency selection and handoff initiation methods in wireless communications
systems employing multiple carrier frequencies are described. Although the receiver is
tuned to a single band, based on the relative energy of one or more beacon signal
components corresponding to the currently used carrier and one or more beacon signal
components corresponding to an alternative carrier, a carrier selection and a handoff
determination is made. Mobile nodes can use a single RF chain with a controllable RF
filter to receive and process a signal within a first selected carrier band including
components from different transmitters, e.g., a first signal component identified with
the first currently selected band and a second signal component identified with a
second alternative band. The signal components, e.g., beacon signal components from
different transmitters may be obtained from a signal which corresponds to multiple
symbol transmission time periods. Separate signal energy measurements are performed
December 30, 2010-‫כג' בטבת התשע"א‬
on the first and second signal components. The signal component energy is compared,
and a determination is made as to whether a handoff should be initiated.
__________________
]00[]00[
178605
‫שיטות ומערכת לבחירה בין מספר ספקים על‬
‫ידי מקלט משורשר יחיד המכוון לספק יחיד‬
]34[
METHODS AND APPARATUS FOR
SELECTING BETWEEN
MULTIPLE CARRIERS USING A
SINGLE RECEIVER CHAIN
TUNED TO A SINGLE CARRIER
]00[
]30[
15.10.2004
60/562900
]30[ 15.04.2004
]33[ US
020710614
0002600224
US
Int. Cl.(2010.01) H04B 01//10, 01//40, 15//00, 17//02, H04W 40//12
QUALCOMM INCORPORATED,
U.S.A.
WO/2005/109701
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
]30[
]10[
]71[
]14[
]31[
280
Receivers accommodating carrier frequency selection methods in wireless
communications systems employing multiple carrier frequencies are described.
Although the receiver is tuned to a single band, an estimate of the channel quality
corresponding to the currently used carrier and an alternative carrier is generated
without switching between carriers. Transmitters of different cells and/or different
sectors primarily use different carrier frequencies but periodically transmit using a
neighboring sector's carrier frequency. Mobile node receivers use a single RF chain
with a controllable RF filter to receive and process a signal within a first selected
carrier band including two components, a first signal component identified with the
first currently selected band and a second signal component identified with a second
alternative band. Separate quality indicator values are obtained from the first and
December 30, 2010-‫כג' בטבת התשע"א‬
second signal components, compared, and a determination is made as to whether the
receiver's RF filter should be switched to the second band.
__________________
]00[]00[
179094
‫מערכת ושיטה לישום העברה עצמאית של תוכן‬
]34[
SYSTEM AND METHOD FOR
IMPLEMENTING A MEDIA
INDEPENDENT HANDOVER
]00[
]30[
02.05.2005
60/569015
]30[ 07.05.2004
]33[ US
000200030
0702300223
US
Int. Cl.(2010.01) H04L 12//00, H04W 36//14, 36//18, 36//36
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2006/001902
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]30[
]10[
]71[
]14[
]31[
281
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A system for implementing a media independent handover (706) in a station (700) in a
wireless communication system includes a physical sublayer management entity (702),
a medium access control sublayer management entity (704), a management
information base (608), and a handover policy function (606). The handover policy
function (606) is capable of receiving measurements and system information from the
physical sublayer management entity (702), the medium access control sublayer
management entity (704), and the management information base (608). The handover
policy function (606) is capable of then autonomously determining whether to execute
a handover.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
179199
]34[
METHOD OF SCREENING FOR
MODULATORS OF WRN
]00[
]30[
]30[
]10[
19.05.2005
60/572625
]30[ 19.05.2004
]33[
Int. Cl.(2010.01) C12N 09//14, G01N 33//68
TRUSTEES OF BOSTON
UNIVERSITY, U.S.A.
WO/2005/113764
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]71[
]14[
]31[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The use of modulators of WRN is described. Activators of WRN may be used to
induce growth arrest, apoptosis or proliferative senescence, whereas inhibitors of
WRN may be used to reduce growth arrest, apoptosis or prolifertative senescence.
Methods of identifying modulators of WRN are also described.
The applications for division
from this application have
not yet been published
282
WRN ‫שיטת סינון מאפנני‬
014110/
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
179318
‫ תרביות תאים ושימוש‬,‫שיטות לגידול תאי גזע‬
‫בביצה לגידול של תאי גזע‬
]34[
METHODS FOR CULTIVATING
STEM CELLS, CELL CULTURES
AND THE USE OF AN EGG FOR
THE CULTIVATION OF THE STEM
CELLS
]00[
]30[
]30[
]10[
09.05.2005
102004025086.3 ]30[ 21.05.2004
]33[ DE
Int. Cl.(2010.01) C12M 01//26, 03//10, C12N 05//00
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V., GERMANY
WO/2005/113750
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]71[
]14[
]31[
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
The invention relates to methods and devices for culturing stem cells (2, 3, 5)
involving the following steps: introducing cell material, which comprises at least one
stem cell (2, 3, 5) of a donor organism, into a host egg (4) having a nutrient reservoir,
and culturing the cell material inside the host egg (4). The invention also relates to a
cell culture and to a cell culture device for carrying out the method.
__________________
]00[]00[
]34[
283
REACTOR FOR GENERATING
MOISTURE AND MOISTURE
179335
‫ריאקטור לייצור לחות והתקן לייצור והזנת לחות‬
‫המשתמש בו‬
December 30, 2010-‫כג' בטבת התשע"א‬
GENERATING AND FEEDING
APPARATUS USING THE SAME
]00[
]30[
]30[
]10[
]71[
]14[
]31[
04.07.2005
2004-211129 ]30[ 20.07.2004
Int. Cl.(2010.01) C01B 05//00
FUJIKIN INCORPORATED, JAPAN
WO/2006/008949
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]33[
JP
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
A reactor with a limited volumetric capacity for generating moisture capable of safely
doubling the generated amount of moisture by increasing the heat radiation
characteristic of a reactor body and a feeding apparatus using the reactor. More
specifically in the reactor, hydrogen and oxygen fed into the reactor body are brought
into contact with a platinum coated catalyst layer to active the reactivity thereof so that
the hydrogen and the oxygen are allowed to react with each other under a noncombustion state. A cooler is formed of an outlet side cooler having a heat radiating
body substrate with a heater insert hole at a center which is fixed to the outer surface
of an outlet side furnace body member and a plurality of heat radiating bodies
vertically installed on those portions of the heat radiating body substrate other than the
heater insert hole parallel with each other. A part of a heater for heating the reactor
body is inserted into the heater insert hole of the outlet side cooler and fixed to the
outer surface of the outlet side furnace body member.
__________________
]00[]00[
]34[
284
PURINE DERIVATIVES AS
ADENOSINE A1 RECEPTOR
AGONISTS AND COMPOSITIONS
COMPRISING THEM
179400
A1 ‫תולדות פורין כאגוניסטים לקולטן אדנוסין‬
‫ותרכובות המכילות אותן‬
December 30, 2010-‫כג' בטבת התשע"א‬
]00[
]30[
]30[
]10[
]71[
]14[
]31[
25.05.2005
60/574805
]30[ 26.05.2004
]33[ US
620377063
0302100224
US
Int. Cl.(2010.01) A61K 31//7056, 31//7076, 31//708, C07H 19//12
INOTEK PHARMACEUTICALS
CORPORATION, U.S.A.
WO/2005/117910
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
The invention relates to Purine Derivatives, compositions comprising an effective
amount of a Purine Derivative; and methods for reducing an animal’s rate of
metabolism, protecting an animal’s heart against myocardial damage during
cardioplegia; or for treating or preventing a cardiovascular disease, a neurological
disorder, an ischemic condition, a reperfusion injury, obesity, or wasting disease, or
diabetes, comprising administering an effective amount of a Purine Derivative to an
animal in need thereof.
__________________
]00[]00[
179440
‫דיווח על יכולות מסוף עבור תמיכה בשירות‬
‫הודעות קצרות‬
]34[
REPORTING TERMINAL
CAPABILITIES FOR
SUPPORTING SHORT MESSAGE
SERVICE
]00[
]30[
25.05.2005
60/576700
]30[ 02.06.2004
]33[ US
000000323
0002400223
US
Int. Cl.(2010.01) H04L 12//58, H04W 04//12, 04//14, 88//02
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
]30[
]10[
285
December 30, 2010-‫כג' בטבת התשע"א‬
]71[
]14[
]31[
WO/2005/122604
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A method for delivering a short message service (SMS) message to an interworking
wireless local area network user equipment (UE) (122) begins by registering the UE
with an Internet Protocol short message gateway (IP- SM-GW) (118). A capability
report is sent from the UE to the IP-SM-GW, the capability report including the
capabilities of the UE. A SMS message is transmitted from a short message service
center (SMSC) (104) to the IP-SM-GW. The capabilities of the UE are evaluated at the
IP-SM-GW to determine whether the UE can receive the SMS message, and the SMS
message is delivered to the UE via the IP-SM-GW if the UE has the capabilities to
receive the SMS message.
__________________
]00[]00[
179464
,‫ חלל המשמש לייצור השקית‬,‫שקית זילוף‬
‫ושיטה לייצורה‬
]34[
PIPING BAG, BLANK FOR
MANUFACTURING A PIPING
BAG AND METHOD OF
MANUFACTURING A PIPING
BAG
]00[
]30[
04.02.2005
0401356-1
]30[ 26.05.2004
]33[ SE
620314030
0602300224
US
Int. Cl.(2010.01) A23G 03//28, B65D 37//00, 75//06
KEE PLASTICS AB, SWEDEN
ALLAN EJEBLAD
WO/2005/115162
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
]30[
]10[
]10[
]71[
]14[
286
December 30, 2010-‫כג' בטבת התשע"א‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
P.O. B. 2081,
HERZLIYA 46120
]31[
A disposable piping bag (1) comprises a container of polymer film. The piping bag is
formed essentially from a thin-walled polymer tube, and an outwardly oriented surface
of the piping bag has a surface structure.
__________________
]00[]00[
179757
,‫נגזרות פלורוגליקוזידיות של פירזולים‬
‫ תהליך להכנתן‬,‫תרופות המכילות אותן‬
‫ושימוש שלהן‬
]34[
FLUOROGLYCOSIDE
DERIVATIVES OF PYRAZOLES,
MEDICAMENTS CONTAINING
THESE COMPOUNDS, PROCESS
FOR PREPARING SUCH
MEDICAMENTS AND THE USE
THEREOF
]00[
]30[
]30[
]10[
03.06.2005
102004028241.2 ]30[ 11.06.2004
]33[ DE
Int. Cl.(2010.01) A61K 31//7056, A61P 03//10, C07H 17//02
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2005/121161
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
]71[
]14[
]31[
287
The invention relates to substituted fluoroglycoside derivatives of pyrazoles of formula
(I), in which the radicals have the indicated meanings, to the physiologically
compatible salts thereof, and to a method for the production thereof. The compounds
are suited for as, e.g. antidiabetics.
December 30, 2010-‫כג' בטבת התשע"א‬
‫__________________‬
‫‪179840‬‬
‫התקן למיטת תינוק למניעת מוות בעריסה‬
‫ענת גבאי‪ ,‬אשדוד‬
‫משה גבאי‪ ,‬אשדוד‬
‫ענת גבאי‪ ,‬משה גבאי‬
‫ענת גבאי‪,‬‬
‫השקמה ‪11‬‬
‫אשדוד‬
‫[‪]00[]00‬‬
‫‪APPARATUS FOR CRIB FOR‬‬
‫‪SUDDEN INFANT DEATH‬‬
‫‪PREVENTION‬‬
‫[‪]34‬‬
‫‪05.12.2006‬‬
‫‪Int. Cl.(2010.01) A47C 21//04, A47D 01//00‬‬
‫‪ANATTE GABBAI‬‬
‫‪MOSHE GABBAI‬‬
‫[‪]00‬‬
‫[‪]30‬‬
‫[‪]10‬‬
‫‪ANATTE GABBAI, MOSHE‬‬
‫‪GABBAI‬‬
‫‪ANATTE GABBAI,‬‬
‫‪11 HA SHIKMA STREET‬‬
‫‪ASHDOD 77259‬‬
‫[‪]10‬‬
‫התקן הבא לסייע במניעת תסמונת מוות בעריסה‪ ,‬הכולל מזרון למיטת‪-‬תינוק סטנדרטית במימדי מזרון‪-‬תינוקות סטנדרטי‪,‬‬
‫שמעליו נמתח בחוזקה סדין עשוי מאריג‪-‬רשת‪ ,‬מורכב משלוש שכבות מודבקות זו לזו לכדי מיקשה אחת כאשר‪:‬‬
‫‪o‬א) לשכבה התחתונה של המזרון‪ ,‬שהיא דחוסה בהרכבה ומהווה מצע קשיח‪ ,‬יש תעלות רוחביות המאפשרות מעבר אופקי‬
‫של‬
‫אויר מקצה אחד של המזרון לקצהו השני;‬
‫‪o‬ב) לשכבה האמצעית של המזרון‪ ,‬הזהה בדחיסותה לשכבה התחתונה‪ ,‬יש חללים ריבועיים לאורכה ולרוחבה‪ ,‬המאפשרים‬
‫זרימת‪ -‬אויר אנכית דרכם;‬
‫‪o‬ג) גם לשכבה העליונה של המזרון יש חללים ריבועיים לאורכה ולרוחבה‪ ,‬בזהה לשכבה האמצעית‪ ,‬אך היא פחות צפופה‬
‫בהרכבה‬
‫ורכה יותר למגע;‬
‫כך ששילוב שתי השכבות העליונות של המזרון עם השכבה התחתונה של המזרון מהווה מזרון יציב ונוח שמעליו נמתח‬
‫ונקשר אל סורגי‪-‬המיטה סדין מרשת‪ ,‬אשר דרכה מתאפשר גם מעבר‪-‬אוויר לנשימה וגם ניקוז פליטות‪-‬מזון אל תוך התעלות‬
‫שבשכבה התחתונה‪ ,‬ובכך מתאפשרת סירקולצית‪-‬אוויר דו‪-‬כיוונית ורציפה לתינוק הישן על בטנו על‪-‬גבי ההתקן‪0‬‬
‫[‪]14‬‬
‫[‪]31‬‬
‫__________________‬
‫כג' בטבת התשע"א‪December 30, 2010-‬‬
‫‪288‬‬
]00[]00[
179895
‫שיטה לייצור וקו ייצור ליריעות על בסיס חומר‬
‫מצמיד הידראולי והתקן להטבעה‬
]34[
METHOD FOR
MANUFACTURING SHEETS
BASED ON HYDRAULIC BINDER,
PRODUCTION LINE FOR
PRODUCING SUCH SHEETS AND
APPARATUS FOR MAKING AN
IMPRESSION
]00[
]30[
25.02.2003
02290462.7
]30[ 26.02.2002
]33[ EP
2000003003
2602300220
EP
Int. Cl.(2010.01) B26D 05//34, B28B 11//14, 19//00
DIVISION FROM 163517
LAFARGE PLATRES, FRANCE
PAUL JALLON, MICHEL
RIGAUDON, JEAN LOUIS
LAURENT, JEAN PAUL SOLOMUT
WO/2003/072326
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
]30[
]60[
]10[
]10[
]71[
]14[
]31[
289
,‫אגמון‬-‫סורוקר‬
14 ‫ רחוב שנקר‬,‫בית נולטון‬
‫הרצליה פיתוח‬
The invention relates to a method for production of sheets made from binder, in
particular plasterboards with recessed edges. Said method comprises the following
steps: 1) generation of a marking (301) on a face (2 or 3) of the pre-form (5); 2)
detection of the marking (301) and 3) transmission of an actuation signal to a cutting
device (9) for the pre-form (5). The invention further relates to a production line for
said sheets, and a unit, particularly for the generation of an impression (12, 12bis) in a
pre-form (5). Said unit comprises a frame (101), first (102, 103) and second
pulleys(105, 106), two belts (108, 109) around the pulleys (102, 103, 105, 106) and at
least one line (111) running between said belts (108, 109), such that the axis thereof is
parallel to the axis of the pulleys (102, 103, 105, 106).
__________________
December 30, 2010-‫כג' בטבת התשע"א‬
]00[]00[
179940
‫שיטה לייצור מערכת קירור להתקן אלקטרוני‬
]34[
METHOD OF MAKING AN
ELECTRONIC DEVICE COOLING
SYSTEM
]00[
]30[
]30[
]10[
10.12.2006
11/297868
]30[ 09.12.2005
]33[ US
Int. Cl.(2010.01) F25B 15//06, H01L 21//302
GENERAL ELECTRIC COMPANY,
U.S.A.
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
A method is provided. The method includes forming a conductive layer on an inner
surface of a substrate and providing a sacrificial layer over the conductive layer. The
method includes forming a plurality of channels in the sacrificial layer and plating the
sacrificial layer to substantially fill the plurality of channels with a plating material
comprising conducting material. The method also includes etching the sacrificial layer
to form a conducting structure having fins where conducting material remains
separated by microchannels where the sacrificial layer is etched.
]14[
]31[
__________________
]00[]00[
]34[
ALLOCATION OF RADIO
RESOURCE IN ORTHOGONAL
FREQUENCY DIVISION
MULTIPLEXING SYSTEM
]00[
]30[
24.06.2005
10-20040048436
02-02242233030
02-0224-
290
]30[
25.06.2004
179959
OFDM ‫הקצאת משאבי רדיו במערכת‬
]33[
KR
2702100224
KR
3000000224
KR
December 30, 2010-‫כג' בטבת התשע"א‬
]30[
]10[
]71[
]14[
]31[
2007271
Int. Cl.(2010.01) H04B 07//26
LG ELECTRONICS INC., REPUBLIC
OF KOREA
WO/2006/001658
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
An uplink capacity is increased by a method in which more than two mobile stations
simultaneously use a radio resource allocated to one mobile station. A method of
allocating a radio resource in an orthogonal frequency division multiplexing system
comprises receiving data associated with a radio resource allocation map from a base
station, wherein the radio allocation map comprises control parameters for transmitting
uplink data to the base station. The control parameters comprises orthogonal pilot
pattern indicator for using orthogonal pilot patterns associated with supporting at least
concurrent dual transmission by at least one mobile station, and for use in the same
frequency band and same time duration. The orthogonal pilot patterns comprises at
least a minus pilot being used for an uplink basic allocation unit. The mobile station
then transmits uplink data to the base station by using the orthogonal pilot patterns.
__________________
]00[]00[
]34[
PROCESS FOR PRODUCING (Z)-1PHENYL-1DIETHYLAMINOCARBONYL-2HYDROXYMETHYLCYCLOPROPANE
]00[
]30[
]30[
]10[
23.06.2005
2004-188901
]30[
25.06.2004
Int. Cl.(2010.01) C07C 23/1/02, 23/5/40
SUMITOMO CHEMICAL COMPANY,
291
180189
– 5 – ‫ – פאניל‬Z) – 1( ‫הליך עבור ייצור‬
– 1 – ‫דיאת'ילאמינוקרבוניל‬
‫הידרוקסימת'ילציקלופרופאן‬
]33[
JP
December 30, 2010-‫כג' בטבת התשע"א‬
]71[
]14[
]31[
LIMITED., JAPAN
WO/2006/001498
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
,‫ד"ר יצחק הס ושותפיו‬
516 ‫רחוב הירקון‬
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
Disclosed is a method for producing (Z)-1-phenyl-1-diethylaminocarbonyl-2hydroxymethyl cyclopropane which comprises a process for reacting 2-oxo-1-phenyl-3oxabicyclo[3.1.0]hexane with diethylamine in the presence of an alkali metal alkoxide.
__________________
]00[]00[
180233
]34[
CD34+ HEMATOPOIETIC CELLS
ENGINEERED TO PRODUCE
TUMOR NECROSIS FACTORRELATED APOPTOSIS INDUCING
LIGAND (TRAIL)
]00[
]30[
]30[
]10[
]71[
]14[
21.07.2005
04017907.9
]30[ 29.07.2004
]33[ EP
Int. Cl.(2010.01) C07K 14//435, 14//705, C12N 05//0789
DOMPE PHA.R.MA S.P.A., ITALY
WO/2006/010558
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]31[
292
‫ המטופויטיים מהונדסים לייצור‬+CD34 ‫תאי‬
TRAIL
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention refers to tumor-homing cells expressing the tumor necrosis factorrelated apoptosis inducing ligand (TRIAL), particularly to CD34+ and NK cells
transduced with adenoviral vectors coding for TRIAL. The cells of the invention are
useful for the intravenous treatment of tumors, particularly of lymphoma.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
180261
‫התקן ומערכת לחישה תוך גופית של חללים בגוף‬
]34[
DEVICE AND SYSTEM FOR INVIVO SENSING OF A BODY
LUMEN
]00[
]30[
]30[
]10[
]10[
]14[
21.12.2006
11/319772
]30[ 29.12.2005
]33[ US
Int. Cl.(2010.01) A61B 01//00, 05//07, 05//12
GIVEN IMAGING LTD.
‫ יקנעם‬,‫גיוון אימג'ינג בע"מ‬
ZVIKA GILAD
‫צביקה גלעד‬
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
An in-vivo system comprising:
a plurality of unconnected in-vivo devices,
wherein a first in-vivo device comprises an imager and a transmitter,
wherein each of the devices may be detachably coupled to another of the devices by a
magnetic connection, and
wherein an in vivo device of the in vivo devices comprises a ball and socket joint
connection.
]31[
293
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
180845
‫חיישן תנודות‬
]34[
VIBRATION SENSOR
]00[
]30[
]30[
]10[
26.07.2005
60/590896
]30[ 26.07.2004
]33[ US
Int. Cl.(2010.01) G01N 29//00, G03F 01//14
SPIDER TECHNOLOGIES
‫ לוד‬,‫ספיידר טכנולוגיות סקיוריטי בע"מ‬
SECURITY LTD.
WO/2006/011145
FISHER WEILER JONES,
,‫פישר וילר ג'ונס‬
26 HABARZEL STREET
51 ‫הברזל רמת החיל‬
RAMAT HACHAYAL,
‫תל אביב‬
TEL-AVIV 69710
]71[
]14[
]31[
294
A method for measuring a vibration from four or more equidistant points in a chamber
(150), comprising centering a chamber surface (154) around a center point (156),
containing a fluid (152) within the chamber surface (154), measuring a fluid vibration
from at least four measuring points in juxtaposition with the chamber surface, wherein
at least two measuring points are located along a first axis passing through the center
point and at least two measuring points are located along a second axis passing through
the center point (156).
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
METHOD FOR THE
PREPARATION OF A DERYTHRO-2,2-DIFLUORO-2DEOXY-1-OXORIBOSE
DERIVATIVE
]00[
]30[
23.06.2005
10-2004]30[ 23.07.2004
0057711
Int. Cl.(2010.01) C07H 03//08
HANMI PHARM. CO. LTD.,
REPUBLIC OF KOREA
WO/2006/009353
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]30[
]10[
]71[
]14[
]31[
180893
–1,1–‫–אריתרו‬D ‫תהליך להכנת תולדה של‬
‫–אוקסוריבוזה‬5–‫–דיאקסי‬1–‫דיפלורו‬
]33[
KR
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
3R-carboxylate enantiomer derivative of formula (III) can be prepared easily and
selectively by the method of the present invention, and a highly pure D-erythro-2,2difluoro-2-deoxy-1-oxoribose derivative can be prepared efficiently from the
compound of formula (III) as an intermediate.
__________________
]00[]00[
]34[
295
FLUID FLOW METER AND
181180
‫מד זרימת ניגר ומערבל בעל יחידת העתקה‬
‫הניתנת להסרה והחלפה‬
December 30, 2010-‫כג' בטבת התשע"א‬
MIXER HAVING REMOVABLE
AND REPLACEABLE
DISPLACEMENT MEMBER
]00[
]30[
]10[
]71[
]14[
]31[
10.08.2004
Int. Cl.(2010.01) G01F 01//37
MCCROMETER, INC., U.S.A.
WO/2006/022702
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
A fluid flow meter (10), including a displacement member (40) removably mounted in
a conduit (20) and a pipe extending through the wall of the conduit and having a
portion extending through the displacement member to its downstream face for
sensing flow conditions at the axis of the conduit downstream of the displacement
member. The displacement member is removable and replacebly mounted so that one
member can be replaced by another and thereby accommodate a very broad range of
flows.
__________________
]00[]00[
181183
‫שימוש במעכב אלאסטז להכנת תרופה לטיפול‬
‫בלוקמיה‬
]34[
USE OF AN ELASTASE
INHIBITOR IN THE
MANUFACTURE OF A
MEDICAMENT FOR THE
TREATMENT OF LEUKEMIA
]00[
]30[
]30[
04.08.2005
163453
]30[ 10.08.2004
]33[ IL
Int. Cl.(2010.01) A61K 38//07, 38//55, 45//00, C07K 16//40, C12Q 01//37, G01N
33//574
YEDA RESEARCH AND
‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬
]10[
296
December 30, 2010-‫כג' בטבת התשע"א‬
]10[
]71[
]14[
]31[
DEVELOPMENT CO. LTD.
TSVEE LAPIDOT, SIGAL TAVOR,
ISABELLE PETIT
WO/2006/016353
INTERLAB LTD.,
18 HAKISHON ST.
YAVNE 81220
,‫אינטר לאב בע"מ‬
11 ‫הקישון‬
‫יבנה‬
The invention relates to the use of an elastase inhibitor in the manufacture of a
medicament for the treatment of leukemia, preferably acute leukemia and more
preferably for the treatment of AML.
__________________
]00[]00[
181468
]34[
E2 SUBUNIT VACCINE
COMPRISING RECOMBINANT
PESTIVIRUS E2 PROTEIN
]00[
]30[
]30[
]60[
]10[
17.12.1998
97203989.5
]30[ 18.12.1997
]33[
Int. Cl.(2010.01) A61K 39//12, C12N 15//866
DIVISION FROM 136815
BAYER AKTIENGESELLSCHAFT,
GERMANY
STICHTING INSTITUUT VOOR
DIERHOUDERIJ EN
DIERGEZONDHEID, THE
NETHERLANDS
DIETMAR KRETZDORN, DIRK
FRANCISCUS MARINUS VAN DE
WIEL, ABRAHAM JOHANNES DE
SMIT, ERIK KEES HAMANN,
ROBERTUS JACOBUS MARIA
MOORMANN
WO/1999/031257
]10[
]71[
297
‫ המכיל חלבון רקומביננטי‬E2 ‫חיסון תת יחידה‬
‫ של פסטיוירוס‬E2
EP
December 30, 2010-‫כג' בטבת התשע"א‬
]14[
]31[
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
1 ‫רחוב שנקר‬
‫הרצליה‬15111 .‫ד‬.‫ ת‬,
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
An E2 subunit vaccine comprising recombinant Classical Swine Fever Virus (CSFV)
E2 glycoprotein produced in a baculovirus system, wherein said E2 glycoprotein is not
immunoaffinity plurified and confers protection against a CSFV infection at the PD95
level after one single vaccination with 32 micrograms of said E2 glycoprotein, and
wherein said E2 glycoprotein lacks a transmembrane region (TMR).
__________________
]00[]00[
181542
‫התקן לניקוי צינורות סינון המשמשים לסחיטת‬
‫מיץ פרי‬
]34[
DEVICE FOR CLEANING
FILTER PIPES USED TO
EXTRACT FRUIT JUICE
]00[
]30[
]10[
25.02.2007
Int. Cl.(2010.01) A23N 01//00, B08B 05//00, 05//02, 09//00
FOOD MACHINERY ESPANOLA
S.A., SPAIN
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
A device for cleaning a filter pipe used to extract fruit juice, said filter pipe having a
plurality of holes defined therein, said device comprising:
a cylindrically shaped tube that runs radially inward of the filter pipe, said tube having
a first end, at least one inlet for a fluid proximate said first end, and a plurality of
circumferential openings such that said circumferential openings and said holes are in
fluid communication; and
a chamber radially inward of said tube such that said chamber is configured to channel
the fluid therethrough along a length of said tube between said inlet and said
circumferential openings and holes.
]14[
]31[
298
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
181643
‫התקן קידוח בעל כנפיים המשתרעות זו אחר זו‬
‫ושיטה להנעתו‬
]34[
DRILLING APPARATUS HAVING
IN-LINE EXTENDING WINGS
AND DRIVING METHOD
THEREOF
]00[
]30[
02.09.2005
10-2004]30[ 03.09.2004
]33[ KR
0070565
Int. Cl.(2010.01) E21B 01//30, 10//26, 10//32, 10//36
BYUNG-DUK LIM, REPUBLIC OF
KOREA
WO/2006/025713
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
]30[
]10[
]71[
]14[
]31[
299
The present invention relates to a borehole drilling apparatus with in-line extending
wings and driving method thereof. The drilling apparatus comprises a guide device
rotating while moving upwardly and downwardly in a casing to fit into aborehole,
extending wings for exterκling the diameter of adriUedhole,
arκiapUotbitinstelledatalowerportionofthe guide deviceto strike the bottom of the
borehole, wherein spiral projections formed at a lower surface of tiie guide device
slidably engage with guide grooves formed at a side of the extending wings to each
other, and a window is formed at a side of Hie pilot bit for advancing and retracting the
extending wings so that they can spread and return linearly from the center of the pilot
bit
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
SHORT MESSAGE CONVERSION
BETWEEN DIFFERENT
FORMATS FOR WIRELESS
COMMUNICATION SYSTEMS
]00[
]30[
]30[
]60[
]10[
09.07.2003
10/192134
]30[ 09.07.2002
Int. Cl.(2010.01) H04W 04//14, 04//18
DIVISION FROM 165833
QUALCOMM INCORPORATED,
U.S.A.
WO/2004/006595
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]71[
]14[
]31[
181993
‫המרת הודעה קצרה בין פורמטים שונים עבור‬
‫מערכות תקשורת אלחוטית‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A method for converting a first short message in a first format to a second short
message in a second format comprisindg:
setting a first field in the second message to a value indicative of a short message in
the first format being included in the second short message;
setting a second field in the second short message to a value indicative of the data
coding scheme used for the first short message;
setting a data field in the second sort message to the data in the data field included in
the first short message;
setting a length field in the second message to a value indicative of the length of the
data included in the first message; and
defining a new value for said first field in the second short message, wherein said new
value is indicative of the data code scheme used for an encapsulated message in the
300
December 30, 2010-‫כג' בטבת התשע"א‬
first format,
wherein the first short message is a GMS SMS message, the second short message is a
CDM SMS message, said first feild in the second short message is a Msg_Encoding
field , said second field in the second short message is Message_Type field 0
__________________
]00[]00[
182008
‫שימוש בתרכובת נוגדת פקקת ליצור תרופה‬
‫למתן ריאתי למניעה או טיפול בפקקת או‬
‫בהפרעות דומות‬
]34[
USE OF AN ANTITHROMBOTIC
COMPOUND FOR THE
MANUFACTURE OF A
MEDICAMENT FOR
PULMONARY DELIVERY FOR
PREVENTION OR TREATMENT
OF THROMBOSIS OR RELATED
DISORDERS
]00[
]30[
]30[
]10[
03.10.2005
04104897.6
]30[ 06.10.2004
]33[
Int. Cl.(2010.01) A61K 09//10, 31//70, 38//14
N.V. ORGANON, THE
NETHERLANDS
WO/2006/037771
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]71[
]14[
]31[
EP
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to the use of an oligosaccharide conjugated to a direct thrombin
inhibitor for the manufacture of a medicament for the pulmonary delivery of said
compound for the prevention or treatment of thrombosis or related disorders.
__________________
]00[]00[
]34[
301
PRE-ALIGNMENT OUTSIDE AN
ANTENNA MEASUREMENT
RANGE
182032
‫קדם–כיוון משושה מחוץ לתחום מדידה‬
December 30, 2010-‫כג' בטבת התשע"א‬
]00[
]30[
]10[
]71[
]14[
]31[
30.09.2004
Int. Cl.(2010.01) G01R 29//08
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL), SWEDEN
WO/2006/036094
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
A method is disclosed for optically pre-aligning and referencing an antenna set-up
outside an antenna measurement range. The pre-alignment is performed in an
integration room close to the antenna measurement range in order to avoid
unnecessary occupation of the measurement range. The method teaches a technique
using generally a pair of high accuracy theodolites (T1, T2) to by means of a room
mirror reference (RM) and an antenna mirror-cube transfer a difference between the
co-ordinate system of an integration tower (INT) used and the measurement range
antenna tower.
.
__________________
]00[]00[
182383
‫ המבוססת על השתקה‬,‫מערכת כפולת היבריד‬
‫גנית באמצעות הפרעת תיעתוק‬
]34[
DOUBLE HYBRID SYSTEM
BASED ON GENE SILENCING BY
TRANSCRIPTIONAL
INTERFERENCE
]00[
]30[
]30[
]10[
]71[
]14[
24.10.2005
0411372
]30[ 25.10.2004
]33[ FR
Int. Cl.(2010.01) C12N 01//19, 15//65, 15//81, C12Q 01//68, G01N 33//53
AVENTIS PHARMA S.A, FRANCE
WO/2006/045941
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
302
December 30, 2010-‫כג' בטבת התשע"א‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
REHOVOT 76122
]31[
The invention relates to a novel double hybrid system and to the uses thereof. This
system provides, in particular, a tool that enables the detection of the interruption of a
protein-protein interaction. The developed system uses transcription interference as a
mechanism for detecting a breaking up of interacting protein pairs. The developed
double hybrid system can be applied to the screening of molecules enabling the
detection of molecules breaking up a protein-protein interaction as well as enabling the
identification of alleles lacking in the interaction of proteins involved in the proteinprotein interactions.
__________________
]00[]00[
182451
‫מחסנית סינון‬
]34[
FILTER CARTRIDGE
]00[
]30[
11.10.2005
10 2004 049
]30[ 13.10.2004
]33[ DE
876.8
Int. Cl.(2010.01) A47J 31//60, B01D 24//10, C02F 01//00
BRITA GMBH, GERMANY
WO/2006/040121
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
]30[
]10[
]71[
]14[
]31[
303
The invention relates to a filter cartridge (1), in particular a suction filter cartridge, in
which the inlet region (10) and the outlet opening (20) are arranged in the base region.
The outlet opening (20) is connected to the inlet region (10) via a bypass, which is
located in a lower section of the outflow chamber (2a) or below the outflow chamber
(2a).
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
182481
‫מחסנית סינון ותושבת למחסנית סינון‬
]34[
FILTER CARTRIDGE AND SEAT
ELEMENT FOR A FILTER
CARTRIDGE
]00[
]30[
]30[
]10[
]71[
]14[
11.10.2005
102004049877.6 ]30[ 13.10.2004
]33[ DE
Int. Cl.(2010.01) A47J 31//60, B01D 24//10, C02F 01//00
BRITA GMBH, GERMANY
WO/2006/040120
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
]31[
The invention relates to a filter cartridge (1), especially a suction filter cartridge, which
is provided, in the outlet opening (20), with an inward-pointing, peripheral snap-on rim
(22) which can be folded from a first lower snap position into a second upper snap
position and vice versa. The invention also relates to a seat element (30) for such a
filter cartridge, comprising a connecting sleeve (33) which engages with the outlet
opening (20) of the filter cartridge (1). Said connecting sleeve (33) comprises at least
one actuator which displaces, when the filter cartridge (1) is placed on the rim, the
snap-on rim from a first lower snap position to the second upper snap position in which
the snap-on rim rests against the connecting sleeve (33) in a sealing and clamping
manner.
__________________
304
December 30, 2010-‫כג' בטבת התשע"א‬
]00[]00[
182866
‫תהליך ליצוב תולדות תיאופן‬
]34[
PROCESS FOR STABILISING
THIOPHENE DERIVATIVES
]00[
]30[
]30[
]10[
]14[
30.04.2007
102006020744.0 ]30[ 04.05.2006
]33[
Int. Cl.(2010.01) A61K 33//00, C07D 49/5/04
H.C. STARCK GMBH, GERMANY
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]31[
Methods of stabilizing thiophene derivatives of the formula (I) as given in the
specification comprise their treatment with basic compounds.
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]00[]00[
182984
‫הכנה של מלחי בורהידריד‬
]34[
PREPARATION OF
BOROHYDRIDE SALTS
]00[
]30[
]30[
]10[
03.05.2007
60/801917
]30[ 19.05.2006
]33[
Int. Cl.(2010.01) A61K 35//00, C01B 06//21
ROHM AND HAAS COMPANY,
U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]31[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A method for preparing a metal borohydride salt, M(BH4)n, where n is 1 or 2, from a
slurry of sodium borohydride and a sodium alkoxide in a liquid hydrocarbon, wherein
M is Li, K, Rb, Cs, Mg, Ca, Sr or Ba.
__________________
]00[]00[
]34[
305
IMPLANTABLE COLLAGEN
COMPOSITIONS
183083
‫תרכובות קולגן ניתנו להשתלה‬
December 30, 2010-‫כג' בטבת התשע"א‬
]00[
]30[
]30[
]10[
]71[
]14[
]31[
25.10.2005
10/985570
]30[ 10.11.2004
]33[ US
Int. Cl.(2010.01) A61F 02//00, 02//02, A61L 24//10
FIBROGEN, INC., U.S.A.
WO/2006/052451
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to collagen compositions suitable for use in various tissue
augmentation procedures.
__________________
]00[]00[
183953
,‫שיטה להפחתת קלקול הנגרם על–ידי מחמצנים‬
‫ בתרופות או בדם מאוחסן ותרכובות‬,‫במוצרי מזון‬
‫עבורה‬
]34[
METHOD OF REDUCING
OXIDANT INDUCED DAMAGE OF
A FOOD PRODUCT, A
PHARMACEUTICAL OR STORED
BLOOD AND NOVEL
COMPOUNDS THEREFOR
]00[
]30[
]30[
]60[
]10[
25.01.2000
60/117010
]30[ 25.01.1999
]33[ US
Int. Cl.(2010.01) A61K 31//409, A61P 11//00, C07D 48/7/22
DIVISION FROM 144503
NATIONAL JEWISH MEDICAL AND
RESEARCH CENTER, U.S.A.
DUKE UNIVERSITY, U.S.A.
AEOLUS SCIENCES, INC., U.S.A.
MICHAEL P. TROVA, IRWIN
FRIDOVICH, INES BATINICHABERLE, JAMES D. CRAPO,
BRIAN J. DAY, POLIVINI JOLICIA
F. GAUUAN, DOUGLAS B.
KITCHEN
WO/2000/043395
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
JERUSALEM 91450
]10[
]71[
]14[
]31[
306
The present invention relates, in general, to a method of modulating physiological and
December 30, 2010-‫כג' בטבת התשע"א‬
pathological processes and, in particular, to a method of modulating cellular levels of
oxidants and thereby processes in which such oxidants are a participant. The invention
also relates to compounds and compositions suitable for use in such methods.
__________________
]00[]00[
‫פרוטזת דיסק בין–חולייתית‬
]34[
INTERVERTEBRAL DISC
PROSTHESIS
]00[
]30[
]30[
]10[
]10[
]71[
]14[
14.12.2005
0413728
]30[ 22.12.2004
Int. Cl.(2010.01) A61F 02//44
LDR MEDICAL, FRANCE
WILLEM ZEEGERS
WO/2006/120505
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
]31[
307
184068
]33[
FR
,‫ד"ר מרק פרידמן בע"מ‬
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
The present invention relates to an intervertebral disc prosthesis comprising at least
three pieces including an upper plate (1), a lower plate (2), and a movable core (3) at
least in relation to a plate, wherein it also comprises two anatomic adaptation elements
(11, 22) of which each has, on one hand, a surface (110, 220) in contact with a surface
of a vertebra and, on the other hand, a surface (111) of which at least a part has a
surface in contact with a least a part of the plate (1 or 2) opposite to which the
anatomic adaptation element (11 or 22) is mounted, the anatomic adaptation elements
(11, 22) being fixed onto the plates (1, 2) via fixation means (113, 223).
__________________
December 30, 2010-‫כג' בטבת התשע"א‬
]00[]00[
184175
‫ שיטה לייצורם‬,‫פירולידינים סולפוניל‬
‫ושימוש שלהם כתרופות‬
]34[
SULFONYL PYRROLIDINES,
METHOD FOR PRODUCING THE
SAME AND THEIR USE AS DRUGS
]00[
]30[
]30[
]10[
]71[
]14[
21.12.2005
102005000666.3 ]30[ 04.01.2005
]33[ DE
Int. Cl.(2010.01) A61K 31//4025, C07D 29/5/22, 40/3/00
SANOFI AVENTIS, FRANCE
WO/2006/072393
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]31[
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
The invention relates to substituted sulfonyl pyrrolidines and to their physiologically
acceptable salts. The invention also relates to the compounds of formula (I), wherein
the substituents are defined as indicated, and to the physiologically acceptable salts
thereof. The inventive compounds are e.g. suitable as drugs for increasing HDL.
__________________
]00[]00[
184282
‫תרכובות זהב קולואידיות ושימושיהן‬
]34[
COLLOIDAL GOLD
COMPOSITIONS AND THEIR
USES
]00[
]30[
30.04.2002
60/287363
]30[ 30.04.2001
]33[ US
620320123
2002700220
US
020203317
2702300220
US
Int. Cl.(2010.01) A61K 38//00, 47//48, A61P 35//00
]30[
308
December 30, 2010-‫כג' בטבת התשע"א‬
]60[
]10[
]71[
]14[
]31[
DIVISION FROM 158654
CYTIMMUNE SCIENCES, INC.,
U.S.A.
WO/2002/087509
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
1 ‫רחוב שנקר‬
‫הרצליה‬15111 .‫ד‬.‫ ת‬,
Use of a colloidal gold particle, at least one anti-cancer agent, and a polyethylene
glycol derivative covalently bound to the colloidal gold particle for the production of a
cector composition for treating a solid tumor.
__________________
]00[]00[
]34[
PROCESS COMPRISING
SOLUTION SPINNING OF UHMW
POLY(ALPHA-OLEFIN) WITH
RECOVERY AND RECYCLING OF
VOLATILE SPINNING SOLVENT
]00[
]30[
]30[
]10[
19.12.2005
11/028273
]30[ 03.01.2005
Int. Cl.(2010.01) D01F 06//04, 13//04
HONEYWELL INTERNATIONAL
INC., U.S.A.
WO/2006/073743
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]71[
]14[
]31[
309
184369
‫תהליך הכולל סחרור תמיסה המכילה אלפא‬
‫אולפין בעל משקל מולקולרי גבוה ביותר ושחזור‬
‫ומיחזור של ממס נדיף מסוחרר‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A process for spinning high molecular weight poly (alph-olefin) filament, particularly
ultrahigh molecular weight polyethylene filament, from solution in a volatile spinning
solvent with recovery and recycling of the solvent.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
METHOD AND CONTROL
CIRCUITRY FOR PROVIDING
AVERAGE CURRENT MODE
CONTROL IN A POWER
CONVERTER AND AN ACTIVE
POWER FILTER
]00[
]30[
]30[
]10[
]71[
]14[
13.03.2006
11/109433
]30[ 19.04.2005
Int. Cl.(2010.01) H05B 37//02
RAYTHEON COMPANY, U.S.A.
WO/2006/112991
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]31[
310
184486
‫שיטה ותוכנית מעגל חשמלי להספקת זרם‬
‫ממוצע באופן מבוקר בממיר כוח ובמסנן כוח‬
‫פעיל‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
In some embodiments, control circuitry (107) uses modified average current mode
control to regulate average current through an inductor (122) of a power converter
(106). In some embodiments, control circuitry (107) uses modified average current
mode control to regulate average current through an inductor (122) of an active power
filter. In some embodiments, control circuitry (107) uses average current mode control
to regulate average current through an inductor of an active power filter. This average
current mode control negates modulation of the average inductor current. In this way,
output ripple current of the power converter does not have a significant effect on the
input current drawn by the power converter.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
METHOD AND APPARATUS FOR
AZIMUTH DETERMINATION,
FOR EXAMPLE, FOR
AUTONOMOUS NAVIGATION
APPLICATIONS
]00[
]30[
]30[
]10[
]71[
]14[
17.02.2006
11/067665
]30[ 28.02.2005
Int. Cl.(2010.01) G01C 17//00
VECTRONIX AG, SWITZERLAND
WO/2006/089864
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]31[
311
185261
‫שיטה ומערכת לקביעת אזימוט לדוגמה עבור‬
‫יישומי ניווט אוטונומים‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
For an observer equipped with a first azimuth data source responsive to a magnetic
field to deliver first azimuth data, such as a compass, and with a second azimuth data
source delivering second azimuth data and which is independent of magnetic fields,
such as a gyroscope. The azimuth is determined by: - analyzing the first and second
azimuth data to determine whether a magnetic disturbance is present, and determining azimuth selectively on the basis of: the first azimuth data, the second
azimuth data, or a combination of the first and second azimuth data, as a function of
the result of the comparing step. In an embodiment, the choices of azimuth data source
and events such as magnetic disturbances, sensor updates, types of trajectory deduced,
are stored as a history sequence over successive time windows, by analogy with a
DNA sequence, and is exploited for optimizing azimuth or navigation results.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
FACIAL RECOGNITION AND THE
OPEN MOUTH PROBLEM
]00[
]30[
]30[
]10[
09.02.2006
11/058171
]30[ 16.02.2005
Int. Cl.(2010.01) G06K 09//00
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION
LTD.
MICHAEL BRONSTEIN,
ALEXANDER BRONSTEYN, RON
KIMMEL
WO/2006/087701
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
]10[
]71[
]14[
]31[
312
185282
‫הכרת הפנים ובעיית הפה הפתוח‬
]33[
US
‫ חיפה‬,‫מוסד הטכניון למחקר ופתוח בע"מ‬
‫ רון‬,‫ אלכסנדר ברונשטיין‬,‫מיכאל ברונשטיין‬
‫קימל‬
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
‫רמת גן‬
A method, for electronic face recognition using geodesic representations, of processing
such a geodesic representation of a face having a mouth and being able to adopt openmouthed or closed mouth states, so that the electronic recognition works regardless of
whether the mouth in the representation is open or closed. The method comprises:
identifying a mouth region within a face; applying a topological constraint to the
mouth region, and representing the face with the constraint. The topological constraint
is chosen to render the geodesic representation invariant to the mouth state being open
or closed.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
185578
‫שיטה ומערכת לסימון בלייזר בנפח של אבני חן‬
‫כגון יהלומים‬
]34[
METHOD AND SYSTEM FOR
LASER MARKING IN THE
VOLUME OF GEMSTONES SUCH
AS DIAMONDS
]00[
]30[
26.08.2005
60/656915
]30[ 01.03.2005
]33[ US
000060001
0002700223
US
Int. Cl.(2010.01) A44C 17//00, B23K 26//03, 26//40
INTERNATIONAL GEMSTONE
REGISTRY INC., CANADA
WO/2006/092035
BOROCHOV, KORAKH & CO.,
15TH FLOOR, ATIDIM TOWER,
KIRYAT ATIDIM,
P.O.B. 58100,
TEL AVIV 61580
]30[
]10[
]71[
]14[
]31[
313
,'‫בורוכוב קורח ושות‬
‫מגדל כלל עתידים‬
‫אביב‬-‫תל‬51100 .‫ד‬.‫ ת‬,
A method and an apparatus for laser marking indicia in the volume of gemstones such
as diamonds, the indicia being made up of a plurality of microscopic dot-shaped marks
whose build-up can be initiated by exposing naturally-occurring internal defects or
impurities in the volume of a gemstone to a tightly focused train of laser pulses.
Authentication data is encoded in the gemstone from the relative spatial arrangement
of the dot-shaped marks that form the indicium. Taking advantage of the presence of
otherwise invisible defects in the gemstone allows for inscribing indicia with laser
pulses carrying energies substantially lower than the threshold energy required for
inscribing in the volume of a perfect gemstone material. The marking process is then
much less susceptible to inflict damages to the surface of the gemstone, and the
marking can be performed using a broad variety of femtosecond laser systems. The
dot-shaped marks engraved at a depth below the surface of a gemstone can be made
undetectable with the unaided eye or with a loupe by limiting their individual size to a
December 30, 2010-‫כג' בטבת התשע"א‬
few micrometres, while devising indicia made up of only a few marks. As a result, the
marking does not detract from the appearance and value of the gemstone. The
procedure for laser marking accounts for the random spatial distribution of the defects
present in natural gemstones as well as for their strongly localized character. The
presence of an indicium can be detected by using a dedicated optical reader that can be
afforded by every jewellery store.
__________________
]00[]00[
185630
‫מקור אור רב תכליתי‬
]34[
MULTI-FUNCTION LIGHT
SOURCE
]00[
]30[
]30[
]10[
]71[
]14[
01.03.2006
60/656898
]30[ 01.03.2005
]33[ US
Int. Cl.(2010.01) F21L 04//08, F21S 08//00, F21V 21//14
ANGELIGHT LTD
WO/2006/092794
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]31[
314
‫ אביב‬-‫ תל‬,‫אנג'לייט בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A light source assembly (10) includes a light source (12) and a base (14) to which the
light source is detachably attachable. The base is adapted to orient the light source to a
plurality of positions when the light source is mounted thereon. The light source
comprises a battery mounted therein for providing power thereto, at least when the
light source is disconnected therefrom. The base is also adapted for being powered by
the battery and/or by an alternative power source. The light source is adapted to be
operational both when mounted on the base and when disconnected therefrom. The
light source assembly may further comprise a mounting plate for attachment thereof,
for example, to a building or an external surface of a vehicle.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
STABILIZED PHOTORESIST
STRUCTURE FOR ETCHING
PROCESS
]00[
]30[
02.03.2006
11/076087
]30[ 08.03.2005
000003363
2002000223
Int. Cl.(2010.01) H01L 21//027
LAM RESEARCH CORPORATION,
U.S.A.
PETER CIRIGLIANO, S.M. REZA
SADJADI, ERIC HUDSON, ZHISONG
HUANG, JI SOO KIM
WO/2006/096528
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]30[
]10[
]10[
]71[
]14[
]31[
315
185743
‫מבנה פוטורסיסט מיוצב עבור תהליך צריבה‬
]33[
US
US
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
A method for forming features in an etch layer is provided. A first mask is formed over
the etch layer where the first mask defines a plurality of spaces with widths. The first
mask is laterally etched where the etched first mask defines a plurality of spaces with
widths that are greater than the widths of the spaces of the first mask. A sidewall layer
is formed over the etched first mask where the sidewall layer defines a plurality of
spaces with widths that are less than the widths of the spaces defined by the etched
first mask. Features are etched into the etch layer through the sidewall layer, where the
features have widths that are smaller than the widths of the spaces defined by the
etched first mask. The mask and sidewall layer are removed.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
185831
‫סופית לכבל גרירה‬
]34[
TOW CABLE TERMINATION
]00[
]30[
03.03.2006
0504842.6
]30[ 09.03.2005
]33[ GB
2303040401
2002300223
EP
Int. Cl.(2010.01) B64D 03//00, F16G 11//00, F41J 09//10
SELEX GALILEO LTD, UNITED
KINGDOM
WO/2006/095206
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
]30[
]10[
]71[
]14[
]31[
316
A specialist tow cable termination for sustaining the tensile load when an object (9) is
towed at high speeds at the end of an cable behind an aircraft, the termination
comprises a closed eye bolt (3) attached to the cable and a U-bolt looped through the
eye bolt attached to the object. The arrangement allows 5 significant pivoting bending
stresses to the tow cable.
December 30, 2010-‫כג' בטבת התשע"א‬
__________________
]00[]00[
]34[
TOOL FOR MAKING ENHANCED
HEAT TRANSFER SURFACES
]00[
]30[
]30[
]10[
]71[
]14[
24.03.2006
60/665528
]30[ 25.03.2005
Int. Cl.(2010.01) B21B 19//08
WOLVERINE TUBE, INC., U.S.A.
WO/2006/105002
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]31[
186024
‫כלי ליצירת משטחים מוגדלים להעברת חם‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
An improved tool assembly for enhancing the surface of a heat transfer tube is
provided. The tool assembly includes rods having cutting tips and positioned in rod
guides which are slidably positioned in shafts provided in a tool holder. In an
equilibrium state, the cutting tips do not extend from the tool holder. When a force is
applied to the rod guides, the rod guides move in a first direction along the shafts in the
tool holder, resulting in exposure of the cutting tips which enhance the tube surface.
When the force is removed from the rod guides, the rod guides move along the shafts
in a direction opposite the first direction to retract the cutting tips within the tool
holder. In this way, the cutting tips are protected when not in use.
__________________
]00[]00[
]34[
317
METHOD FOR DETERMINING
TRUE MERIDIAN AND DEVICE
186077
‫השיטה לקביעת קו האורך האמיתי ומכשיר‬
‫ליישום השיטה‬
December 30, 2010-‫כג' בטבת התשע"א‬
FOR ITS IMPLEMENTATION
]00[
]30[
]10[
19.09.2007
Int. Cl.(2010.01) G01C 21//10
MICHAEL NAUMOV
GEORGE NAUMOV
]14[
MICHAEL NAUMOV,
HAZOR 3
TEL AVIV
]31[
A method for determining true meridian comprising the following stages:
rotating vessels making part of a sensor for measuring horizontal acceleration by
means of, for example, an electric motor, around the vertical of a mobile object, the
said vessels comprising pressure determination points which being positioned
symmetrically relative to the said vertical ,
determining a ground speed vector of the mobile object by any of the known ways,
determining accelerations by the said sensor for measuring horizontal along its axis
of sensitivity, the accelerations being produced due to changes in the projection of the
ground speed vector of the mobile object on the axis of sensitivity and due to changes
in the projection of a linear speed vector of the mobile object on the said axis of
sensitivity, the said linear speed being caused by the rotation of a heavenly body, more
specifically the terrestrial globe creating counteraction along the said axis of
sensitivity, equal by module and oppositely directed to action produced by the varying
projection of the ground speed vector of the mobile object,
determining the direction of the linear speed vector by a zero signal of the varying
linear acceleration which is produced due to change in the said projection of the linear
speed vector on the said axis of sensitivity of the sensor for measuring horizontal
acceleration,
determining a true heading of the mobile object,
autonomous determining a true meridian of the mobile object in accordance with the
said true heading of the mobile object.
‫ תל אביב‬,‫מיכאל נאומוב‬
‫ אביב‬-‫ תל‬,‫גאורגי נאומוב‬
,‫מיכאל נאומוב‬
2 ‫חצור‬
‫תל אביב‬
__________________
]00[]00[
]34[
SIDE-PORTED FILAMENT
WOUND PRESSURE VESSELS
]00[
]30[
]30[
]10[
07.04.2006
60/670362
]30[ 11.04.2005
Int. Cl.(2010.01) B32B 37//14, 37//20
BEKAERT PROGRESSIVE
COMPOSITES, LLC, U.S.A.
318
186466
‫מיכלי לחץ מליפופי סיבים עם פתח צדדי‬
]33[
US
December 30, 2010-‫כג' בטבת התשע"א‬
]10[
]71[
]14[
]31[
TERRY E. GILBERTSON, LINDA S.
GILBERTSON, RICARDO R.
TORRES
WO/2006/110754
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
A method of making a cylindrical pressure vessel (11) with a large diameter port in its
sidewall includes the step of providing a mandrel (23) of desired diameter and filament
winding upon the same. After winding one overall innermost layer, an annular
reinforcement belt (16) is helically wound atop a defined region using a band (60) of
resin impregnated parallel strands (39) under tension. The annular belt (16) is then
itself helically overwound with the resin impregnated parallel strands of filamentary
material under tension to provide two complete outer layers. After curing and removal
from the mandrel (23) at least one aperture (71) is cut in the sidewall within the
reinforcement belt (16) and a side port fitting (75) is installed in the aperture (71).
__________________
]00[]00[
]34[
USE OF DISACCHARIDE-BASED
COMPOUNDS FOR THE
MANUFACTURE OF
MEDICAMENTS WITHOUT AN
EXOGENOUS ANTIGEN FOR
PROPHYLACTIC AND
THERAPEUTIC TREATMENT OF
INFECTIOUS AND OTHER
DISEASES
]00[
]30[
18.05.2001
60/205820
319
]30[
19.05.2000
186495
‫שימוש בתרכובות המבוססות על דו–סוכרים‬
‫להכנת תרופות ללא אנטיגן ממקור חיצוני‬
‫למניעה וטיפול רפואי של זיהומים ומחלות‬
‫אחרות‬
]33[
US
December 30, 2010-‫כג' בטבת התשע"א‬
]30[
]60[
]10[
]71[
]14[
]31[
620070361
2402400220
US
Int. Cl.(2010.01) A61K 31//7024, A61P 01//02, 01//04, 01//16, 11//00, 11//02, 11//06,
17//00, 17//06, 19//02, 25//28, 29//00, 31//00, 31//04, 31//12, 31//18, 33//02, 37//00,
37//04, 37//08, C07H 05//06, 11//00, 13//04, 13//06
DIVISION FROM 152935
CORIXA CORPORATION, U.S.A.
WO/2001/090129
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
Methods and compositions for treating or ameliorating diseases and other conditions,
such as infectious diseases, autoimmune diseases and allergies are provided. The
methods employ mono- and disaccharide-based compounds for selectively stimulating
immune responses in animals and plants.
__________________
]00[]00[
]34[
PACKAGE FOR GOODS
]00[
]30[
]30[
]10[
]71[
]14[
11.05.2006
05010449.6
]30[ 13.05.2005
Int. Cl.(2010.01) B65D 75//36, 77//04
NOVARTIS AG, SWITZERLAND
WO/2006/119992
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]31[
320
186776
‫אריזה לטובין‬
]33[
EP
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
A package comprises an outer package (2) having two members (20, 21) connected to
one another via a flexible web portion (22). Each member (20, 21) comprises a base
panel (200, 210) and two opposite side wall panels (201, 202, 211, 212). One of the
December 30, 2010-‫כג' בטבת התשע"א‬
side wall panels (201, 211 ) has an attachment (204, 214) portion extending towards
the opposite side wall panel (202, 212). An inner package comprises blister pack
members (3) comprising an edge portion (304, 314) attached to the attachment portion
(204,214) of the outer package member (20, 21 ) such, that in a closed state the goods
carried by the blister pack member are facing towards the base panel (200,210). The
members (20,21) are folded towards each other via the flexible web portion (22). In an
open state the outer package members (20, 21 ) are unfolded and the members (3) can
be accessed by folding the blister pack member (30, 31 ) away from the opposite side
(202, 212) wall panel.
__________________
]00[]00[
]34[
SYSTEM AND METHOD FOR
PRODUCING AN AUGMENTED
IMAGE OF AN ORGAN OF A
PATIENT
]00[
]30[
]30[
]10[
]71[
]14[
20.04.2006
60/673257
]30[ 20.04.2005
Int. Cl.(2010.01) G06K 09//00
VISIONSENSE LTD.
WO/2006/111965
BOROCHOV, KORAKH & CO.,
15TH FLOOR, ATIDIM TOWER,
KIRYAT ATIDIM,
P.O.B. 58100,
TEL AVIV 61580
]31[
321
186794
‫מערכת ושיטה ליצירת תמונה מוגברת של איבר‬
‫של מטופל‬
]33[
US
‫ פתח תקוה‬,‫ויז'נסנס בע"מ‬
,'‫בורוכוב קורח ושות‬
‫מגדל כלל עתידים‬
‫אביב‬-‫תל‬51100 .‫ד‬.‫ ת‬,
System for displaying an augmented image of an organ of a patient, including an
image fusion processor coupled with a stereoscopic image detector, a tomographic
image processor, and with a display, the tomographic image processor being further
coupled with a tomographic image detector, the stereoscopic image detector producing
a pair of stereoscopic images respective of an exposed region of the organ, the
December 30, 2010-‫כג' בטבת התשע"א‬
tomographic image detector acquiring at least one two dimensional image of a
concealed region of the organ, the concealed region being concealed from the view of
the stereoscopic image detector, the tomographic image processor producing at least
one tomographic image representation of the concealed region, according to an output
of the tomographic image detector, the image fusion processor registering the pair of
stereoscopic images with the tomographic image representation, the image fusion
processor producing the augmented image, by superimposing the tomographic image
representation on the pair of stereoscopic images, the display displaying the augmented
image.
__________________
]00[]00[
]34[
ELECTROMECHANICAL LOCK
DEVICE
]00[
]30[
]30[
]10[
]71[
]14[
27.04.2006
0500975-8
]30[ 29.04.2005
Int. Cl.(2010.01) E05B 47//06
ASSA AB, SWEDEN
WO/2006/118519
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]31[
322
186920
‫התקן נעילה אלקטרו מכני‬
]33[
SE
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
A lock device comprises a housing (2) which includes an opening (4) and a core (10)
which is rotatably disposed in the opening. A latching element (20) co-acts between
the housing and the core and can be moved between a release position in which the
core is rotatable relative to the housing, and a latching position in which rotation of the
core relative to the housing is blocked. An electronically controllable actuator (30) is
disposed in the core and is moveable between an opening-registering-position in which
the latching element is movable to the release position, and a latching position in
December 30, 2010-‫כג' בטבת התשע"א‬
which movement of the latching element to said release position is blocked. A
returning means (50) co-acts mechanically with a key in a key way in the core and
with the actuator and such as to move the actuator away from the position of the
opening to a further latching position in response to the key being drawn out of the
keyway. Movement of the latching element to said release position is blocked by the
actuator in this further latching position. Because the returning means is rotatable there
is obtained a small latching mechanism that is returned mechanically to a latching
position upon removal of the key.
__________________
]00[]00[
]34[
DENTAL PROSTHESIS AND ITS
MANUFACTURING METHOD
]00[
]30[
10.02.2006
10-2005]30[ 10.06.2005
0049604
02-02232302100223
2230073
02-02230002100223
2260603
02-02230400000223
2000710
02-02262602000226
2220342
Int. Cl.(2010.01) A61C 13//08
OH-DAL KWON, REPUBLIC OF
KOREA
WO/2006/132464
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]30[
]10[
]71[
]14[
323
187823
‫תותב דנטלי ושיטת ייצורו‬
]33[
KR
KR
KR
KR
KR
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
December 30, 2010-‫כג' בטבת התשע"א‬
]31[
Disclosed herein are a dental prosthesis and its manufacturing method for restoring a
lost tooth. The dental prosthesis has a male member formed on a holding part attached
on an adjacent tooth for attaching an artificial tooth on the adjacent tooth and a female
member formed in the artificial tooth so that the artificial tooth and the adjacent tooth
can be connected with each other without grinding the adjacent tooth. The method for
manufacturing the dental prosthesis includes the steps of duplicating an original model,
waxing up the duplicated model, holding a sprue on the duplicated model in a state
where the duplicated model is waxed up, and investing, burning out and casting the
duplicating model.
__________________
]00[]00[
]34[
METHOD FOR DETERMINING
LINEAR ACCELERATION AND
DEVICE FOR ITS
IMPLEMENTATION
]00[
]30[
]10[
06.12.2007
Int. Cl.(2010.01) G01P 15//00
MICHAEL NAUMOV
GEORGE NAUMOV
]14[
]31[
187933
‫שיטה לקביעת תאוצה קווית ומכשיר ליישומ‬
‫השיטה‬
‫ אביב‬-‫ תל‬,‫מיכאל נאומוב‬
‫ אביב‬-‫ תל‬,‫גאורגי נאומוב‬
MICHAEL NAUMOV,
,‫מיכאל נאומוב‬
HAZOR 3
2 ‫חצור‬
TEL AVIV 69016
‫ אביב‬-‫תל‬
A method for determining linear acceleration comprising, along each axis chosen, in
particular, horizontal axis the following stages:
determining axial acceleration representing the sum of axial linear acceleration and
axial differential centrifugal acceleration,
determining axial differential centrifugal acceleration,
determining axial linear acceleration by the difference of said axial acceleration and
said axial differential centrifugal acceleration.
__________________
324
December 30, 2010-‫כג' בטבת התשע"א‬
]00[]00[
]34[
LIQUID DRUG TRANSFER
DEVICES FOR FAILSAFE
CORRECT SNAP FITTING ONTO
MEDICINAL VIALS
]00[
]30[
]30[
]10[
08.08.2006
60/707183
]30[ 11.08.2005
Int. Cl.(2010.01) A61J 01//00
MEDIMOP MEDICAL PROJECTS
LTD.
WO/2007/017868
MEDIMOP MEDICAL PROJECTS
LTD.,
17 HATIDHAR STREET
P.O.B. 2499
RA'ANANA
]71[
]14[
]31[
188974
‫התקנים להעברת תרופות נוזליות המיועדים‬
‫להתקנה נכונה מובטחת על מיכלים לתרופות‬
]33[
US
‫ רעננה‬,‫מדימופ פרויקטים רפואיים בע"מ‬
,‫מדימופ פרוייקטים רפואיים בע"מ‬
11 ‫רח' התדהר‬
‫רעננה‬5466 .‫ד‬.‫ ת‬,
Liquid drug transfer devices including a vial adapter designed for failsafe correct snap
fitting on a medicinal vial for ensuring flow communication with the vial's interior.
The vial adapters include at least two non-adjacent vial retention flex members for
snap fitting over a vial opening for vial retention purposes and at least two nonadjacent vial guidance flex members longer than their counterpart vial retention flex
members for guiding a vial adapter with respect to a vial prior to snap fittnig the vial
adapter thereon.
__________________
]00[]00[
]34[
325
METHOD OF VIRAL
INACTIVATION BY DRY
192194
‫שיטה לאינאקטיבציה של וירוסים על ידי חימום‬
‫יבש‬
December 30, 2010-‫כג' בטבת התשע"א‬
HEATING
]00[
]30[
]30[
]10[
]71[
]14[
]31[
19.12.2006
0512875
]30[ 19.12.2005
Int. Cl.(2010.01) A61L 02//04
LABORATOIRE FRANCAIS DU
FRACTIONNEMENT ET DES
BIOTECHNOLOGIES SOCIETE
ANONYME, FRANCE
WO/2007/071845
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]33[
FR
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The invention concerns a method of viral inactivation by dry heating of a virus present
or potentially present in a biological product that has been dried according to the glass
transition temperature. In a first step, the glass transition temperature of the dried
product is determined. In a second step, the product is heated to a temperature not less
than the determined glass transition temperature.
__________________
]00[]00[
]34[
HARNESS FOR STRETCHING
THE PENIS
]00[
]30[
]30[
]10[
]71[
]14[
18.01.2007
P-2006/0030
]30[ 19.01.2006
Int. Cl.(2010.01) A61F 05//41
MIODRAG CVETANOVIC, SERBIA
WO/2007/084022
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]31[
326
192718
‫ריתמה למתיחת הפין‬
]33[
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
A harness for generating an elongation of the penis comprises a belt (1), adapted to be
worn around one's waist, connected at the rear portion via small rotating snap-hooks
with two inextensible cinching straps (8,15), said straps each having a pair of half rings (9,16) for length adjustment. One said strap (8) on lower end carrying adjustable
rope loop (13) to be placed around penis base. Second said strap (15) on lower end is
connected via L- shaped connecting member (17) with flexible adjustable loop (19)
December 30, 2010-‫כג' בטבת התשע"א‬
being encircled and tightened around penis next to the penis head. Penis stretching
force is easily and quickly managed by tightening or loosening said straps, even while
walking and even over the clothing.
__________________
]00[]00[
193592
‫רצועה מורכבת הניתנת לליפוף ליצירת צינור‬
‫לולייני ושיטה ליצורו‬
]34[
COMPOSITE STRIP WINDABLE
TO FORM A HELICAL PIPE AND
METHOD THEREFOR
]00[
]30[
]30[
]60[
]10[
17.04.2003
PS 1824
]30[ 22.04.2002
]33[ AU
Int. Cl.(2010.01) B29C 53//58, 53//78, F16L 09//16, 55//165
DIVISION FROM 164686
RIB LOC AUSTRALIA PTY
LIMITED, AUSTRALIA
WO/2003/089226
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]71[
]14[
]31[
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
A helically wound composite pipe produced from a composite strip, the composite
strip comprising:
an elongate plastic strip having a base portion that forms the inside of the wound pipe
and a lengthwise extending rib portion upstanding from the base portion;
an elongate reinforcing strip extending adjacent to or integral with the rib portion; and
an elongate planar lamina extending lengthwise and bonded to the base portion, the
lamina having a higher Young's modulus and strength than those of the plastic strip.
__________________
]00[]00[
]34[
327
ANTIBODIES THAT BIND TO
LDCAM SEQUENCES
193886
LDCAM ‫נוגדנים הנקשרים לרצפי‬
December 30, 2010-‫כג' בטבת התשע"א‬
]00[
]30[
]30[
]60[
]10[
]71[
]14[
]31[
05.08.1999
60/095672
]30[ 07.08.1998
Int. Cl.(2010.01) C07K 16//18
DIVISION FROM 140937
IMMUNEX CORPORATION, U.S.A.
WO/2000/008158
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
An isolated antibody that specifically binds to a sequence selected from SEQ ID NO:2
and SEQ ID NO:4
__________________
]00[]00[
200255
‫שיטה להכנה של או–דסמתיל–ונלפקסין‬
]34[
METHOD OF PREPARING ODESMETHYL-VENLAFAXINE
]00[
]30[
11.02.2002
60/268214
]30[ 12.02.2001
]33[ US
620001063
0302600220
US
Int. Cl.(2010.01) C07C 21/5/64, 55//00
DIVISION FROM 157340
WYETH LLC, U.S.A.
WO/2002/064543
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
1 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬15111 .‫ד‬.‫ ת‬,
HERZLIYA 46733
A method of preparing O-desmethyl venlafaxine comprising the step of demethylating
venlafaxine or a salt thereof with an alkali metal salt of a trialkyl borohydride.
]30[
]60[
]10[
]71[
]14[
]31[
The applications for division
from this application have
not yet been published
0140000
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]00[]00[
328
202877
December 30, 2010-‫כג' בטבת התשע"א‬
‫מאיץ למחמם מיים אופקי‬
]34[
ACCELERATOR FOR
HORIZONTAL WATER
HEATERS
]00[
]30[
]10[
]14[
22.12.2009
Int. Cl.(2010.01) F16H 01//10, F24H 01//20
RONI GINOSSAR
RONI GINOSSAR,
87 HEY BE'IYAR ST.,
ROSH HAAYIN 48056
]31[
‫ ראש העין‬,‫רוני גינוסר‬
,‫רוני גינוסר‬
11 ‫ה' באייר‬
‫ראש העין‬
Water heating means to be installed in a horizontal domestic tank, comprising:
an electric heating element;
an accelerating envelope comprising a plastic sleeve and a rubber unit which in turn
comprise of a flexible rubber holder, rubber sealer and a flexible downward extending
rubber spout;
wherein the outer of said accelerating envelope reach the upper space of the tank and
the inlet of said extending spout ends at the lower space of the tank, in a way that said
heating means can be installed in the center of one of the side walls of horizontally
positioned existing water tank, accelerating hot water via the outlet of the tank.
‫ לתקנות‬1/ ‫פירוט זה נבחן בהתאם לתקנה‬
/0/1 – ‫ תשכ"ח‬0‫הפטנטים‬
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
__________________
]00[]00[
205173
]34[
FAN BLADE
]00[
]30[
]30[
]60[
]10[
28.01.2005
60/589945
]30[ 21.07.2004
]33[
Int. Cl.(2010.01) F01D 01//02, F04D 29//38
DIVISION FROM 180822
DELTA T CORPORATION, U.S.A.
329
‫להב מניפה‬
US
December 30, 2010-‫כג' בטבת התשע"א‬
]71[
]14[
]31[
WO/2006/022812
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
A fan blade configured to mount to a rotating fan hub, the fan blade comprising:
(a) a top surface having a generally elliptical curvature, wherein the curvature of the
top surface is based on a first ellipse;
(b) a bottom surface having a generally elliptical curvature, wherein the curvature of the
bottom surface is based on a second ellipse;
(c) a leading edge, wherein the top surface and bottom surface each terminate at the leading
edge; and
(d) a trailing edge, wherein the top surface and bottom surface each terminate at the trailing edge.
The parent application from which
this application has been divided has
not yet been published
/14111
‫בקשת הורה לבקשה זו שטרם פורסמה‬
__________________
330
December 30, 2010-‫כג' בטבת התשע"א‬
‫פטנטים‬
PATENTS
‫פטנטים שחודשו‬
PATENTS RENEWED
020322
024200
000130
000000
000632
004636
004730
003223
032307
042030
042300
040407
040373
040000
032010
032623
033002
062723
060637
063401
061071
060012
010320
014007
011227
076217
020134
024004
000103
000000
000630
004641
004021
003204
031434
042340
042300
044033
040100
032213
032043
032110
036001
060203
060630
063337
061000
060166
010143
014100
017233
077123
023002
024020
000700
000043
000101
004663
004020
003241
037037
042330
042336
044131
040104
032213
032330
032071
036036
060200
063031
063373
061431
060717
010333
014101
017030
000300
023031
024003
000737
000063
000442
004133
004003
003260
037003
042330
042302
044164
040147
032270
032330
030403
031240
060611
063470
063637
061066
012230
013032
013210
017361
023040
024032
000743
000406
000400
004113
004076
003000
037330
042403
042300
044733
040742
032001
032310
030373
031003
060032
063403
066221
067363
012030
013343
013337
017636
023071
024063
000776
000463
004340
004707
004003
003010
030700
042400
042602
046710
040701
032004
032420
033261
031063
060323
064234
066200
067107
012001
013440
016220
010124
023007
004017
000707
000363
004300
004733
004006
003004
042010
042430
042663
046007
040073
032007
032430
034344
037001
060333
064004
066001
067722
012363
013332
016233
070100
024267
007462
000026
000603
004336
004737
003223
003066
042073
042321
040032
040403
040070
032060
032303
034637
030301
060310
063444
061214
067010
012730
014236
016300
070070
‫פטנטים שחודשו לעשרים שנה‬
PATENTS RENEWED FOR 20 YEARS
043621
043600
043600
043603
043600
034300
010263
‫צווי הארכה שחודשו‬
EXTENSION ORDERS RENEWED
331
December 30, 2010-‫כג' בטבת התשע"א‬
‫הודעה‬
NOTICE
‫ לחוק‬10 ‫לפי סעיף‬
1611-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
///11/
//1440
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
‫לומוס בע"מ‬
LUMUS LTD.
:‫שם האמצאה‬
‫התקן אופטי במיוחד עבור יישומים של צפייה מרחוק‬
OPTICAL DEVICES PARTICULARLY FOR REMOTE VIEWING APPLICATIONS
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
65 ‫ לחוק ובתקנה‬11 ‫בסעיף‬
the law and by regulation 92
-‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
5728-1968
1611
Title of invention:
332
December 30, 2010-‫כג' בטבת התשע"א‬
‫שינויים בפרטים רשומים בפנקס‬
CHANGES IN PARTICULARS ENTERED IN REGISTER
333
December 30, 2010-‫כג' בטבת התשע"א‬
‫תיקונים ביומן‬
Gournal Corrections
Patent application No
No. of Patent:
/001//
/14/4
'‫בקשת פטנט מס‬
:‫מספר יומן בו נפלה טעות‬
‫הוספת תקציר‬
‫להלן התקציר‬
ABRIDGEMENT
ABRIDGEMENT IS AS FOLLOWS
A tissue expansion device is composed of a hollow expanding pouch (5) made
of resorbable material that can be attached to a cannula (6). The pouch (5) can
be filled with biocompatible materials, one or more times in a few days interval,
after the insertion of the device. While filling the pouch (5) every few days, the
tissue expands and the filling material, if it is bioactive, starts to function. The
cannula (6) is connected to the pouch (5) in one side and in the other side it can
be filled and closed with a screw (7). There are three fixation components. One
fixating components is slot (8) and the other two are holes (9) for sutures.
Patent application No
No. of Patent:
DELETE THE APPLICATION
THE APPLICATION WAS
PUBLISHED BY MISTAKE
334
//1/0/
114/4
'‫בקשת פטנט מס‬
:‫מספר יומן בו נפלה טעות‬
‫מחק את הבקשה‬
‫הבקשה פורסמה בטעות‬
December 30, 2010-‫כג' בטבת התשע"א‬
‫מדגמים‬
DESIGNS
‫מדגמים שנרשמו‬
DESIGNS REGISTERED
Class
41300
0)23o
2602400220
‫סוג פרסום‬
‫מאי שיווק‬
‫מגש למזון‬
MAY MARKETING
Food tray
Class
40300 ,41740
03)23o
0302600220
KETER PLASTIC LTD.
Storage
Convention date (OHIM)
Class
0300000227
41702 ,41770 ,41777
41703 ,41700 ,41700
41706 ,41703 ,41704
41700 ,41707 ,41701
41020 ,41020
03)20o
0702600220
‫סוג פרסום‬
‫כתר פלסטיק בע"מ‬
‫מחסן‬
)‫תאריך האמנה (איחוד אירופי‬
‫סוג פרסום‬
‫אקסטל בע"מ‬
‫פרופיל‬
EXTAL LTD.
Profile
Class
335
47062
7)20o
2002700220
‫סוג פרסום‬
December 30, 2010-‫כג' בטבת התשע"א‬
‫אקסטל בע"מ‬
‫מעצור‬
‫כג' בטבת התשע"א‪December 30, 2010-‬‬
‫‪EXTAL LTD.‬‬
‫‪Stopper‬‬
‫‪336‬‬
Class
47060
7)20o
2002700220
‫סוג פרסום‬
‫אקסטל בע"מ‬
‫סגר‬
EXTAL LTD.
Lock
Class
47010
03)20o
2002000220
‫סוג פרסום‬
‫אקסטל בע"מ‬
‫אביזר פינה לחלון‬
EXTAL LTD.
Window leaf corner
Class
47330
00)20o
0302000220
‫סוג פרסום‬
‫ דלומי בע"מ‬.‫יהלומי א‬
‫אבן חן‬
A. DALUMI DIAMONDS LTD.
Gemstone
Class
47320
0)23o
2300000220
‫סוג פרסום‬
‫ייצור מוצרי אריזה‬-1660 .‫א‬.‫מ‬.‫י‬
I.M.A.1990 -ITZUR MUTZAREI
ARIZA
‫מגש‬
Try
Class
VALENTINA FERNANDEZ
Jewel
337
47636
00)20o
2000000220
‫סוג פרסום‬
‫ואלנטינה פרנדז‬
‫תכשיט‬
December 30, 2010-‫כג' בטבת התשע"א‬
‫כג' בטבת התשע"א‪December 30, 2010-‬‬
‫‪338‬‬
Class
47003 ,47004 ,47003
47007 ,47001 ,47006
47030 ,47032 ,47000
47034 ,47033 ,47030
47036 ,47033
0)24o
0602000202
‫סוג פרסום‬
GRENDENE S/A
‫נעל‬
Shoe
Class
47016
6)24o
2302000202
‫סוג פרסום‬
‫כתר פלסטיק בע"מ‬
‫ארון‬
KETER PLASTIC LTD.
Cabinet
Class
40031
3)20o
0302600220
‫סוג פרסום‬
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Pill dispenser
Convention date (OHIM)
Class
EXTAL LTD.
Profile
339
0300000227
40043 ,40040 ,40040
40046 ,40043 ,40044
40040 ,40047 ,40041
40032
03)20o
2102400202
‫מושיט גלולות‬
)‫תאריך האמנה (איחוד אירופי‬
‫סוג פרסום‬
‫אקסטל בע"מ‬
‫פרופיל‬
December 30, 2010-‫כג' בטבת התשע"א‬
‫סוג פרסום‬
‫וויש און ליין הולדינגס בע"מ‬
‫תיק‬
‫כג' בטבת התשע"א‪December 30, 2010-‬‬
‫‪40431‬‬
‫‪3)20o‬‬
‫‪0002300202‬‬
‫‪Class‬‬
‫‪WISH ON LINE HOLDINGS LTD.‬‬
‫‪Bag‬‬
‫‪340‬‬
Class
40322
03)23o
0302300202
‫סוג פרסום‬
‫חנן ברודזקי‬
‫מחבר‬
HANAN BRODZKY
Connector
40123 ,40120 ,40120
40126 ,40123 ,40124
40100 ,40120 ,40121
Class
03)20o
0702600202
‫סוג פרסום‬
‫אקסטל בע"מ‬
‫פרופיל‬
EXTAL LTD.
Profile
Class
40107 ,40101
00)20o
0002600202
‫סוג פרסום‬
‫עמי מוצרי נוי בע"מ‬
‫חפץ קישוטי‬
AMY-ART WORK LTD.
Decorative object
Class
40720
7)23o
0302100202
‫סוג פרסום‬
THE OTIS PATENT TRUST
Rail inspection tool
Convention date (U.S.A.)
Class
341
0302000202
40742 ,40731 ,40733
40743 ,40740 ,40740
40746 ,40744
0)24o
‫מכשיר לבדיקת מסילות‬
)‫תאריך האמנה (ארצות הברית‬
‫סוג פרסום‬
December 30, 2010-‫כג' בטבת התשע"א‬
‫‪0302100202‬‬
‫קפלה בע"מ‬
‫ג'וני יוני יונתן אלבז‬
‫נעל‬
‫כג' בטבת התשע"א‪December 30, 2010-‬‬
‫‪CAPLA LTD.‬‬
‫‪JHONY ELBAZ‬‬
‫‪Footwear‬‬
‫‪342‬‬
‫מדגמים שבוטלו‬
DESIGNS VOID
03307
03300
Dr. Meir Noam
Commissioner of Patents,
Designs and Trade Marks
343
33643
33647
33632
33667
‫ד"ר מאיר נועם‬
‫ המדגמים‬,‫רשם הפטנטים‬
‫וסימני מסחר‬
December 30, 2010-‫כג' בטבת התשע"א‬
‫מפתחות לבקשות שקובלו‬
‫‪INDICES OF APPLICATIONS ACCEPTED‬‬
‫מפתח שמי‬
‫‪NAME INDEX‬‬
‫אברהם אלואיל ‪111111 -‬‬
‫אודיוקודס בע"מ ‪115112 -‬‬
‫איפורטנט בע"מ ‪111155 -‬‬
‫אלונים אחזקות אגש"ח בע"מ ‪111415 -‬‬
‫אנג'לייט בע"מ ‪115120 -‬‬
‫אפרים מולק ‪115055 -‬‬
‫אקסיד אימג'ינג בע"מ ‪111152 -‬‬
‫אר אנד דרם בע"מ ‪145151 -‬‬
‫מדידרמיס בע"מ ‪145151 -‬‬
‫מדימופ פרויקטים רפואיים בע"מ ‪111614 -‬‬
‫מוסד הטכניון למחקר ופתוח בע"מ ‪-‬‬
‫‪115515 , 115611‬‬
‫מיכאל נאומוב ‪111011 -‬‬
‫מיכאל נאומוב ‪111622 -‬‬
‫מיקרוסמי קורפ ‪ -‬אנאלוג מיקסד סינגל‬
‫גרופ בע"מ ‪114116 -‬‬
‫משה גבאי ‪116140 -‬‬
‫ביומס בע"מ ‪141164 -‬‬
‫נטפים בע"מ ‪112114 -‬‬
‫גאורגי נאומוב ‪111622 , 111011 -‬‬
‫גיוון אימג'ינג בע"מ ‪, 111155 , 111112 -‬‬
‫‪110511‬‬
‫ספיידר טכנולוגיות סקיוריטי בע"מ ‪110145 -‬‬
‫סרקונט בע"מ ‪111160 -‬‬
‫ענת גבאי ‪116140 -‬‬
‫התעשייה האוירית לישראל בע"מ ‪115561 -‬‬
‫ויז'נסנס בע"מ ‪111164 -‬‬
‫ולדימיר גרצנוב ‪111122 -‬‬
‫ולדימיר פוגדייב ‪114541 -‬‬
‫חכם ריבה ‪152146 -‬‬
‫חנוך פרבר ‪151412 -‬‬
‫ידע חברה למחקר ופיתוח בע"מ ‪111112 -‬‬
‫יהודה יעבץ‪-‬חן ‪151412 -‬‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים בע"מ ‪-‬‬
‫‪110211‬‬
‫צבי לוי ‪114106 -‬‬
‫צדוק לוי ‪115055 -‬‬
‫קוראסיסט קרדיווסקולר בע"מ ‪154141 -‬‬
‫קמהדע בע"מ פארק המדע ‪114410 -‬‬
‫קרן מחקרים ופיתוח תשתיות שליד המרכז‬
‫הרפואי תל אביב ע"ש סוראסקי ‪110211 -‬‬
‫רב בריח מוצרי בטחון בע"מ ‪152151 -‬‬
‫רוני גינוסר ‪505111 -‬‬
‫ריט טכנולוגיות בע"מ ‪151502 -‬‬
‫ריינהולד כהן ושותפיו ‪114540 -‬‬
‫רפאל מערכות לחימה מתקדמות בע"מ ‪-‬‬
‫‪115155 , 110515‬‬
‫כצט תעשיות כימיות בע"מ ‪115142 -‬‬
‫ליתוטק מדיקל בע"מ ‪116216 -‬‬
‫כג' בטבת התשע"א‪December 30, 2010-‬‬
‫שוניה רוזנטל ‪152146 -‬‬
‫שלום משעלי ‪115511 -‬‬
‫שמואל כהן ‪110011 -‬‬
‫‪344‬‬
A. ALLWEIL - ///1//
AAR CORP. - 175564
AEOLUS SCIENCES, INC. - 183953
AGENSYS, INC. - 149046
AIR PRODUCTS AND CHEMICALS,
INC. - 150315
ALONIM HOLDINGS AGRICULTURAL
COOPERATIVE SOCIETY LTD - 177412
ANATTE GABBAI - 179840
ANGELIGHT LTD - 185630
ANGKOR TECHNOLOGY, LLP - 159700
APPLIED RESEARCH SYSTEMS ARS
HOLDING N.V. - 154775
ARCHER-DANIELS-MIDLAND
COMPANY - 171704
ARM LIMITED - 177507
ARQULE, INC. - 164240
ASSA AB - 186920
AUDIOCODES LTD. - 175783
Aventis Pharma S.A - 182383
AVENTIS PHARMA S.A. - 177535
AZIENDE CHIMICHE RIUNITE
ANGELINI FRANCESCO A.C.R.A.F.
S.p.A. - 176280
BASF SE - 175713
BAYER AKTIENGESELLSCHAFT 181468
BAYER SCHERING PHARMA AG 160445
BEKAERT PROGRESSIVE
COMPOSITES, LLC - 186466
BIOINCEPT, INC. - 159671
BIOMAS LTD. - 146694
BIOMOLECULAR PRODUCTS, INC. 161178
BIOSAFE ENGINEERING, LLC - 167649
BIOSENSE WEBSTER INC. - 144272
BRITA GMBH - 182451 , 182481
BYUNG-DUK LIM - 181643
CHAKSHU RESEARCH INC. - 169287
CHANOCH FARBER - 157483
COMMONWEALTH SCIENTIFIC AND
345
INDUSTRIAL RESEARCH
ORGANISATION - 174899
CORASSIST CARDIOVASCULAR LTD 154141
CORIXA CORPORATION - 186495
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH - 176542
CTS CHEMICAL INDUSTRIES LTD. 165843
CYTIMMUNE SCIENCES, INC. - 184282
DAIICHI SANKYO COMPANY,
LIMITED - 155976
DANIEL B. BORTNICK - 159700
DEGREMONT - 175707
DELTA T CORPORATION - 205173
DIGESTOR, LLC - 167649
DOMPE PHA.R.MA S.P.A. - 177169 ,
180233
DOW AGROSCIENCES LLC - 171093
DOW AGROSCIENCES LLC - 173445
DSM IP ASSETS B.V. - 176417
DTVG LICENSING, INC. - 173491
DUKE UNIVERSITY - 183953
DUPONT PHARMACEUTICALS
COMPANY - 150163
EFRAIM MOLEK - 162022
EISAI CO. LTD. - 175933
EISAI CO., LTD. - 158491
EISAI R&D MANAGEMENT CO., LTD. 158491 , 175933
ELI LILLY AND COMPANY - 171926
ENCYSIVE PHARMACEUTICALS INC. 146313
F. HOFFMANN-LA ROCHE AG - 171769
F. HOFFMANN-LA ROCHE AG - 171930
FIBROGEN, INC. - 183083
FIRMENICH SA - 175984
FOOD MACHINERY ESPANOLA S.A. 181542
FORT JAMES CORPORATION - 177760
FRAUNHOFER-GESELLSCHAFT ZUR
December 30, 2010-‫כג' בטבת התשע"א‬
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V. - 174286 , 178513 ,
179318
FUJIKIN INCORPORATED - 179335
FUMAPHARM AG - 171987
GENENTECH, INC. - 142269
GENERAL ELECTRIC COMPANY 179940
GEORGE NAUMOV - 186077 , 187933
GERON CORPORATION - 162131
GEWISS S.P.A. - 177567
GFK TELECONTROL AG - 173928
GILEAD PALO ALTO, INC. - 163613 ,
164388
GIVEN IMAGING LTD. - 166113 , 167755
, 180261
GREGORY TUROCY - 159700
H.C. STARCK GMBH - 182866
HANMI PHARM. CO. LTD. - 180893
HARRIS CORPORATION - 169947
HIMANSHU S. AMIN - 159700
HINDUSTAN LEVER LIMITED - 176542
HONEYWELL INTERNATIONAL INC. 184369
IBM CORPORATION - 167738 , 178482
IMMUNEX CORPORATION - 193886
IMMUNOMEDICS, INC. - 169045
INDENA S.P.A. - 172773
INOTEK PHARMACEUTICALS
CORPORATION - 179400
INTELLIGENT COFFEE COMPANY.
L.L.C. - 177461
INTERDIGITAL TECHNOLOGY
CORPORATION - 173834 , 177800 ,
178301 , 179094 , 179440
INTERNATIONAL BUSINESS
MACHINES CORPORATION - 152595
INTERNATIONAL GEMSTONE
REGISTRY INC. - 185578
INTEVAC, INC. - 174680
IPORTENT LTD. - 177855
ISRAEL AEROSPACE INDUSTRIES
LTD. - 172591
346
KAMADA LTD. - 174410
KAMALUDDIN ABDUR-RASHID 164915
KAO CORPORATION - 171704
KEE PLASTICS AB - 179464
KUNIHIDE TANAKA - 159480
LABORATOIRE FRANCAIS DU
FRACTIONNEMENT ET DES
BIOTECHNOLOGIES SOCIETE
ANONYME - 192194
LAFARGE PLATRES - 179895
LAICA S.P.A. - 175066
LAM RESEARCH CORPORATION 185743
LDR MEDICAL - 184068
LEK PHARMACEUTICALS D.D. 166191
LENTJES GMBH - 174035
LG ELECTRONICS INC. - 179959
LITHOTECH MEDICAL LTD. - 169319
LTS LOHMANN THERAPIE-SYSTEME
AG - 170045
LURGI LENTJES AG - 174035
MAIO S. CHEN - 142989
MARTIN E. SCHWAB - 142989
MCCROMETER, INC. - 181180
MEDIDERMIS LTD. - 145751
MEDIMOP MEDICAL PROJECTS LTD. 188974
MERCK SERONO S.A. - 154775 , 175171
MERCK SHARP & DOHME CORP. 163825
MESHALI SHALOM - 165566
MESSER ITALIA S.P.A - 175171
MICHAEL NAUMOV - 186077
MICHAEL NAUMOV - 187933
MICROSEMI CORP - ANALOG MIXED
SIGNAL GROUP LTD - 174879
MICROSOFT CORPORATION - 162694 ,
166473 , 169467 , 170115
MIODRAG CVETANOVIC - 192718
MITSUBISHI TANABE PHARMA
CORPORATION - 170468
MODESAT COMMUNICATIONS OU 178363
December 30, 2010-‫כג' בטבת התשע"א‬
MOSAID TECHNOLOGIES
INCORPORATED - 161190
MOSHE GABBAI - 179840
MYELOS CORPORATION - 147095
N.V. ORGANON - 182008
NATIONAL JEWISH MEDICAL AND
RESEARCH CENTER - 183953
NESTEC S.A. - 171302
NETAFIM LTD. - 173874
NICHOLAS V. PERRICONE - 169169
NIPPON CHEMIPHAR CO., LTD. 160304
NOVARTIS AG - 186776
NOVIMMUNE S.A. - 178478
NYCOMED GMBH - 168170 , 168307
OH-DAL KWON - 187823
ONCOLYTICS BIOTECH INC. - 163343
ORIGIN ENERGY SOLAR PTY.LTD. 162190
PALANTYR RESEARCH, LLC - 159700
PETER SCHMIDKONZ - 174157
QUALCOMM FLARION
TECHNOLOGIES, INC. - 178601 , 178605
QUALCOMM INCORPORATED - 165866
, 170642 , 181993
QUALCOMM INCORPORATED - 177311
QUALCOMM INCORPORATED - 178601
, 178605
QUILL MEDICAL, INC. - 160496
R&DERM LTD. - 145751
RADIANCY, INC. - 159376
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD. - 160265 , 165852
RAV BARIACH SECURITY PRODUCTS
LTD. - 153751
RAYTHEON COMPANY - 169448 ,
170679 , 175201 , 184486
REINHOLD COHN AND PARTNERS 164240
RESPONSE GENETICS, INC. - 170217
RIB LOC AUSTRALIA PTY LIMITED 193592
347
RIETER PERFOJET - 164472 , 174348
RIT TECHNOLOGIES LTD. - 157203
RIVA HAHAM - 153749
ROHM AND HAAS COMPANY - 182984
RONI GINOSSAR - 202877
SANOFI AVENTIS - 184175
SANOFI PASTEUR BIOLOGICS CO. 168584
SANOFI-AVENTIS - 170468 , 177088
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 165935 , 179757
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 172119
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 177257
SCHERING CORPORATION - 153308
SECURE64 SOFTWARE CORPORATION
- 170581
SELEX GALILEO LTD - 185831
SERCONET LTD. - 161190
SHMUEL COHEN - 170081
SHUNIA ROSENTAL - 153749
SILVERBROOK RESEARCH PTY.LTD. 178586
SOLVAY PHARMACEUTICALS B.V. 164240 , 173294
SPIDER TECHNOLOGIES SECURITY
LTD. - 180845
STICHTING INSTITUUT VOOR
DIERHOUDERIJ EN
DIERGEZONDHEID - 181468
SUMITOMO CHEMICAL COMPANY,
LIMITED. - 180189
SUTTER FINANZIARA S.P.A. - 173285
SYNGENTA LIMITED - 169096
TAKEDA PHARMACEUTICAL
COMPANY LIMITED - 177533
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD. 175987 , 185282
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL) - 182032
TEXAS BIOTECHNOLOGY
CORPORATION - 146313
THE DIRECTV GROUP, INC. - 173491
December 30, 2010-‫כג' בטבת התשע"א‬
THE MEDICAL RESEARCH,
INFRASTRUCTURE, AND HEALTH
SERVICES FUND OF THE TEL-AVIV
MEDICAL CENTER - 160376
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA - 171355
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA, - 162357
THE ROGOSIN INSTITUTE - 177967
TRANSDERMAL BIOTECHNOLOGY,
INC. - 169169
TRUSTEES OF BOSTON UNIVERSITY 179199
TZADOK LEVY - 162022
UAB RESEARCH FOUNDATION 161686
UNIVERSITAT ZURICH - 142989
VOMARIS INNOVATION, INC. - 177587
WASTE REDUCTION BY WASTE
REDUCTION, INC. - 167649
WISCONSIN ALUMNI RESEARCH
FOUNDATION - 167943
WOLVERINE TUBE, INC. - 186024
WYETH LLC - 200255
XCEED IMAGING LTD - 171853
YEDA RESEARCH AND
DEVELOPMENT CO. LTD. - 181183
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD. 160376
ZVI LEVI - 174109
VECTRONIX AG - 185261
VEHUDA YAVETS-CHEN - 157483
VISIONSENSE LTD. - 186794
VLADIMIR GERTSENOV - 177733
VLADIMIR POGADAEV - 174548
‫מפתח ענייני‬
SUBJECT MATTER INDEX
A21D - 171302
A47C - 179840
A47J - 157483, 182451, 182481
A61B - 144272, 159376, 160496,
166113, 167755, 169319,
180261
A61C - 187823
A61F - 153749, 169169, 183083,
184068, 192718
A61J - 188974
A61K - 145751, 146694, 160376,
161686, 164388, 165843,
168307, 169045, 169287,
348
170045,
172773,
181183,
183953,
A61K - 177967
A61L - 192194
A61M - 154141
A61N - 177587
A63B - 170081
171926, 171987,
177169, 178478,
181468, 182008,
184282
B01D - 174035
B01J - 175171
B05B - 173874, 174109
December 30, 2010-‫כג' בטבת התשע"א‬
B08B - 181542
B09B - 167649
B21B - 186024
B23K - 185578
B26D - 179895
B29C - 193592
B32B - 169448, 186466
B41J - 178586
B42C - 174157
B64D - 185831
B65D - 165566, 175564, 179464,
186776
B67D - 177461
C01B - 179335,
C01D - 176542
C02F - 175066,
C07B - 164915
C07C - 169096,
180189,
C07D - 146313,
155976,
163825,
166191,
171093,
173294,
175933,
182866,
C07H - 163613,
180893,
C07J - 154775
C07K - 142989,
162357,
174410,
C08B - 177535
C08K - 174899
C11C - 171704
C12M - 160445
C12N - 162131,
178513,
C12P - 142269,
C12Q - 163343,
C25D - 177412
C30B - 150315
D01F - 184369
D04H - 164472
349
182984
175707
175984,
200255
150163,
158491,
164240,
168170,
171769,
173445,
177088,
184175
179400,
186495
176280,
153308,
160304,
165935,
170468,
171930,
175713,
177533,
179757,
147095, 159671,
167943, 168584,
180233, 193886
171355, 175987,
179318
161178, 176417
177257
D06C - 174348
D21H - 177760
E05B - 153751
E05B - 162022, 186920
E21B - 181643
F04D - 205173
F21L - 185630
F24H - 202877
F25B - 174548
F41G - 175201
G01C - 185261,
G01F - 173285,
G01N - 149046,
179199,
G01P - 187933
G01R - 182032
G01S - 160265,
G02B - 159700
G03F - 180845
G06F - 162694,
170581,
G06K - 157203,
G06Q - 173928
G06T - 165852
G08B - 177733
G10L - 169947
186077
181180
170217, 172119,
182383
170679, 172591
167738, 169467,
177507
185282, 186794
H01J - 174680
H01L - 159480, 162190, 179940,
185743
H01R - 176867
H02H - 177567
H04B - 166473, 179959
H04L - 152595, 161190, 170115,
173491, 174879, 175783,
177855, 178363, 178482
H04N - 171853
H04S - 174286
H04W - 165866, 170642, 173834,
177311, 177800, 178301,
178601, 178605, 179094,
179440, 181993
H05B - 184486
December 30, 2010-‫כג' בטבת התשע"א‬
‫קודים למדינת המופיעים ביומן‬
COUNTRY CODES APPEARING IN THIS JOURNAL
Code
AR
AT
AU
BA
BE
BR
CA
CH
CN
CU
CZ
DE
DK
EC
EP
ES
FI
FR
GB
GE
GR
GT
HR
HU
IE
IL
IN
IT
JP
KR
LK
350
Country or Organization
Argentina
Austria
Australia
Herzegovina
Belgium
Brazil
Canada
Switzerland
China
Cuba
Czech Republic
Germany
Denmark
Ecuador
European Patent Office
Spain
Finland
France
United Kingdom
Georgia
Greece
Guatemala
Croatia
Hungary
Ireland
Israel
India
Italy
Japan
Republic of Korea
Sri Lanka
Code
MX
MY
NL
NO
NZ
PL
PT
RU
SE
SG
SI
SK
TH
TR
TW
UA
US
UY
UZ
WO
ZA
Country or Organization
Mexico
Malaysia
The Netherlands
Norway
New Zealand
Poland
Portugal
Russian Federation
Sweden
Singapore
Slovenia
Slovakia
Thailand
Turkey
Taiwan
Ukraine
United States of America
Uruguay
Uzbekistan
World Intellectual Property
Organization (W.I.P.O.)
South Africa
December 30, 2010-‫כג' בטבת התשע"א‬
LU
LV
Luxembourg
Latvia
‫ ירושלים‬,‫ משרד המשפטים‬,‫נערך ע"י רשות הפטנטים‬
EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM
351
December 30, 2010-‫כג' בטבת התשע"א‬